RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
|
|
| G
|
Abat
|
4-aminobutyrate aminotransferase
|
|
IDA
|
|
RGD |
PMID:10375453 |
RGD:1598516 |
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19458120 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Adnp
|
activity-dependent neuroprotector homeobox
|
|
IDA
|
|
RGD |
PMID:18414890 |
RGD:2312783 |
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18950269 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora3
|
adenosine A3 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7774659 |
|
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
|
IMP
|
|
RGD |
PMID:19084003 |
RGD:2313316 |
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Angpt2
|
angiopoietin 2
|
|
IDA
|
|
RGD |
PMID:19672036 |
RGD:2313934 |
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Anxa1
|
annexin A1
|
|
IEP
|
|
RGD |
PMID:17653046 |
RGD:2306896 |
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Arid1b
|
AT-rich interaction domain 1B
|
|
IDA IEP
|
mRNA,protein:increased expression:renal medulla, cortex of kidney
|
RGD |
PMID:14633620 PMID:14633620 |
RGD:1302474, RGD:1302474 |
NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793
|
|
| G
|
Atg5
|
autophagy related 5
|
|
IEP
|
|
RGD |
PMID:25435100 |
RGD:11561945 |
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821
|
|
| G
|
Avp
|
arginine vasopressin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:2139164 PMID:10440088 |
|
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15172883 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Becn1
|
beclin 1
|
|
IEP
|
|
RGD |
PMID:25435100 |
RGD:11561945 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
|
IMP
|
|
RGD |
PMID:21181115 |
RGD:5684019 |
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
ISO
|
|
RGD |
PMID:15308783 |
RGD:1581163 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cd68
|
Cd68 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19458120 |
|
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,880,563...54,882,540
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21912612 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Cp
|
ceruloplasmin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15668637 PMID:18091701 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Crhr2
|
corticotropin releasing hormone receptor 2
|
|
IDA
|
|
RGD |
PMID:19429103 |
RGD:5130953 |
NCBI chr 4:85,553,163...85,596,203
Ensembl chr 4:85,554,268...85,596,318
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
|
IDA
|
|
RGD |
PMID:18006432 |
RGD:4892022 |
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
ISO
|
mRNA:increased expression:lung
|
RGD |
PMID:16709871 |
RGD:5135441 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18227068 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcr3
|
C-X-C motif chemokine receptor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12517959 |
|
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:70,883,958...70,886,871
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15172883 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
ameliorates
|
IEP ISO
|
mRNA,protein:increased expression:skin,endothelial cells
|
RGD |
PMID:25834117 PMID:22252294 |
RGD:155663350, RGD:155663358 |
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Egr1
|
early growth response 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12468449 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
|
ISO
|
protein:increased expression:skeletal muscle
|
RGD |
PMID:17823371 |
RGD:2313719 |
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
|
IEP
|
protein:increased expression:urothelium:
|
RGD |
PMID:24728265 |
RGD:11568671 |
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gjb2
|
gap junction protein, beta 2
|
|
IEP
|
in urinary bladder; protein:increased expression:urothelium:
|
RGD |
PMID:24728265 |
RGD:11568671 |
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:35,375,692...35,393,877
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:15036356 PMID:19667931 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Htr1b
|
5-hydroxytryptamine receptor 1B
|
|
IEP
|
mRNA:increased expression:skeletal muscle
|
RGD |
PMID:12393100 |
RGD:1626445 |
NCBI chr 8:91,395,405...91,414,815
Ensembl chr 8:91,052,432...91,418,583
|
|
| G
|
Il18
|
interleukin 18
|
|
IEP
|
|
RGD |
PMID:21289055 |
RGD:6893448 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il6
|
interleukin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18091701 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
|
IDA
|
|
RGD |
PMID:15956135 |
RGD:1582457 |
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Lipc
|
lipase C, hepatic type
|
|
IEP
|
protein:decreased expression:liver (rat)
|
RGD |
PMID:1918876 |
RGD:2308796 |
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
|
|
| G
|
Lonp1
|
lon peptidase 1, mitochondrial
|
|
IDA
|
|
RGD |
PMID:12082077 |
RGD:633879 |
NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,534,584...1,547,427
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
|
IEP
|
|
RGD |
PMID:25435100 |
RGD:11561945 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19667931 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
|
IDA
|
|
RGD |
PMID:16077081 |
RGD:1582563 |
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
|
ISO
|
|
RGD |
PMID:12842442 |
RGD:1582562 |
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
|
RGD |
PMID:15047130 |
RGD:1582640 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
susceptibility
|
ISO
|
associated with Retinal Vein Occlusion;DNA:SNP:cds:677C>T(human)
|
RGD |
PMID:17719079 |
RGD:7387251 |
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Muc13
|
mucin 13, cell surface associated
|
|
IEP
|
protein:increased degradation:jejunum
|
RGD |
PMID:22768227 |
RGD:7349363 |
NCBI chr11:80,462,350...80,489,773
Ensembl chr11:80,465,737...80,485,474
|
|
| G
|
Muc2
|
mucin 2, oligomeric mucus/gel-forming
|
|
IEP
|
protein:decreased expression:jejunum
|
RGD |
PMID:22768227 |
RGD:7349363 |
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:15036356 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Oxt
|
oxytocin/neurophysin I prepropeptide
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10440088 |
|
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19458120 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:8662173 PMID:15557913 PMID:17653104 |
RGD:6484145 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12468449 PMID:24433871 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
|
IEP
|
|
RGD |
PMID:17700073 |
RGD:2292478 |
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Ptges
|
prostaglandin E synthase
|
|
IEP
|
|
RGD |
PMID:12431630 |
RGD:2300116 |
NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
|
IEP
|
protein:decreased tyrosine phosphorylation:kidney
|
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Raf1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
ISO
|
|
RGD |
PMID:16172266 |
RGD:1580696 |
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
|
|
| G
|
Ren
|
renin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:3915608 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
S100a4
|
S100 calcium-binding protein A4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19458120 |
|
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:178,388,526...178,390,837
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
|
RGD |
PMID:21885854 |
RGD:6218989 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpinh1
|
serpin family H member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19458120 |
|
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:163,055,630...163,062,976
|
|
| G
|
Sf1
|
splicing factor 1
|
|
IDA
|
|
RGD |
PMID:10103072 |
RGD:727772 |
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:10698074 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:11328670 PMID:18227068 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sst
|
somatostatin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18624922 |
|
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:90,461,546...90,462,823
|
|
| G
|
Thbd
|
thrombomodulin
|
|
IEP
|
|
RGD |
PMID:19461288 |
RGD:2312461 |
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IDA
|
|
RGD |
PMID:14970118 |
RGD:1624195 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tp53
|
tumor protein p53
|
|
IEP ISO
|
associated with Wounds and Injuries;protein:increased expression:skin CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15172883 PMID:18337831 |
RGD:2290551 |
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22688000 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Actg1
|
actin, gamma 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:21663912 |
RGD:5508825 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Alb
|
albumin
|
treatment
|
ISO
|
|
RGD |
PMID:20716836 |
RGD:11036086 |
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Arhgdib
|
Rho GDP dissociation inhibitor beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068
|
|
| G
|
Capzb
|
capping actin protein of muscle Z-line subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
susceptibility
|
ISO
|
DNA:SNP,haplotypes:5'utr: (rs6576776) (human)
|
RGD |
PMID:33906697 |
RGD:329845569 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Cd40
|
CD40 molecule
|
|
ISO
|
DNA:SNP:5' utr:rs1883832 (human)
|
RGD |
PMID:21091218 |
RGD:5490523 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
treatment
|
ISO
|
associated with Anxiety Disorders;protein:increased expression:serum
|
RGD |
PMID:20170788 PMID:31624788 |
RGD:5490548, RGD:21081509 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Ckb
|
creatine kinase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15966572 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15966572 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Crp
|
C-reactive protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression: :
|
CTD RGD |
PMID:15966572 PMID:23305094 PMID:18973750 PMID:21794939 |
RGD:6907401, RGD:9491837 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
treatment
|
ISO
|
DNA:SNPs::CYP2C19*2 (681G>A,rs4244285), CYP2C19*17 (-806C>T, rs12248560) (human) ClinVar Annotator: match by term: Acute coronary syndrome
|
ClinVar RGD |
PMID:7969038 PMID:9093256 PMID:19444287 PMID:21270786 PMID:27441996 PMID:34384383 More...
|
RGD:401960861 |
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Eno1
|
enolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
|
RGD |
PMID:21496882 |
RGD:5147784 |
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
Fasn
|
fatty acid synthase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23305094 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
susceptibility
|
ISO
|
DNA:SNP: :rs17817449 (human)
|
RGD |
PMID:20362563 |
RGD:329813083 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
|
ISO
|
DNa:SNP: :rs3783637 (human)
|
RGD |
PMID:26232608 |
RGD:329961571 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gp6
|
glycoprotein 6
|
disease_progression
|
ISO
|
protein:increased expression:platelet (human)
|
RGD |
PMID:17340467 PMID:20071043 |
RGD:401794408, RGD:401824680 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
|
ISO
|
mRNA, protein:increased expression:blood, plasma
|
RGD |
PMID:28298473 |
RGD:401827171 |
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
ISO
|
mRNA, protein:increased expression:blood, plasma
|
RGD |
PMID:28298473 |
RGD:401827171 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gpx4
|
glutathione peroxidase 4
|
|
ISO
|
mRNA, protein:increased expression:blood, plasma
|
RGD |
PMID:28298473 |
RGD:401827171 |
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
| G
|
Gsn
|
gelsolin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
ISO
|
DNA:SNP: :190G>C(human)
|
RGD |
PMID:21849784 |
RGD:7257650 |
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
|
CTD RGD |
PMID:23305094 PMID:32178736 PMID:32178736 |
RGD:155230830, RGD:155230830 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15840736 |
|
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Ldhb
|
lactate dehydrogenase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
|
|
| G
|
Mir126a
|
microRNA 126a
|
|
ISO
|
RNA:decreased expression:plasma
|
RGD |
PMID:27900989 |
RGD:401850572 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir145
|
microRNA 145
|
disease_progression treatment
|
ISO IEP
|
RNA:decreased expression:blood serum (human)
|
RGD |
PMID:32178736 PMID:32178736 |
RGD:155230830, RGD:155230830 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20981132 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
susceptibility
|
ISO
|
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
|
RGD |
PMID:23368530 |
RGD:401827273 |
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Pappa
|
pappalysin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11586954 |
|
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
ISO
|
protein:increased expression:coronary artery, intima (human)
|
RGD |
PMID:22336504 |
RGD:6767292 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
exacerbates
|
ISO
|
protein:increased expression:monocyte (human)
|
RGD |
PMID:32857129 |
RGD:401900689 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
disease_progression
|
ISO
|
|
RGD |
PMID:22024276 |
RGD:6482773 |
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Pon1
|
paraoxonase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26241956 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Psmb1
|
proteasome 20S subunit beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640
|
|
| G
|
Rab7b
|
Rab7b, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr13:45,673,396...45,699,798
Ensembl chr13:45,673,416...45,709,933
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
severity onset
|
ISO
|
protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human)
|
RGD |
PMID:25437889 PMID:32449048 |
RGD:329845573, RGD:329845576 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:21663912 |
RGD:5508825 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Serpinc1
|
serpin family C member 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:7923645 |
|
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20981132 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
|
CTD RGD |
PMID:20981132 PMID:32178736 PMID:32178736 |
RGD:155230830, RGD:155230830 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15966572 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15966572 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tpm4
|
tropomyosin 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr16:17,718,442...17,732,483
Ensembl chr16:17,717,230...17,732,494
|
|
| G
|
Tuba1c
|
tubulin, alpha 1C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:132,070,536...132,079,311
|
|
| G
|
Tubb1
|
tubulin, beta 1 class VI
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr 3:183,666,189...183,675,656
Ensembl chr 3:183,666,242...183,674,795
|
|
| G
|
Vcl
|
vinculin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163
|
|
| G
|
Vim
|
vimentin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21751358 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
|
|
| G
|
Arhgap17
|
Rho GTPase activating protein 17
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 1:187,238,675...187,328,093
Ensembl chr 1:187,238,380...187,327,936
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
C3
|
complement C3
|
|
ISO
|
|
RGD |
PMID:26476955 |
RGD:11552746 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Cacng4
|
calcium voltage-gated channel auxiliary subunit gamma 4
|
|
ISO
|
mRNA:decreased expression:blood:
|
RGD |
PMID:27746059 |
RGD:13524557 |
NCBI chr10:93,183,410...93,245,470
Ensembl chr10:93,183,410...93,245,470
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IEP
|
|
RGD |
PMID:26550220 |
RGD:13782284 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
treatment
|
IEP
|
|
RGD |
PMID:26550220 |
RGD:13782284 |
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:30371213 |
RGD:329845516 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Dram1
|
DNA-damage regulated autophagy modulator 1
|
ameliorates
|
IEP ISO
|
mRNA,protein:decreased expression:heart
|
RGD |
PMID:30144448 PMID:30144448 |
RGD:407571674, RGD:407571674 |
NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354
|
|
| G
|
Dsc2
|
desmocollin 2
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
treatment
|
IEP
|
|
RGD |
PMID:23054911 |
RGD:405650598 |
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
|
ISO
|
mRNA:increased expression:blood
|
RGD |
PMID:35693610 |
RGD:329901852 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
Gata5
|
GATA binding protein 5
|
susceptibility
|
ISO
|
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
|
RGD |
PMID:33684162 |
RGD:155260335 |
NCBI chr 3:187,796,140...187,804,327
Ensembl chr 3:187,796,142...187,804,327
|
|
| G
|
Gp6
|
glycoprotein 6
|
ameliorates sexual_dimorphism
|
ISO
|
DNA:missense mutation:CDS:p.S219P (rs1613662) (human) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human)
|
RGD |
PMID:20227257 PMID:20227257 |
RGD:401794138, RGD:401794138 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:28374671 |
RGD:401827832 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
treatment ameliorates
|
IEP
|
|
RGD |
PMID:26591365 PMID:32068187 |
RGD:13792778, RGD:267358468 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
ameliorates
|
IMP
|
|
RGD |
PMID:31755219 |
RGD:213230161 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
ISO
|
ClinVar Annotator: match by term: Acute myocardial infarction
|
ClinVar |
|
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Ifng
|
interferon gamma
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Ifngr2
|
interferon gamma receptor 2
|
susceptibility
|
ISO
|
DNA:SNP:intron:rs9978223
|
RGD |
PMID:29434065 |
RGD:628360902 |
NCBI chr11:44,265,703...44,283,975
Ensembl chr11:44,265,703...44,283,975
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Il10
|
interleukin 10
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il17a
|
interleukin 17A
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il1b
|
interleukin 1 beta
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
|
IEP
|
|
RGD |
PMID:24837094 |
RGD:40813741 |
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Il33
|
interleukin 33
|
|
IEP
|
|
RGD |
PMID:24837094 |
RGD:40813741 |
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
|
|
| G
|
Il4
|
interleukin 4
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
treatment
|
ISO
|
|
RGD |
PMID:21238619 |
RGD:329901664 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Kif6
|
kinesin family member 6
|
|
ISO
|
DNA:SNP: :p.W719R (rs20455) (human)
|
RGD |
PMID:20044086 |
RGD:243048455 |
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:18,573,789...18,870,729
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
treatment
|
IEP
|
|
RGD |
PMID:30144448 |
RGD:407571674 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Mir126a
|
microRNA 126a
|
disease_progression
|
ISO
|
|
RGD |
PMID:36523365 PMID:32595526 |
RGD:401851047, RGD:401851053 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir146a
|
microRNA 146a
|
|
ISO
|
miRNA:increased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr10:28,349,996...28,350,090
|
|
| G
|
Mir155
|
microRNA 155
|
|
ISO
|
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir17
|
microRNA 17
|
treatment
|
IMP
|
|
RGD |
PMID:29536180 |
RGD:329403057 |
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931
|
|
| G
|
Mir21
|
microRNA 21
|
|
ISO
|
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
|
RGD |
PMID:31866771 PMID:32595526 |
RGD:21081515, RGD:401851053 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir223
|
microRNA 223
|
treatment
|
IMP
|
|
RGD |
PMID:29689569 |
RGD:25823140 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mir320a
|
microRNA 320a
|
|
ISO
|
|
RGD |
PMID:29990866 |
RGD:155882565 |
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
| G
|
Mt-co2
|
mitochondrially encoded cytochrome c oxidase II
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674
|
|
| G
|
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5
|
ameliorates
|
IEP
|
associated with obesity
|
RGD |
PMID:35257523 |
RGD:401794445 |
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:117,447,035...117,461,590
|
|
| G
|
Pf4
|
platelet factor 4
|
treatment
|
IEP
|
|
RGD |
PMID:29407168 |
RGD:329901925 |
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392
|
|
| G
|
Plcg1
|
phospholipase C, gamma 1
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 3:169,805,299...169,836,040
Ensembl chr 3:169,804,846...169,836,050
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
treatment
|
IEP
|
|
RGD |
PMID:29407168 |
RGD:329901925 |
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
ameliorates
|
IEP ISO
|
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
|
RGD |
PMID:26973267 PMID:29990866 PMID:32595526 |
RGD:11526378, RGD:155882565, RGD:401851053 |
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Rhoa
|
ras homolog family member A
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Rit2
|
Ras-like without CAAX 2
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr18:22,839,914...23,196,137
Ensembl chr18:22,839,915...23,269,823
|
|
| G
|
Rora
|
RAR-related orphan receptor A
|
|
ISO
|
mRNA, protein:increaesed expression:blood mRNA:decreased expression:blood
|
RGD |
PMID:34101510 PMID:33174051 |
RGD:626469565, RGD:628374608 |
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
|
|
| G
|
Sdhb
|
succinate dehydrogenase complex iron sulfur subunit B
|
ameliorates
|
IEP
|
associated with obesity
|
RGD |
PMID:35257523 |
RGD:401794445 |
NCBI chr 5:158,547,775...158,568,589
Ensembl chr 5:158,547,689...158,569,667
|
|
| G
|
Serping1
|
serpin family G member 1
|
|
ISO IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:26476955 PMID:26476955 |
RGD:11552746, RGD:11552746 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Sqstm1
|
sequestosome 1
|
treatment
|
IEP
|
|
RGD |
PMID:30144448 |
RGD:407571674 |
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
|
|
| G
|
Tbx1
|
T-box transcription factor 1
|
treatment
|
IEP
|
|
RGD |
PMID:27422448 |
RGD:155882497 |
NCBI chr11:95,913,610...95,923,392
Ensembl chr11:95,913,610...95,923,392
|
|
| G
|
Tnf
|
tumor necrosis factor
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
ameliorates
|
IEP
|
|
RGD |
PMID:32068187 |
RGD:267358468 |
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
|
ISO
|
|
RGD |
PMID:11527135 |
RGD:5129114 |
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
|
ISO
|
|
RGD |
PMID:11527135 |
RGD:5129114 |
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Avp
|
arginine vasopressin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11128043 PMID:11791009 |
|
NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522
|
|
| G
|
Cpb2
|
carboxypeptidase B2
|
|
ISO
|
|
RGD |
PMID:12624641 |
RGD:1598479 |
NCBI chr15:56,967,128...57,015,964
Ensembl chr15:56,966,839...57,015,962
|
|
| G
|
Mir146a
|
microRNA 146a
|
|
ISO
|
miRNA:increased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr10:28,349,996...28,350,090
|
|
| G
|
Mir155
|
microRNA 155
|
|
ISO
|
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir21
|
microRNA 21
|
|
ISO
|
miRNA:increased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:1730212 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:17045893 |
RGD:401794448 |
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
|
RGD |
PMID:16421174 |
RGD:1581390 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:36193742 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
|
|
| G
|
Edn1
|
endothelin 1
|
|
ISO
|
protein:increased expression:aortic root, coronary sinus, plasma (human)
|
RGD |
PMID:12581682 |
RGD:8661757 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Serpine1
|
serpin family E member 1
|
disease_progression
|
ISO
|
protein:decreased expression, decreased activity:heart:
|
RGD |
PMID:12615902 PMID:12615902 |
RGD:13208541, RGD:13208541 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
severity
|
ISO
|
mRNA, protein:increased expression:umbilical cord blood (human)
|
RGD |
PMID:27957679 |
RGD:329849106 |
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Ada
|
adenosine deaminase
|
|
IEP
|
protein:increased activity:brain:
|
RGD |
PMID:25720338 |
RGD:152995398 |
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adk
|
adenosine kinase
|
|
IEP
|
protein:decreased expression:brain:
|
RGD |
PMID:25720338 |
RGD:152995398 |
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745
|
|
| G
|
Adnp
|
activity-dependent neuroprotector homeobox
|
|
IDA
|
|
RGD |
PMID:16938277 |
RGD:2312775 |
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
IEP
|
protein:decreased expression:brain:
|
RGD |
PMID:25720338 |
RGD:152995398 |
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Agtr2
|
angiotensin II receptor, type 2
|
|
IMP
|
|
RGD |
PMID:22569153 |
RGD:6903872 |
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:116,913,656...116,918,745
|
|
| G
|
Aif1
|
allograft inflammatory factor 1
|
|
IEP
|
protein:increased expression:right cerebral hemisphere (rat)
|
RGD |
PMID:19447505 |
RGD:2313021 |
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
|
IEP
|
protein:increased expression:nucleus:
|
RGD |
PMID:12871572 PMID:28108258 |
RGD:10053564, RGD:13524865 |
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:21189961 PMID:24089674 PMID:29635023 |
RGD:10054502, RGD:155882465, RGD:13782292 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcan
|
brevican
|
|
IEP
|
|
RGD |
PMID:15817274 |
RGD:14392799 |
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:21189961 PMID:24089674 PMID:29635023 |
RGD:10054502, RGD:155882465, RGD:13782292 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
|
IDA
|
|
RGD |
PMID:24195677 |
RGD:10053669 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Becn1
|
beclin 1
|
|
IEP
|
protein:increased expression:cerebral cortex protein:increased expression:brain
|
RGD |
PMID:22449108 PMID:25919564 |
RGD:6483050, RGD:11558017 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
|
IEP
|
protein:increased expression:pineal gland
|
RGD |
PMID:23336172 |
RGD:10043348 |
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
| G
|
Bmp4
|
bone morphogenetic protein 4
|
|
IEP
|
mRNA,protein:decreased expression:brain:
|
RGD |
PMID:23236544 |
RGD:8699519 |
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:22,098,470...22,105,172
|
|
| G
|
Casp1
|
caspase 1
|
|
IEP
|
|
RGD |
PMID:23046993 |
RGD:13782359 |
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
|
IDA
|
protein:increased activity:cerebral cortex, hippocampus
|
RGD |
PMID:18603371 |
RGD:2311455 |
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IDA IEP
|
protein:increased activity:cerebral cortex, hippocampus
|
RGD |
PMID:18603371 PMID:24089674 PMID:23046993 PMID:29635023 PMID:27216999 PMID:21189961 More...
|
RGD:2311455, RGD:155882465, RGD:13782359, RGD:13782292, RGD:13782279, RGD:10054502 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
treatment
|
IEP
|
|
RGD |
PMID:29635023 PMID:23046993 |
RGD:13782292, RGD:13782359 |
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
treatment
|
IEP
|
|
RGD |
PMID:23046993 PMID:24089674 |
RGD:13782359, RGD:155882465 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cast
|
calpastatin
|
|
IEP
|
|
RGD |
PMID:10318818 |
RGD:5683321 |
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
| G
|
Cat
|
catalase
|
treatment
|
ISO
|
|
RGD |
PMID:21978706 |
RGD:9068474 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP
|
protein:increased expression:forebrain (rat)
|
RGD |
PMID:9270493 |
RGD:8549543 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:18095591 |
RGD:4144890 |
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
|
IEP
|
mRNA:increased expression:cerebral hemisphere (rat)
|
RGD |
PMID:16516309 |
RGD:4890442 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
treatment
|
IMP
|
|
RGD |
PMID:25665755 |
RGD:13782373 |
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
| G
|
Clock
|
clock circadian regulator
|
|
IEP
|
protein:increased expression:pineal gland
|
RGD |
PMID:23336172 |
RGD:10043348 |
NCBI chr14:32,262,747...32,346,872
Ensembl chr14:32,262,750...32,346,872
|
|
| G
|
Cnp
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
|
IEP
|
|
RGD |
PMID:19747899 |
RGD:6483337 |
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063
|
|
| G
|
Crp
|
C-reactive protein
|
|
ISO
|
|
RGD |
PMID:20220110 |
RGD:9585994 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cs
|
citrate synthase
|
treatment
|
IDA
|
|
RGD |
PMID:15132986 PMID:15569775 |
RGD:243048479, RGD:243048481 |
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Csf1r
|
colony stimulating factor 1 receptor
|
exacerbates
|
IMP IEP
|
protein:increased expression:right cerebral hemisphere, astrocyte, neuron (rat)
|
RGD |
PMID:32522286 PMID:33101590 |
RGD:151665765, RGD:151665766 |
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
|
|
| G
|
Cxcr3
|
C-X-C motif chemokine receptor 3
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:17549754 |
RGD:2311381 |
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:70,883,958...70,886,871
|
|
| G
|
Daxx
|
death-domain associated protein
|
|
IMP
|
|
RGD |
PMID:21843499 |
RGD:9587791 |
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
|
IEP
|
protein:decreased expression:brain:
|
RGD |
PMID:23716065 |
RGD:9588620 |
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
| G
|
Egr1
|
early growth response 1
|
|
IEP
|
mRNA:increased expression:forebrain (rat)
|
RGD |
PMID:7684483 |
RGD:2289081 |
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
|
IDA
|
|
RGD |
PMID:8092984 |
RGD:10395352 |
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Epha4
|
Eph receptor A4
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:21736568 |
RGD:5688765 |
NCBI chr 9:86,263,982...86,406,744
Ensembl chr 9:86,263,982...86,406,755
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
IEP ISO
|
|
RGD |
PMID:24034924 PMID:22156696 |
RGD:10400911, RGD:10401072 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Ero1a
|
endoplasmic reticulum oxidoreductase 1 alpha
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:12694393 |
RGD:632668 |
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
|
|
| G
|
Fadd
|
Fas associated via death domain
|
treatment
|
IEP
|
|
RGD |
PMID:29635023 |
RGD:13782292 |
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
|
IEP
|
|
RGD |
PMID:21843499 |
RGD:9587791 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:25262910 |
RGD:405650622 |
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxo3
|
forkhead box O3
|
|
IEP
|
protein:increased expression:cerebral cortex,nucleus:
|
RGD |
PMID:24229603 |
RGD:10402203 |
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
|
|
| G
|
Fst
|
follistatin
|
|
IEP
|
mRNA:decreased expression:brain (rat)
|
RGD |
PMID:10415398 |
RGD:329322882 |
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491
|
|
| G
|
Ghr
|
growth hormone receptor
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:19524466 |
RGD:2315620 |
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
|
IEP
|
mRNA:decreased expression:hippocampus (rat)
|
RGD |
PMID:19761817 |
RGD:2325954 |
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
|
IEP
|
mRNA:decreased expression:hippocampus (rat)
|
RGD |
PMID:19761817 |
RGD:2325954 |
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
|
IEP
|
mRNA:decreased expression:hippocampus (rat)
|
RGD |
PMID:19761817 |
RGD:2325954 |
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Gsn
|
gelsolin
|
severity
|
ISO
|
protein:decreased expression:blood plasma (human)
|
RGD |
PMID:29466895 |
RGD:329333029 |
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Hcn1
|
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
|
|
IEP
|
mRNA:decreased expression:hippocampus,cortex:
|
RGD |
PMID:19892002 |
RGD:9686395 |
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:51,228,710...51,632,806
|
|
| G
|
Hdac3
|
histone deacetylase 3
|
|
IEP
|
protein:decreased expression:brain:
|
RGD |
PMID:23716065 |
RGD:9588620 |
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IEP ISO IDA
|
protein:increased expression:brain (rat) mRNA, protein:increased expression:brain,kidney (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:23694759 PMID:18210138 PMID:31784544 PMID:19595151 |
RGD:9068873, RGD:155882534, RGD:9068901 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:25447631 |
RGD:10766440 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
IEP
|
|
RGD |
PMID:22526757 |
RGD:7257595 |
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
|
IMP
|
|
RGD |
PMID:16397188 |
RGD:1626654 |
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
treatment
|
ISO IDA IEP
|
|
RGD |
PMID:11672597 PMID:23694759 PMID:19766709 |
RGD:8549456, RGD:12904932, RGD:10046049 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
disease_progression
|
ISO
|
|
RGD |
PMID:16787587 |
RGD:5510005 |
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
|
IEP
|
|
RGD |
PMID:10709766 |
RGD:10402756 |
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:23110519 |
RGD:7204438 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
severity
|
ISO
|
DNA:polymorphism: :174G>C(human)
|
RGD |
PMID:22117975 |
RGD:12792241 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
severity treatment
|
IEP ISO
|
mRNA:increased expression:brain (rat) mRNA, protein:increased expression:umbilical cord blood (human) human construct in rat model
|
RGD |
PMID:10415398 PMID:27957679 PMID:10415398 |
RGD:329322882, RGD:329849106, RGD:329322882 |
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21925238 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irak4
|
interleukin-1 receptor-associated kinase 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21925238 |
|
NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:127,561,717...127,597,109
|
|
| G
|
Ireb2
|
iron responsive element binding protein 2
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:27602087 |
RGD:12903962 |
NCBI chr 8:64,124,152...64,207,702
Ensembl chr 8:64,154,945...64,205,520
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
IMP
|
|
RGD |
PMID:21277350 |
RGD:5684383 |
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
|
IEP
|
|
RGD |
PMID:25919564 |
RGD:11558017 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
|
IDA
|
|
RGD |
PMID:21300124 |
RGD:6483088 |
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
|
IEP
|
|
RGD |
PMID:21843499 |
RGD:9587791 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
ameliorates
|
ISO IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:29138854 PMID:32734729 |
RGD:155804273, RGD:155804275 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
treatment
|
IDA
|
|
RGD |
PMID:25665755 |
RGD:13782373 |
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mbd2
|
methyl-CpG binding domain protein 2
|
|
IEP
|
protein:increased expression:brain:
|
RGD |
PMID:23716065 |
RGD:9588620 |
NCBI chr18:66,449,196...66,516,112
Ensembl chr18:66,449,358...66,516,111
|
|
| G
|
Mbp
|
myelin basic protein
|
|
IEP
|
protein:decreased expression:white matter:
|
RGD |
PMID:23715956 |
RGD:7327196 |
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mir140
|
microRNA 140
|
severity
|
ISO
|
miRNA:decreased expression:blood serum (human)
|
RGD |
PMID:34331407 |
RGD:329347831 |
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391
|
|
| G
|
Mir17
|
microRNA 17
|
|
ISO
|
|
RGD |
PMID:35085690 |
RGD:329349305 |
NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931
|
|
| G
|
Mir210
|
microRNA 210
|
treatment disease_progression
|
IMP ISO
|
miRNA:decreased expression:blood serum (human) associated with Brain Injuries;miRNA:increased expression:brain, cerebral hemisphere (human)
|
RGD |
PMID:26875527 PMID:24089674 PMID:29568675 PMID:33402183 |
RGD:11572290, RGD:155882465, RGD:155598592, RGD:155582222 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
treatment
|
IEP
|
|
RGD |
PMID:21038694 |
RGD:8694100 |
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mpo
|
myeloperoxidase
|
|
IEP
|
protein:increased activity:brain:
|
RGD |
PMID:25720338 |
RGD:152995398 |
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Naglu
|
N-acetyl-alpha-glucosaminidase
|
|
IEP
|
protein:increased activity:brain:
|
RGD |
PMID:25720338 |
RGD:152995398 |
NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,501,836...86,509,315
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23694759 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nrf1
|
nuclear respiratory factor 1
|
|
IEP
|
mRNA, protein:increase expression:cerebral cortex
|
RGD |
PMID:18723421 |
RGD:2302400 |
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353
|
|
| G
|
Ntrk1
|
neurotrophic receptor tyrosine kinase 1
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:19633950 |
RGD:5684358 |
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
|
|
| G
|
Pdgfb
|
platelet derived growth factor subunit B
|
|
IEP
|
|
RGD |
PMID:10215166 |
RGD:10449494 |
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
onset
|
IEP
|
|
RGD |
PMID:18467699 |
RGD:6483831 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
IDA IEP
|
mRNA, protein:increased expression, increased activity:hippocampus (rat)
|
RGD |
PMID:19587273 PMID:18467699 |
RGD:2316117, RGD:6483831 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
IEP
|
|
RGD |
PMID:23153068 |
RGD:13515077 |
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063
|
|
| G
|
Prkdc
|
protein kinase, DNA-activated, catalytic subunit
|
treatment
|
IMP
|
|
RGD |
PMID:30485360 |
RGD:39938998 |
NCBI chr11:98,544,952...98,762,499
Ensembl chr11:98,544,954...98,762,108
|
|
| G
|
Prkdcem1Sage
|
protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage
|
treatment
|
IMP
|
|
RGD |
PMID:30485360 |
RGD:39938998 |
|
|
| G
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5
|
|
IEP
|
STEP33;protein:increased expression:forebrain (rat)
|
RGD |
PMID:10537057 |
RGD:9835021 |
NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:106,756,896...106,816,828
|
|
| G
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1
|
|
IEP
|
|
RGD |
PMID:16041802 |
RGD:9590116 |
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903
|
|
| G
|
Rnf146
|
ring finger protein 146
|
|
IEP
|
|
RGD |
PMID:28108258 |
RGD:13524865 |
NCBI chr 1:30,286,680...30,304,367
Ensembl chr 1:30,287,511...30,304,361
|
|
| G
|
Robo1
|
roundabout guidance receptor 1
|
exacerbates
|
IMP
|
|
RGD |
PMID:31356825 |
RGD:242905191 |
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
severity
|
ISO
|
associated with Asphyxia Neonatorum;protein:increased expression:urine protein:increased expression:blood serum (human)
|
RGD |
PMID:14707571 PMID:29568675 |
RGD:5508819, RGD:155598592 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
ISO
|
|
RGD |
PMID:19587273 |
RGD:2316117 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
|
IMP
|
|
RGD |
PMID:20883671 |
RGD:6771331 |
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Slit2
|
slit guidance ligand 2
|
treatment
|
IEP
|
|
RGD |
PMID:31356825 |
RGD:242905191 |
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146
|
|
| G
|
Spi1
|
Spi-1 proto-oncogene
|
|
IEP
|
protein:increased expression:CA1 field of hippocampus
|
RGD |
PMID:10713349 |
RGD:9586724 |
NCBI chr 3:97,529,509...97,548,204
Ensembl chr 3:97,527,572...97,549,540
|
|
| G
|
Srgap1
|
SLIT-ROBO Rho GTPase activating protein 1
|
exacerbates
|
IMP
|
|
RGD |
PMID:31356825 |
RGD:242905191 |
NCBI chr 7:59,215,007...59,479,600
Ensembl chr 7:59,215,007...59,656,213
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
treatment
|
IDA
|
|
RGD |
PMID:21940960 |
RGD:11038672 |
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tf
|
transferrin
|
treatment
|
ISO
|
|
RGD |
PMID:22736466 |
RGD:7244383 |
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:112,647,642...112,695,400
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:18723421 |
RGD:2302400 |
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
|
ISO IEP
|
protein:increased expression:hippocampus mRNA, protein:increased expression:brain
|
RGD |
PMID:28139935 PMID:25530127 PMID:26475712 |
RGD:15090829, RGD:11096611, RGD:11353246 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:25530127 |
RGD:11096611 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
IEP
|
mRNA:increased expression:glomerular podocytes (rat)
|
RGD |
PMID:31784544 |
RGD:155882534 |
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23694759 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
|
IEP IMP
|
mRNA:increased expression:glomerular podocytes (rat)
|
RGD |
PMID:31784544 PMID:34852714 |
RGD:155882534, RGD:155882542 |
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
IDA
|
|
RGD |
PMID:19362080 |
RGD:5686830 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adk
|
adenosine kinase
|
|
ISO IMP
|
|
RGD |
PMID:16685255 PMID:9731623 |
RGD:6482657, RGD:6482667 |
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745
|
|
| G
|
Adm
|
adrenomedullin
|
treatment
|
ISO
|
|
RGD |
PMID:21695352 |
RGD:5508764 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adnp
|
activity-dependent neuroprotector homeobox
|
|
IDA
|
|
RGD |
PMID:11935065 |
RGD:1358226 |
NCBI chr 3:177,310,258...177,340,379
Ensembl chr 3:177,310,258...177,336,188
|
|
| G
|
Aif1
|
allograft inflammatory factor 1
|
|
IEP ISO
|
protein:increased expression:brain subventricular zone (rat) protein:increased expression:brain white matter (human)
|
RGD |
PMID:19053043 PMID:10683518 |
RGD:2313025, RGD:2313026 |
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
susceptibility
|
ISO
|
|
RGD |
PMID:17388993 |
RGD:1601161 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
|
ISO
|
associated with Metabolic Syndrome X; DNA:polymorphism:g.162A>C rs4769055 (human)
|
RGD |
PMID:18506375 |
RGD:2311309 |
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Arrb2
|
arrestin, beta 2
|
|
IEP
|
protein:increased expression:spleen
|
RGD |
PMID:29636059 |
RGD:401938621 |
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487
|
|
| G
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2
|
|
IEP
|
mRNA:decreased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 4:148,450,207...148,763,653
Ensembl chr 4:148,450,207...148,696,239
|
|
| G
|
Becn1
|
beclin 1
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:22227058 |
RGD:6483057 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Cacna2d1
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1
|
|
IEP
|
mRNA:decreased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147
|
|
| G
|
Calcrl
|
calcitonin receptor like receptor
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 3:89,835,071...89,932,616
Ensembl chr 3:89,835,077...89,887,350
|
|
| G
|
Cd8a
|
CD8 subunit alpha
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 4:104,924,116...104,928,353
Ensembl chr 4:104,900,833...104,928,358
|
|
| G
|
Cfh
|
complement factor H
|
treatment
|
ISO
|
|
RGD |
PMID:21695352 |
RGD:5508764 |
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Cort
|
cortistatin
|
|
IEP
|
mRNA:decreased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 5:164,843,682...164,845,796
|
|
| G
|
Ctsb
|
cathepsin B
|
|
IEP
|
protein:increased expression:cerebral cortical segment, cytoplasm (rat)
|
RGD |
PMID:19941836 |
RGD:2315502 |
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:19895873 |
RGD:2325193 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19417757 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyp11b1
|
cytochrome P450, family 11, subfamily b, polypeptide 1
|
|
IEP
|
mRNA:decreased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 7:108,653,385...108,660,062
Ensembl chr 7:108,653,378...108,660,995 Ensembl chr 7:108,653,378...108,660,995
|
|
| G
|
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1
|
|
ISO
|
DNA:variants:CDS:multiple (human)
|
RGD |
PMID:36762557 |
RGD:401901151 |
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423
|
|
| G
|
Dcx
|
doublecortin
|
|
IEP
|
protein:altered expression:brain (rat)
|
RGD |
PMID:12161747 |
RGD:155630606 |
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
|
ISO
|
|
RGD |
PMID:15485550 |
RGD:1580908 |
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:17524524 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Gpnmb
|
glycoprotein nmb
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
|
|
| G
|
Gpr17
|
G protein-coupled receptor 17
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18974869 |
|
NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702
|
|
| G
|
Gzmb
|
granzyme B
|
|
IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:19895873 |
RGD:2325193 |
NCBI chr15:34,459,007...34,462,469
Ensembl chr15:34,459,007...34,462,469
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
treatment
|
IDA
|
|
RGD |
PMID:16421510 |
RGD:8548626 |
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
exacerbates
|
IMP
|
|
RGD |
PMID:30052311 |
RGD:155663378 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
IMP
|
|
RGD |
PMID:19944723 |
RGD:2316741 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hnmt
|
histamine N-methyltransferase
|
severity
|
IMP
|
|
RGD |
PMID:21131122 PMID:16330002 |
RGD:5509772, RGD:5509773 |
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482
|
|
| G
|
Htr2b
|
5-hydroxytryptamine receptor 2B
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 9:94,184,442...94,206,851
Ensembl chr 9:94,190,109...94,204,087
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum
|
RGD |
PMID:18692933 |
RGD:2313474 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Igf2
|
insulin-like growth factor 2
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:7770004 |
RGD:5509999 |
NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667
|
|
| G
|
Il15
|
interleukin 15
|
|
ISO
|
associated with Hypertension;protein:increased expression:serum
|
RGD |
PMID:16109314 |
RGD:1626610 |
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
IEP
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:17678971 |
RGD:1626644 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2
|
interleukin 2
|
|
IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:19895873 |
RGD:2325193 |
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Kcnk6
|
potassium two pore domain channel subfamily K member 6
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 1:93,652,888...93,661,419
|
|
| G
|
Mdk
|
midkine
|
|
IDA
|
|
RGD |
PMID:15450683 |
RGD:1582478 |
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Meis2
|
Meis homeobox 2
|
|
IEP
|
protein:altered expression:brain (rat)
|
RGD |
PMID:12161747 |
RGD:155630606 |
NCBI chr 3:123,197,066...123,399,002
Ensembl chr 3:123,197,066...123,397,751
|
|
| G
|
Mgp
|
matrix Gla protein
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
|
|
| G
|
Mir223
|
microRNA 223
|
|
IEP
|
RNA:increased expression:brain,blood
|
RGD |
PMID:31342956 |
RGD:25824952 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp8
|
matrix metallopeptidase 8
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 8:13,008,873...13,018,729
Ensembl chr 8:13,008,890...13,018,729
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
|
RGD |
PMID:16599837 |
RGD:1582617 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Msi1
|
musashi RNA-binding protein 1
|
|
IEP
|
|
RGD |
PMID:15250238 |
RGD:1582664 |
NCBI chr12:46,815,225...46,911,852
Ensembl chr12:46,819,039...46,845,425
|
|
| G
|
Nes
|
nestin
|
|
IEP
|
associated with Hypertension
|
RGD |
PMID:16321245 |
RGD:1642069 |
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Parg
|
poly (ADP-ribose) glycohydrolase
|
|
IMP
|
associated with Reperfusion Injury
|
RGD |
PMID:12834903 |
RGD:2316742 |
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584
|
|
| G
|
Pbx1
|
PBX homeobox 1
|
|
IEP
|
protein:altered expression:brain (rat)
|
RGD |
PMID:12161747 |
RGD:155630606 |
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:82,812,131...83,121,066
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16190367 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
IEP
|
protein:altered expression:brain (rat)
|
RGD |
PMID:12161747 |
RGD:155630606 |
NCBI chr10:83,843,948...83,853,063
Ensembl chr10:83,844,036...83,853,063
|
|
| G
|
Prcp
|
prolylcarboxypeptidase
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 1:156,343,894...156,396,295
Ensembl chr 1:156,343,896...156,396,939
|
|
| G
|
Rbfox3
|
RNA binding fox-1 homolog 3
|
|
IEP
|
protein:altered expression:brain (rat)
|
RGD |
PMID:12161747 |
RGD:155630606 |
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
|
|
| G
|
RT1-Ba
|
RT1 class II, locus Ba
|
|
ISO
|
DNA:polymorphisms (human)
|
RGD |
PMID:11798899 |
RGD:5147807 |
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
|
|
| G
|
Scn7a
|
sodium voltage-gated channel alpha subunit 7
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 3:71,743,873...71,846,454
Ensembl chr 3:71,743,873...71,846,284
|
|
| G
|
Sirt1
|
sirtuin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22878646 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
|
IDA
|
|
RGD |
PMID:14650360 |
RGD:1601455 |
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
IEP
|
protein:increased expression:brain (rat)
|
RGD |
PMID:19895873 |
RGD:2325193 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tpcn2
|
two pore segment channel 2
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:23251410 |
RGD:329845556 |
NCBI chr 1:209,845,827...209,875,561
Ensembl chr 1:209,845,835...209,875,457
|
|
|
|
| G
|
Abcb1b
|
ATP-binding cassette, sub-family B member 1B
|
|
IEP
|
|
RGD |
PMID:15049514 |
RGD:1598554 |
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15534175 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:17073862 |
RGD:9681750 |
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Add3
|
adducin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17901229 |
|
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:262,154,996...262,260,504
|
|
| G
|
Adk
|
adenosine kinase
|
|
ISO
|
|
RGD |
PMID:21427729 PMID:17457365 |
RGD:6482652, RGD:6482655 |
NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
IEP
|
mRNA:increased expression:pyramidal cell, hippocampus
|
RGD |
PMID:12618340 |
RGD:1625348 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Aif1
|
allograft inflammatory factor 1
|
|
IEP
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:18301954 |
RGD:2313032 |
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
|
|
| G
|
Akap1
|
A-kinase anchoring protein 1
|
|
IEP
|
protein:altered expression:parietal cortex, hippocampus (rat)
|
RGD |
PMID:18323779 |
RGD:2313128 |
NCBI chr10:74,118,232...74,151,366
Ensembl chr10:74,119,124...74,138,190
|
|
| G
|
Akap12
|
A-kinase anchoring protein 12
|
|
IEP
|
|
RGD |
PMID:21334414 |
RGD:14348963 |
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
IEP
|
protein:decreased serine phosphorylation:cerebral cortex
|
RGD |
PMID:21596097 |
RGD:5509066 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alb
|
albumin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16809570 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:20167207 |
RGD:5509598 |
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
IMP
|
|
RGD |
PMID:20204486 |
RGD:2317525 |
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Angpt1
|
angiopoietin 1
|
|
ISO
|
|
RGD |
PMID:17637706 |
RGD:1643339 |
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Angpt2
|
angiopoietin 2
|
|
IDA
|
|
RGD |
PMID:17494864 |
RGD:2314206 |
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Anxa1
|
annexin A1
|
treatment
|
ISO IMP
|
|
RGD |
PMID:1830327 PMID:1830327 |
RGD:7421662, RGD:7421662 |
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
|
IEP
|
protein:increased expression:striatum
|
RGD |
PMID:17640469 |
RGD:2325742 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
IEP
|
protein:decreased expression:hippocampus CA1, neuron
|
RGD |
PMID:9030714 |
RGD:2315686 |
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Aqp3
|
aquaporin 3 (Gill blood group)
|
|
IEP
|
|
RGD |
PMID:19616516 |
RGD:5490152 |
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
|
|
| G
|
Aqp4
|
aquaporin 4
|
|
IEP
|
|
RGD |
PMID:19616516 |
RGD:5490152 |
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Aqp5
|
aquaporin 5
|
|
IEP
|
|
RGD |
PMID:19616516 |
RGD:5490152 |
NCBI chr 7:132,601,528...132,605,060
Ensembl chr 7:132,601,059...132,605,062
|
|
| G
|
Aqp8
|
aquaporin 8
|
|
IEP
|
|
RGD |
PMID:19616516 |
RGD:5490152 |
NCBI chr 1:187,424,314...187,430,243
Ensembl chr 1:187,424,417...187,430,242
|
|
| G
|
Asic1
|
acid sensing ion channel subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21307247 |
|
NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
|
IEP
|
protein:decreased serine phosphorylation:brain
|
RGD |
PMID:18078455 PMID:22843461 |
RGD:2292681, RGD:10053716 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19095966 |
|
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IDA
|
|
RGD |
PMID:15585409 |
RGD:11522731 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:17706879 PMID:22843461 |
RGD:1643491, RGD:10053716 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19922383 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
|
IMP IEP
|
protein:increased expression:hippocampus, frontal cortex
|
RGD |
PMID:19574998 PMID:17936001 |
RGD:6483094, RGD:6483313 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
|
IEP
|
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
|
IEP
|
mRNA:increased expression:forebrain (rat)
|
RGD |
PMID:7684483 |
RGD:2289081 |
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
C3
|
complement C3
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:14561876 |
RGD:5129543 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Casp12
|
caspase 12
|
|
IEP
|
mRNA, protein:increased expresssion:brain
|
RGD |
PMID:12598725 |
RGD:1299333 |
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11756504 PMID:17901229 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp6
|
caspase 6
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:11311984 |
RGD:2301331 |
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp9
|
caspase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11756504 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cast
|
calpastatin
|
|
IDA
|
|
RGD |
PMID:16467455 |
RGD:5509813 |
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
| G
|
Cat
|
catalase
|
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17564305 PMID:21213399 |
RGD:5130891 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cav1
|
caveolin 1
|
|
IEP
|
|
RGD |
PMID:16417587 |
RGD:1581152 |
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Ccl11
|
C-C motif chemokine ligand 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
|
|
| G
|
Ccl12
|
C-C motif chemokine ligand 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15829914 PMID:17394460 PMID:19260320 |
RGD:2306998 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:9916893 |
RGD:69987 |
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 PMID:17394460 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl4
|
C-C motif chemokine ligand 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
| G
|
Ccr4
|
C-C motif chemokine receptor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr 8:123,054,505...123,060,244
Ensembl chr 8:123,054,324...123,077,642
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
|
IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:9670989 |
RGD:632396 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cd36
|
CD36 molecule
|
|
ISO
|
|
RGD |
PMID:20360550 |
RGD:6893498 |
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
|
IMP
|
|
RGD |
PMID:14502288 |
RGD:734740 |
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cebpb
|
CCAAT/enhancer binding protein beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17394460 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
|
|
| G
|
Chrm1
|
cholinergic receptor, muscarinic 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18501976 |
|
NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602
|
|
| G
|
Cited2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
IEP
|
|
RGD |
PMID:16434029 |
RGD:1581188 |
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782
|
|
| G
|
Clu
|
clusterin
|
|
IEP
|
|
RGD |
PMID:12782389 |
RGD:727237 |
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cp
|
ceruloplasmin
|
|
IEP
|
mRNA, protein:decreased expression:cerebral cortex, hippocampus
|
RGD |
PMID:18273071 |
RGD:2314688 |
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
treatment
|
IEP
|
mRNA,protein:decreased expression,decreased phosphorylation:brain:
|
RGD |
PMID:23644141 |
RGD:10059580 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crh
|
corticotropin releasing hormone
|
|
IEP
|
mRNA:increased expression:cerebral cortex (rat)
|
RGD |
PMID:8541482 |
RGD:1581300 |
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
|
|
| G
|
Csf2rb
|
colony stimulating factor 2 receptor subunit beta
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:7643220 |
RGD:632531 |
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
|
ISO
|
associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:18832793 |
RGD:2311241 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
|
IEP
|
|
RGD |
PMID:21864831 |
RGD:5686850 |
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
|
|
| G
|
Cst3
|
cystatin C
|
|
ISO
|
protein:decreased expression:cerebrospinal fluid
|
RGD |
PMID:18261165 |
RGD:2314349 |
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Ctsb
|
cathepsin B
|
|
IEP
|
protein:increased activity:cerebrum (rat)
|
RGD |
PMID:18404379 |
RGD:2315571 |
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsc
|
cathepsin C
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:12843783 |
RGD:1599640 |
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
|
|
| G
|
Ctsl
|
cathepsin L
|
|
IEP
|
protein:increased activity:cerebrum (rat)
|
RGD |
PMID:18404379 |
RGD:2315571 |
NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
IEP ISO
|
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15829914 PMID:17549754 |
RGD:2311381 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:18206136 |
RGD:2306577 |
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11756504 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Dbh
|
dopamine beta-hydroxylase
|
|
IEP
|
protein:decreased expression:forebrain (rat)
|
RGD |
PMID:18356740 |
RGD:5129691 |
NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
|
IEP
|
Protein:increased expression:brain
|
RGD |
PMID:15921666 |
RGD:1599731 |
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11756504 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
|
|
| G
|
Dpysl2
|
dihydropyrimidinase-like 2
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:19524114 |
RGD:2316241 |
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
|
|
| G
|
Drd2
|
dopamine receptor D2
|
|
IEP
|
|
RGD |
PMID:11474153 |
RGD:1580883 |
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Dusp6
|
dual specificity phosphatase 6
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:10908038 |
RGD:2316092 |
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
|
|
| G
|
Dynll1
|
dynein light chain LC8-type 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9522364 |
|
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
|
|
| G
|
Edn1
|
endothelin 1
|
|
IEP
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:8113329 |
RGD:4144887 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Egr1
|
early growth response 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17394460 |
|
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Endog
|
endonuclease G
|
|
IEP
|
|
RGD |
PMID:18568342 |
RGD:9685367 |
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:33,846,885...33,849,573
|
|
| G
|
Epor
|
erythropoietin receptor
|
|
IEP
|
protein:increased expression:brain:
|
RGD |
PMID:14732457 |
RGD:11041652 |
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
| G
|
Esr2
|
estrogen receptor 2
|
|
IEP
|
mRNA:decreased expression:cerebral cortex, ipsilateral side (rat)
|
RGD |
PMID:10414967 |
RGD:8694344 |
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14753426 PMID:15534175 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
|
IEP
|
|
RGD |
PMID:14705148 |
RGD:1302269 |
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
F5
|
coagulation factor V
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15534175 |
|
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:16796407 |
RGD:1600333 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:18410517 |
RGD:2311437 |
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fga
|
fibrinogen alpha chain
|
treatment
|
IDA
|
|
RGD |
PMID:22737923 |
RGD:11040923 |
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
|
IDA ISO
|
Rat model using human FGF1
|
RGD |
PMID:19497570 PMID:16635575 |
RGD:5509879, RGD:5509881 |
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Gal
|
galanin and GMAP prepropeptide
|
|
IEP
|
|
RGD |
PMID:16458372 |
RGD:1624341 |
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:210,079,702...210,084,229
|
|
| G
|
Gc
|
GC, vitamin D binding protein
|
|
IEP
|
protein:increased expression:urine
|
RGD |
PMID:11239198 |
RGD:1625796 |
NCBI chr14:18,916,255...18,951,670
Ensembl chr14:18,916,246...18,951,673
|
|
| G
|
Gfra1
|
GDNF family receptor alpha 1
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:10407114 |
RGD:6218981 |
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:21718970 |
RGD:6480433 |
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
|
IEP
|
protein:decreased activity:brain
|
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Gp1ba
|
glycoprotein Ib platelet subunit alpha
|
exacerbates
|
ISO
|
associated with Pneumococcal Infections
|
RGD |
PMID:24644058 |
RGD:42722626 |
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,829,832...55,854,560
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12531513 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:30025402 |
RGD:401827828 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
ISO IDA IEP
|
protein:increased expression:brain CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:cerebral cortex (rat)
|
CTD RGD |
PMID:19429140 PMID:17554006 PMID:18369388 PMID:17101276 |
RGD:1626331, RGD:9068895, RGD:9068892 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IEP IMP
|
|
RGD |
PMID:16464361 PMID:21276833 |
RGD:1582709, RGD:10755576 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
|
ISO
|
associated with advanced age and Diabetes Mellitus, Type 2 (MeSH:D003924)
|
RGD |
PMID:15992611 |
RGD:1626649 |
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
|
IEP
|
|
RGD |
PMID:16805800 |
RGD:6480229 |
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:7629893 |
RGD:6784525 |
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17394460 PMID:19417757 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
|
IDA ISO
|
|
RGD |
PMID:16882007 PMID:19332057 |
RGD:1598411, RGD:2306694 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Il10rb
|
interleukin 10 receptor subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr11:44,132,471...44,154,062
Ensembl chr11:44,132,189...44,154,053
|
|
| G
|
Il12rb1
|
interleukin 12 receptor subunit beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr16:18,654,207...18,668,887
Ensembl chr16:18,654,207...18,666,824
|
|
| G
|
Il17a
|
interleukin 17A
|
|
IEP ISO
|
protein, mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism protein:increased expression:brain
|
CTD RGD |
PMID:15829914 PMID:16305645 PMID:16305645 |
RGD:4846398, RGD:4846398 |
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il17ra
|
interleukin 17 receptor A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr 4:155,339,742...155,362,382
Ensembl chr 4:155,339,400...155,362,382
|
|
| G
|
Il18
|
interleukin 18
|
|
IEP ISO
|
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15829914 PMID:11807395 |
RGD:4889510 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9236716 PMID:15737438 PMID:15756928 PMID:17394460 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:9236716 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il6
|
interleukin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 PMID:17394460 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
|
IEP
|
mRNA:increased expression:brain, astrocyte
|
RGD |
PMID:15469886 |
RGD:1627568 |
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:21925238 |
RGD:7495802 |
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irak4
|
interleukin-1 receptor-associated kinase 4
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:21925238 |
RGD:7495802 |
NCBI chr 7:127,561,777...127,588,762
Ensembl chr 7:127,561,717...127,597,109
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
|
IEP
|
associated with Hypotension;protein:increased expression:pyramidal layer of CA1 (rat)
|
RGD |
PMID:19019197 |
RGD:329853772 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17901229 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kcnk10
|
potassium two pore domain channel subfamily K member 10
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex, hippocampus (rat)
|
RGD |
PMID:15652517 |
RGD:9831167 |
NCBI chr 6:123,419,778...123,555,820
Ensembl chr 6:123,423,950...123,555,614
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
|
IEP
|
mRNA:increased expression:hippocampus (rat)
|
RGD |
PMID:14741413 |
RGD:9831127 |
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
IMP
|
|
RGD |
PMID:18951929 |
RGD:5684407 |
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Lgals3
|
galectin 3
|
|
IEP
|
|
RGD |
PMID:10931529 |
RGD:9685227 |
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Lif
|
LIF, interleukin 6 family cytokine
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:20221422 |
RGD:2326053 |
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
|
|
| G
|
Lonp1
|
lon peptidase 1, mitochondrial
|
|
IDA
|
|
RGD |
PMID:12082077 |
RGD:633879 |
NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,534,584...1,547,427
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map2k1
|
mitogen activated protein kinase kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17901229 PMID:10536014 |
RGD:1582169 |
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
treatment
|
ISO
|
|
RGD |
PMID:21475303 |
RGD:155882442 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17901229 PMID:15669185 |
RGD:1582281 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17901229 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
|
IDA
|
|
RGD |
PMID:15797868 |
RGD:1582325 |
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
|
IDA
|
protein:increased phosphorylation
|
RGD |
PMID:15353210 |
RGD:1599927 |
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mdh2
|
malate dehydrogenase 2
|
|
IDA
|
|
RGD |
PMID:6282622 |
RGD:1582465 |
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
| G
|
Mdk
|
midkine
|
|
ISO
|
|
RGD |
PMID:12127679 |
RGD:1582476 |
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mir223
|
microRNA 223
|
treatment
|
IMP
|
|
RGD |
PMID:31791013 |
RGD:26884340 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
|
IDA
|
|
RGD |
PMID:16112096 |
RGD:1582554 |
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
|
IEP
|
|
RGD |
PMID:15963646 |
RGD:1582577 |
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
|
IEP
|
|
RGD |
PMID:15963646 |
RGD:1582577 |
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15060315 PMID:16846501 |
RGD:1582611 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19417757 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Msi1
|
musashi RNA-binding protein 1
|
|
IEP
|
|
RGD |
PMID:12205668 |
RGD:633285 |
NCBI chr12:46,815,225...46,911,852
Ensembl chr12:46,819,039...46,845,425
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15534175 |
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Naip6
|
NLR family, apoptosis inhibitory protein 6
|
|
IEP
|
protein:increased expression:thalamus (rat)
|
RGD |
PMID:9288726 |
RGD:2317254 |
NCBI chr 2:33,241,520...33,293,184
Ensembl chr 2:33,241,521...33,276,859
|
|
| G
|
Nes
|
nestin
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:17697621 |
RGD:1642071 |
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18628779 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18628779 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
|
IMP IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:17451676 PMID:21718970 |
RGD:1642142, RGD:6480433 |
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9778187 PMID:17394460 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
IDA IMP
|
|
RGD |
PMID:21212863 PMID:17600658 |
RGD:4891961, RGD:2292134 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
|
ISO
|
mRNA, protein:increased expression:cerebral cortex (human)
|
RGD |
PMID:15802177 |
RGD:1580980 |
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Nppa
|
natriuretic peptide A
|
no_association
|
ISO
|
|
RGD |
PMID:11706124 |
RGD:1626244 |
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nptxr
|
neuronal pentraxin receptor
|
|
IEP
|
mRNA:decreased expression:neocortex
|
RGD |
PMID:12242102 |
RGD:1642302 |
NCBI chr 7:113,217,046...113,235,122
Ensembl chr 7:113,217,050...113,235,156
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
|
IEP
|
protein:decreased expression:brain cortex
|
RGD |
PMID:17344647 |
RGD:4892115 |
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Oaz1
|
ornithine decarboxylase antizyme 1
|
|
IEP
|
mRNA:altered expression:cerebral cortex (rat)
|
RGD |
PMID:19531214 |
RGD:401851038 |
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990
|
|
| G
|
Oprm1
|
opioid receptor, mu 1
|
|
IEP
|
|
RGD |
PMID:16176345 |
RGD:2316630 |
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:45,565,371...45,638,756
|
|
| G
|
Pak1
|
p21 (RAC1) activated kinase 1
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:17997827 |
RGD:2299171 |
NCBI chr 1:161,522,399...161,637,623
Ensembl chr 1:161,491,847...161,637,612
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17640816 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:12099899 |
RGD:729592 |
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pgf
|
placental growth factor
|
|
ISO
|
|
RGD |
PMID:16901914 |
RGD:6483783 |
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
no_association
|
ISO
|
DNA:polymorphism:-7351C>T (human) CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:7477192 PMID:9259745 PMID:9400355 PMID:9479658 PMID:9566367 PMID:9633741 PMID:10572812 PMID:11108748 PMID:11940547 PMID:12221155 PMID:12511774 PMID:14986460 PMID:15017018 PMID:15087567 PMID:16126134 PMID:16763187 PMID:16809570 PMID:17086147 PMID:17525387 PMID:17903870 PMID:20123226 PMID:20212195 PMID:20488584 PMID:20536612 PMID:21037505 PMID:23876515 PMID:16179568 More...
|
RGD:1580879 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:9731615 PMID:10472989 PMID:10512912 PMID:17927297 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
|
ISO
|
|
RGD |
PMID:26307429 |
RGD:11553187 |
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Ppid
|
peptidylprolyl isomerase D
|
|
ISO
|
|
RGD |
PMID:16103352 |
RGD:1580699 |
NCBI chr 2:167,025,985...167,037,998
Ensembl chr 2:167,025,931...167,054,493
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
|
IEP
|
protein:increased expression:cerebral cortex, caudate nucleus (rat)
|
RGD |
PMID:15713259 |
RGD:9999408 |
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Prkaca
|
protein kinase cAMP-activated catalytic subunit alpha
|
|
IEP
|
protein:decreased expression:hippocampus, cerebral cortex, nucleus
|
RGD |
PMID:12150772 |
RGD:7327190 |
NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
|
|
| G
|
Prkacb
|
protein kinase cAMP-activated catalytic subunit beta
|
|
IEP
|
protein:decreased expression:hippocampus, cerebral cortex, cytosol, nucleus
|
RGD |
PMID:12150772 |
RGD:7327190 |
NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:238,300,127...238,386,315
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
|
IEP
|
associated with Subarachnoid Hemorrhage;protein:increased phosphorylation:cerebral artery
|
RGD |
PMID:18032736 |
RGD:2293301 |
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
|
IMP
|
|
RGD |
PMID:17350602 |
RGD:1642524 |
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Proz
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
ISO
|
|
RGD |
PMID:14671240 |
RGD:1358564 |
NCBI chr16:83,150,104...83,165,688
Ensembl chr16:83,152,152...83,165,619
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
|
IDA
|
|
RGD |
PMID:16094316 |
RGD:8693629 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
|
ISO
|
protein:increased expression:microglia, macrophage
|
RGD |
PMID:11740205 PMID:10867793 |
RGD:5688240, RGD:5688247 |
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
IEP ISO IDA
|
protein:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15737438 PMID:17394460 PMID:17564305 PMID:19417757 PMID:21718970 PMID:11158633 PMID:12535784 More...
|
RGD:6480433, RGD:5688292, RGD:1581286 |
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptk2b
|
protein tyrosine kinase 2 beta
|
|
IDA
|
protein:increased tyrosine phosphorylation:cerebral cortex
|
RGD |
PMID:10964954 |
RGD:1642647 |
NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806
|
|
| G
|
Rb1
|
RB transcriptional corepressor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17901229 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18628779 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Ret
|
ret proto-oncogene
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:10407114 |
RGD:6218981 |
NCBI chr 4:152,998,344...153,040,556
Ensembl chr 4:152,998,812...153,040,556
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:21695352 |
RGD:5508764 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Scn5a
|
sodium voltage-gated channel alpha subunit 5
|
|
IEP
|
|
RGD |
PMID:19471098 |
RGD:6484225 |
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470
|
|
| G
|
Sele
|
selectin E
|
|
ISO
|
associated with Hypertension CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17394460 PMID:19107136 |
RGD:2313600 |
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Serpine1
|
serpin family E member 1
|
treatment
|
IDA
|
|
RGD |
PMID:27108052 |
RGD:11073613 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Slc11a2
|
solute carrier family 11 member 2
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:21325818 |
RGD:5688411 |
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:133,381,878...133,418,941
|
|
| G
|
Slc29a1
|
solute carrier family 29 member 1
|
|
IMP
|
|
RGD |
PMID:15829178 |
RGD:2316942 |
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
|
|
| G
|
Slc6a1
|
solute carrier family 6 member 1
|
|
IMP
|
|
RGD |
PMID:15084665 |
RGD:1643209 |
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:149,004,635...149,037,839
|
|
| G
|
Slc8a1
|
solute carrier family 8 member A1
|
|
IEP IMP
|
protein:increased expression:brain mRNA:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:17662498 PMID:22036625 PMID:12377375 |
RGD:1642717, RGD:6771236, RGD:727449 |
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
| G
|
Slc8a2
|
solute carrier family 8 member A2
|
|
IEP
|
|
RGD |
PMID:16107787 |
RGD:2316979 |
NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:85,947,204...85,981,889
|
|
| G
|
Slc8a3
|
solute carrier family 8 member A3
|
|
IEP
|
|
RGD |
PMID:16107787 |
RGD:2316979 |
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:11756504 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15060315 PMID:17901229 PMID:19429140 PMID:10212301 |
RGD:1625695 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
ISO
|
|
RGD |
PMID:10833313 |
RGD:1580852 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
|
IDA
|
|
RGD |
PMID:26442853 |
RGD:155630597 |
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
IDA
|
|
RGD |
PMID:15854740 |
RGD:1581411 |
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17901229 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tek
|
TEK receptor tyrosine kinase
|
|
IEP
|
|
RGD |
PMID:11919509 |
RGD:634324 |
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:14997937 |
RGD:2302105 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Th
|
tyrosine hydroxylase
|
|
IEP
|
protein:decreased expression:solitary tract nucleus, medulla oblongata, locus coeruleus (rat)
|
RGD |
PMID:18356740 |
RGD:5129691 |
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Tjp1
|
tight junction protein 1
|
|
IEP
|
protein:decreased expression:brain
|
RGD |
PMID:19712057 |
RGD:2325131 |
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
no_association
|
ISO
|
DNA:polymorphisms: :p.N299G, p.T399I (human)
|
RGD |
PMID:15258789 |
RGD:1580737 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15756928 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15829914 PMID:16442237 |
RGD:1624184 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf1b
|
TNF receptor superfamily member 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
|
|
| G
|
Tp53
|
tumor protein p53
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19095966 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Ttr
|
transthyretin
|
|
IEP
|
|
RGD |
PMID:15469881 |
RGD:1580523 |
NCBI chr18:12,216,684...12,225,972
Ensembl chr18:12,216,732...12,225,969
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17052689 |
|
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Vip
|
vasoactive intestinal peptide
|
|
IDA
|
|
RGD |
PMID:18158987 |
RGD:5685617 |
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:44,470,462...44,478,558
|
|
| G
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
IEP
|
protein:increased expression:cerebrospinal fluid
|
RGD |
PMID:15902199 |
RGD:2306031 |
NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854
|
|
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
|
IEP
|
|
RGD |
PMID:9916935 |
RGD:11341701 |
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
Hnrnpk
|
heterogeneous nuclear ribonucleoprotein K
|
|
ISO
|
|
RGD |
PMID:21489814 |
RGD:155260371 |
NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565
|
|
| G
|
Pdgfd
|
platelet derived growth factor D
|
|
ISO
|
|
RGD |
PMID:19213942 |
RGD:9854642 |
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:11,773,475...12,007,271
|
|
|
|
| G
|
Epo
|
erythropoietin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19337937 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:1430592 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21062213 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
|
|
| G
|
Notch3
|
notch receptor 3
|
|
ISO
|
|
OMIM |
|
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
|
|
| G
|
Htra1
|
HtrA serine peptidase 1
|
|
ISO
|
ClinVar Annotator: match by term: Cerebrovascular disease with thin skin, alopecia, and disc disease | ClinVar Annotator: match by term: HTRA1-related cerebral small vessel disease | ClinVar Annotator: match by term: SUBCORTICAL VASCULAR ENCEPHALOPATHY, PROGRESSIVE
|
OMIM ClinVar |
PMID:11889251 PMID:19387015 PMID:21115960 PMID:21482952 PMID:22900900 PMID:23963851 PMID:24500651 PMID:24535794 PMID:25506911 PMID:25712943 PMID:25741868 PMID:25770224 PMID:25772074 PMID:25957642 PMID:26063658 PMID:26467025 PMID:27164673 PMID:27353043 PMID:28402226 PMID:28492532 PMID:28782182 PMID:29546604 PMID:29561953 PMID:29895533 PMID:30447605 PMID:30859180 PMID:31316458 PMID:32017060 PMID:32042911 PMID:32101834 PMID:32581362 PMID:32719647 PMID:33268848 PMID:34220097 PMID:34626176 PMID:35307828 PMID:35606766 PMID:35946346 PMID:36047879 PMID:36253578 PMID:36261288 PMID:36380532 PMID:37348440 More...
|
|
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:194,927,687...194,977,620
|
|
|
|
| G
|
A2m
|
alpha-2-macroglobulin
|
disease_progression
|
ISO
|
|
RGD |
PMID:28266892 |
RGD:13702087 |
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
ISO
|
DNA:deletion:intron:IVS16+1464-1751del (human) ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
|
ClinVar RGD |
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:11596779 More...
|
RGD:11038922 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
IDA
|
|
RGD |
PMID:17067559 |
RGD:1625229 |
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:23288172 |
RGD:8696004 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agxt2
|
alanine-glyoxylate aminotransferase 2
|
onset
|
ISO
|
DNA:missense mutation:cds:V498L (rs16899974) (human)
|
RGD |
PMID:26984639 |
RGD:329961314 |
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
|
|
| G
|
Ahsp
|
alpha hemoglobin stabilizing protein
|
|
ISO
|
mRNA:increased expression:venous blood (human)
|
RGD |
PMID:29284304 |
RGD:329961296 |
NCBI chr 1:192,310,306...192,315,943
Ensembl chr 1:192,310,244...192,315,942
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: ALOX5AP-related disorder
|
OMIM ClinVar |
|
|
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Ang
|
angiogenin
|
severity
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:17823536 |
RGD:6892714 |
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Anxa1
|
annexin A1
|
treatment
|
IEP
|
associated with Ischemic Attack, Transient
|
RGD |
PMID:22617647 |
RGD:7483559 |
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Apoa5
|
apolipoprotein A5
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :-1131T>C (human)
|
RGD |
PMID:19107359 |
RGD:2313314 |
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:55,456,899...55,460,507
|
|
| G
|
Apob
|
apolipoprotein B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:2352345 |
RGD:2313973 |
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO
|
DNA:polymorphism: :3932T>C (human)
|
RGD |
PMID:17016617 |
RGD:1601237 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Bhmt
|
betaine-homocysteine S-methyltransferase
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:26,594,854...26,614,715
|
|
| G
|
Brinp3
|
BMP/retinoic acid inducible neural specific 3
|
|
ISO
|
associated with diabetes mellitus;mRNA:protein:increased expression:blood mononuclear cell:
|
RGD |
PMID:26717922 |
RGD:14398486 |
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:60,966,100...61,397,039
|
|
| G
|
Cartpt
|
CART prepropeptide
|
ameliorates
|
IDA
|
|
RGD |
PMID:16971488 |
RGD:407986645 |
NCBI chr 2:32,989,215...32,991,794
Ensembl chr 2:32,989,215...32,999,712
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
treatment
|
ISO
|
|
RGD |
PMID:29111308 |
RGD:155260331 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
treatment
|
ISO
|
|
RGD |
PMID:29111308 |
RGD:155260331 |
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
|
ISO
|
|
RGD |
PMID:23602964 |
RGD:8552262 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cd36
|
CD36 molecule
|
|
ISO
|
associated with Hyperlipidemias
|
RGD |
PMID:22718544 |
RGD:6893487 |
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
IDA
|
|
RGD |
PMID:16306811 |
RGD:1580986 |
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke | ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
|
ClinVar OMIM |
PMID:2222810 PMID:2429850 PMID:2825773 PMID:6305407 PMID:6405779 PMID:8696333 PMID:8896550 PMID:8916933 PMID:9106528 PMID:9292507 PMID:9462220 PMID:9493607 PMID:9531249 PMID:9569177 PMID:9694698 PMID:9869612 PMID:10027711 PMID:10233438 PMID:10233439 PMID:10336270 PMID:10348710 PMID:10348711 PMID:10348712 PMID:10406905 PMID:10477778 PMID:10544935 PMID:11358905 PMID:11443298 PMID:11506076 PMID:11796466 PMID:11874997 PMID:11904676 PMID:14629473 PMID:15059842 PMID:15534175 PMID:16493002 PMID:16606808 PMID:19159930 PMID:19289024 PMID:19531787 PMID:19554541 PMID:19560233 PMID:19652888 PMID:20301327 PMID:21243428 PMID:21349849 PMID:23429074 PMID:24033266 PMID:25741868 PMID:27031503 PMID:28492532 PMID:28707429 PMID:30297698 PMID:31064749 PMID:31352677 PMID:34110897 PMID:34355501 PMID:38498041 More...
|
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
F5
|
coagulation factor V
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke | ClinVar Annotator: match by term: Ischemic stroke, susceptibility to
|
ClinVar OMIM |
PMID:7586244 PMID:7803250 PMID:7877648 PMID:7910348 PMID:7911872 PMID:7968118 PMID:8049422 PMID:8164730 PMID:8164741 PMID:8566967 PMID:8616100 PMID:8822583 PMID:9245936 PMID:9339109 PMID:9372726 PMID:9415695 PMID:9454741 PMID:9459326 PMID:9518910 PMID:9734642 PMID:10328130 PMID:10348711 PMID:10477778 PMID:10494770 PMID:10507841 PMID:10666427 PMID:11018168 PMID:11110695 PMID:11686338 PMID:11950065 PMID:12069454 PMID:12070000 PMID:12421138 PMID:12816860 PMID:14996674 PMID:15208046 PMID:15534175 PMID:15638861 PMID:15946211 PMID:16199547 PMID:16246256 PMID:16493002 PMID:16769590 PMID:16931580 PMID:19652888 PMID:20051284 PMID:21116184 PMID:21774968 PMID:22704462 PMID:22992668 PMID:23382263 PMID:23677252 PMID:23900608 PMID:24033266 PMID:25741868 PMID:25977387 PMID:26251307 PMID:26990548 PMID:27797270 PMID:28492532 PMID:28750087 PMID:30924984 PMID:31064749 PMID:31399523 PMID:34355501 More...
|
|
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
F7
|
coagulation factor VII
|
treatment
|
ISO
|
protein:increased expression, increased activity:plasma (human) human protein in a mouse model
|
RGD |
PMID:14733777 PMID:21998055 |
RGD:11049518, RGD:11049520 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Fbn1
|
fibrillin 1
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar |
PMID:7611299 PMID:8894692 PMID:9401003 PMID:9536098 PMID:10533071 PMID:10874320 PMID:11700157 PMID:12402346 PMID:12938084 PMID:14695540 PMID:16220557 PMID:16222657 PMID:16835936 PMID:17253931 PMID:17576681 PMID:17657824 PMID:17663468 PMID:19159394 PMID:19293843 PMID:21542060 PMID:24033266 PMID:24161884 PMID:25741868 PMID:26133393 PMID:28492532 PMID:29357934 PMID:31098894 PMID:37684520 More...
|
|
NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283
|
|
| G
|
Folh1
|
folate hydrolase 1
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr 1:149,828,286...149,914,313
Ensembl chr 1:149,840,760...149,914,035
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
exacerbates treatment
|
ISO IMP
|
DNA:SNP:3' UTR:+243C>T (human) DNA:SNP, haplotype:rs841 (human)
|
RGD |
PMID:21181356 PMID:16282548 PMID:21963893 |
RGD:329961322, RGD:329961574, RGD:329961572 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gp6
|
glycoprotein 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:34237320 |
RGD:401794450 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
susceptibility
|
ISO
|
DNA, protein:SNP,decreased expression:promoter,plasma:-861A>T (human) DNA:SNPs, haplotypes:promoter:rs8177412, rs870407, rs870406 (human) DNA:SNPs, haplotype:promoter:-942 A>C, -927 T>C, -861 A>T, -302 A>T, -284 T>A, -568 T>C, -518 T>C, -65 T>C (human)
|
RGD |
PMID:25126700 PMID:20946167 PMID:17122425 |
RGD:401827128, RGD:401827165, RGD:401827163 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
severity
|
ISO
|
|
RGD |
PMID:23723305 |
RGD:13792693 |
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grn
|
granulin precursor
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar |
PMID:18723524 PMID:25741868 PMID:28492532 |
|
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
|
|
| G
|
Gsn
|
gelsolin
|
severity
|
ISO
|
protein:decreased expression:blood plasma (human)
|
RGD |
PMID:21481565 |
RGD:329337334 |
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
disease_progression susceptibility ameliorates
|
ISO
|
RNA:increased expression:blood plasma, plasma exosome (human) DNA:SNP::(rs217727) (human) DNA:SNPs,haplotypes: (rs217727,rs4929984) (human) associated with atherosclerosis
|
RGD |
PMID:36453417 PMID:33541284 PMID:28203482 PMID:30778327 PMID:36453417 |
RGD:155882574, RGD:156430336, RGD:155900760, RGD:155900761, RGD:155882574 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hba-a2
|
hemoglobin alpha, adult chain 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:1634355 |
|
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,828,377...15,829,141
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
severity
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:34708885 |
RGD:155260326 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:23288172 |
RGD:8696004 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
|
RGD |
PMID:23311871 |
RGD:10755574 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf1a
|
HNF1 homeobox A
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:28035729 |
RGD:329901837 |
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:20083630 |
RGD:8547724 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ifnb1
|
interferon beta 1
|
susceptibility no_association
|
ISO IDA
|
DNA:SNP,haplotype: rs9333358(human)
|
RGD |
PMID:31810024 PMID:16514094 |
RGD:401851921, RGD:401854228 |
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
ISO
|
|
RGD |
PMID:29111308 |
RGD:155260331 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il18
|
interleukin 18
|
treatment
|
IEP
|
|
RGD |
PMID:20584315 |
RGD:8655991 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1b
|
interleukin 1 beta
|
treatment
|
ISO
|
|
RGD |
PMID:29111308 |
RGD:155260331 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
ISO
|
|
RGD |
PMID:29111308 |
RGD:155260331 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irf8
|
interferon regulatory factor 8
|
exacerbates
|
ISO
|
|
RGD |
PMID:24528256 |
RGD:329902074 |
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
|
|
| G
|
Itga9
|
integrin subunit alpha 9
|
susceptibility
|
ISO
|
DNA:SNPs,haplotype:rs189897,rs2212020(human)
|
RGD |
PMID:21764681 |
RGD:13602007 |
NCBI chr 8:127,185,244...127,493,296
Ensembl chr 8:127,169,226...127,493,296
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
|
ISO
|
protein:increased expression:neutrophil (human)
|
RGD |
PMID:31355307 |
RGD:329901831 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Kalrn
|
kalirin, RhoGEF kinase
|
susceptibility sexual_dimorphism
|
ISO
|
DNA:SNP:intron: (rs6438833) (human) DNA:SNPs, haplotypes:intron,cds: (rs7620580, rs1708303) (human)
|
RGD |
PMID:25917671 PMID:28706949 |
RGD:11085239, RGD:329956420 |
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:79,703,366...80,133,329
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
ameliorates
|
ISO
|
|
RGD |
PMID:29037241 |
RGD:329969881 |
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Lipg
|
lipase G, endothelial type
|
susceptibility
|
ISO
|
DNA:polymorphism: :584C>T (human)
|
RGD |
PMID:17016617 |
RGD:1601237 |
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260
|
|
| G
|
Lta
|
lymphotoxin alpha
|
|
ISO
|
|
RGD |
PMID:14593215 |
RGD:1580416 |
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
|
ISO
|
DNA:SNPs:promoter:g.-444A>C, g.-1072G>A
|
RGD |
PMID:19280718 |
RGD:626168270 |
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
|
IDA
|
|
RGD |
PMID:22444278 |
RGD:6483079 |
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
treatment
|
IMP
|
|
RGD |
PMID:23968852 |
RGD:10412642 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Mir145
|
microRNA 145
|
ameliorates
|
ISO
|
miRNA:increased expression:blood (human)
|
RGD |
PMID:22370881 PMID:26722607 |
RGD:155260291, RGD:155260295 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mir21
|
microRNA 21
|
|
IEP
|
RNA:increased expression:brain
|
RGD |
PMID:20840605 |
RGD:41410884 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir210
|
microRNA 210
|
severity treatment
|
ISO
|
miRNA:decreased expression:blood (human) miRNA:decreased expression:blood serum (human)
|
RGD |
PMID:21622133 PMID:29111308 PMID:34708885 |
RGD:155260318, RGD:155260331, RGD:155260326 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mir223
|
microRNA 223
|
treatment
|
IEP
|
|
RGD |
PMID:28469772 |
RGD:35668865 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mir30a
|
microRNA 30a
|
treatment
|
IEP
|
|
RGD |
PMID:28469772 |
RGD:35668865 |
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011
|
|
| G
|
Mir383
|
microRNA 383
|
treatment
|
IEP
|
|
RGD |
PMID:28469772 |
RGD:35668865 |
NCBI chr16:60,743,764...60,743,837
Ensembl chr16:60,743,764...60,743,837
|
|
| G
|
Mir494
|
microRNA 494
|
disease_progression
|
ISO
|
|
RGD |
PMID:32239566 |
RGD:155883173 |
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16846501 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16846501 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mt-co2
|
mitochondrially encoded cytochrome c oxidase II
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar |
|
|
NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674
|
|
| G
|
Mt-cyb
|
mitochondrially encoded cytochrome b
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar |
|
|
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,124...15,266
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
|
ISO
|
DNA:transition:cds:g.677C>T (human)
|
RGD |
PMID:10929044 |
RGD:1580590 |
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Mtr
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541
|
|
| G
|
Myrf
|
myelin regulatory factor
|
|
ISO
|
DNA:SNP:exon:rs174535(human)
|
RGD |
PMID:36193932 |
RGD:213230151 |
NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:216,279,057...216,311,178
|
|
| G
|
Ndufa13
|
NADH:ubiquinone oxidoreductase subunit A13
|
|
IEP
|
protein:increased expression:brain, neuron, astrocyte:
|
RGD |
PMID:17523870 |
RGD:401854233 |
NCBI chr16:19,560,526...19,567,500
Ensembl chr 7:32,257,006...32,257,492
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar OMIM |
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch3
|
notch receptor 3
|
|
ISO
|
ClinVar Annotator: match by term: Ischemic stroke
|
ClinVar |
PMID:9388399 PMID:10371548 PMID:10802804 PMID:10854111 PMID:11102981 PMID:11755616 PMID:15364702 PMID:16009764 PMID:16193256 PMID:17729386 PMID:20301673 PMID:20329594 PMID:22422895 PMID:25623805 PMID:25741868 PMID:26308724 PMID:26467025 PMID:26843489 PMID:26912635 PMID:27206574 PMID:27890607 PMID:28492532 PMID:28710804 PMID:31915071 PMID:32277177 PMID:32457593 PMID:32581362 PMID:34335700 PMID:34691145 More...
|
|
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Npy
|
neuropeptide Y
|
|
IEP ISO
|
protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11821007 PMID:17123484 |
RGD:10448931 |
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
susceptibility
|
ISO
|
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
|
RGD |
PMID:21903943 |
RGD:401842365 |
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
|
ISO
|
DNA:SNPs:peripheral blood, leukocyte, 3' utr
|
RGD |
PMID:33209049 |
RGD:408418730 |
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
treatment
|
ISO
|
|
RGD |
PMID:18003894 PMID:18003894 |
RGD:13462069, RGD:13462069 |
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
| G
|
Pdx1
|
pancreatic and duodenal homeobox 1
|
|
ISO
|
associated with Metabolic Syndrome; DNA:duplication:5' utr:-108 3G>4G (human)
|
RGD |
PMID:18506375 |
RGD:2311309 |
NCBI chr12:12,793,957...12,799,156
Ensembl chr12:12,793,957...12,799,156
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
|
ISO
|
DNA:SNP:intron: (rs12526453) (human)
|
RGD |
PMID:23042660 |
RGD:401900685 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
|
ISO
|
|
RGD |
PMID:18201705 |
RGD:6482775 |
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:1579960 PMID:1899364 PMID:9183334 PMID:16148626 PMID:18195371 PMID:18544249 More...
|
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12133459 PMID:16773802 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
|
ISO
|
|
RGD |
PMID:20138161 |
RGD:6483804 |
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Pon1
|
paraoxonase 1
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.Q192R (human)
|
RGD |
PMID:10729395 |
RGD:1580196 |
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes: (rs11545941, rs6954345) (human)
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Prkch
|
protein kinase C, eta
|
|
ISO
|
ClinVar Annotator: match by term: Cerebral infarction, susceptibility to
|
ClinVar |
PMID:12958323 PMID:17206144 |
|
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:33761690 |
|
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Pros1
|
protein S
|
|
ISO
|
DNA:missense mutation:exon:p.R355C (1063C>T) (human)
|
RGD |
PMID:21172841 |
RGD:11250416 |
NCBI chr11:13,676,310...13,757,858
Ensembl chr11:13,676,769...13,757,852
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
exacerbates treatment
|
ISO IMP
|
DNA:SNP, haplotype:3' utr: (rs5602) (human) DNA:SNPs:exon, 3' utr: (rs5629, rs5602) (human) DNA:repeat:promoter:g.-6(CCGCCAGCC)3-7 (human)
|
RGD |
PMID:28478978 PMID:28108096 PMID:11130769 PMID:11997284 |
RGD:401901149, RGD:401959400, RGD:401901269, RGD:401901194 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
exacerbates severity
|
ISO
|
protein:increased expression:blood plasma (human) protein:increased expression:blood serum (human) associated with diabetes mellitus; protein:increased expression:blood serum (human)
|
RGD |
PMID:19846170 PMID:30030781 PMID:30038059 |
RGD:329845582, RGD:329853305, RGD:329845588 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
RT1-CE16
|
RT1 class I, locus CE16
|
susceptibility
|
ISO
|
DNA:polymorphism::HLA-A31:01 (human)
|
RGD |
PMID:24767290 |
RGD:401827096 |
NCBI chr20:3,261,656...3,265,548
|
|
| G
|
RT1-Db1
|
RT1 class II, locus Db1
|
susceptibility
|
ISO
|
DNA:polymorphism,haplotype::HLA-B37:01 (human)
|
RGD |
PMID:24767290 |
RGD:401827096 |
NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,550,596...4,560,165
|
|
| G
|
Serpine1
|
serpin family E member 1
|
treatment
|
IDA
|
|
RGD |
PMID:25702149 |
RGD:11075081 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serping1
|
serpin family G member 1
|
treatment
|
ISO
|
associated with Venous Thrombosis
|
RGD |
PMID:10446335 |
RGD:8661653 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Slc6a1
|
solute carrier family 6 member 1
|
|
IEP
|
mRNA:increased expression:cerebral cortex, neuron
|
RGD |
PMID:15349978 |
RGD:1643205 |
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:149,004,635...149,037,839
|
|
| G
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1
|
|
ISO
|
mRNA:increased expression:blood (human)
|
RGD |
PMID:35041140 |
RGD:155598600 |
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
susceptibility
|
ISO
|
DNA:polymorphisms: :
|
RGD |
PMID:19403042 |
RGD:11059536 |
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Thbd
|
thrombomodulin
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.A455V (human)
|
RGD |
PMID:15574195 |
RGD:5685021 |
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
ISO
|
|
RGD |
PMID:16173529 PMID:29111308 |
RGD:1580315, RGD:155260331 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
disease_progression
|
ISO
|
|
RGD |
PMID:19895657 |
RGD:7205492 |
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tomm40
|
translocase of outer mitochondrial membrane 40
|
|
ISO
|
DNA:SNP: :rs2075650 (human)
|
RGD |
PMID:26171154 |
RGD:13464126 |
NCBI chr 1:88,486,745...88,498,833
Ensembl chr 1:88,486,758...88,499,671
|
|
| G
|
Tyms
|
thymidylate synthetase
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes: (rs502396,rs16430,rs8423)
|
RGD |
PMID:20458436 |
RGD:401794454 |
NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097
|
|
| G
|
Vim
|
vimentin
|
|
IEP
|
|
RGD |
PMID:18802758 |
RGD:6480442 |
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
treatment
|
IEP
|
|
RGD |
PMID:22217518 PMID:23769041 |
RGD:7245568, RGD:8695995 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
C3
|
complement C3
|
treatment
|
IDA
|
|
RGD |
PMID:25122638 |
RGD:11040803 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Cd40
|
CD40 molecule
|
treatment
|
IDA
|
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
treatment
|
IDA
|
liver
|
RGD |
PMID:22826618 |
RGD:11352297 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
F7
|
coagulation factor VII
|
treatment
|
ISO
|
human protein in a rat model
|
RGD |
PMID:12095034 |
RGD:11049508 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IEP
|
|
RGD |
PMID:22217518 |
RGD:7245568 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
ameliorates
|
IMP
|
|
RGD |
PMID:24312257 |
RGD:401700379 |
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
treatment
|
IDA
|
|
RGD |
PMID:23985719 |
RGD:10041002 |
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
IMP
|
|
RGD |
PMID:24598936 |
RGD:10450586 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
|
| G
|
Aco1
|
aconitase 1
|
|
IEP
|
|
RGD |
PMID:20176611 |
RGD:11541086 |
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
|
|
| G
|
Alb
|
albumin
|
disease_progression
|
ISO
|
|
RGD |
PMID:24370342 |
RGD:11035281 |
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
|
ISO
|
|
RGD |
PMID:17298994 |
RGD:7241819 |
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
disease_progression
|
IEP
|
mRNA, protein:increased expression:kidney (rat)
|
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Clu
|
clusterin
|
treatment
|
IEP
|
|
RGD |
PMID:22494435 |
RGD:9068431 |
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cs
|
citrate synthase
|
treatment
|
IDA
|
|
RGD |
PMID:20005400 |
RGD:243048470 |
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
|
ISO
|
|
RGD |
PMID:22845765 |
RGD:7241226 |
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
treatment
|
IDA
|
|
RGD |
PMID:18209025 |
RGD:9685339 |
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Pdgfa
|
platelet derived growth factor subunit A
|
|
IEP
|
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322
|
|
| G
|
Pdgfb
|
platelet derived growth factor subunit B
|
|
IEP
|
mRNA:increased expression:kidney:
|
RGD |
PMID:15785371 PMID:11889420 |
RGD:10449491, RGD:11080974 |
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
|
IEP
|
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
|
IEP
|
|
RGD |
PMID:11889420 |
RGD:11080974 |
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
protein:increased secretion:T lymphocyte (human)
|
RGD |
PMID:16387096 |
RGD:7241259 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
ISO
|
protein:increased expression:kidney:
|
RGD |
PMID:16221712 |
RGD:13208600 |
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Serpine1
|
serpin family E member 1
|
treatment
|
ISO
|
protein:increased expression:kidney:
|
RGD |
PMID:16221712 PMID:18192922 |
RGD:13208600, RGD:13208601 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
|
|
| G
|
Aco1
|
aconitase 1
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:22639386 |
RGD:11541085 |
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
|
|
| G
|
Apoe
|
apolipoprotein E
|
|
IEP
|
protein:increased expression:cerebral cortex, synapse
|
RGD |
PMID:28620701 |
RGD:13703133 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
App
|
amyloid beta precursor protein
|
|
IEP
|
protein:increased expression:cerebral white matter:
|
RGD |
PMID:11743996 |
RGD:10054250 |
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Bace1
|
beta-secretase 1
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:28683457 |
RGD:13782142 |
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:24072673 |
RGD:10402542 |
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
Dag1
|
dystroglycan 1
|
|
IEP
|
|
RGD |
PMID:21192954 |
RGD:11541061 |
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199
|
|
| G
|
Fth1
|
ferritin heavy chain 1
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:22639386 |
RGD:11541085 |
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
treatment
|
IDA
|
|
RGD |
PMID:16645134 |
RGD:10401930 |
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Hcn1
|
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1
|
|
IEP
|
|
RGD |
PMID:24838625 |
RGD:9686415 |
NCBI chr 2:51,228,710...51,632,806
Ensembl chr 2:51,228,710...51,632,806
|
|
| G
|
Hcn2
|
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
|
|
IEP
|
|
RGD |
PMID:24838625 |
RGD:9686415 |
NCBI chr 7:10,620,422...10,639,457
Ensembl chr 7:10,620,422...10,639,457
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:24072673 |
RGD:10402542 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
|
ISO
|
protein:hyperphosphorylation:brain:
|
RGD |
PMID:24371084 |
RGD:10412307 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
|
ISO
|
protein:hyperphosphorylation:corpus callosum, endothelial cell, astrocyte:
|
RGD |
PMID:24371084 |
RGD:10412307 |
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mcm2
|
minichromosome maintenance complex component 2
|
|
IEP
|
protein:increased expression:dentate gyrus
|
RGD |
PMID:17931356 |
RGD:10412049 |
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
IMP
|
|
RGD |
PMID:15703700 |
RGD:13824977 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
ameliorates
|
IMP
|
|
RGD |
PMID:24294978 |
RGD:329955573 |
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
treatment
|
IEP
|
|
RGD |
PMID:32184165 |
RGD:597538600 |
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Tfrc
|
transferrin receptor
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:22639386 |
RGD:11541085 |
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
|
IEP
|
mRNA:increased expression:lung
|
RGD |
PMID:22305384 |
RGD:10395369 |
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Glcci1
|
glucocorticoid induced 1
|
disease_progression
|
ISO
|
DNA:SNP:promoter: rs37972
|
RGD |
PMID:30229311 |
RGD:628359295 |
NCBI chr 4:37,274,271...37,601,898
Ensembl chr 4:37,529,364...37,599,802 Ensembl chr 4:37,529,364...37,599,802
|
|
|
|
| G
|
Hpx
|
hemopexin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:14500188 |
|
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
|
|
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
associated with Mucocutaneous Lymph Node Syndrome;protein:increased expression:serum
|
RGD |
PMID:22683371 |
RGD:8694456 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15548583 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Itpkc
|
inositol-trisphosphate 3-kinase C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18084290 |
|
NCBI chr 1:91,628,606...91,650,182
Ensembl chr 1:91,628,608...91,653,350
|
|
| G
|
Mill1
|
MHC I like leukocyte 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10899738 |
|
NCBI chr 1:87,500,591...87,526,983
Ensembl chr 1:87,500,676...87,526,981
|
|
| G
|
Mmp12
|
matrix metallopeptidase 12
|
susceptibility
|
ISO
|
|
RGD |
PMID:12103254 |
RGD:1582363 |
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
|
|
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
|
ISO
|
|
RGD GAD |
PMID:11086027 PMID:15118671 |
RGD:1600951, RGD:1331525 |
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abcc6
|
ATP binding cassette subfamily C member 6
|
|
ISO
|
DNA:nonsense mutation:exon:p.R1141X (3421C>T) (human)
|
RGD |
PMID:12176944 |
RGD:11038788 |
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895
|
|
| G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11099417 PMID:11138003 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
| G
|
Abcg8
|
ATP binding cassette subfamily G member 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
CTD ClinVar |
PMID:11099417 PMID:25741868 |
|
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
|
|
| G
|
Abo
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 3:30,560,172...30,604,758
|
|
| G
|
Acat2
|
acetyl-CoA acetyltransferase 2
|
susceptibility
|
ISO
|
DNA:polymorphisms: :41A>G, 734C>T, IVS4-57_58ins48bp
|
RGD |
PMID:16195894 |
RGD:1601112 |
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
susceptibility
|
ISO
|
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:14989558 PMID:12975417 PMID:15118671 |
RGD:1566498, RGD:1331525 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Acp1
|
acid phosphatase 1
|
|
ISO
|
|
RGD |
PMID:19246900 |
RGD:2313179 |
NCBI chr 6:53,233,937...53,249,576
Ensembl chr 6:53,233,948...53,251,959
|
|
| G
|
Adamts7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
susceptibility
|
ISO
|
protein:decreased expression:adipose tissue associated with type 2 diabetes mellitus; DNA:SNP: (rs2241766) +45T>G(human)
|
RGD |
PMID:17878891 PMID:27218147 |
RGD:5686802, RGD:329956419 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adrb3
|
adrenoceptor beta 3
|
no_association
|
ISO
|
DNA:missense mutation:cds:p.W64R (human) DNA:missense mutation:cds:p.W64R rs4994 (human)
|
RGD |
PMID:9126344 PMID:11229427 |
RGD:1559325, RGD:5684412 |
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
| G
|
Adtrp
|
androgen-dependent TFPI-regulating protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378986 |
|
NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
susceptibility
|
ISO
|
DNA:polymorphism:cds:p.G82S (human) associated with Mucocutaneous Lymph Node Syndrome
|
RGD |
PMID:20668462 PMID:22337222 |
RGD:6767569, RGD:8695960 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agt
|
angiotensinogen
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
susceptibility
|
ISO
|
DNA:polymorphism:3' utr:1166A>C
|
RGD GAD |
PMID:12975417 PMID:15118671 |
RGD:1566498, RGD:1331525 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Agxt2
|
alanine-glyoxylate aminotransferase 2
|
|
ISO
|
DNA:missense mutation:cds:rs37369, rs16899974 (human)
|
RGD |
PMID:30284143 |
RGD:329961317 |
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
|
|
| G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Type 2;DNA:SNPs
|
RGD |
PMID:17062776 PMID:17062776 |
RGD:1625792, RGD:1625792 |
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
ISO
|
|
RGD |
PMID:18054314 |
RGD:5509083 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
|
ISO
|
DNA:snps:multiple (human)
|
RGD |
PMID:19596330 |
RGD:2313883 |
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Ampd1
|
adenosine monophosphate deaminase 1
|
susceptibility
|
ISO
|
DNA:SNP:exon 2:34C>T (human)
|
RGD |
PMID:11028479 |
RGD:329349360 |
NCBI chr 2:193,287,219...193,308,446
Ensembl chr 2:193,287,265...193,308,443
|
|
| G
|
Angptl4
|
angiopoietin-like 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:27135400 |
|
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
|
|
| G
|
Anks1a
|
ankyrin repeat and sterile alpha motif domain containing 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,965,028...6,118,875
|
|
| G
|
Apcs
|
amyloid P component, serum
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12714198 |
|
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824
|
|
| G
|
Aph1b
|
aph-1 homolog B, gamma secretase subunit
|
|
ISO
|
DNA:SNP:CDS:p.F217L (rs1047552) (human)
|
RGD |
PMID:18987747 |
RGD:13703124 |
NCBI chr 8:76,310,380...76,334,146
Ensembl chr 8:76,310,380...76,331,428
|
|
| G
|
Apoa1
|
apolipoprotein A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:27135400 PMID:2128269 PMID:15118671 |
RGD:1601188, RGD:1331525 |
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
|
|
| G
|
Apoa2
|
apolipoprotein A2
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:17923573 |
RGD:2313956 |
NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410
|
|
| G
|
Apoa5
|
apolipoprotein A5
|
no_association
|
ISO
|
DNA:polymorphism:promoter:-1131T>C (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-1131T>C, c.56C>G (human)
|
CTD RGD |
PMID:24097064 PMID:15177130 PMID:15306190 |
RGD:2313322, RGD:1578412 |
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:55,456,899...55,460,507
|
|
| G
|
Apob
|
apolipoprotein B
|
no_association
|
ISO
|
DNA:SNP:CDS:rs1042031 (human)
|
RGD GAD |
PMID:9585673 PMID:28167353 PMID:15118671 PMID:1732399 |
RGD:1578418, RGD:329901772, RGD:1331525, RGD:1578417 |
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoc3
|
apolipoprotein C3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:24097064 PMID:14709372 PMID:15118671 PMID:15059615 |
RGD:1578443, RGD:1331525, RGD:1626412 |
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679
|
|
| G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO IMP
|
DNA:snp, missense mutation:promoter, cds:g.-219G>T, p.C112R (human) associated with Diabetes Mellitus, Non-Insulin Dependent;DNA:SNP:promoter:-219G>T (human) DNA:missense mutation:cds:p.C112R (human)
|
RGD GAD |
PMID:14563588 PMID:28808185 PMID:15118671 PMID:15059615 PMID:12860263 |
RGD:1580039, RGD:13703132, RGD:1331525, RGD:1626412, RGD:1578449 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Apom
|
apolipoprotein M
|
susceptibility
|
ISO
|
DNA:SNP:promoter:g.-778T>C(rs805296)(human)
|
RGD |
PMID:17674965 |
RGD:2314241 |
NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,692,737...3,698,218
|
|
| G
|
Ar
|
androgen receptor
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Arhgap31
|
Rho GTPase activating protein 31
|
susceptibility
|
ISO
|
associated with nicotine dependence;DNA:SNP: (rs10934490) (human)
|
RGD |
PMID:19706030 |
RGD:329970276 |
NCBI chr11:75,544,176...75,657,087
Ensembl chr11:75,544,040...75,661,076
|
|
| G
|
Atp2b1
|
ATPase plasma membrane Ca2+ transporting 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22751097 |
|
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904
|
|
| G
|
Bche
|
butyrylcholinesterase
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.A539T (human)
|
RGD |
PMID:17852836 |
RGD:2306777 |
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Brinp3
|
BMP/retinoic acid inducible neural specific 3
|
|
ISO
|
DNA:SNP: :rs12732361(human), associated with male.
|
RGD |
PMID:27461004 |
RGD:14398490 |
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:60,966,100...61,397,039
|
|
| G
|
Btnl2
|
butyrophilin-like 2
|
susceptibility
|
ISO
|
associated with Mucocutaneous Lymph Node Syndrome; DNA:SNP: :rs 2395158(human)
|
RGD |
PMID:19882345 |
RGD:9685030 |
NCBI chr20:4,492,100...4,505,932
Ensembl chr20:4,492,111...4,505,932
|
|
| G
|
C5h1orf167
|
similar to human chromosome 1 open reading frame 167
|
|
ISO
|
DNA:SNP: :rs56001051(human)
|
RGD |
PMID:31175347 |
RGD:14696712 |
NCBI chr 5:163,770,495...163,788,791
|
|
| G
|
Carf
|
calcium responsive transcription factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 9:68,996,419...69,046,480
Ensembl chr 9:68,996,250...69,046,479
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
|
ISO
|
CBS variant c.844ins68
|
RGD |
PMID:12855221 |
RGD:1600626 |
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP ISO
|
protein:increased expression:myocardium (rat) CTD Direct Evidence: marker/mechanism protein:increased expression:serum (human)
|
CTD RGD |
PMID:11500196 PMID:16934270 PMID:16297799 PMID:9537339 |
RGD:8549513, RGD:8549577 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl26
|
C-C motif chemokine ligand 26
|
susceptibility
|
ISO
|
protein:decreased expression:plasma (human)
|
RGD |
PMID:16620281 |
RGD:11081161 |
NCBI chr12:26,745,972...26,750,924
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
|
ISO
|
|
RGD |
PMID:12742282 |
RGD:5508477 |
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
|
ISO
|
|
RGD |
PMID:12426226 |
RGD:1581178 |
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
|
IEP
|
mRNA:increased expression:heart (rat)
|
RGD |
PMID:17449418 |
RGD:4890438 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cd14
|
CD14 molecule
|
no_association
|
ISO
|
DNA:SNP:promoter
|
RGD |
PMID:18157711 |
RGD:2314154 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd36
|
CD36 molecule
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
PMID:25741868 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd40lg
|
CD40 ligand
|
|
ISO IEP
|
protein:increased expression:serum CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome;DNA:SNP: :rs4810485 (human) protein:increased expression:coronary artery, serum associated with Kidney Failure, Chronic
|
CTD RGD |
PMID:16368305 PMID:17635572 PMID:22645426 PMID:23819214 PMID:16494885 |
RGD:2314209, RGD:8547776, RGD:7248750, RGD:7248436 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cdh5
|
cadherin 5
|
|
ISO
|
|
RGD |
PMID:14695457 |
RGD:1598391 |
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
|
|
| G
|
Cdkn2b
|
cyclin-dependent kinase inhibitor 2B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23104008 PMID:34961328 |
|
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
|
|
| G
|
Cela2a
|
chymotrypsin like elastase 2A
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar |
PMID:25741868 PMID:31358993 |
|
NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208
|
|
| G
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:198,717,896...198,741,581
|
|
| G
|
Chi3l1
|
chitinase 3 like 1
|
|
ISO
|
protein:increased secretion:serum (human)
|
RGD |
PMID:17627189 |
RGD:4892665 |
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
|
|
| G
|
Clcn6
|
chloride voltage-gated channel 6
|
susceptibility
|
ISO
|
DNA:SNP: :rs3737964(human)
|
RGD |
PMID:26740945 |
RGD:14696742 |
NCBI chr 5:163,715,593...163,748,301
Ensembl chr 5:163,717,439...163,748,198
|
|
| G
|
Clu
|
clusterin
|
|
ISO
|
associated with Mucocutaneous Lymph Node Syndrome;protein:decreased expression:plasma
|
RGD |
PMID:20711835 |
RGD:9068393 |
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cpe
|
carboxypeptidase E
|
severity
|
ISO
|
DNA:SNPs:CDS:intron 4, exon 4 (A2925G, G2855A) (human)
|
RGD |
PMID:18080843 |
RGD:405650688 |
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524
|
|
| G
|
Crp
|
C-reactive protein
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:serum CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:24868163 PMID:19615354 |
RGD:2313344 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cst3
|
cystatin C
|
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:17983622 |
RGD:2314352 |
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Cubn
|
cubilin
|
susceptibility
|
ISO
|
DNA:SNP,haplotypes:intron: (rs2291521)G>A (human)
|
RGD |
PMID:33004870 |
RGD:329901841 |
NCBI chr17:81,293,619...81,501,694
Ensembl chr17:81,293,619...81,501,694
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
|
ISO
|
|
RGD GAD |
PMID:14709372 PMID:15118671 |
RGD:1578443, RGD:1331525 |
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cyp27a1
|
cytochrome P450, family 27, subfamily a, polypeptide 1
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
|
|
| G
|
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1
|
|
ISO
|
DNA:SNP:CDS:rs10741657 (human)
|
RGD |
PMID:25003556 |
RGD:401901077 |
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423
|
|
| G
|
Dab2ip
|
DAB2 interacting protein
|
onset
|
ISO
|
DNA:SNP:CDS:rs7025486 (human)
|
RGD |
PMID:30595311 |
RGD:401938617 |
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730
|
|
| G
|
Ddah1
|
dimethylarginine dimethylaminohydrolase 1
|
|
ISO
|
DNA:missense mutation:cds:rs997251 (human)
|
RGD |
PMID:30284143 |
RGD:329961317 |
NCBI chr 2:237,327,812...237,460,624
Ensembl chr 2:237,327,766...237,460,626
|
|
| G
|
Ddah2
|
DDAH family member 2, ADMA-independent
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17267746 |
|
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,766,120...3,769,183
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
|
ISO
|
protein:increased expression:smooth muscle cell,macrophage
|
RGD |
PMID:10973835 PMID:8994440 |
RGD:1580909, RGD:7244168 |
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Edn1
|
endothelin 1
|
treatment severity
|
ISO IMP
|
protein:increased expression:atherosclerotic lesions (human) associated with Hypertension;DNA:missense mutation:cds:p.L198N (human)
|
RGD |
PMID:7968078 PMID:11927217 PMID:18923236 |
RGD:4144886, RGD:8662294, RGD:8661705 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Eng
|
endoglin
|
severity
|
ISO
|
protein:increased expression:plasma (human)
|
RGD |
PMID:21667051 |
RGD:7248776 |
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
|
RGD |
PMID:14732757 |
RGD:1580982 |
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Epo
|
erythropoietin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:25245553 |
|
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Ercc2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
susceptibility
|
ISO
|
DNA:SNP: :rs13181(human)
|
RGD |
PMID:27566080 |
RGD:12880440 |
NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102
|
|
| G
|
Ercc5
|
ERCC excision repair 5, endonuclease
|
|
ISO
|
mRNA: decreased expression:blood
|
RGD |
PMID:35934844 |
RGD:628374611 |
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084
|
|
| G
|
Esr1
|
estrogen receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:9396482 PMID:20559769 PMID:16159931 |
RGD:1580335 |
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20559769 PMID:16099331 |
RGD:1581014 |
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
treatment
|
ISO
|
|
RGD |
PMID:14961168 |
RGD:10449426 |
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
F7
|
coagulation factor VII
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) DNA:polymorphisms:cds:R353Q (human)
|
RGD |
PMID:10599031 PMID:8522401 PMID:11334615 |
RGD:2312400, RGD:2312408, RGD:2312397 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Fabp2
|
fatty acid binding protein 2
|
|
ISO
|
associated with Diabetes Mellitus, Type 2 (MeSH:D003924)
|
RGD |
PMID:15059615 |
RGD:1626412 |
NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:213,724,629...213,728,686
|
|
| G
|
Fcgr2a
|
Fc gamma receptor 2A
|
|
ISO
|
DNA:polymorphism: :p.H131R (human)
|
RGD |
PMID:20973705 |
RGD:5147917 |
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
|
|
| G
|
Fcgr3a
|
Fc gamma receptor 3A
|
susceptibility
|
ISO
|
DNA:SNP:exon:p.F158V (rs396991)(human)
|
RGD |
PMID:15910853 |
RGD:5508464 |
NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651
|
|
| G
|
Fes
|
FES proto-oncogene, tyrosine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:143,746,945...143,756,181
|
|
| G
|
Fgb
|
fibrinogen beta chain
|
|
ISO
|
|
RGD |
PMID:8565160 |
RGD:1580382 |
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
|
ISO
|
associated with Diabetes Mellitus
|
RGD |
PMID:14585103 |
RGD:2315879 |
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
|
ISO
|
DNA:SNP: :rs9939609 (human) DNA:SNP:intron:rs9939609 (human)
|
RGD |
PMID:24622111 PMID:28167353 |
RGD:329812039, RGD:329901772 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
Furin
|
furin (paired basic amino acid cleaving enzyme)
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497
|
|
| G
|
Gck
|
glucokinase
|
susceptibility
|
ISO
|
DNA:SNP:promoter:-30G>A (human)
|
RGD |
PMID:15173029 |
RGD:2301876 |
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20855664 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Gfod1
|
Gfo/Idh/MocA-like oxidoreductase domain containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr17:21,606,090...21,710,922
Ensembl chr17:21,605,415...21,710,920
|
|
| G
|
Ggcx
|
gamma-glutamyl carboxylase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 4:106,027,918...106,043,653
Ensembl chr 4:106,027,912...106,043,923
|
|
| G
|
Gja4
|
gap junction protein, alpha 4
|
|
ISO
|
|
RGD |
PMID:15059615 |
RGD:1626412 |
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216
|
|
| G
|
Gnb3
|
G protein subunit beta 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16141801 |
|
NCBI chr 4:159,325,741...159,331,443
Ensembl chr 4:159,325,742...159,331,445
|
|
| G
|
Gp6
|
glycoprotein 6
|
treatment
|
ISO
|
protein:increased expression:platelet (human)
|
RGD |
PMID:18585516 |
RGD:401794134 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
|
ISO
|
cardiovascular complications in type 2 diabetics DNA:repeat:exon
|
RGD |
PMID:16338763 PMID:12655278 |
RGD:1600708, RGD:1600677 |
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
ISO
|
mRNA:increased expression:epicardial fat
|
RGD |
PMID:21679057 |
RGD:401827169 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
|
ISO
|
cardiovascular complications in type 2 diabetics
|
RGD |
PMID:16338763 |
RGD:1600708 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
|
RGD |
PMID:19102712 PMID:16620396 |
RGD:2306625, RGD:2306633 |
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent DNA:deletion
|
RGD |
PMID:19102712 PMID:16620396 |
RGD:2306625, RGD:2306633 |
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22751097 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
susceptibility
|
ISO
|
DNA:SNPs,haplotype:intron: (rs2735971,rs2839698,rs3024270) (human)
|
RGD |
PMID:32454910 |
RGD:242905209 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hectd4
|
HECT domain E3 ubiquitin protein ligase 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22751097 |
|
NCBI chr12:40,800,232...40,991,584
Ensembl chr12:40,843,770...40,991,798
|
|
| G
|
Hes6
|
hes family bHLH transcription factor 6
|
|
ISO
|
mRNA: increased expression:blood
|
RGD |
PMID:35934844 |
RGD:628374611 |
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:99,449,371...99,451,096
|
|
| G
|
Hfe
|
homeostatic iron regulator
|
no_association
|
ISO
|
|
RGD |
PMID:12746412 |
RGD:1582673 |
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
|
RGD |
PMID:11669408 |
RGD:8548610 |
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hhipl1
|
HHIP-like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 6:132,984,028...133,008,248
Ensembl chr 6:132,984,032...133,006,947
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
ISO
|
|
RGD |
PMID:12742282 |
RGD:5508477 |
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
no_association susceptibility
|
ISO
|
DNA:repeat:promoter CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12136229 PMID:14691581 PMID:12377749 PMID:12136229 |
RGD:1580470, RGD:1580454, RGD:1598401 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf1a
|
HNF1 homeobox A
|
susceptibility
|
ISO
|
DNA:SNP:intron 1: (rs7310409) G>A (human) DNA:SNP,haplotypes:intron: (rs55783344) C>T(human) DNA:SNPs,haplotypes:multiple
|
RGD |
PMID:25202455 PMID:33004870 PMID:28035729 |
RGD:329901832, RGD:329901841, RGD:329901837 |
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
| G
|
Hp
|
haptoglobin
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:884791 |
RGD:1626363 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Hs3st1
|
heparan sulfate-glucosamine 3-sulfotransferase 1
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar |
PMID:15266341 PMID:15965027 PMID:16024819 PMID:16410828 PMID:17179217 PMID:17558387 PMID:17568005 PMID:19122651 PMID:19303047 PMID:19858363 PMID:21152010 PMID:22090374 PMID:28126521 More...
|
|
NCBI chr14:75,398,101...75,429,628
Ensembl chr14:75,398,026...75,436,848
|
|
| G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
sexual_dimorphism
|
ISO
|
associated with obesity;mRNA,protein:increased expression:multiple (human)
|
RGD |
PMID:23009206 |
RGD:329901914 |
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
severity
|
ISO
|
|
RGD |
PMID:11222468 |
RGD:1624218 |
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Ica1l
|
islet cell autoantigen 1-like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 9:68,906,148...68,964,078
Ensembl chr 9:68,906,148...68,963,692
|
|
| G
|
Il10
|
interleukin 10
|
no_association susceptibility
|
ISO
|
DNA:SNPs:promoter:-592C>A (rs1800872), -819C>T (rs1800871) (human) DNA:SNP:promoter:-1082A>G (rs1800896) (human)
|
RGD |
PMID:16460885 PMID:29525679 PMID:29525679 |
RGD:1598621, RGD:14975129, RGD:14975129 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il15
|
interleukin 15
|
|
ISO
|
associated with Hypertension;protein:increased expression:serum
|
RGD |
PMID:16109314 |
RGD:1626610 |
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
mRNA:increased expression:peripheral blood (human)
|
RGD |
PMID:22780915 |
RGD:7175093 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rl1
|
interleukin 1 receptor-like 1
|
severity
|
ISO
|
DNA:polymorphisms: :-27307T>A, -27614C>A (human)
|
RGD |
PMID:20602249 |
RGD:5144241 |
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
|
|
| G
|
Il6
|
interleukin 6
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human)
|
RGD |
PMID:19368923 |
RGD:2307251 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20524934 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
|
ISO
|
DNA:polymorphism:exon:G972R CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10591678 PMID:10591678 |
RGD:1624974 |
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
no_association
|
ISO
|
|
RGD |
PMID:15227729 |
RGD:1582294 |
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Jcad
|
junctional cadherin 5 associated
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378988 PMID:34961328 |
|
NCBI chr17:57,784,634...57,826,213
Ensembl chr17:57,784,634...57,826,183
|
|
| G
|
Kalrn
|
kalirin, RhoGEF kinase
|
susceptibility onset severity
|
ISO
|
DNA:SNP:intron: (rs9289231) T>G (human) associated with nicotine dependence; DNA:SNPs:multiple associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs9289231) T>G (human) DNA:SNP:intron: (rs9289231) (human)
|
RGD |
PMID:30483314 PMID:19706030 PMID:27218147 PMID:25316661 |
RGD:329955537, RGD:329970276, RGD:329956419, RGD:11076452 |
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:79,703,366...80,133,329
|
|
| G
|
Kcne2
|
potassium voltage-gated channel subfamily E regulatory subunit 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr11:45,003,468...45,015,942
Ensembl chr11:45,014,406...45,016,168
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
|
ISS
|
OMIM:300464 | OMIM:607339 | OMIM:608316 | OMIM:608318 | OMIM:608320 | OMIM:608901 | OMIM:610938 | OMIM:610947 | OMIM:611139 | OMIM:612030 | OMIM:614293 | OMIM:614466
|
MouseDO |
|
|
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kif6
|
kinesin family member 6
|
sexual_dimorphism no_association treatment
|
ISO
|
DNA:SNP: :rs20455 (human) associated with type 2 diabetes mellitus;DNA:SNP: :p.W719R (rs20455) (human)
|
RGD |
PMID:18222354 PMID:25629058 PMID:21458191 PMID:26443250 PMID:26997531 PMID:19371834 More...
|
RGD:243048446, RGD:243048454, RGD:243048451, RGD:11527801, RGD:243048449, RGD:243048447 |
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:18,573,789...18,870,729
|
|
| G
|
Kl
|
Klotho
|
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter: -G395>A (human)
|
CTD RGD |
PMID:12669274 PMID:16979405 PMID:16579981 |
RGD:1581721, RGD:1581723 |
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
no_association
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21378990 PMID:27135400 PMID:16459141 |
RGD:1581823 |
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lepr
|
leptin receptor
|
susceptibility
|
ISO
|
DNA:SNP:cds:p.Q223R(human)
|
RGD |
PMID:27257426 |
RGD:21079462 |
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Lipa
|
lipase A, lysosomal acid type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378988 PMID:34961328 PMID:35590109 |
|
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:241,437,524...241,470,740
|
|
| G
|
Lipc
|
lipase C, hepatic type
|
susceptibility no_association
|
ISO
|
associated with Diabetes Mellitus, Insulin-Dependent; DNA:transition:promoter:-480C>T (human) DNA:SNP,haplotypes: (rs17269397)A>G (human)
|
RGD GAD |
PMID:11916946 PMID:33004870 PMID:15118671 PMID:12689525 PMID:15099346 |
RGD:2308839, RGD:329901841, RGD:1331525, RGD:1600664, RGD:1600663 |
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
|
|
| G
|
Lipg
|
lipase G, endothelial type
|
|
ISO
|
|
RGD |
PMID:16354105 |
RGD:1580865 |
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260
|
|
| G
|
Lmod1
|
leiomodin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28530674 |
|
NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116
|
|
| G
|
Lox
|
lysyl oxidase
|
|
IDA
|
|
RGD |
PMID:12393934 |
RGD:1581886 |
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Lpl
|
lipoprotein lipase
|
|
ISO
|
|
RGD |
PMID:8641022 |
RGD:1580537 |
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lrp6
|
LDL receptor related protein 6
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar |
PMID:28492532 |
|
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716
|
|
| G
|
Lrp8
|
LDL receptor related protein 8
|
no_association onset
|
ISO
|
DNA:missense mutation:cds:p.R952Q (human)
|
RGD |
PMID:18592168 PMID:17847002 |
RGD:2306125, RGD:2306124 |
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207
|
|
| G
|
Lta
|
lymphotoxin alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15266304 PMID:15973460 |
RGD:1580414 |
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
|
|
| G
|
Lum
|
lumican
|
|
ISO
|
|
RGD |
PMID:11890723 |
RGD:1582121 |
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
|
ISO
|
associated with hypothyroidism;mRNA:decreased expression:venous blood (human)
|
RGD |
PMID:32495070 |
RGD:155791451 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mat2a
|
methionine adenosyltransferase 2A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
|
ISO
|
|
RGD |
PMID:15811259 |
RGD:1580548 |
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Mia3
|
MIA SH3 domain ER export factor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease
|
CTD ClinVar |
PMID:21378990 PMID:25741868 PMID:34961328 |
|
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:97,494,275...97,543,587
|
|
| G
|
Mir1
|
microRNA 1
|
disease_progression
|
ISO
|
miRNA:decreased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr18:2,160,327...2,160,413
|
|
| G
|
Mir126a
|
microRNA 126a
|
disease_progression severity
|
ISO
|
miRNA:increased expression:blood plasma (human) associated with Stable Angina,
|
RGD |
PMID:25728840 PMID:27497911 |
RGD:11056497, RGD:401850779 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir133a1
|
microRNA 133a-1
|
|
ISO
|
miRNA:decreased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr18:2,157,872...2,157,958
|
|
| G
|
Mir145
|
microRNA 145
|
disease_progression
|
ISO
|
miRNA:decreased expression:artery wall (human)
|
RGD |
PMID:25938589 |
RGD:11054026 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mir146a
|
microRNA 146a
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs2910164) (human) miRNA:increased expression:peripheral blood mononuclear cell, plasma
|
CTD RGD |
PMID:20524934 PMID:26909569 PMID:31866771 |
RGD:329337364, RGD:21081515 |
NCBI chr10:28,349,996...28,350,090
|
|
| G
|
Mir146b
|
microRNA 146b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20524934 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947
|
|
| G
|
Mir155
|
microRNA 155
|
|
ISO
|
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
|
RGD |
PMID:31866771 |
RGD:21081515 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir195
|
microRNA 195
|
|
ISO
|
miRNA:decreased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581
|
|
| G
|
Mir208a
|
microRNA 208a
|
|
ISO
|
miRNA:decreased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr15:32,395,552...32,395,634
|
|
| G
|
Mir21
|
microRNA 21
|
|
ISO
|
miRNA:increased expression:peripheral blood mononuclear cell, plasma miRNA:increased expression:blood plasma (human)
|
RGD |
PMID:31866771 PMID:25728840 |
RGD:21081515, RGD:11056497 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir214
|
microRNA 214
|
|
ISO
|
miRNA:increased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752
|
|
| G
|
Mir223
|
microRNA 223
|
treatment
|
ISO
|
|
RGD |
PMID:25350775 |
RGD:11076984 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mir30a
|
microRNA 30a
|
disease_progression
|
ISO
|
miRNA:increased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011
|
|
| G
|
Mir30e
|
microRNA 30e
|
|
ISO
|
miRNA:increased expression:plasma, extracellular exosome (human)
|
RGD |
PMID:30816508 |
RGD:401827150 |
NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:139,637,450...139,637,541
|
|
| G
|
Mir320a
|
microRNA 320a
|
disease_progression
|
ISO
|
miRNA:increased expression:blood plasma (human)
|
RGD |
PMID:25728840 |
RGD:11056497 |
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
| G
|
Mir423
|
microRNA 423
|
disease_progression
|
ISO
|
DNA:SNP: :rs6505162 (human) miRNA:decreased expression:serum
|
RGD |
PMID:30289085 PMID:32404537 |
RGD:158014893, RGD:158014898 |
NCBI chr10:62,412,272...62,412,350
|
|
| G
|
Mlxipl
|
MLX interacting protein-like
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes: (rs3812316) (human) DNA:SNP:cds: G771C, Q241H (rs381231) DNA:SNP:cds: C771G, H241Q
|
RGD |
PMID:21726544 PMID:19571538 PMID:25179879 |
RGD:401794579, RGD:401794582, RGD:401794581 |
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
severity
|
ISO
|
DNA:insertion, haplotype:promoter:g.-1607insG rs799750 (human)
|
RGD |
PMID:15619398 PMID:17893005 |
RGD:1582527, RGD:7207049 |
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp12
|
matrix metallopeptidase 12
|
susceptibility
|
ISO
|
|
RGD |
PMID:10807873 |
RGD:1582366 |
NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
|
ISO
|
DNA:insertion, haplotype:promoter:g.-1613insA rs3025058 (human) CTD Direct Evidence: marker/mechanism associated with Mucocutaneous Lymph Node Syndrome
|
CTD RGD |
PMID:8662692 PMID:17893005 PMID:16100452 |
RGD:7207049, RGD:8693322 |
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
susceptibility treatment
|
ISO IEP
|
|
RGD |
PMID:15191941 PMID:26261622 |
RGD:1582644, RGD:11344965 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mras
|
muscle RAS oncogene homolog
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 PMID:35590109 |
|
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911
|
|
| G
|
Mrps6
|
mitochondrial ribosomal protein S6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 PMID:34961328 |
|
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:44,781,554...44,834,962
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
no_association susceptibility
|
ISO
|
DNA:transition:cds:g.677C>T (human) DNA:SNPs: (rs1801133, rs4846049) (Human)
|
RGD |
PMID:15648053 PMID:24315498 PMID:12387655 |
RGD:1580579, RGD:401850782, RGD:6893453 |
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Mylk
|
myosin light chain kinase
|
susceptibility
|
ISO
|
associated with nicotine dependence; DNA:SNP: (rs16834817)
|
RGD |
PMID:19706030 |
RGD:329970276 |
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
|
ISO
|
|
RGD |
PMID:17283255 |
RGD:1642340 |
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Nat2
|
N-acetyltransferase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21572414 |
|
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
|
|
| G
|
Nbeal1
|
neurobeachin-like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 9:69,069,326...69,237,932
Ensembl chr 9:69,070,247...69,231,307
|
|
| G
|
Ngf
|
nerve growth factor
|
|
ISO
|
|
RGD |
PMID:11935372 |
RGD:1580935 |
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
|
ISO
|
|
RGD |
PMID:11935372 |
RGD:1580935 |
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nnmt
|
nicotinamide N-methyltransferase
|
severity
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:28174167 |
RGD:401793727 |
NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:57,825,464...57,843,174
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
|
ISO
|
DNA:polymorphisms: :p.G908R, 3020_3021insC (human)
|
RGD |
PMID:21565239 |
RGD:5508725 |
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
associated with Mucocutaneous Lymph Node Syndrome; protein:increased expression:neutrophil, monocyte
|
RGD |
PMID:14764920 |
RGD:1580941 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
susceptibility
|
ISO
|
DNA:duplication:intron:IVS4?-?+27 (human) CTD Direct Evidence: marker/mechanism DNA:snp:promoter:g.-786T>C (human) DNA:snp:cds:c.894G>T (human)
|
CTD RGD |
PMID:10510054 PMID:14989558 PMID:17267746 PMID:19696404 PMID:8564837 PMID:19761682 PMID:16284093 More...
|
RGD:7421529, RGD:7771578, RGD:7771567 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nppa
|
natriuretic peptide A
|
|
ISO
|
DNA:snp:cds:c.2238T>C (human) associated with Diabetes Mellitus, Type 2;DNA:SNP:exon: 2238T>C,rs5065 (human)
|
RGD |
PMID:12514664 PMID:22170009 |
RGD:1579982, RGD:7247716 |
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18022110 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
|
ISO
|
associated with type 2 diabetes mellitus;mRNA:increased expression:peripheral blood mononuclear cell (human)
|
RGD |
PMID:28871240 |
RGD:401850555 |
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
|
ISO
|
DNA:missense mutation:cds:p.N363S (human)
|
RGD |
PMID:12623935 |
RGD:1580790 |
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
susceptibility
|
ISO
|
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
|
RGD |
PMID:23368530 |
RGD:401827273 |
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Olr1
|
oxidized low density lipoprotein receptor 1
|
severity
|
ISO
|
DNA:snp:3' utr:T>C (human) DNA:missense mutation:cds:p.K167N (human)
|
RGD |
PMID:12810610 PMID:15562935 |
RGD:1580995, RGD:1580994 |
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
|
|
| G
|
Pappa
|
pappalysin 1
|
severity
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11586954 PMID:16055491 |
RGD:1642327 |
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Parl
|
presenilin associated, rhomboid-like
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.L262V (human)
|
RGD |
PMID:18758826 |
RGD:12902623 |
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:94,097,934...94,148,287
|
|
| G
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 PMID:27135400 |
|
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
|
|
| G
|
Pdgfd
|
platelet derived growth factor D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378988 PMID:34961328 |
|
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:11,773,475...12,007,271
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
no_association
|
ISO
|
DNA:missense mutations:cds:p.N536S, p.G670R (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.L125V (human) DNA:polymorphism:5' utr:g.53G>A (human)
|
CTD RGD |
PMID:28530674 PMID:11795274 PMID:10780329 PMID:12732396 |
RGD:2311656, RGD:6771225, RGD:1581010 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
susceptibility sexual_dimorphism
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:hypermethylation, hypomethylation:promoter, exon: (human) DNA:SNP:exon: (rs4714955) (human) DNA:SNPs:intron: (rs9381439, rs9349379) (human) associated with familial hypercholesterolemia;DNA:SNP:intron: (rs12526453) (human) DNA:SNP:intron:g.12903957A>G (rs9349379) (human) DNA:SNP:intron:g.12903725A>G (rs9349379) (human)
|
CTD RGD |
PMID:21378990 PMID:22751097 PMID:26098115 PMID:34961328 PMID:31499127 PMID:27066539 PMID:27893421 PMID:29784573 PMID:27517945 PMID:30777881 More...
|
RGD:401901251, RGD:401901243, RGD:401900688, RGD:401900687, RGD:401900135, RGD:401851919 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Pik3c2g
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
PMID:25741868 |
|
NCBI chr 4:174,215,527...174,583,378
Ensembl chr 4:174,215,527...174,581,705
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
disease_progression susceptibility
|
ISO
|
DNA:polymorphism: :p.A379V (human)
|
RGD |
PMID:17070179 PMID:15115767 |
RGD:6482777, RGD:6482781 |
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plpp3
|
phospholipid phosphatase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
|
|
| G
|
Pnpla3
|
patatin-like phospholipase domain containing 3
|
|
ISO
|
associated with type 2 diabetes mellitus;DNA:SNP: :rs738409 (p.I148M) (human)
|
RGD |
PMID:31377187 |
RGD:14981594 |
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594
|
|
| G
|
Pon1
|
paraoxonase 1
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.Q192R (human) CTD Direct Evidence: marker/mechanism|therapeutic protein:increased activity:serum (human)
|
CTD RGD |
PMID:8675673 PMID:9215303 PMID:21629682 PMID:10729395 PMID:15785307 PMID:11917194 More...
|
RGD:1580196, RGD:8547681, RGD:1580203 |
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
severity
|
ISO
|
DNA:missense mutation:cds:p.C311S (human) ClinVar Annotator: match by term: PON2-related disorder
|
ClinVar RGD |
PMID:25741868 PMID:12454802 |
RGD:1580217 |
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
susceptibility
|
ISO
|
DNA:snp:intron: (human)
|
RGD |
PMID:16043164 |
RGD:1580228 |
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
ISO
|
protein:decreased expression:carotid artery, macrophage, smooth muscle cell (human)
|
RGD |
PMID:21709632 |
RGD:8552814 |
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppp4c
|
protein phosphatase 4, catalytic subunit
|
|
ISO
|
mRNA:decreased expression:blood (human)
|
RGD |
PMID:30015926 |
RGD:401901084 |
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168
|
|
| G
|
Prdm16
|
PR/SET domain 16
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35590109 |
|
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:170,162,275...170,485,804
|
|
| G
|
Prkag2
|
protein kinase AMP-activated non-catalytic subunit gamma 2
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar |
PMID:25741868 PMID:28492532 PMID:37198425 |
|
NCBI chr 4:10,744,695...10,985,939
Ensembl chr 4:10,744,588...10,985,939
|
|
| G
|
Procr
|
protein C receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28530674 |
|
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:164,711,636...164,718,989
|
|
| G
|
Psrc1
|
proline and serine rich coiled-coil 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:198,705,839...198,714,997
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14642682 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Pth
|
parathyroid hormone
|
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:23460043 |
RGD:7242420 |
NCBI chr 1:176,942,901...176,946,034
Ensembl chr 1:176,943,102...176,946,034
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
ISO
|
DNA:SNP:exon 8:g.981C>T (human)
|
RGD |
PMID:21676396 |
RGD:401965429 |
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22
|
|
ISO
|
DNA: snp: cds: rs2476601
|
RGD |
PMID:21846984 |
RGD:6484553 |
NCBI chr 2:194,055,165...194,103,209
Ensembl chr 2:194,045,746...194,103,209
|
|
| G
|
Ptprd
|
protein tyrosine phosphatase, receptor type, D
|
|
ISO
|
DNA:SNP:intron: (rs10115782) (human)
|
RGD |
PMID:22216278 |
RGD:401976461 |
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:95,095,858...96,178,903
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
sexual_dimorphism susceptibility severity disease_progression
|
ISO
|
protein:increased expression:blood plasma (human) DNA:SNP:intron: (rs7094671) (human) associated with hypothyroidism;protein:increased expression:blood serum (human) protein:increased expression:epicardial fat (human)
|
RGD |
PMID:25437889 PMID:25479076 PMID:31278889 PMID:18854400 PMID:21645024 |
RGD:329845573, RGD:329845882, RGD:329845849, RGD:329845843, RGD:329845584 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
Rora
|
RAR-related orphan receptor A
|
|
ISO
|
mRNA: decreased expression:blood
|
RGD |
PMID:35934844 |
RGD:628374611 |
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
|
|
| G
|
Ryr2
|
ryanodine receptor 2
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
PMID:25741868 |
|
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705
|
|
| G
|
Sars1
|
seryl-tRNA synthetase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365
|
|
| G
|
Sele
|
selectin E
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:mutation: :p.S128R (human) ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar RGD |
PMID:25741868 PMID:17578587 |
RGD:2313596 |
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
|
|
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpina1
|
serpin family A member 1
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:7832094 |
RGD:1643149 |
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpine1
|
serpin family E member 1
|
susceptibility
|
ISO
|
DNA:insertion:promoter: (human)
|
RGD |
PMID:9484978 |
RGD:1580190 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serpinf2
|
serpin family F member 2
|
|
ISO
|
|
RGD |
PMID:9184412 |
RGD:1625532 |
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996
|
|
| G
|
Sh2b3
|
SH2B adaptor protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
|
ISO
|
mRNA:decreased expression:epicardial fat, subcutaneous adipose tissue (human)
|
RGD |
PMID:21645024 |
RGD:329845584 |
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slc5a3
|
solute carrier family 5 member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
|
|
| G
|
Smad3
|
SMAD family member 3
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease
|
ClinVar |
PMID:25741868 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Soat2
|
sterol O-acyltransferase 2
|
susceptibility
|
ISO
|
DNA:polymorphisms: :p.E41G, p.T734I, IVS4-57_-58ins48bp (human)
|
RGD |
PMID:16195894 |
RGD:1601112 |
NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:135,160,402...135,173,513
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent
|
RGD |
PMID:16338763 |
RGD:1600708 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
ISO
|
|
RGD |
PMID:10811593 |
RGD:1580853 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sort1
|
sortilin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 PMID:34961328 |
|
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
In type 2 diabetic patients
|
RGD |
PMID:21034455 |
RGD:6903271 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
susceptibility disease_progression severity
|
ISO
|
DNA:SNP, haplotype:: -36delG (human) associated with type 2 diabetes mellitus; mRNA:increased expression:epicardial fat (human) mRNA:decreased expression:blood serum (human)
|
RGD |
PMID:12752570 PMID:28367087 PMID:31610782 |
RGD:401827912, RGD:401842368, RGD:401842364 |
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
| G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
disease_progression
|
ISO
|
associated with type 2 diabetes mellitus;mRNA:increased expression:epicardial fat (human)
|
RGD |
PMID:28367087 |
RGD:401842368 |
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
| G
|
Tap1
|
transporter 1, ATP binding cassette subfamily B member
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810
|
|
| G
|
Tbx2
|
T-box transcription factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35590109 |
|
NCBI chr10:71,177,082...71,186,275
Ensembl chr10:71,177,082...71,186,275
|
|
| G
|
Tcf21
|
transcription factor 21
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNP: (rs12190287) (human)
|
CTD RGD |
PMID:21378990 PMID:22751097 PMID:26909569 |
RGD:329337364 |
NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:24,520,481...24,523,348
|
|
| G
|
Tek
|
TEK receptor tyrosine kinase
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:12814387 |
RGD:1601489 |
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16890917 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Thbd
|
thrombomodulin
|
severity
|
ISO
|
|
RGD |
PMID:17012137 |
RGD:1601638 |
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Tll1
|
tolloid-like 1
|
severity
|
ISO
|
associated with type 2 diabetes:DNA:SNP:CDS:rs1503298 (human)
|
RGD |
PMID:21911782 |
RGD:155883159 |
NCBI chr16:30,275,492...30,476,673
Ensembl chr16:30,275,492...30,475,886
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20524934 PMID:15632890 |
RGD:1580736 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
|
RGD |
PMID:15059615 |
RGD:1626412 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:15926884 |
RGD:1620893 |
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
severity
|
ISO
|
|
RGD |
PMID:19845893 |
RGD:5131425 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
|
ISO
|
|
RGD |
PMID:12221049 |
RGD:1580780 |
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tp53
|
tumor protein p53
|
|
ISO
|
DNA:misssense mutation: :p.R72P (rs1042522) (human)
|
RGD |
PMID:29482350 |
RGD:14995930 |
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Traf6
|
TNF receptor associated factor 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20524934 |
|
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328
|
|
| G
|
Trib1
|
tribbles pseudokinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24097064 |
|
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:93,095,973...93,117,480
|
|
| G
|
Ttn
|
titin
|
|
ISO
|
|
RGD |
PMID:12221049 |
RGD:1580780 |
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:82,059,648...82,332,171
|
|
| G
|
Twist1
|
twist family bHLH transcription factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 6:56,402,309...56,404,303
Ensembl chr 6:56,398,061...56,404,965
|
|
| G
|
Vamp5
|
vesicle-associated membrane protein 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 4:105,982,004...105,993,247
Ensembl chr 4:105,982,009...105,993,247
|
|
| G
|
Vamp8
|
vesicle-associated membrane protein 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34961328 |
|
NCBI chr 4:106,000,570...106,011,081
Ensembl chr 4:106,000,570...106,011,073
|
|
| G
|
Vdr
|
vitamin D receptor
|
severity
|
ISO
|
DNA:SNP (human)
|
RGD |
PMID:9761785 |
RGD:4889864 |
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:14668888 PMID:15937083 PMID:15754021 |
RGD:1580569 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vim
|
vimentin
|
|
ISO
|
protein:increased expression:monocyte
|
RGD |
PMID:21938407 |
RGD:6480617 |
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vtn
|
vitronectin
|
|
ISO
|
|
RGD |
PMID:15678274 |
RGD:1580816 |
NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,892,766...63,895,860
|
|
| G
|
Wdr12
|
WD repeat domain 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 9:68,969,547...68,996,811
Ensembl chr 9:68,969,547...68,996,811
|
|
| G
|
Wrn
|
WRN RecQ like helicase
|
|
ISO
|
|
RGD |
PMID:11186893 |
RGD:1580824 |
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:65,456,254...65,602,951
|
|
| G
|
Xrcc1
|
X-ray repair cross complementing 1
|
onset
|
ISO
|
DNA:polymorphism:: (rs1799782) (human)
|
RGD |
PMID:24315498 |
RGD:401850782 |
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
|
|
| G
|
Xrcc3
|
X-ray repair cross complementing 3
|
susceptibility
|
ISO
|
DNA:SNP,haplotypes:exon 7: p.T241M (rs861539) (Human)
|
RGD |
PMID:23368530 |
RGD:401827273 |
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822
|
|
| G
|
Zc3hc1
|
zinc finger, C3HC-type containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21378990 |
|
NCBI chr 4:59,957,402...59,979,336
Ensembl chr 4:59,957,402...59,979,336
|
|
| G
|
Zfyve21
|
zinc finger FYVE-type containing 21
|
|
ISO
|
ClinVar Annotator: match by term: Premature coronary artery atherosclerosis
|
ClinVar |
PMID:25741868 |
|
NCBI chr 6:136,695,132...136,715,601
Ensembl chr 6:136,694,908...136,715,601
|
|
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 | ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction | ClinVar Annotator: match by term: MEF2A-related disorder CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD |
PMID:14645853 PMID:15496429 PMID:15841183 PMID:25741868 |
|
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
|
|
| G
|
Cad
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
|
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297
|
|
| G
|
Lrp6
|
LDL receptor related protein 6
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2 CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD |
PMID:17332414 PMID:23703864 PMID:25741868 PMID:27713038 PMID:28492532 PMID:31589614 PMID:33118644 More...
|
|
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716
|
|
|
|
| G
|
Arhgap9
|
Rho GTPase activating protein 9
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery spasm 3, susceptibility to CTD Direct Evidence: marker/mechanism
|
ClinVar CTD |
PMID:19911011 |
|
NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: CORONARY ARTERY SPASM 1, SUSCEPTIBILITY TO
|
CTD OMIM ClinVar |
PMID:9737779 PMID:9894802 PMID:10359729 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
|
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Pon1
|
paraoxonase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11810302 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
|
|
| G
|
Abca1
|
ATP binding cassette subfamily A member 1
|
|
ISO
|
ClinVar Annotator: match by term: Early-onset coronary artery disease
|
ClinVar |
|
|
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
|
|
| G
|
Abcg5
|
ATP binding cassette subfamily G member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19060911 |
|
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
|
|
| G
|
Abcg8
|
ATP binding cassette subfamily G member 8
|
|
ISO
|
ClinVar Annotator: match by term: Early-onset coronary artery disease
|
ClinVar |
PMID:3706300 PMID:6110091 PMID:11099417 PMID:11264985 PMID:11452359 PMID:12124998 PMID:15054092 PMID:15375183 PMID:15996216 PMID:16029460 PMID:16199547 PMID:23241408 PMID:25073796 PMID:25741868 PMID:28492532 PMID:30545335 PMID:32088153 PMID:34317312 PMID:34969652 More...
|
|
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
|
|
| G
|
Abo
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
|
ISO
|
ClinVar Annotator: match by term: Three Vessel Coronary Disease
|
ClinVar |
PMID:25741868 |
|
NCBI chr 3:30,560,172...30,604,758
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
susceptibility
|
ISO
|
DNA:deletion:intron:IVS16+1464-1751del (human) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:8170965 PMID:9488209 |
RGD:8142364 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ace2
|
angiotensin converting enzyme 2
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism: :8790G>A (human)
|
RGD |
PMID:18753062 |
RGD:2313798 |
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
| G
|
Ada
|
adenosine deaminase
|
|
ISO
|
protein:increased expression:leukocyte
|
RGD |
PMID:17259686 |
RGD:1624286 |
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adamts13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ISO
|
protein:decreased activity:plasma (human) ClinVar Annotator: match by term: Three Vessel Coronary Disease
|
ClinVar RGD |
PMID:25741868 PMID:28492532 PMID:12670342 |
RGD:10449044 |
NCBI chr 3:30,697,354...30,736,539
Ensembl chr 3:30,697,942...30,736,540
|
|
| G
|
Adamts7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
ISO
|
ClinVar Annotator: match by term: Three Vessel Coronary Disease
|
ClinVar |
PMID:25741868 |
|
NCBI chr 8:99,584,529...99,624,132
Ensembl chr 8:99,584,529...99,624,132
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
disease_progression
|
ISO
|
associated with Diabetes mellitus, Type2;
|
RGD |
PMID:22207678 PMID:22019747 |
RGD:5686379, RGD:5686406 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.Q27E
|
RGD |
PMID:12682000 |
RGD:1601128 |
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Adrb3
|
adrenoceptor beta 3
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.W64R rs4994(human)
|
RGD GAD |
PMID:10421225 PMID:20536507 PMID:15118671 |
RGD:1559326, RGD:5684776, RGD:1331525 |
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:71,542,567...71,547,420
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
susceptibility
|
ISO
|
protein:decreased expression:plasma (human) associated with Heart Failure; protein:increased expression:plasma (human)
|
RGD |
PMID:23396398 PMID:20685687 |
RGD:7243186, RGD:7244134 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
susceptibility no_association
|
ISO
|
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
|
RGD |
PMID:9456365 PMID:9857918 |
RGD:1601152, RGD:1566499 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Agxt2
|
alanine-glyoxylate aminotransferase 2
|
|
ISO
|
DNA:missense mutation:cds:V140I (rs37369)(human)
|
RGD |
PMID:24834905 |
RGD:329961320 |
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
|
|
| G
|
Apoa4
|
apolipoprotein A4
|
susceptibility no_association
|
ISO
|
DNA:missense mutation:cds:p.T347S (human)
|
RGD |
PMID:12676816 PMID:9013087 |
RGD:1578411, RGD:5685683 |
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
|
|
| G
|
Apob
|
apolipoprotein B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
|
CTD ClinVar |
PMID:17658632 |
|
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoc2
|
apolipoprotein C2
|
susceptibility
|
ISO
|
|
RGD |
PMID:7590197 |
RGD:1601205 |
NCBI chr 1:88,457,397...88,462,365
Ensembl chr 1:88,457,396...88,463,438
|
|
| G
|
Apoc3
|
apolipoprotein C3
|
no_association susceptibility
|
ISO
|
DNA:polymorphism:promoter:-482C>T ClinVar Annotator: match by term: Coronary heart disease associated with Diabetes Mellitus, Non-Insulin-Dependent
|
ClinVar RGD |
PMID:9536098 PMID:11060345 PMID:17576681 PMID:19074352 PMID:20097930 PMID:23701270 PMID:24941081 PMID:24941082 PMID:25225788 PMID:25741868 PMID:25962519 PMID:27114411 PMID:28406212 PMID:28492532 PMID:28825717 PMID:29237685 PMID:30255797 PMID:32041611 PMID:34548093 PMID:36325899 PMID:36876364 PMID:16321685 PMID:17654446 More...
|
RGD:1601224, RGD:2306754 |
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679
|
|
| G
|
Apoe
|
apolipoprotein E
|
onset
|
ISO
|
DNA:polymorphisms, haplotype:promoter, cds:g.-219G>T, p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism
|
RGD CTD |
PMID:10736278 PMID:11862316 PMID:11862316 |
RGD:1578479, RGD:1578479 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Ccdc92
|
coiled-coil domain containing 92
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr12:37,457,676...37,484,080
Ensembl chr12:37,457,068...37,484,327
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
resistance
|
ISO
|
DNA:polymorphisms:multiple (human)
|
RGD |
PMID:16055130 |
RGD:1581176 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cd14
|
CD14 molecule
|
|
ISO
|
protein:increased expression:monocyte
|
RGD |
PMID:10831941 |
RGD:2314175 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd36
|
CD36 molecule
|
susceptibility
|
ISO
|
mRNA:increased expression:monocyte ClinVar Annotator: match by term: CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7 | ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 7 CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD RGD |
PMID:25741868 PMID:28960434 PMID:33116287 PMID:18067591 |
RGD:6893507 |
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd40lg
|
CD40 ligand
|
treatment
|
IDA
|
|
RGD |
PMID:23819214 |
RGD:7248750 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
|
ISO
|
DNA:polymorphism: :p.V249I (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 1
|
CTD OMIM ClinVar RGD |
PMID:25741868 PMID:11532900 |
RGD:4891901 |
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
|
ISO
|
|
RGD |
PMID:10488959 |
RGD:1580275 |
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4
|
resistance
|
ISO
|
DNA:polymorphism:promoter:-50G>T (human)
|
RGD |
PMID:17429317 |
RGD:1625377 |
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042
|
|
| G
|
Dab2ip
|
DAB2 interacting protein
|
|
ISO
|
DNA:SNP:CDS:rs7025486 (human)
|
RGD |
PMID:21444365 |
RGD:401938618 |
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730
|
|
| G
|
Dnah11
|
dynein, axonemal, heavy chain 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19060911 |
|
NCBI chr 6:144,982,130...145,298,523
Ensembl chr 6:144,973,797...145,298,692
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
|
RGD |
PMID:16595607 |
RGD:1580981 |
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Esr2
|
estrogen receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17367797 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
F12
|
coagulation factor XII
|
|
ISO
|
protein:decreased activity::
|
RGD |
PMID:18021303 |
RGD:11041785 |
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
F13a1
|
coagulation factor XIII A1 chain
|
|
ISO
|
|
RGD |
PMID:11391716 |
RGD:1581030 |
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
|
ISO
|
associated with Diabetes Mellitus
|
RGD |
PMID:15451784 |
RGD:2315870 |
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
|
ISO
|
mRNA, protein:increased expression:ventricle myocardium
|
RGD |
PMID:16139132 |
RGD:2313728 |
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
|
ISO
|
DNA:SNP: :rs9939609 (human)
|
RGD |
PMID:26555680 |
RGD:11555922 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
Ggt1
|
gamma-glutamyltransferase 1
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:serum
|
RGD |
PMID:16772340 |
RGD:2315604 |
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
|
ISO
|
associated with type 2 diabetes mellitus;DNA:SNP: :rs10911021 (human)
|
RGD |
PMID:23982368 |
RGD:401794410 |
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Gp1ba
|
glycoprotein Ib platelet subunit alpha
|
|
ISO
|
|
RGD |
PMID:14592833 |
RGD:1580433 |
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,829,832...55,854,560
|
|
| G
|
Gp6
|
glycoprotein 6
|
treatment exacerbates
|
ISO
|
protein:increased expression:venous blood, platelet (human) DNA:hypomethylation:promoter
|
RGD |
PMID:17105818 PMID:20049463 PMID:31783053 |
RGD:401794440, RGD:401824649, RGD:401824645 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
disease_progression
|
ISO
|
|
RGD |
PMID:15809366 |
RGD:5508474 |
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
ISO
|
|
RGD |
PMID:15869055 |
RGD:1598404 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hnf1a
|
HNF1 homeobox A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr12:47,299,171...47,333,457
Ensembl chr12:47,306,245...47,332,755
|
|
| G
|
Hp
|
haptoglobin
|
severity
|
ISO
|
|
RGD |
PMID:16673012 |
RGD:1626344 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
ISO
|
DNA:SNPs: : -110A>C (rs1008438), 190G>C (rs1043618) (human)
|
RGD |
PMID:19333379 |
RGD:7257652 |
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
|
ISO
|
|
RGD |
PMID:12059985 |
RGD:1624217 |
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
|
ISO
|
|
RGD |
PMID:15521962 |
RGD:1626121 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit
|
|
ISO
|
|
RGD |
PMID:15521962 |
RGD:1626121 |
NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
|
ISO
|
|
RGD |
PMID:15521962 |
RGD:1626121 |
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Igfbp5
|
insulin-like growth factor binding protein 5
|
|
ISO
|
|
RGD |
PMID:15521962 |
RGD:1626121 |
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
|
|
| G
|
Il18
|
interleukin 18
|
|
ISO
|
ClinVar Annotator: match by term: Three Vessel Coronary Disease
|
ClinVar |
PMID:25741868 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
DNA:polymorphism
|
RGD |
PMID:15379752 |
RGD:1626636 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Irf8
|
interferon regulatory factor 8
|
susceptibility
|
ISO
|
DNA:SNPs:intron 4, intron 2: (rs925994,rs10514610) (human)
|
RGD |
PMID:23661672 |
RGD:329902076 |
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
|
|
| G
|
Irs1
|
insulin receptor substrate 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
no_association
|
ISO
|
|
RGD |
PMID:9684730 |
RGD:1582306 |
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
exacerbates
|
ISO
|
protein:increased expression:monocyte (human)
|
RGD |
PMID:20876457 |
RGD:329901842 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
|
ISO
|
DNA:polymorphism:exon
|
RGD |
PMID:10583927 |
RGD:5128478 |
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Kalrn
|
kalirin, RhoGEF kinase
|
|
ISO
|
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 5
|
ClinVar |
PMID:17357071 PMID:25741868 |
|
NCBI chr11:79,703,345...80,309,210
Ensembl chr11:79,703,366...80,133,329
|
|
| G
|
Kat2b
|
lysine acetyltransferase 2B
|
severity
|
ISO
|
DNA:snp:promoter:g.-2481G>C (human)
|
RGD |
PMID:21062767 |
RGD:9590309 |
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
no_association
|
ISO
|
|
RGD |
PMID:12964027 |
RGD:1581699 |
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
ISO
|
mRNA, protein:increased expression:ventricle myocardium
|
RGD |
PMID:16139132 |
RGD:2313728 |
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Early-onset coronary artery disease
|
CTD ClinVar |
PMID:9430375 PMID:9712531 PMID:10422804 PMID:11810272 PMID:11845603 PMID:17765246 PMID:19318025 PMID:20506408 PMID:21382890 PMID:21642693 PMID:22390909 PMID:23375686 PMID:24033266 PMID:25487149 PMID:25647241 PMID:25741868 PMID:26467025 PMID:28161202 PMID:28492532 PMID:28895539 PMID:29353225 PMID:29396260 PMID:30293936 PMID:30312929 PMID:30637778 PMID:30971288 PMID:32719484 PMID:33418990 PMID:33454241 PMID:33740630 PMID:34037665 PMID:35339733 PMID:35568682 PMID:35910211 PMID:36105085 PMID:36499307 PMID:37409534 PMID:37589137 More...
|
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lepr
|
leptin receptor
|
onset
|
ISO
|
DNA:SNP: C>T (rs6656451) (human)
|
RGD |
PMID:29848931 |
RGD:401799677 |
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Lgals2
|
galectin 2
|
susceptibility
|
ISO
|
|
RGD |
PMID:17040205 |
RGD:1581853 |
NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:112,282,822...112,285,392
|
|
| G
|
Lipc
|
lipase C, hepatic type
|
susceptibility
|
ISO
|
associated with Obesity and Diabetes; DNA:transition:promoter:-514C>T (human)
|
RGD |
PMID:16570154 |
RGD:2308824 |
NCBI chr 8:80,390,470...80,516,463
Ensembl chr 8:80,390,471...80,516,285
|
|
| G
|
Lpl
|
lipoprotein lipase
|
|
IEP ISO
|
ClinVar Annotator: match by term: Coronary heart disease
|
ClinVar RGD |
PMID:8199176 PMID:8541837 PMID:8872057 PMID:10364086 PMID:10517255 PMID:21146168 PMID:24033266 PMID:25741868 PMID:28492532 PMID:27000070 More...
|
RGD:13794381 |
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lrp1
|
LDL receptor related protein 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:15121769 |
RGD:1581911 |
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196
|
|
| G
|
Maco1
|
macoilin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19060911 |
|
NCBI chr 5:152,296,107...152,358,684
Ensembl chr 5:152,296,558...152,358,684
|
|
| G
|
Mb
|
myoglobin
|
severity
|
ISO
|
|
RGD |
PMID:15976963 |
RGD:1582388 |
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Mgp
|
matrix Gla protein
|
susceptibility
|
ISO
|
|
RGD |
PMID:16973975 |
RGD:1582502 |
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
|
IEP
|
coronary occlusion; mRNA:increased expression:myocardium
|
RGD |
PMID:20367970 |
RGD:4890973 |
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mlxip
|
MLX interacting protein
|
susceptibility
|
ISO
|
DNA:SNP:3'utr: (rs4758685) (human)
|
RGD |
PMID:23840567 |
RGD:401794443 |
NCBI chr12:38,789,404...38,853,059
Ensembl chr12:38,789,404...38,853,059
|
|
| G
|
Mlxipl
|
MLX interacting protein-like
|
susceptibility
|
ISO
|
DNA:SNP: (rs35493868); in younger than 55 years of age
|
RGD |
PMID:29848931 |
RGD:401799677 |
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
susceptibility
|
ISO
|
DNA:insertion:promoter:g.-1607insG (human)
|
RGD |
PMID:14499230 |
RGD:1582537 |
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
susceptibility
|
ISO
|
ClinVar Annotator: match by term: Coronary heart disease, susceptibility to, 6 | ClinVar Annotator: match by term: MMP3-related condition CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD |
PMID:7727178 PMID:8662692 PMID:9699891 PMID:10190398 PMID:10351963 PMID:12477941 PMID:12485468 PMID:25741868 PMID:28492532 More...
|
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mras
|
muscle RAS oncogene homolog
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr 8:108,823,374...108,886,104
Ensembl chr 8:108,823,374...108,875,911
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16792904 |
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Mttp
|
microsomal triglyceride transfer protein
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-493G>T
|
RGD |
PMID:15136504 |
RGD:1625487 |
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
|
|
| G
|
Myh15
|
myosin, heavy chain 15
|
|
ISO
|
DNA:snp:exon:EX28T>C rs3900940 (human)
|
RGD |
PMID:18073581 |
RGD:2317145 |
NCBI chr11:65,084,666...65,226,010
Ensembl chr11:65,084,467...65,245,716
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
exacerbates
|
ISO
|
mRNA:decreased expression:peripheral blood mononuclear cell (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
|
RGD |
PMID:16252156 PMID:19211025 |
RGD:401827902, RGD:401850788 |
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Oaz1
|
ornithine decarboxylase antizyme 1
|
susceptibility
|
ISO
|
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
|
RGD |
PMID:17761941 |
RGD:401851037 |
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990
|
|
| G
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9
|
susceptibility
|
ISO
|
DNA:missense mutation, nonsense mutations:cds:p.R46L, p.Y142X, p.C679X (human)
|
RGD |
PMID:16554528 |
RGD:1581000 |
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
ISO
|
ClinVar Annotator: match by term: Three Vessel Coronary Disease
|
ClinVar |
PMID:8532023 |
|
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
no_association susceptibility
|
ISO
|
DNA:SNP:intron 3: (rs12526453) (human) associated with type 2 diabetes mellitus;DNA:SNP:intron: (rs12526453) (human)
|
RGD |
PMID:28287809 PMID:22152955 |
RGD:401901081, RGD:11055500 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21356620 PMID:15699277 |
RGD:6482780 |
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:1730212 PMID:9181759 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Pltp
|
phospholipid transfer protein
|
susceptibility
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:14695459 |
RGD:1581038 |
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
|
|
| G
|
Pon1
|
paraoxonase 1
|
severity no_association
|
ISO
|
protein:decreased expression:serum CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.Q192R (human) associated with Diabetes Mellitus, Type 2;DNA:missense mutation:cds:p.Q192R (human)
|
CTD RGD |
PMID:16353344 PMID:16882531 PMID:19005291 PMID:15214960 PMID:9215303 |
RGD:2313267, RGD:8547675, RGD:1580201 |
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Pon2
|
paraoxonase 2
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.C311S (human)
|
RGD |
PMID:9443862 |
RGD:1580216 |
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:34,356,274...34,391,996
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
|
ISO
|
associated with menopause; mRNA,protein:increased expression:peripheral blood mononuclear cell ,plasma
|
RGD |
PMID:35734636 |
RGD:401794436 |
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
|
ISO
|
protein:increased expression:blood plasma (human)
|
RGD |
PMID:23584360 |
RGD:329845574 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
Retn
|
resistin
|
|
ISO
|
protein:increased expression:blood
|
RGD |
PMID:17175295 |
RGD:7207156 |
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116
|
|
| G
|
Rtel1
|
regulator of telomere elongation helicase 1
|
ameliorates
|
ISO
|
DNA:SNP:cds:rs6010620|rs4809324 (human)
|
RGD |
PMID:30623606 |
RGD:152985693 |
NCBI chr 3:188,778,329...188,842,877
Ensembl chr 3:188,807,951...188,843,709
|
|
| G
|
Scarb1
|
scavenger receptor class B, member 1
|
|
ISO
|
|
RGD |
PMID:15967843 |
RGD:1580004 |
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
protein:altered expression:serum
|
RGD |
PMID:11597943 |
RGD:1580074 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpinf2
|
serpin family F member 2
|
|
ISO
|
protein:increased expression:blood
|
RGD |
PMID:15771120 |
RGD:1625529 |
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996
|
|
| G
|
Tcf7l2
|
transcription factor 7 like 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
|
ISO
|
ClinVar Annotator: match by term: Coronary artery disease, susceptibility to
|
ClinVar |
PMID:16890917 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Thbd
|
thrombomodulin
|
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma
|
RGD |
PMID:17200788 |
RGD:2312456 |
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
mRNA, protein:increased expression:ventricle myocardium
|
RGD |
PMID:16139132 |
RGD:2313728 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16549638 |
|
NCBI chr 1:191,932,969...191,935,490
|
|
| G
|
Vwf
|
von Willebrand factor
|
|
ISO
|
|
RGD |
PMID:11864703 |
RGD:1580647 |
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
| G
|
Zc3hc1
|
zinc finger, C3HC-type containing 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28869590 |
|
NCBI chr 4:59,957,402...59,979,336
Ensembl chr 4:59,957,402...59,979,336
|
|
|
|
| G
|
Aldh1a2
|
aldehyde dehydrogenase 1 family, member A2
|
disease_progression
|
ISO
|
|
RGD |
PMID:26315408 |
RGD:14367880 |
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
ISO
|
mRNA:increased expression:heart:
|
RGD |
PMID:21439970 |
RGD:7257651 |
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9236417 |
|
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12138120 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Ahsp
|
alpha hemoglobin stabilizing protein
|
|
ISO
|
mRNA:decreased expression:blood (human)
|
RGD |
PMID:35144391 |
RGD:329961301 |
NCBI chr 1:192,310,306...192,315,943
Ensembl chr 1:192,310,244...192,315,942
|
|
| G
|
Bche
|
butyrylcholinesterase
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.A539T (human)
|
RGD |
PMID:17275003 |
RGD:2306778 |
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Cdh13
|
cadherin 13
|
|
IEP
|
protein:increased expression:artery, smooth muscle cell
|
RGD |
PMID:12376824 |
RGD:2293553 |
NCBI chr19:63,258,251...64,296,122
Ensembl chr19:63,258,122...64,296,119
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:14578618 |
RGD:1598500 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcr3
|
C-X-C motif chemokine receptor 3
|
|
ISO
|
|
RGD |
PMID:14578618 |
RGD:1598500 |
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:70,883,958...70,886,871
|
|
| G
|
F2r
|
coagulation factor II (thrombin) receptor
|
|
ISO
|
|
RGD |
PMID:14529396 |
RGD:1581036 |
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:16020495 PMID:14529548 |
RGD:1598402, RGD:1580472 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Itgb2
|
integrin subunit beta 2
|
|
ISO
|
|
RGD |
PMID:11703955 |
RGD:1581185 |
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
|
|
| G
|
Lox
|
lysyl oxidase
|
|
IDA
|
|
RGD |
PMID:15218472 |
RGD:1581881 |
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
|
IDA
|
|
RGD |
PMID:15583728 |
RGD:1582284 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
susceptibility
|
ISO
|
DNA:polymorphisms:5' utr, exon:multiple (human)
|
RGD |
PMID:15790942 |
RGD:1582150 |
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8662692 |
|
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
treatment
|
IEP
|
|
RGD |
PMID:21139058 |
RGD:9685362 |
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16489563 |
|
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
treatment
|
IDA
|
|
RGD |
PMID:7955204 |
RGD:10059621 |
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Npy5r
|
neuropeptide Y receptor Y5
|
|
IEP
|
mRNA, protein:increased expression:carotid artery
|
RGD |
PMID:12689918 |
RGD:1625501 |
NCBI chr16:27,822,055...27,830,012
Ensembl chr16:27,816,065...27,830,290
|
|
| G
|
Oaz1
|
ornithine decarboxylase antizyme 1
|
susceptibility
|
ISO
|
DNA:SNP:intron:c.2222A>G (rs2074458) (human)
|
RGD |
PMID:17761941 |
RGD:401851037 |
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:9,533,811...9,536,990
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
|
RGD |
PMID:12114325 PMID:16373617 |
RGD:1581358, RGD:1581366 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16319143 PMID:16319143 |
RGD:1580322 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tp53
|
tumor protein p53
|
|
ISO
|
|
RGD |
PMID:14740296 |
RGD:1580742 |
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Ucp3
|
uncoupling protein 3
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-55C>T (human)
|
RGD |
PMID:17786284 |
RGD:2313513 |
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210
|
|
|
|
| G
|
Apln
|
apelin
|
|
ISO
|
protein:decreased expression:plasma
|
RGD |
PMID:19015606 |
RGD:2313942 |
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246
|
|
| G
|
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1
|
|
ISO
|
DNA:SNP:CDS: (Rs6486205|rs10741657|rs2060793)
|
RGD |
PMID:34262949 |
RGD:401901074 |
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423
|
|
| G
|
Edn1
|
endothelin 1
|
treatment
|
ISO
|
|
RGD |
PMID:10854676 |
RGD:8661796 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Hrh2
|
histamine receptor H 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12721106 |
|
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
|
IEP
|
mRNA:increased expression:myocyte:
|
RGD |
PMID:8102103 |
RGD:10046053 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
|
IEP
|
mRNA:increased expression:myocyte:
|
RGD |
PMID:8102103 |
RGD:10046053 |
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
|
IDA
|
|
RGD |
PMID:11922905 |
RGD:1582454 |
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
|
ISO
|
protein:increased expression:coronary artery
|
RGD |
PMID:32160773 |
RGD:243065232 |
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Mdk
|
midkine
|
|
IDA
|
|
RGD |
PMID:10683378 |
RGD:1299187 |
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12721106 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Nppa
|
natriuretic peptide A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12721106 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
ISO
|
DNA:missense mutations:cds:p.L125V, p.S563N (human)
|
RGD |
PMID:10571959 |
RGD:1598382 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
susceptibility
|
ISO
|
DNA:SNP::g.13011943A>G (rs9349379) (human)
|
RGD |
PMID:22745674 |
RGD:401900726 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Prkce
|
protein kinase C, epsilon
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16782078 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:15569000 |
RGD:1624167 |
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
|
|
| G
|
Gp6
|
glycoprotein 6
|
|
ISO
|
DNA:missense mutation:CDS:c.13254T>C (human)
|
RGD |
PMID:15306180 |
RGD:401793750 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8598867 |
|
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:1452937 PMID:8172379 PMID:15301905 |
|
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
|
|
| G
|
Kit
|
KIT proto-oncogene receptor tyrosine kinase
|
|
IEP
|
mRNA,protein:decreased expression:stomach:
|
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812
|
|
| G
|
Kitlg
|
KIT ligand
|
|
IEP
|
mRNA:decreased expression:stomach:
|
RGD |
PMID:20040059 |
RGD:12911222 |
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
susceptibility
|
ISO
|
DNA:deletion:cds: (human)
|
RGD |
PMID:19279659 |
RGD:7495846 |
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
ISO
|
ClinVar Annotator: match by term: HYPERTENSION RESISTANT TO CONVENTIONAL THERAPY
|
ClinVar |
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 More...
|
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Ptprd
|
protein tyrosine phosphatase, receptor type, D
|
susceptibility
|
ISO
|
associated with coronary artery disease;DNA:SNP:intron: (rs324498) (human)
|
RGD |
PMID:30237584 |
RGD:401976431 |
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:95,095,858...96,178,903
|
|
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:15135374 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
|
IEP
|
|
RGD |
PMID:12911537 |
RGD:10395384 |
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
IEP
|
|
RGD |
PMID:12911537 |
RGD:10395384 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Notch3
|
notch receptor 3
|
|
TAS
|
|
RGD |
PMID:11925448 |
RGD:632418 |
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
|
|
| G
|
Polr2a
|
RNA polymerase II subunit A
|
|
IEP
|
|
RGD |
PMID:22535878 |
RGD:9681722 |
NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179
|
|
| G
|
Prl
|
prolactin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:718334 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
|
|
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
ISO
|
mRNA:increased expression:ventricular myocardium (human) mRNA:increased expression:myocardium
|
RGD |
PMID:15131005 PMID:11451295 |
RGD:8142363, RGD:8548894 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Agt
|
angiotensinogen
|
|
ISO
|
mRNA:increased expression:myocardium
|
RGD |
PMID:11451295 |
RGD:8548894 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
|
ISO
|
mRNA:increased expression:myocardium
|
RGD |
PMID:11451295 |
RGD:8548894 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
ISO
|
protein:increased serine phosphorylation:platelet
|
RGD |
PMID:20467748 |
RGD:5509094 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Apoa4
|
apolipoprotein A4
|
|
ISO
|
protein:decreased expression:blood plasma (human)
|
RGD |
PMID:20367977 |
RGD:5685646 |
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
|
ISO
|
|
RGD |
PMID:16186425 |
RGD:4891111 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Crp
|
C-reactive protein
|
disease_progression
|
ISO
|
|
RGD |
PMID:9761079 |
RGD:9491780 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Edn1
|
endothelin 1
|
|
ISO
|
associated with Coronary Artery Disease;protein:increased expression:coronary sinus, plasma (human)
|
RGD |
PMID:14556009 |
RGD:8661755 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
F7
|
coagulation factor VII
|
|
ISO
|
protein:increased expression:plasma (human)
|
RGD |
PMID:10653827 |
RGD:2312399 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
ISO
|
|
RGD |
PMID:18333374 |
RGD:5508458 |
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
susceptibility
|
ISO
|
|
RGD |
PMID:15104219 |
RGD:1582303 |
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
ameliorates
|
ISO
|
protein:decreased expression:neutrophil (human)
|
RGD |
PMID:18043994 |
RGD:329901840 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itih4
|
inter-alpha-trypsin inhibitor heavy chain 4
|
|
ISO
|
|
RGD |
PMID:10486281 |
RGD:1582334 |
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,086,973...6,102,160
|
|
| G
|
Mir126a
|
microRNA 126a
|
disease_progression
|
ISO
|
|
RGD |
PMID:32595526 |
RGD:401851053 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir21
|
microRNA 21
|
|
ISO
|
RNA:decreased expression:serum
|
RGD |
PMID:32595526 |
RGD:401851053 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
|
ISO
|
|
RGD |
PMID:14675588 |
RGD:1582536 |
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Pappa
|
pappalysin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11586954 |
|
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:2382605 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
|
ISO
|
RNA:increased expression:serum
|
RGD |
PMID:32595526 |
RGD:401851053 |
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:21162967 |
RGD:6219003 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpinc1
|
serpin family C member 1
|
treatment
|
ISO
|
|
RGD |
PMID:8122184 |
RGD:11035255 |
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
ISO
|
|
RGD |
PMID:14592844 |
RGD:1580841 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Txn1
|
thioredoxin 1
|
|
ISO
|
|
RGD |
PMID:15749180 |
RGD:1580784 |
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
|
|
| G
|
Adm
|
adrenomedullin
|
|
IEP
|
protein:decreased expression:plasma
|
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Cfh
|
complement factor H
|
|
IEP
|
protein:decreased expression:plasma
|
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
|
IEP
|
associated with Experimental Radiation Injuries;mRNA,protein:decreased expression:mesenteric artery
|
RGD |
PMID:32562786 |
RGD:329961328 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Npy
|
neuropeptide Y
|
|
IEP
|
associated with Brain Injuries;mRNA, protein:increased expression:jejunum, plasma
|
RGD |
PMID:23622727 |
RGD:10448970 |
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
IEP
|
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Agt
|
angiotensinogen
|
|
IEP
|
protein:increased expression:plasma
|
RGD |
PMID:15001561 |
RGD:13515113 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
treatment
|
IEP
|
|
RGD |
PMID:22079846 PMID:37387514 |
RGD:401794136, RGD:407419876 |
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
treatment
|
IEP
|
|
RGD |
PMID:24232000 |
RGD:13792678 |
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IEP
|
|
RGD |
PMID:23946597 |
RGD:13782356 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
treatment
|
IEP
|
|
RGD |
PMID:23946597 |
RGD:13782356 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP
|
mRNA:increased expression:small intestine
|
RGD |
PMID:18475188 |
RGD:2307016 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Cd14
|
CD14 molecule
|
|
IEP
|
protein:increased expression:heart, kidney, liver, lung
|
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cldn1
|
claudin 1
|
|
IEP
|
protein:decreased expression:colon:
|
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
|
|
| G
|
Cldn3
|
claudin 3
|
|
IEP
|
protein:decreased expression:colon:
|
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr12:27,345,075...27,346,547
Ensembl chr12:27,345,076...27,348,841
|
|
| G
|
Cldn5
|
claudin 5
|
|
IEP
|
protein:decreased expression:colon:
|
RGD |
PMID:19929946 |
RGD:2325127 |
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
| G
|
Crp
|
C-reactive protein
|
|
IEP
|
protein:increased expression:intestine:
|
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
|
RGD |
PMID:9117128 |
RGD:11039476 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
treatment
|
IEP
|
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
F7
|
coagulation factor VII
|
|
ISO
|
human protein in a rat model
|
RGD |
PMID:22920553 |
RGD:11041662 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Faslg
|
Fas ligand
|
treatment
|
IEP
|
|
RGD |
PMID:29170412 |
RGD:13792603 |
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:16557159 |
RGD:401717563 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
IEP
|
|
RGD |
PMID:22093738 |
RGD:10402181 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:19362701 |
RGD:10766423 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hp
|
haptoglobin
|
treatment
|
IEP
|
|
RGD |
PMID:11922743 |
RGD:11041790 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IEP
|
|
RGD |
PMID:12095141 PMID:22079846 |
RGD:11522715, RGD:401794136 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
IDA IEP
|
|
RGD |
PMID:11959089 PMID:22079846 |
RGD:11062110, RGD:401794136 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Jak2
|
Janus kinase 2
|
|
IMP
|
|
RGD |
PMID:22777122 |
RGD:10403072 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Lbp
|
lipopolysaccharide binding protein
|
|
IEP
|
protein:increased expression:heart, kidney, liver, lung
|
RGD |
PMID:22493902 |
RGD:9685194 |
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
severity
|
ISO
|
DNA:polymorphisms:exon:
|
RGD |
PMID:19477015 |
RGD:12910933 |
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mir155
|
microRNA 155
|
|
ISO
|
miRNA:increased expression:Peyer's patch
|
RGD |
PMID:30206757 |
RGD:21409753 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir21
|
microRNA 21
|
|
IEP
|
|
RGD |
PMID:30309483 |
RGD:41410822 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
treatment
|
IEP
|
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IDA
|
|
RGD |
PMID:16610051 |
RGD:7777112 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:28382390 |
RGD:13440093 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4
|
disease_progression
|
IEP
|
mRNA:decreased expression:liver (rat)
|
RGD |
PMID:23331901 |
RGD:15042883 |
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:25,733,471...25,829,389
|
|
| G
|
Parg
|
poly (ADP-ribose) glycohydrolase
|
treatment
|
IMP
|
|
RGD |
PMID:15791006 |
RGD:13514040 |
NCBI chr16:7,442,696...7,550,585
Ensembl chr16:7,442,726...7,550,584
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
|
ISO
|
mRNA:increased expression:jejunum (human)
|
RGD |
PMID:20965186 |
RGD:9999150 |
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
treatment
|
ISO
|
|
RGD |
PMID:15187522 |
RGD:11250409 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
treatment
|
IEP
|
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Serpinc1
|
serpin family C member 1
|
treatment
|
IEP
|
|
RGD |
PMID:21046505 |
RGD:11035258 |
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
IDA
|
protein:increased activity:plasma (rat)
|
RGD |
PMID:12717359 |
RGD:11081012 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Socs1
|
suppressor of cytokine signaling 1
|
treatment
|
IEP
|
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
IEP
|
|
RGD |
PMID:22079846 |
RGD:401794136 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Traf6
|
TNF receptor associated factor 6
|
|
IEP
|
|
RGD |
PMID:27538408 |
RGD:151347179 |
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328
|
|
| G
|
Trem1
|
triggering receptor expressed on myeloid cells 1
|
ameliorates
|
IDA
|
associated with mesenteric vascular occlusion;
|
RGD |
PMID:18091551 |
RGD:127284848 |
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892
|
|
| G
|
Vwf
|
von Willebrand factor
|
|
IEP
|
protein:increased expression:plasma:
|
RGD |
PMID:10365842 |
RGD:11080742 |
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:23010742 |
RGD:13209016 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
IMP
|
|
RGD |
PMID:21680852 |
RGD:6893484 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ace2
|
angiotensin converting enzyme 2
|
|
IEP
|
mRNA:decreased expression:kidney
|
RGD |
PMID:20528771 |
RGD:9685432 |
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
| G
|
Acta1
|
actin, alpha 1, skeletal muscle
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr19:68,781,168...68,784,194
Ensembl chr19:68,781,168...68,786,178
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
treatment
|
ISO
|
human construct in rat model
|
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Adam17
|
ADAM metallopeptidase domain 17
|
treatment
|
IEP
|
|
RGD |
PMID:22015440 |
RGD:13703100 |
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
|
|
| G
|
Adam2
|
ADAM metallopeptidase domain 2
|
|
IEP
|
|
RGD |
PMID:11967014 |
RGD:10047130 |
NCBI chr15:44,418,191...44,459,570
Ensembl chr15:44,418,199...44,459,516
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
IEP
|
|
RGD |
PMID:18272597 |
RGD:9684850 |
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
treatment
|
ISO
|
|
RGD |
PMID:21412771 |
RGD:8695946 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adm
|
adrenomedullin
|
treatment
|
IEP ISO
|
protein:increased expression:serum:
|
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Akr1a1
|
aldo-keto reductase family 1 member A1
|
|
ISO
|
|
RGD |
PMID:31089212 |
RGD:27226686 |
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
|
ISO
|
|
RGD |
PMID:22022451 |
RGD:7241603 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Anxa1
|
annexin A1
|
treatment
|
IDA
|
|
RGD |
PMID:20953576 |
RGD:7421585 |
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Anxa5
|
annexin A5
|
|
ISO
|
|
RGD |
PMID:21918686 |
RGD:7242028 |
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
treatment
|
IEP
|
|
RGD |
PMID:26362957 |
RGD:13703110 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apoa1
|
apolipoprotein A1
|
treatment
|
ISO
|
|
RGD |
PMID:18535924 |
RGD:7241574 |
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
|
IEP
|
protein:increased expression:kidney
|
RGD |
PMID:22768306 |
RGD:10053607 |
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:18221257 PMID:29285062 |
RGD:2293026, RGD:13792599 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
|
ISO
|
|
RGD |
PMID:18725957 |
RGD:7241559 |
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
IEP
|
|
RGD |
PMID:26412257 |
RGD:11561958 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bmi1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr17:86,240,683...86,250,044
Ensembl chr17:86,243,491...86,250,024
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
|
IEP
|
mRNA, protein:increased expression:kidney
|
RGD |
PMID:23698117 |
RGD:11561968 |
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
C3
|
complement C3
|
treatment
|
IEP
|
|
RGD |
PMID:19691975 |
RGD:7411689 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
|
IMP
|
|
RGD |
PMID:19194162 |
RGD:7204479 |
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IEP
|
|
RGD |
PMID:23151253 |
RGD:10054101 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
|
IEP
|
|
RGD |
PMID:17596683 |
RGD:5684536 |
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Ccl11
|
C-C motif chemokine ligand 11
|
treatment
|
ISO
|
|
RGD |
PMID:22160777 |
RGD:7247742 |
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
ameliorates treatment
|
ISO IDA
|
mRNA, protein:increased expression:kidney, lung, serum
|
RGD |
PMID:24920753 PMID:20396927 PMID:18650485 |
RGD:329845564, RGD:4891433, RGD:11526113 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Cd14
|
CD14 molecule
|
|
ISO
|
mRNA,protein:increased expression:kidney
|
RGD |
PMID:10966493 |
RGD:7204444 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd40
|
CD40 molecule
|
treatment
|
IMP
|
|
RGD |
PMID:25993320 |
RGD:11251055 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cfb
|
complement factor B
|
|
ISO
|
|
RGD |
PMID:16467447 PMID:12538716 |
RGD:7242709, RGD:7242734 |
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
|
|
| G
|
Cfh
|
complement factor H
|
treatment
|
IEP ISO
|
protein:decreased expression:serum:
|
RGD |
PMID:20538296 PMID:20538296 |
RGD:7364948, RGD:7364948 |
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Ciita
|
class II, major histocompatibility complex, transactivator
|
|
ISO
|
|
RGD |
PMID:14569092 |
RGD:7242896 |
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342
|
|
| G
|
Cited1
|
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr X:71,390,328...71,395,023
Ensembl chr X:71,390,331...71,393,649
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Csf1
|
colony stimulating factor 1
|
|
ISO
|
mRNA:increased expression:kidney
|
RGD |
PMID:23143303 PMID:19196448 |
RGD:7257565, RGD:7257570 |
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
|
|
| G
|
Csf1r
|
colony stimulating factor 1 receptor
|
|
ISO
|
|
RGD |
PMID:23143303 |
RGD:7257565 |
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
|
|
| G
|
Ctla4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
ISO
|
|
RGD |
PMID:22189844 PMID:9407517 |
RGD:7204675, RGD:7204727 |
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcr2
|
C-X-C motif chemokine receptor 2
|
|
ISO
|
|
RGD |
PMID:20038794 |
RGD:7257679 |
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
|
IEP
|
protein:increased expression:kidney
|
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
treatment
|
IMP
|
|
RGD |
PMID:23552495 |
RGD:7244372 |
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Daxx
|
death-domain associated protein
|
|
ISO
|
protein:increased expression:kidney:
|
RGD |
PMID:18480747 PMID:18480747 |
RGD:9587836, RGD:9587836 |
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Ddr1
|
discoidin domain receptor tyrosine kinase 1
|
|
ISO
|
protein:increased expression:kidney (mouse)
|
RGD |
PMID:31383731 |
RGD:151347540 |
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,050,375...3,069,276
|
|
| G
|
Dhfr
|
dihydrofolate reductase
|
treatment
|
IEP
|
mRNA,protein:decreased expression:kidney:
|
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chr 2:25,320,895...25,346,004
|
|
| G
|
Drd3
|
dopamine receptor D3
|
treatment
|
IDA
|
|
RGD |
PMID:25989500 |
RGD:13506961 |
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:70,385,586...70,446,760
|
|
| G
|
Eed
|
embryonic ectoderm development
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500
|
|
| G
|
Egln1
|
egl-9 family hypoxia-inducible factor 1
|
|
IEP
|
mRNA, protein:decreased expression:kidney
|
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr19:69,765,276...69,804,681
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
|
IEP
|
mRNA, protein:decreased expression:kidney
|
RGD |
PMID:19349364 |
RGD:11252083 |
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
treatment
|
IMP
|
|
RGD |
PMID:16980042 |
RGD:10450580 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Eng
|
endoglin
|
|
IEP ISO
|
mRNA, protein:increased expression:kidney (rat)
|
RGD |
PMID:16751653 PMID:16751653 |
RGD:7248779, RGD:7248779 |
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
| G
|
Ep300
|
E1A binding protein p300
|
|
IEP
|
protein:altered localization:kidney (rat)
|
RGD |
PMID:23936185 |
RGD:7257563 |
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
ISO
|
|
RGD |
PMID:19961832 PMID:25581532 |
RGD:10401077, RGD:11041698 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Ezh2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
|
IEP
|
protein:decreased expression:lung
|
RGD |
PMID:25883098 |
RGD:11341735 |
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
IEP
|
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
treatment
|
IEP
|
|
RGD |
PMID:29285062 |
RGD:13792599 |
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fcgr1a
|
Fc gamma receptor 1A
|
treatment
|
ISO
|
|
RGD |
PMID:22402584 |
RGD:9685699 |
NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858
|
|
| G
|
Fga
|
fibrinogen alpha chain
|
|
IEP
|
mRNA,protein:increased expression:kidney
|
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
|
|
| G
|
Fgb
|
fibrinogen beta chain
|
treatment
|
IEP ISO
|
mRNA, protein:increased expression:kidney
|
RGD |
PMID:21685370 PMID:21685370 |
RGD:7175292, RGD:7175292 |
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
exacerbates ameliorates
|
ISO IMP
|
protein:increased phosphorylation:kidney (mouse)
|
RGD |
PMID:20591940 PMID:22688984 PMID:29344510 PMID:32523960 |
RGD:155663667, RGD:155882537, RGD:155782904, RGD:155782882 |
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Fgg
|
fibrinogen gamma chain
|
|
IEP
|
mRNA,protein:increased expression:kidney
|
RGD |
PMID:21685370 |
RGD:7175292 |
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
|
|
| G
|
Fn1
|
fibronectin 1
|
|
IEP
|
|
RGD |
PMID:11352844 |
RGD:7205629 |
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
|
RGD |
PMID:19095962 |
RGD:7242184 |
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
|
IEP
|
|
RGD |
PMID:17250641 |
RGD:2307361 |
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gfer
|
growth factor, augmenter of liver regeneration
|
treatment
|
IEP ISO
|
protein:increased expression:kidney:
|
RGD |
PMID:20332418 PMID:20332418 |
RGD:9685723, RGD:9685723 |
NCBI chr10:14,223,023...14,225,736
Ensembl chr10:14,223,023...14,225,935
|
|
| G
|
Glo1
|
glyoxalase 1
|
|
IMP
|
|
RGD |
PMID:19211689 |
RGD:7242566 |
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
IEP
|
protein:decreased expression:kidney mRNA:decreased expression:kidney
|
RGD |
PMID:37033969 PMID:22442209 |
RGD:401827821, RGD:401827906 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
treatment
|
IEP
|
|
RGD |
PMID:24630969 |
RGD:10401866 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
|
IEP
|
mRNA, protein:decreased expression:kidney
|
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
Gstt1
|
glutathione S-transferase theta 1
|
|
IEP
|
protein:decreased expression:kidney
|
RGD |
PMID:37033969 |
RGD:401827821 |
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
|
|
| G
|
H2ax
|
H2A.X variant histone
|
treatment
|
IEP
|
|
RGD |
PMID:23726287 |
RGD:8693706 |
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Has1
|
hyaluronan synthase 1
|
|
IEP
|
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 1:67,366,460...67,378,686
Ensembl chr 1:67,366,460...67,378,444
|
|
| G
|
Has2
|
hyaluronan synthase 2
|
|
IEP
|
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
|
IEP ISO
|
protein:increased expression:urine:
|
RGD |
PMID:23552495 PMID:23019274 PMID:23085062 |
RGD:7244372, RGD:7245495, RGD:7245489 |
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment severity
|
IDA IMP
|
|
RGD |
PMID:17519789 PMID:22432008 |
RGD:1626334, RGD:9068883 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IMP
|
|
RGD |
PMID:21291499 |
RGD:10755580 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
|
IEP
|
protein:increased expression:kidney (rat)
|
RGD |
PMID:23102208 |
RGD:10402775 |
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
|
IEP
|
|
RGD |
PMID:7569112 |
RGD:7242788 |
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hyal1
|
hyaluronidase 1
|
|
IEP
|
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:117,129,277...117,133,146
|
|
| G
|
Hyal2
|
hyaluronidase 2
|
|
IEP
|
|
RGD |
PMID:22529164 |
RGD:9588636 |
NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:117,121,787...117,125,493
|
|
| G
|
Ifng
|
interferon gamma
|
treatment
|
ISO
|
|
RGD |
PMID:28355607 |
RGD:14975115 |
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
|
IEP
|
mRNA: increased expression: kidney: 3 and 5 days post ischemia
|
RGD |
PMID:10990448 |
RGD:7242905 |
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
treatment
|
IMP
|
|
RGD |
PMID:19546526 |
RGD:7495779 |
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
IDA ISO
|
|
RGD |
PMID:24079335 PMID:28664613 |
RGD:7364864, RGD:14975137 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12b
|
interleukin 12B
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
| G
|
Il18
|
interleukin 18
|
treatment
|
IMP
|
|
RGD |
PMID:22089199 |
RGD:8655971 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1b
|
interleukin 1 beta
|
ameliorates
|
IDA ISO
|
|
RGD |
PMID:20030532 PMID:24920753 |
RGD:7175501, RGD:329845564 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
rat model treated with human protein mouse model treated with human protein
|
RGD |
PMID:18363573 PMID:9555664 PMID:16849996 |
RGD:6907101, RGD:6909149, RGD:6907359 |
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il6
|
interleukin 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Inhbb
|
inhibin subunit beta B
|
|
IEP
|
protein:increased expression:serum (rat)
|
RGD |
PMID:27732750 |
RGD:329322881 |
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609
|
|
| G
|
Itgb2
|
integrin subunit beta 2
|
|
ISO IMP
|
Associated with renal transplant patients
|
RGD |
PMID:20504838 PMID:11007822 |
RGD:6907049, RGD:6907073 |
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
|
IEP
|
protein:decreased expression:kidney
|
RGD |
PMID:21250976 |
RGD:7297045 |
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Kl
|
Klotho
|
treatment
|
IEP ISO
|
mRNA,protein:decreased expression:renal tubule:
|
RGD |
PMID:16204278 PMID:16204278 |
RGD:10403064, RGD:10403064 |
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
|
|
| G
|
Kmt2a
|
lysine methyltransferase 2A
|
|
ISO
|
protein:increased expression:kidney (mouse)
|
RGD |
PMID:31570196 |
RGD:155888490 |
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317
|
|
| G
|
Lcn2
|
lipocalin 2
|
|
IEP ISO
|
protein:increased expression:urine: mRNA,protein:increased expression:kidney,urine mRNA,protein:increased expression:kidney:
|
RGD |
PMID:23364806 PMID:27800610 PMID:20181666 PMID:23085062 |
RGD:7245469, RGD:126790572, RGD:126779563, RGD:7245489 |
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Lep
|
leptin
|
resistance
|
IDA
|
|
RGD |
PMID:22969992 |
RGD:6909133 |
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lgals3
|
galectin 3
|
|
IEP
|
mRNA:increased expression:kidney
|
RGD |
PMID:10980121 |
RGD:9685228 |
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
treatment
|
ISO IEP
|
|
RGD |
PMID:20075199 PMID:26412257 |
RGD:11561916, RGD:11561958 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
treatment
|
IMP
|
|
RGD |
PMID:23952292 |
RGD:10412647 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Mc1r
|
melanocortin 1 receptor
|
|
IEP
|
protein:decreased expression:kidney outer medulla
|
RGD |
PMID:18790174 |
RGD:5687322 |
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877
|
|
| G
|
Mir146a
|
microRNA 146a
|
treatment
|
IEP
|
|
RGD |
PMID:27760486 |
RGD:155882556 |
NCBI chr10:28,349,996...28,350,090
|
|
| G
|
Mir320a
|
microRNA 320a
|
treatment
|
IEP
|
|
RGD |
PMID:31089916 PMID:27760486 |
RGD:155882543, RGD:155882556 |
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
| G
|
Mir381
|
microRNA 381
|
|
IEP
|
RNA:decreased expression:kidney
|
RGD |
PMID:29073721 |
RGD:13825150 |
NCBI chr 6:134,562,381...134,562,441
|
|
| G
|
Mir423
|
microRNA 423
|
treatment
|
IMP
|
|
RGD |
PMID:29137244 |
RGD:158014894 |
NCBI chr10:62,412,272...62,412,350
|
|
| G
|
Mir494
|
microRNA 494
|
ameliorates
|
ISO
|
|
RGD |
PMID:23160513 |
RGD:155883172 |
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
|
|
| G
|
Mpo
|
myeloperoxidase
|
|
IEP ISO
|
protein:increased activity:kidney
|
RGD |
PMID:22950848 PMID:18055546 |
RGD:6909167, RGD:7174699 |
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
treatment
|
IDA
|
|
RGD |
PMID:22019164 |
RGD:7245959 |
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
|
IEP
|
mRNA:increased expression:kidney (rat)
|
RGD |
PMID:17220792 |
RGD:7207777 |
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Ndufb8
|
NADH:ubiquinone oxidoreductase subunit B8
|
|
IEP ISO
|
|
RGD |
PMID:24096033 PMID:22160772 |
RGD:13801197, RGD:13801199 |
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936
|
|
| G
|
Nes
|
nestin
|
|
IEP
|
|
RGD |
PMID:24503548 |
RGD:11570523 |
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
treatment
|
IEP
|
|
RGD |
PMID:31089916 |
RGD:155882543 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
treatment
|
IEP
|
|
RGD |
PMID:18408363 |
RGD:11040540 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IEP
|
|
RGD |
PMID:29291552 PMID:18408363 |
RGD:13504682, RGD:11040540 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
treatment
|
IEP
|
|
RGD |
PMID:34244746 |
RGD:329955363 |
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nppa
|
natriuretic peptide A
|
|
ISO
|
|
RGD |
PMID:20471588 |
RGD:7247717 |
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:21545725 |
RGD:11035217 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
severity
|
ISO
|
mRNA:increased expression:kidney
|
RGD |
PMID:22343121 PMID:22343121 |
RGD:14700869, RGD:14700869 |
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
|
IEP
|
|
RGD |
PMID:12531391 |
RGD:2317150 |
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Pax2
|
paired box 2
|
|
IEP
|
mRNA, protein:increased expression:kidney
|
RGD |
PMID:12444203 |
RGD:727468 |
NCBI chr 1:253,555,447...253,646,623
Ensembl chr 1:253,555,418...253,645,438
|
|
| G
|
Pdgfb
|
platelet derived growth factor subunit B
|
|
IEP
|
mRNA,protein:increased expression:tubule, S3 segment:
|
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
|
IEP
|
mRNA:increased expression:kidney
|
RGD |
PMID:10550325 |
RGD:8554477 |
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
|
IMP IEP
|
mRNA:increased expression:kidney
|
RGD |
PMID:12819032 PMID:10550325 |
RGD:1580850, RGD:8554477 |
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Peg10
|
paternally expressed 10
|
|
ISO
|
mRNA:increased expression:kidney (mouse)
|
RGD |
PMID:16778176 |
RGD:401851077 |
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:33,817,190...33,819,166 Ensembl chr 4:33,817,190...33,819,166
|
|
| G
|
Pkd2
|
polycystin 2, transient receptor potential cation channel
|
|
IEP
|
protein:increased expression:kidney (rat)
|
RGD |
PMID:12454224 |
RGD:1580868 |
NCBI chr14:5,541,821...5,585,140
Ensembl chr14:5,495,401...5,587,594
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
treatment
|
IDA
|
|
RGD |
PMID:24918615 |
RGD:10059636 |
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
|
ISO
|
mRNA:increased expression:kidney (mouse)
|
RGD |
PMID:30413885 |
RGD:401959745 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Rnls
|
renalase, FAD-dependent amine oxidase
|
|
ISO
|
mRNA,protein:decreased expression:kidney,plasma:
|
RGD |
PMID:23393318 PMID:23393318 |
RGD:7327166, RGD:7327166 |
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:240,450,702...240,723,043
|
|
| G
|
Sell
|
selectin L
|
|
IEP
|
|
RGD |
PMID:7537789 |
RGD:597015754 |
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
|
|
| G
|
Serpina1
|
serpin family A member 1
|
treatment
|
ISO
|
|
RGD |
PMID:28235038 |
RGD:14695051 |
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpinc1
|
serpin family C member 1
|
severity
|
IMP
|
|
RGD |
PMID:26108065 PMID:26108065 |
RGD:11354006, RGD:11354006 |
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|
| G
|
Serpinc1em2Mcwi
|
serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin
|
|
IMP
|
|
RGD |
PMID:26108065 |
RGD:11354006 |
|
|
| G
|
Serpine1
|
serpin family E member 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Shh
|
sonic hedgehog signaling molecule
|
|
ISO
|
mRNA, protein:increased expression:kidney
|
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901
|
|
| G
|
Sirt1
|
sirtuin 1
|
treatment
|
IEP
|
|
RGD |
PMID:22324445 |
RGD:9495930 |
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Six2
|
SIX homeobox 2
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 6:14,727,756...14,734,219
Ensembl chr 6:14,727,859...14,731,941
|
|
| G
|
Slc22a1
|
solute carrier family 22 member 1
|
|
IEP
|
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
|
|
| G
|
Slc22a2
|
solute carrier family 22 member 2
|
|
IEP
|
|
RGD |
PMID:21835768 |
RGD:7243877 |
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019
|
|
| G
|
Slc34a1
|
solute carrier family 34 member 1
|
|
IEP
|
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
|
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,224,010...9,238,983
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
IEP
|
|
RGD |
PMID:12819032 |
RGD:1580850 |
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Stat6
|
signal transducer and activator of transcription 6
|
severity
|
ISO
|
|
RGD |
PMID:12709397 |
RGD:7244143 |
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
| G
|
Suz12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr10:65,464,948...65,510,846
Ensembl chr10:65,464,969...65,510,846
|
|
| G
|
Tfpi
|
tissue factor pathway inhibitor
|
|
ISO
|
|
RGD |
PMID:11796005 |
RGD:11062062 |
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
treatment severity
|
IDA ISO
|
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 PMID:22750071 PMID:23023072 |
RGD:7207892, RGD:7241087, RGD:7240552, RGD:7207896, RGD:7207894 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
treatment
|
IDA ISO
|
|
RGD |
PMID:23239000 PMID:11801667 PMID:20130923 |
RGD:7207892, RGD:7241087, RGD:7240552 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
ameliorates
|
IEP ISO
|
protein:increased expression:serum
|
RGD |
PMID:19925291 PMID:24920753 |
RGD:2315112, RGD:329845564 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
ISO
|
mRNA:increased expression:lung
|
RGD |
PMID:22728466 |
RGD:7245543 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
IEP
|
protein:increased expression:kidney
|
RGD |
PMID:20164827 |
RGD:7240507 |
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vwf
|
von Willebrand factor
|
|
IEP
|
protein:increased expression:serum:
|
RGD |
PMID:12684225 |
RGD:11080744 |
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
| G
|
Wt1
|
WT1 transcription factor
|
|
ISO
|
mRNA:altered expression:kidney (mouse)
|
RGD |
PMID:18467665 |
RGD:155631277 |
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:112,021,641...112,068,444
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IMP
|
associated with Diabetes Mellitus, Type 2
|
RGD |
PMID:22995295 PMID:20616412 |
RGD:7247637, RGD:7247695 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
| G
|
Zfp667
|
zinc finger protein 667
|
ameliorates
|
ISO
|
|
RGD |
PMID:24920753 |
RGD:329845564 |
NCBI chr 1:76,634,897...76,655,133
Ensembl chr 1:76,634,901...76,655,213
|
|
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17344003 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
|
ISO
|
|
RGD |
PMID:11877468 |
RGD:737810 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Aldh1a2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ISO
|
|
RGD |
PMID:26315408 |
RGD:14367880 |
NCBI chr 8:80,758,641...80,837,891
Ensembl chr 8:80,758,142...80,837,883
|
|
| G
|
Cs
|
citrate synthase
|
|
IDA
|
|
RGD |
PMID:571116 |
RGD:243049254 |
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Csf2
|
colony stimulating factor 2
|
|
ISO
|
protein:increased expression:plasma:
|
RGD |
PMID:16648859 |
RGD:10449511 |
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
|
RGD |
PMID:23294128 PMID:16224058 |
RGD:10400895, RGD:11039414 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
exacerbates ameliorates
|
ISO
|
|
RGD |
PMID:20508179 PMID:35301145 PMID:22252294 |
RGD:155641249, RGD:155663375, RGD:155663358 |
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
ISO
|
|
RGD |
PMID:23294128 |
RGD:10400895 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Etv2
|
ETS variant transcription factor 2
|
exacerbates ameliorates
|
ISO
|
|
RGD |
PMID:26586661 PMID:28466428 PMID:32075417 PMID:28424975 PMID:28424975 |
RGD:11076207, RGD:192379484, RGD:192186227, RGD:156451664, RGD:156451664 |
NCBI chr 1:95,017,980...95,021,582
Ensembl chr 1:95,017,687...95,021,457
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
treatment
|
IEP
|
|
RGD |
PMID:25388665 |
RGD:11568031 |
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
treatment
|
IMP
|
|
RGD |
PMID:26604244 |
RGD:13514042 |
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
treatment
|
ISO
|
|
RGD |
PMID:15238569 |
RGD:8548639 |
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
IEP
|
protein:increased expression:skeletal muscle
|
RGD |
PMID:17522350 |
RGD:1626332 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IDA
|
|
RGD |
PMID:12593860 |
RGD:1598394 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
|
ISO
|
protein:increased expression:monocyte (human)
|
RGD |
PMID:20816321 |
RGD:329901827 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
|
ISO
|
|
RGD |
PMID:15750161 |
RGD:1582449 |
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Mir126a
|
microRNA 126a
|
ameliorates
|
ISO
|
associated with type 1 diabetes mellitus;
|
RGD |
PMID:29242072 PMID:35151721 |
RGD:401851035, RGD:401851044 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir210
|
microRNA 210
|
severity
|
ISO
|
|
RGD |
PMID:31878120 |
RGD:155882482 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IDA IEP ISO
|
associated with Diabetes Mellitus, Experimental human gene in rat model
|
RGD |
PMID:19080171 PMID:28979692 PMID:12171788 |
RGD:7794710, RGD:13450931, RGD:7794776 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
ISO
|
|
RGD |
PMID:22369073 PMID:21940947 |
RGD:6767285, RGD:6906905 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Ppbp
|
pro-platelet basic protein
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:30638058 |
RGD:401794451 |
NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
treatment
|
ISO IMP
|
human gene in a mouse model rat gene in human cells in a mouse model
|
RGD |
PMID:12586736 PMID:19344900 PMID:14568901 |
RGD:401959585, RGD:401960096, RGD:401960079 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptpn1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
ISO
|
protein:increased expression, increased activity:hindlimb muscle (mouse)
|
RGD |
PMID:18451337 |
RGD:401965417 |
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
treatment
|
IDA
|
|
RGD |
PMID:23562340 |
RGD:7421600 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
treatment
|
IEP
|
|
RGD |
PMID:36495512 |
RGD:401717522 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
treatment
|
IDA
|
|
RGD |
PMID:23762489 |
RGD:8695935 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adm
|
adrenomedullin
|
treatment
|
IEP ISO
|
mRNA,protein:increased expression:liver,plasma:
|
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
IEP
|
mRNA:increased expression:liver
|
RGD |
PMID:21431875 |
RGD:10402078 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
treatment
|
ISO IEP
|
protein:altered expression:liver (mouse) protein:altered expression:liver (rat)
|
RGD |
PMID:30671488 PMID:29589772 |
RGD:15036807, RGD:14975297 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Atf6
|
activating transcription factor 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
|
|
| G
|
Atg13
|
autophagy related 13
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:98,101,552...98,136,743
|
|
| G
|
Atg16l1
|
autophagy related 16-like 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 9:95,869,839...95,905,354
Ensembl chr 9:95,869,865...95,905,357
|
|
| G
|
Atg4d
|
autophagy related 4D, cysteine peptidase
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 8:28,083,902...28,093,491
Ensembl chr 8:28,083,936...28,093,491
|
|
| G
|
Atg7
|
autophagy related 7
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
treatment
|
IEP
|
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
|
RGD |
PMID:22647552 PMID:22847887 |
RGD:10053673, RGD:10053710 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
ameliorates treatment
|
IEP ISO
|
mRNA:increased expression:liver associated with Non-alcoholic Fatty Liver Disease
|
RGD |
PMID:22647552 PMID:34144219 PMID:21092002 PMID:22847887 |
RGD:10053673, RGD:329812011, RGD:5134995, RGD:10053710 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment ameliorates
|
IDA ISO IEP
|
associated with Non-alcoholic Fatty Liver Disease
|
RGD |
PMID:22847887 PMID:34144219 PMID:21092002 |
RGD:10053710, RGD:329812011, RGD:5134995 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
treatment
|
IEP
|
associated with Non-alcoholic Fatty Liver Disease
|
RGD |
PMID:22847887 |
RGD:10053710 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Becn1
|
beclin 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
ameliorates
|
IMP
|
|
RGD |
PMID:17893612 |
RGD:408346749 |
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
C3
|
complement C3
|
treatment
|
IEP
|
|
RGD |
PMID:19854450 |
RGD:11040888 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Casp12
|
caspase 12
|
treatment
|
IEP
|
|
RGD |
PMID:29428101 |
RGD:13782166 |
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
ameliorates
|
ISO
|
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp8
|
caspase 8
|
treatment
|
IEP ISO
|
|
RGD |
PMID:23423194 PMID:15300206 |
RGD:8661760, RGD:14695087 |
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
treatment ameliorates
|
IEP ISO
|
|
RGD |
PMID:23364428 PMID:34144219 |
RGD:13782358, RGD:329812011 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
ameliorates treatment severity
|
IEP ISO
|
mRNA, protein:increased expression:liver, serum (rat)
|
RGD |
PMID:9500701 PMID:34400126 PMID:10630515 PMID:27229110 |
RGD:8549627, RGD:329902072, RGD:14995929, RGD:14995460 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
treatment severity
|
ISO
|
|
RGD |
PMID:28623253 PMID:28623253 |
RGD:14995305, RGD:14995305 |
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
severity
|
ISO
|
|
RGD |
PMID:27229110 |
RGD:14995460 |
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Cd14
|
CD14 molecule
|
|
IDA
|
|
RGD |
PMID:22564590 |
RGD:7183676 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd40
|
CD40 molecule
|
treatment
|
IMP
|
|
RGD |
PMID:14741776 |
RGD:8547795 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cfh
|
complement factor H
|
treatment
|
IEP ISO
|
mRNA,protein:decreased expression:liver,plasma:
|
RGD |
PMID:19212187 PMID:19212187 |
RGD:7364958, RGD:7364958 |
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Cs
|
citrate synthase
|
|
IDA
|
|
RGD |
PMID:25416448 |
RGD:13504849 |
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Cst3
|
cystatin C
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
treatment ameliorates
|
IDA ISO
|
|
RGD |
PMID:21092002 PMID:34400126 |
RGD:5134995, RGD:329902072 |
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
treatment ameliorates
|
ISO
|
|
RGD |
PMID:18041715 PMID:34400126 |
RGD:27095942, RGD:329902072 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl6
|
C-X-C motif chemokine ligand 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
|
|
| G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
|
IEP
|
mRNA:decreased expression:lung
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
ameliorates
|
ISO
|
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
ameliorates
|
ISO
|
|
RGD |
PMID:34144219 |
RGD:329812011 |
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
|
IMP
|
|
RGD |
PMID:10588515 |
RGD:10450560 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
ISO
|
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Epor
|
erythropoietin receptor
|
|
IEP
|
protein:increased phosphorylation:liver:
|
RGD |
PMID:25769561 |
RGD:15090809 |
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
treatment
|
IMP
|
|
RGD |
PMID:11750579 |
RGD:11341708 |
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
Fadd
|
Fas associated via death domain
|
treatment
|
IEP
|
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
IMP IEP
|
protein:increased expression:liver
|
RGD |
PMID:17235585 PMID:18561025 PMID:16222447 |
RGD:2290283, RGD:14700680, RGD:1600351 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Faslg
|
Fas ligand
|
treatment
|
IMP
|
|
RGD |
PMID:18561025 |
RGD:14700680 |
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
| G
|
Fga
|
fibrinogen alpha chain
|
|
IEP
|
mRNA:increased expression:liver (rat)
|
RGD |
PMID:23503399 |
RGD:9685021 |
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
|
|
| G
|
Fn1
|
fibronectin 1
|
|
IDA
|
|
RGD |
PMID:12651615 |
RGD:7205470 |
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
treatment
|
IEP
|
|
RGD |
PMID:22564598 PMID:13678701 |
RGD:329970282, RGD:329970285 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
treatment
|
IDA
|
associated with nonalcoholic fatty liver disease
|
RGD |
PMID:28807209 |
RGD:13792730 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gstm1
|
glutathione S-transferase mu 1
|
|
IEP
|
mRNA:decreased expression:lung
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
|
|
| G
|
H2ax
|
H2A.X variant histone
|
treatment
|
IEP
|
|
RGD |
PMID:23792534 |
RGD:8693718 |
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IMP IEP
|
protein:increased oxidation:liver mRNA, protein:increased expression, altered localization:serum, hepatocyte, cytoplasm
|
RGD |
PMID:24578610 PMID:22514737 PMID:21431875 |
RGD:10402068, RGD:10402175, RGD:10402078 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:20446775 |
RGD:10755725 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hp
|
haptoglobin
|
treatment
|
IEP
|
|
RGD |
PMID:17187421 PMID:21699906 |
RGD:1626366, RGD:11041815 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IMP IEP
|
associated with Intestinal Reperfusion Injury;protein:increased expression:liver
|
RGD |
PMID:7884306 PMID:8780571 |
RGD:11520784, RGD:14402044 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
severity
|
ISO
|
|
RGD |
PMID:28938192 |
RGD:14985248 |
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Ikbkg
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
|
treatment
|
IDA
|
|
RGD |
PMID:22381173 |
RGD:12791280 |
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
IDA
|
|
RGD |
PMID:21911118 |
RGD:7364839 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il18
|
interleukin 18
|
treatment
|
IEP ISO
|
|
RGD |
PMID:25919765 PMID:14999688 |
RGD:14696667, RGD:14696668 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18bp
|
interleukin 18 binding protein
|
|
IEP
|
mRNA,protein:increased expression:liver
|
RGD |
PMID:25919765 |
RGD:14696667 |
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
treatment
|
IEP IDA
|
mRNA:increased expression:lung protein:increased expression:serum
|
RGD |
PMID:19595018 PMID:9840148 PMID:19283466 |
RGD:2314952, RGD:11059517, RGD:6907377 |
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
treatment ameliorates
|
IDA IEP ISO
|
associated with Cholestasis associated with steatotic liver disease
|
RGD |
PMID:21468628 PMID:31483550 PMID:34400126 PMID:32155285 |
RGD:7175318, RGD:598147058, RGD:329902072, RGD:155260323 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
treatment
|
ISO IMP
|
rat model treated with human protein
|
RGD |
PMID:9000676 PMID:12451245 |
RGD:6909138, RGD:8551710 |
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il6
|
interleukin 6
|
treatment ameliorates
|
IDA IEP ISO
|
associated with alcoholic hepatitis associated with steatotic liver disease
|
RGD |
PMID:24752458 PMID:22019745 PMID:31483550 PMID:34400126 PMID:34144219 PMID:32155285 More...
|
RGD:11062134, RGD:598147059, RGD:598147058, RGD:329902072, RGD:329812011, RGD:155260323 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Irf8
|
interferon regulatory factor 8
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
treatment exacerbates
|
IMP IEP
|
protein:increased expression:neutrophil (rat)
|
RGD |
PMID:8387952 PMID:11447039 |
RGD:329901847, RGD:329901849 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Jak2
|
Janus kinase 2
|
treatment
|
IDA
|
|
RGD |
PMID:22288937 |
RGD:10403073 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Lamp2
|
lysosomal-associated membrane protein 2
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
|
|
| G
|
Lbp
|
lipopolysaccharide binding protein
|
|
IEP
|
mRNA, protein:increased expression:liver
|
RGD |
PMID:12134092 |
RGD:9685192 |
NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
treatment
|
IEP
|
mRNA:increased expression:liver
|
RGD |
PMID:17397868 PMID:17194456 |
RGD:626419685, RGD:1599839 |
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
ameliorates exacerbates
|
ISO
|
protein:increased phosphorylation:liver (mouse)
|
RGD |
PMID:30076625 PMID:30622220 |
RGD:155804280, RGD:155882441 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
|
IEP
|
protein:increased activity:liver:
|
RGD |
PMID:11679968 |
RGD:10412680 |
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mfn2
|
mitofusin 2
|
treatment
|
IEP
|
mRNA, protein:decreased expression:liver (rat)
|
RGD |
PMID:27363631 PMID:24898700 |
RGD:12910833, RGD:13204829 |
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mgst2
|
microsomal glutathione S-transferase 2
|
|
IEP
|
mRNA:decreased expression:liver
|
RGD |
PMID:17397868 |
RGD:626419685 |
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
|
|
| G
|
Mgst3
|
microsomal glutathione S-transferase 3
|
|
IEP
|
mRNA:decreased expression:liver
|
RGD |
PMID:17397868 |
RGD:626419685 |
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
|
|
| G
|
Mir145
|
microRNA 145
|
|
IEP
|
mRNA:decreased expression:small intestine (rat)
|
RGD |
PMID:23166305 |
RGD:155230822 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mir155
|
microRNA 155
|
|
ISO
|
|
RGD |
PMID:28640790 |
RGD:21079442 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir21
|
microRNA 21
|
|
IEP
|
RNA:increased expression:liver
|
RGD |
PMID:29187695 |
RGD:41410824 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir210
|
microRNA 210
|
treatment
|
ISO
|
|
RGD |
PMID:32155285 |
RGD:155260323 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mir223
|
microRNA 223
|
|
ISO
|
RNA:increased expression:liver RNA:increased expression:serum,liver
|
RGD |
PMID:19104939 PMID:28646120 |
RGD:13831297, RGD:21408574 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mir34a
|
microRNA 34a
|
|
IEP
|
miRNA:increased expression:liver
|
RGD |
PMID:28963950 |
RGD:14695005 |
NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053
|
|
| G
|
Mmp15
|
matrix metallopeptidase 15
|
|
IEP
|
mRNA:increased expression:lung
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
treatment
|
IEP
|
associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver
|
RGD |
PMID:17255325 |
RGD:8547976 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mt-co2
|
mitochondrially encoded cytochrome c oxidase II
|
treatment
|
IEP
|
associated with alcoholic hepatitis
|
RGD |
PMID:22019745 |
RGD:598147059 |
NCBI chr MT:7,006...7,689
Ensembl chr MT:6,991...7,674
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
|
IEP
|
mRNA, protein:decreased expression:bile duct
|
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Muc17
|
mucin 17, cell surface associated
|
|
IEP
|
mRNA, protein:decreased expression:bile duct
|
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr12:25,139,076...25,175,249
|
|
| G
|
Muc4
|
mucin 4, cell surface associated
|
|
IEP
|
mRNA:decreased expression:bile duct
|
RGD |
PMID:21775928 |
RGD:7364757 |
NCBI chr11:81,513,321...81,575,200
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
treatment
|
IEP
|
associated with alcoholic hepatitis
|
RGD |
PMID:22019745 |
RGD:598147059 |
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Nfatc1
|
nuclear factor of activated T-cells 1
|
|
ISO
|
mRNA,protein:increased expression:liver:
|
RGD |
PMID:36092961 |
RGD:268357360 |
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
treatment
|
IEP
|
|
RGD |
PMID:22288937 PMID:31952110 |
RGD:10403073, RGD:21201304 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
treatment
|
IEP
|
associated with alcoholic hepatitis
|
RGD |
PMID:22019745 |
RGD:598147059 |
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
treatment
|
IEP
|
associated with alcoholic hepatitis
|
RGD |
PMID:22019745 |
RGD:598147059 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IEP
|
|
RGD |
PMID:28966130 |
RGD:13450941 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Pf4
|
platelet factor 4
|
exacerbates
|
ISO
|
|
RGD |
PMID:25440775 |
RGD:329901829 |
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
treatment
|
ISO
|
|
RGD |
PMID:12605111 PMID:18507760 |
RGD:11100021, RGD:11100046 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Rab10
|
RAB10, member RAS oncogene family
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 6:31,974,858...32,039,554
Ensembl chr 6:31,986,921...32,039,733
|
|
| G
|
Rab8b
|
RAB8B, member RAS oncogene family
|
ameliorates
|
ISO
|
|
RGD |
PMID:34400126 |
RGD:329902072 |
NCBI chr 8:76,340,106...76,417,638
Ensembl chr 8:76,340,113...76,417,885
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
treatment
|
IEP
|
associated with alcoholic hepatitis
|
RGD |
PMID:22019745 |
RGD:598147059 |
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Selplg
|
selectin P ligand
|
ameliorates
|
IMP
|
|
RGD |
PMID:16365457 |
RGD:401717523 |
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:48,456,932...48,473,154
|
|
| G
|
Serpinc1
|
serpin family C member 1
|
treatment
|
IEP ISO
|
|
RGD |
PMID:24726586 PMID:8589354 |
RGD:10450597, RGD:11038771 |
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:75,790,546...75,817,643
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
IEP
|
protein:increased activity:plasma (rat)
|
RGD |
PMID:12353078 |
RGD:8547901 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serping1
|
serpin family G member 1
|
treatment
|
ISO
|
|
RGD |
PMID:16367929 |
RGD:1580273 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Sirt1
|
sirtuin 1
|
treatment
|
IEP
|
|
RGD |
PMID:24557422 |
RGD:9497542 |
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
|
IEP
|
|
RGD |
PMID:19595018 |
RGD:2314952 |
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
treatment
|
ISO
|
human gene in a rat model
|
RGD |
PMID:16555330 PMID:11779401 |
RGD:8655889, RGD:1581095 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
treatment
|
ISO
|
human gene in a rat model
|
RGD |
PMID:11779401 |
RGD:1581095 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
treatment
|
ISO
|
|
RGD |
PMID:19545665 |
RGD:11038676 |
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tfpi
|
tissue factor pathway inhibitor
|
|
ISO
|
|
RGD |
PMID:9921794 |
RGD:11062061 |
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
treatment
|
ISO IEP
|
protein:increased expression:liver
|
RGD |
PMID:16038046 PMID:25780291 PMID:25769561 |
RGD:15090805, RGD:597538537, RGD:15090809 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
treatment severity
|
IEP ISO
|
mRNA:increased expression:liver associated with alcoholic hepatitis protein:increased expression:membrane raft:
|
RGD |
PMID:21431875 PMID:22019745 PMID:21693218 PMID:22797797 PMID:23395256 PMID:27064547 More...
|
RGD:10402078, RGD:598147059, RGD:5685379, RGD:14697702, RGD:14697699, RGD:14697698 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
IEP IMP ISO
|
associated with alcoholic hepatitis associated with steatotic liver disease protein:increased expression:serum (rat)
|
RGD |
PMID:24726586 PMID:22019745 PMID:31483550 PMID:12131680 PMID:32155285 PMID:11592783 PMID:19357028 PMID:11129814 PMID:21125813 PMID:10454827 PMID:15457564 PMID:17164725 More...
|
RGD:10450597, RGD:598147059, RGD:598147058, RGD:14995454, RGD:155260323, RGD:2325259, RGD:15039406, RGD:14995473, RGD:14995447, RGD:14985258, RGD:14985257, RGD:14696803 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IEP
|
protein:increased localization:mitochondrion
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tradd
|
TNFRSF1A-associated via death domain
|
treatment
|
IEP
|
|
RGD |
PMID:23423194 |
RGD:8661760 |
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
|
IEP
|
mRNA:increased expression:liver
|
RGD |
PMID:22195248 |
RGD:7175309 |
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
IEP
|
|
RGD |
PMID:26451003 |
RGD:15036791 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:24768926 |
RGD:13209011 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment ameliorates
|
IEP ISO
|
|
RGD |
PMID:23953793 PMID:34238924 |
RGD:10054119, RGD:153350155 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IEP
|
|
RGD |
PMID:23953793 |
RGD:10054119 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
|
ISO
|
mRNA:increased expression:lung (mouse)
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
|
ISO
|
mRNA:increased expression:lung (mouse)
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Crebbp
|
CREB binding protein
|
ameliorates
|
ISO
|
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Egr1
|
early growth response 1
|
treatment
|
IMP IEP
|
|
RGD |
PMID:22878149 PMID:23232597 |
RGD:10395282, RGD:10395299 |
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
treatment
|
IMP
|
|
RGD |
PMID:17888675 |
RGD:10450582 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
|
ISO
|
mRNA:increased expression:lung (rat)
|
RGD |
PMID:35600952 |
RGD:155663563 |
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
IEP
|
protein:increased expression:lung
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IEP
|
protein:increased expression:lung
|
RGD |
PMID:21227458 |
RGD:10755577 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IEP
|
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il1b
|
interleukin 1 beta
|
ameliorates
|
IDA ISO IEP
|
protein:increased expression:lung (rat)
|
RGD |
PMID:23142117 PMID:34238924 PMID:23122581 |
RGD:7183185, RGD:153350155, RGD:7204125 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il4
|
interleukin 4
|
treatment
|
IDA
|
|
RGD |
PMID:24365768 |
RGD:10402797 |
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il6
|
interleukin 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Kras
|
KRAS proto-oncogene, GTPase
|
ameliorates
|
ISO
|
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
IEP
|
protein:increased activity:lung
|
RGD |
PMID:18694576 |
RGD:5129703 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
treatment
|
IEP
|
|
RGD |
PMID:22503847 |
RGD:7240537 |
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
IMP ISO
|
mRNA:increased expression:lung (mouse)
|
RGD |
PMID:20815765 PMID:25382268 |
RGD:4892012, RGD:11533932 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:21781312 |
RGD:6771212 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
IDA IEP
|
protein:increased expression:alveolar macrophage (rat)
|
RGD |
PMID:21781312 PMID:16449942 |
RGD:6771212, RGD:11541083 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
treatment
|
ISO
|
|
RGD |
PMID:19782612 |
RGD:11100035 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Serpine1
|
serpin family E member 1
|
treatment
|
ISO IDA
|
protein:increased expression:plasma (human)
|
RGD |
PMID:17846288 PMID:11606484 |
RGD:8547720, RGD:11080966 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
treatment
|
IEP
|
|
RGD |
PMID:22115333 |
RGD:10402095 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
ameliorates
|
IMP ISO
|
|
RGD |
PMID:17294835 PMID:34238924 |
RGD:4143397, RGD:153350155 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
exacerbates
|
ISO
|
|
RGD |
PMID:34238924 |
RGD:153350155 |
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
|
|
| G
|
Enpp1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
ISO
|
ClinVar Annotator: match by term: Coronary sclerosis, medial, of infancy
|
ClinVar |
PMID:9536098 PMID:15940697 PMID:17576681 PMID:25741868 PMID:28492532 |
|
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044
|
|
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
|
ISO
|
mRNA:increased expression:blood, mononuclear cell
|
RGD |
PMID:17852785 |
RGD:4890450 |
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Bdkrb2
|
bradykinin receptor B2
|
|
ISO
|
mRNA:increased expression:blood, mononuclear cell
|
RGD |
PMID:17852785 |
RGD:4890450 |
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
|
ISO
|
DNA:transition:cds:g.677C>T (human) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17491230 PMID:17491230 |
RGD:4891159 |
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:15648548 |
RGD:1620974 |
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
|
|
| G
|
Abcc8
|
ATP binding cassette subfamily C member 8
|
treatment
|
IMP
|
|
RGD |
PMID:23149556 PMID:24602692 |
RGD:12790979, RGD:12791996 |
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
treatment
|
IMP
|
|
RGD |
PMID:24471927 |
RGD:11039026 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ace2
|
angiotensin converting enzyme 2
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:24090950 |
RGD:9685436 |
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
| G
|
Acvr1
|
activin A receptor type 1
|
|
ISO
|
|
RGD |
PMID:33345977 |
RGD:329845521 |
NCBI chr 3:63,387,378...63,506,980
Ensembl chr 3:63,387,381...63,477,884
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
|
ISO
|
mRNA:increased expression:brain (mouse)
|
RGD |
PMID:33763412 |
RGD:329849104 |
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23437309 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
IEP ISO
|
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25446913 PMID:24211797 |
RGD:8696008 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agt
|
angiotensinogen
|
|
IEP
|
protein:increased expression:brain, serum
|
RGD |
PMID:24090950 |
RGD:9685436 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
|
IEP
|
protein:altered localization: :
|
RGD |
PMID:15181376 |
RGD:10047403 |
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Ak1
|
adenylate kinase 1
|
|
IEP
|
protein:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:16468349 |
RGD:5508760 |
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Alb
|
albumin
|
treatment
|
ISO
|
|
RGD |
PMID:22227456 |
RGD:11036100 |
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19309543 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Ap2b1
|
adaptor related protein complex 2 subunit beta 1
|
|
IEP
|
protein:increased degradation:brain
|
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
treatment
|
IEP
|
|
RGD |
PMID:24012531 |
RGD:13703113 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apoe
|
apolipoprotein E
|
|
IDA
|
|
RGD |
PMID:19623195 |
RGD:6903926 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
App
|
amyloid beta precursor protein
|
treatment
|
IEP
|
|
RGD |
PMID:28963051 |
RGD:13782054 |
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Aqp4
|
aquaporin 4
|
treatment
|
IEP IMP
|
|
RGD |
PMID:20815926 PMID:33127515 |
RGD:8695955, RGD:155646130 |
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Arc
|
activity-regulated cytoskeleton-associated protein
|
|
IEP
|
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220
|
|
| G
|
Atf3
|
activating transcription factor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
treatment
|
IDA
|
|
RGD |
PMID:22200499 PMID:21891976 |
RGD:10053665, RGD:10053704 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:23143152 |
RGD:10054501 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcan
|
brevican
|
|
IEP
|
|
RGD |
PMID:15869933 |
RGD:9590118 |
NCBI chr 2:175,752,333...175,765,766
Ensembl chr 2:175,752,336...175,765,314
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:23143152 |
RGD:10054501 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
treatment
|
IEP
|
|
RGD |
PMID:20417695 PMID:31927682 PMID:28202057 PMID:35218623 |
RGD:4891138, RGD:596948420, RGD:405878057, RGD:401960864 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
IMP
|
|
RGD |
PMID:22108007 |
RGD:11561900 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:17379825 |
RGD:9685412 |
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Bnip3l
|
BCL2 interacting protein 3 like
|
|
IEP
|
|
RGD |
PMID:15902200 PMID:21029239 |
RGD:2314138, RGD:9068917 |
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
|
|
| G
|
C1qtnf6
|
C1q and TNF related 6
|
ameliorates
|
IEP
|
|
RGD |
PMID:35322553 |
RGD:242905190 |
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:111,958,350...111,966,871
|
|
| G
|
C3
|
complement C3
|
|
IEP ISO
|
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:23199288 PMID:22103620 |
RGD:7175514 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
treatment
|
IEP
|
|
RGD |
PMID:30531687 |
RGD:329849008 |
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
IEP
|
|
RGD |
PMID:14688616 |
RGD:1358416 |
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IDA IEP
|
|
RGD |
PMID:21891976 PMID:26868427 PMID:23143152 |
RGD:10053704, RGD:13782346, RGD:10054501 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp6
|
caspase 6
|
|
IEP
|
|
RGD |
PMID:26868427 |
RGD:13782346 |
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp9
|
caspase 9
|
treatment
|
IEP
|
|
RGD |
PMID:26868427 |
RGD:13782346 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:12374626 PMID:23043544 PMID:25257527 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Cd36
|
CD36 molecule
|
treatment
|
ISO
|
|
RGD |
PMID:25216018 |
RGD:11041113 |
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd86
|
CD86 molecule
|
|
IEP
|
protein:increased expression:brain subventricular zone, microglial cell (rat)
|
RGD |
PMID:19053043 |
RGD:2313025 |
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
|
ISO
|
|
RGD |
PMID:24920629 |
RGD:13782375 |
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cldn5
|
claudin 5
|
treatment
|
IEP
|
|
RGD |
PMID:24842554 |
RGD:13204729 |
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
treatment
|
IDA
|
|
RGD |
PMID:35218623 |
RGD:401960864 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crh
|
corticotropin releasing hormone
|
|
IEP
|
protein:decreased expression:median eminence of hypothalamus (rat)
|
RGD |
PMID:21741032 |
RGD:5490538 |
NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386
|
|
| G
|
Crp
|
C-reactive protein
|
|
ISO
|
|
RGD |
PMID:15545914 |
RGD:9585995 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Crtc1
|
CREB regulated transcription coactivator 1
|
treatment
|
IEP
|
|
RGD |
PMID:20417695 |
RGD:4891138 |
NCBI chr16:19,022,171...19,080,880
Ensembl chr16:19,022,005...19,080,880
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO IEP
|
mRNA, protein:increased expression:brain:
|
RGD |
PMID:19298757 PMID:15530654 |
RGD:11039420, RGD:11039425 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
ISO
|
|
RGD |
PMID:10825390 |
RGD:632989 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcr2
|
C-X-C motif chemokine receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602
|
|
| G
|
Cxcr3
|
C-X-C motif chemokine receptor 3
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:10825390 |
RGD:632989 |
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:70,883,958...70,886,871
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
|
IEP
|
|
RGD |
PMID:23002367 |
RGD:14700877 |
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Dicer1
|
dicer 1 ribonuclease III
|
|
IEP
|
mRNA:decreased expression:brain:
|
RGD |
PMID:26294080 |
RGD:11553310 |
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:129,396,014...129,457,252
|
|
| G
|
Dnmt1
|
DNA methyltransferase 1
|
|
ISO
|
|
RGD |
PMID:11726790 |
RGD:9588643 |
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
|
|
| G
|
Dnmt3a
|
DNA methyltransferase 3 alpha
|
|
IMP
|
|
RGD |
PMID:23516428 |
RGD:9589049 |
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
|
|
| G
|
Dynll1
|
dynein light chain LC8-type 1
|
|
IEP
|
|
RGD |
PMID:9522364 |
RGD:13208524 |
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
|
|
| G
|
Edn1
|
endothelin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17197033 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Egr1
|
early growth response 1
|
|
IEP
|
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Egr2
|
early growth response 2
|
|
IEP
|
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
| G
|
Egr4
|
early growth response 4
|
|
IEP
|
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:119,605,357...119,608,368
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
treatment
|
IDA IMP
|
|
RGD |
PMID:23669639 PMID:19763736 |
RGD:10395346, RGD:10755569 |
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
treatment
|
IMP
|
|
RGD |
PMID:10700596 |
RGD:10450546 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Eng
|
endoglin
|
|
ISO
|
|
RGD |
PMID:24876084 |
RGD:11041171 |
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
|
|
| G
|
Epcam
|
epithelial cell adhesion molecule
|
|
IEP
|
|
RGD |
PMID:15950761 |
RGD:11038820 |
NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702
|
|
| G
|
Ephb2
|
Eph receptor B2
|
treatment
|
IEP ISO
|
mRNA,protein:increased expression: cortex, cerebral cortex subventricular zone
|
RGD |
PMID:16321245 PMID:16321245 |
RGD:1642069, RGD:1642069 |
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:154,179,065...154,360,615
|
|
| G
|
Epn1
|
Epsin 1
|
|
IEP
|
protein:increased degradation:brain
|
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chr 1:77,771,335...77,789,411
Ensembl chr 1:77,771,335...77,789,411
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
ISO
|
|
RGD |
PMID:20833153 PMID:20547143 |
RGD:10400898, RGD:10401066 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Ercc6
|
ERCC excision repair 6, chromatin remodeling factor
|
|
IEP
|
|
RGD |
PMID:9974119 |
RGD:10401103 |
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
|
|
| G
|
F11
|
coagulation factor XI
|
|
ISO
|
|
RGD |
PMID:16533887 |
RGD:11041786 |
NCBI chr16:53,720,502...53,741,547
Ensembl chr16:53,718,621...53,740,941
|
|
| G
|
F12
|
coagulation factor XII
|
treatment
|
ISO
|
|
RGD |
PMID:16533887 PMID:16533887 |
RGD:11041786, RGD:11041786 |
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29651748 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
Fadd
|
Fas associated via death domain
|
treatment
|
ISO IEP
|
|
RGD |
PMID:18950622 PMID:23378241 |
RGD:11341807, RGD:11344885 |
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
treatment
|
IEP
|
|
RGD |
PMID:30531687 |
RGD:329849008 |
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgf21
|
fibroblast growth factor 21
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Gabra6
|
gamma-aminobutyric acid type A receptor subunit alpha6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr10:27,311,965...27,327,337
Ensembl chr10:27,311,979...27,327,234
|
|
| G
|
Gap43
|
growth associated protein 43
|
treatment
|
IEP
|
|
RGD |
PMID:30531687 |
RGD:329849008 |
NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
IDA
|
|
RGD |
PMID:25882840 |
RGD:13792686 |
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
treatment
|
IEP
|
|
RGD |
PMID:24956890 |
RGD:401717568 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gdnf
|
glial cell derived neurotrophic factor
|
treatment
|
IMP IEP IDA
|
|
RGD |
PMID:29497380 PMID:28202057 PMID:20468049 PMID:21347705 |
RGD:40925919, RGD:405878057, RGD:405866363, RGD:405866359 |
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240
|
|
| G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
treatment
|
IDA
|
|
RGD |
PMID:19352052 |
RGD:9850083 |
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969
|
|
| G
|
Ghsr
|
growth hormone secretagogue receptor
|
|
IMP
|
|
RGD |
PMID:19352052 |
RGD:9850083 |
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:112,196,767...112,201,181
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
treatment
|
IEP
|
protein:increased expression:eye protein:increased expression:cerebrum, astrocyte
|
RGD |
PMID:24518488 PMID:23595285 PMID:26024074 PMID:26093193 |
RGD:401794420, RGD:401794586, RGD:401794592, RGD:401794587 |
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Grin1
|
glutamate ionotropic receptor NMDA type subunit 1
|
treatment
|
IEP
|
|
RGD |
PMID:26674869 |
RGD:11068571 |
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754
|
|
| G
|
Grn
|
granulin precursor
|
treatment
|
ISO
|
|
RGD |
PMID:23972823 |
RGD:10401661 |
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936
|
|
| G
|
Grpel1
|
GrpE-like 1, mitochondrial
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:12505684 |
RGD:632868 |
NCBI chr14:78,517,049...78,522,868
Ensembl chr14:78,517,052...78,522,861
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
treatment
|
IDA
|
|
RGD |
PMID:28440874 |
RGD:13792734 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsn
|
gelsolin
|
ameliorates
|
ISO
|
|
RGD |
PMID:18234195 PMID:9927495 |
RGD:329333031, RGD:329333033 |
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
ameliorates
|
IEP ISO IMP
|
RNA:increased expression:brain (rat) RNA:increased expression:brain (mouse)
|
RGD |
PMID:28203482 PMID:28630232 PMID:35322553 PMID:31170091 PMID:32335212 |
RGD:155900760, RGD:242905192, RGD:242905190, RGD:242905188, RGD:156451661 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex, hippocampus, corpus striatum
|
RGD |
PMID:21957487 |
RGD:11041635 |
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Has2
|
hyaluronan synthase 2
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:11283406 |
RGD:9588631 |
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535
|
|
| G
|
Hdac2
|
histone deacetylase 2
|
exacerbates
|
ISO
|
|
RGD |
PMID:32239566 |
RGD:155883173 |
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311
|
|
| G
|
Hdac4
|
histone deacetylase 4
|
treatment
|
IEP
|
mRNA,protein:decreased expression:brain:
|
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:99,955,116...100,197,637
|
|
| G
|
Hdac5
|
histone deacetylase 5
|
treatment
|
IEP
|
mRNA,protein:decreased expression:brain:
|
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
|
|
| G
|
Hdac9
|
histone deacetylase 9
|
|
IEP
|
mRNA:increased expression:brain:
|
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chr 6:56,489,472...57,351,654
Ensembl chr 6:56,490,988...57,351,835
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IDA
|
|
RGD |
PMID:21029239 |
RGD:9068917 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IEP
|
|
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IEP IDA ISO
|
|
RGD |
PMID:24252362 PMID:23870531 PMID:20888632 |
RGD:10755587, RGD:10755755, RGD:10755588 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hp
|
haptoglobin
|
|
IEP
|
|
RGD |
PMID:22103620 |
RGD:7175514 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Hspa4
|
heat shock protein family A (Hsp70) member 4
|
|
IMP ISO
|
rat gene in mouse model
|
RGD |
PMID:17473852 PMID:21709150 |
RGD:5688754, RGD:6218961 |
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Htra2
|
HtrA serine peptidase 2
|
|
IEP ISO
|
protein:increased expression:brain, cytosol (rat) protein:increased expression:brain, cytosol (mouse)
|
RGD |
PMID:16978742 PMID:15306124 |
RGD:2314385, RGD:5688372 |
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793
|
|
| G
|
Hvcn1
|
hydrogen voltage-gated channel 1
|
|
IMP
|
|
RGD |
PMID:31250553 |
RGD:14985213 |
NCBI chr12:40,001,205...40,030,671
Ensembl chr12:40,001,498...40,042,020
|
|
| G
|
Hvcn1em2Mcwi
|
hydrogen voltage-gated channel 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
|
|
IMP
|
|
RGD |
PMID:31250553 |
RGD:14985213 |
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
treatment
|
ISO
|
|
RGD |
PMID:16286924 |
RGD:10045955 |
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il10
|
interleukin 10
|
ameliorates
|
ISO
|
|
RGD |
PMID:28630232 |
RGD:242905192 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il11
|
interleukin 11
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
|
|
| G
|
Il13
|
interleukin 13
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il1b
|
interleukin 1 beta
|
ameliorates treatment
|
IEP ISO
|
protein:increased expression:cerebral cortex (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25257527 PMID:23028794 PMID:35322553 PMID:29498696 PMID:24916922 |
RGD:7204480, RGD:242905190, RGD:13792833, RGD:10450594 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
treatment
|
ISO
|
human gene in a rat model
|
RGD |
PMID:7790404 |
RGD:8551708 |
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il22
|
interleukin 22
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 7:55,687,061...55,691,526
Ensembl chr 7:55,686,896...55,692,201
|
|
| G
|
Il4
|
interleukin 4
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
|
|
| G
|
Il5
|
interleukin 5
|
|
IEP
|
|
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12374626 PMID:21940958 PMID:25257527 PMID:29498696 |
RGD:13792833 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Il7r
|
interleukin 7 receptor
|
|
IEP
|
protein:increased expression:brain:
|
RGD |
PMID:30676545 |
RGD:151347693 |
NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027
|
|
| G
|
Ina
|
internexin neuronal intermediate filament protein, alpha
|
|
ISO
|
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chr 1:255,838,129...255,849,680
Ensembl chr 1:255,838,129...255,849,680
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
|
ISO
|
|
RGD |
PMID:33345977 |
RGD:329845521 |
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Irf4
|
interferon regulatory factor 4
|
|
IEP
|
|
RGD |
PMID:25652434 |
RGD:11530061 |
NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
ameliorates
|
ISO IMP
|
|
RGD |
PMID:26661208 PMID:25477223 PMID:21750563 |
RGD:329955572, RGD:401700383, RGD:329955444 |
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Lig3
|
DNA ligase 3
|
|
IEP
|
associated with transient cerebral ischemia;protein:increased expression:brain
|
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:68,215,407...68,238,704
|
|
| G
|
Mag
|
myelin-associated glycoprotein
|
treatment
|
IMP
|
|
RGD |
PMID:15678116 |
RGD:9685232 |
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:95,275,635...95,291,060
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
treatment
|
IDA
|
|
RGD |
PMID:27152455 PMID:35218623 |
RGD:13800881, RGD:401960864 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
treatment
|
IDA
|
|
RGD |
PMID:27152455 PMID:35218623 |
RGD:13800881, RGD:401960864 |
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
treatment
|
IEP IDA ISO
|
|
RGD |
PMID:28886009 PMID:25903928 PMID:28886009 |
RGD:13800886, RGD:13800913, RGD:13800886 |
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mir107
|
microRNA 107
|
|
IEP
|
RNA:increased expression:brain
|
RGD |
PMID:26294080 |
RGD:11553310 |
NCBI chr 1:241,750,418...241,750,504
|
|
| G
|
Mir132
|
microRNA 132
|
treatment
|
ISO
|
mRNA:decreased expression:brain (mouse)
|
RGD |
PMID:33763412 PMID:33763412 |
RGD:329849104, RGD:329849104 |
NCBI chr10:60,522,033...60,522,133
Ensembl chr10:60,522,033...60,522,133
|
|
| G
|
Mir140
|
microRNA 140
|
ameliorates
|
ISO IEP
|
miRNA:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:33246036 PMID:27035554 |
RGD:329337375, RGD:329337377 |
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391
|
|
| G
|
Mir19a
|
microRNA 19a
|
|
ISO
|
RNA:decreased expression:brain (mouse)
|
RGD |
PMID:32335212 |
RGD:156451661 |
NCBI chr15:98,588,131...98,588,212
Ensembl chr15:98,588,131...98,588,212
|
|
| G
|
Mir210
|
microRNA 210
|
treatment
|
IEP
|
|
RGD |
PMID:34337881 |
RGD:155269103 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mir29b1
|
microRNA 29b-1
|
exacerbates
|
IMP
|
|
RGD |
PMID:35322553 |
RGD:242905190 |
NCBI chr 4:60,618,334...60,618,414
|
|
| G
|
Mir494
|
microRNA 494
|
ameliorates
|
ISO
|
|
RGD |
PMID:32239566 PMID:31465536 |
RGD:155883173, RGD:156430320 |
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:19309543 PMID:24842554 |
RGD:13204729 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mt3
|
metallothionein 3
|
|
IEP
|
protein:decreased expression:brain
|
RGD |
PMID:8869568 |
RGD:9685807 |
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
treatment
|
IEP IDA
|
|
RGD |
PMID:24583056 PMID:21185267 PMID:23777415 |
RGD:10040971, RGD:10041016, RGD:10040974 |
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Nae1
|
NEDD8 activating enzyme E1 subunit 1
|
|
IEP
|
|
RGD |
PMID:21386696 |
RGD:13801046 |
NCBI chr19:452,462...478,591
Ensembl chr19:452,432...478,831
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
treatment
|
IMP
|
|
RGD |
PMID:28495827 |
RGD:13781880 |
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Ncam1
|
neural cell adhesion molecule 1
|
treatment
|
ISO IMP
|
|
RGD |
PMID:32962079 PMID:29497380 |
RGD:40924633, RGD:40925919 |
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
|
ISO
|
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nefl
|
neurofilament light chain
|
|
ISO
|
protein:increased expression:brain
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
|
|
| G
|
Nefm
|
neurofilament medium chain
|
|
ISO
|
protein:altered expression:brain
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
treatment
|
IDA
|
|
RGD |
PMID:23880501 PMID:24466583 |
RGD:10412696, RGD:10412714 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
treatment
|
IEP
|
|
RGD |
PMID:21122797 |
RGD:10413868 |
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Ngf
|
nerve growth factor
|
treatment
|
ISO IMP
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:10408807 PMID:29409115 |
RGD:402463967 |
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
treatment
|
IDA
|
|
RGD |
PMID:22678884 |
RGD:10413900 |
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
treatment
|
IEP
|
|
RGD |
PMID:24842554 |
RGD:13204729 |
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
IEP ISO
|
protein:increased expression:brain (rat) mRNA:increased expression:brain (mouse)
|
RGD |
PMID:21959178 PMID:22020035 |
RGD:5508751, RGD:5509037 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
treatment
|
IEP
|
|
RGD |
PMID:30816157 |
RGD:329955567 |
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
treatment
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:21120604 PMID:25069640 |
RGD:5133239, RGD:11035212 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nrg1
|
neuregulin 1
|
treatment ameliorates
|
ISO
|
|
RGD |
PMID:20691195 PMID:30206770 |
RGD:10449015, RGD:405650589 |
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
treatment
|
IEP IDA
|
mRNA:increased exprerssion:hippocampus
|
RGD |
PMID:31927682 PMID:30981830 PMID:32992173 |
RGD:596948420, RGD:597538459, RGD:597015758 |
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
treatment
|
IEP
|
associated with Hypertension
|
RGD |
PMID:17920569 |
RGD:8657395 |
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
treatment
|
ISO
|
|
RGD |
PMID:17882163 |
RGD:13463450 |
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
treatment
|
ISO IDA IEP
|
|
RGD |
PMID:21311064 PMID:25882840 PMID:23143152 PMID:23801245 |
RGD:5683909, RGD:13792686, RGD:10054501, RGD:11073732 |
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pawr
|
pro-apoptotic WT1 regulator
|
treatment
|
ISO IEP
|
protein:increased expression:brain:
|
RGD |
PMID:16403464 PMID:19352052 PMID:11323519 |
RGD:9835380, RGD:9850083, RGD:9835381 |
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
treatment
|
IDA
|
|
RGD |
PMID:16917016 |
RGD:11084934 |
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pdgfrb
|
platelet derived growth factor receptor beta
|
treatment
|
IDA
|
|
RGD |
PMID:16917016 |
RGD:11084934 |
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
IEP ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:12297567 PMID:17690543 PMID:18453163 PMID:20547619 PMID:29651748 PMID:14512838 More...
|
RGD:1580876 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:11677890 PMID:15181847 PMID:17702958 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Pld1
|
phospholipase D1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245
|
|
| G
|
Polb
|
DNA polymerase beta
|
|
IEP
|
associated with transient cerebral ischemia;protein:increased expression:brain
|
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr16:76,081,903...76,105,174
Ensembl chr16:76,081,864...76,108,180
|
|
| G
|
Prkcg
|
protein kinase C, gamma
|
|
ISO
|
|
RGD |
PMID:14688616 |
RGD:1358416 |
NCBI chr 1:74,748,272...74,777,611
Ensembl chr 1:74,748,272...74,774,814
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
treatment
|
ISO
|
|
RGD |
PMID:24159062 |
RGD:11100027 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:15869933 |
RGD:9590118 |
NCBI chr 4:52,363,006...52,560,905
Ensembl chr 4:52,363,295...52,560,903
|
|
| G
|
Rbfox3
|
RNA binding fox-1 homolog 3
|
treatment
|
IEP
|
|
RGD |
PMID:30531687 |
RGD:329849008 |
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
|
|
| G
|
Reln
|
reelin
|
severity
|
ISO
|
|
RGD |
PMID:16438965 |
RGD:13207538 |
NCBI chr 4:13,628,440...14,055,201
Ensembl chr 4:13,628,399...14,055,162
|
|
| G
|
Rgma
|
repulsive guidance molecule BMP co-receptor a
|
treatment
|
IEP IMP
|
|
RGD |
PMID:21840379 PMID:23275173 |
RGD:9850121, RGD:9850122 |
NCBI chr 1:136,538,782...136,582,763
Ensembl chr 1:136,538,759...136,582,763
|
|
| G
|
Rpl28
|
ribosomal protein L28
|
|
IEP
|
|
RGD |
PMID:16805800 |
RGD:6480229 |
NCBI chr 1:78,080,945...78,083,532
Ensembl chr 1:78,080,945...78,083,771
|
|
| G
|
Runx1
|
RUNX family transcription factor 1
|
|
IAGP
|
mRNA:increased expression:brain
|
RGD |
PMID:24672479 |
RGD:11251714 |
NCBI chr11:45,325,778...45,560,300
Ensembl chr11:45,329,044...45,564,925
|
|
| G
|
S100a5
|
S100 calcium binding protein A5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25257527 |
|
NCBI chr 2:178,392,922...178,397,128
Ensembl chr 2:178,395,121...178,397,128
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
IEP
|
protein:increased expression:cerebrum, astrocyte
|
RGD |
PMID:23595285 |
RGD:401794586 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Serpine1
|
serpin family E member 1
|
|
IEP
|
|
RGD |
PMID:14512838 |
RGD:1580876 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
treatment
|
IDA
|
|
RGD |
PMID:22714093 |
RGD:8655545 |
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Serpinh1
|
serpin family H member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:163,055,630...163,062,976
|
|
| G
|
Shh
|
sonic hedgehog signaling molecule
|
treatment
|
ISO
|
|
RGD |
PMID:22324418 |
RGD:12879461 |
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901
|
|
| G
|
Sirt1
|
sirtuin 1
|
treatment
|
IMP ISO
|
|
RGD |
PMID:23600725 PMID:23600725 |
RGD:9585664, RGD:9585664 |
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc12a2
|
solute carrier family 12 member 2
|
treatment
|
IMP ISO
|
protein:increased expression:brain:
|
RGD |
PMID:12535773 PMID:27798271 |
RGD:1580583, RGD:14398833 |
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:53,546,333...53,614,470
|
|
| G
|
Slc1a2
|
solute carrier family 1 member 2
|
treatment
|
IEP
|
|
RGD |
PMID:20423712 |
RGD:401794585 |
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:109,459,630...109,605,249
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
treatment
|
IEP
|
|
RGD |
PMID:9419067 |
RGD:12879855 |
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
treatment
|
IMP
|
|
RGD |
PMID:31250553 |
RGD:14985213 |
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
treatment
|
IEP
|
|
RGD |
PMID:14500739 |
RGD:9999390 |
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
| G
|
Smo
|
smoothened, frizzled class receptor
|
treatment
|
IMP
|
|
RGD |
PMID:23696546 PMID:23499832 |
RGD:12832759, RGD:12879404 |
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:59,311,041...59,341,281
|
|
| G
|
Smox
|
spermine oxidase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30576531 |
|
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:139,184,798...139,220,170 Ensembl chr X:139,184,798...139,220,170
|
|
| G
|
Snap91
|
synaptosome associated protein 91
|
|
IEP
|
protein:increased degradation:brain
|
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chr 8:96,618,039...96,732,763
Ensembl chr 8:96,618,041...96,732,507
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
treatment
|
IDA IEP
|
mRNA, protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:22001340 PMID:22133807 |
RGD:8657021, RGD:8657023 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sphk2
|
sphingosine kinase 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23043544 |
|
NCBI chr 1:105,317,332...105,324,985
Ensembl chr 1:105,317,333...105,321,637
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
ameliorates
|
IEP ISO
|
|
RGD |
PMID:31409163 PMID:28630232 |
RGD:14995477, RGD:242905192 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Th
|
tyrosine hydroxylase
|
|
IEP
|
protein:decreased expression:substantia nigra pars compacta, neuron (rat)
|
RGD |
PMID:21366664 |
RGD:5128609 |
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
treatment
|
ISO IEP
|
mRNA:increased expression:microglial cell
|
RGD |
PMID:29039449 PMID:20859668 PMID:24723245 |
RGD:597538462, RGD:597538540, RGD:597538520 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
treatment
|
IEP
|
|
RGD |
PMID:24723245 PMID:20859668 |
RGD:597538520, RGD:597538540 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment ameliorates
|
IEP ISO IMP
|
|
RGD |
PMID:24916922 PMID:28630232 PMID:35322553 PMID:15647744 PMID:29498696 |
RGD:10450594, RGD:242905192, RGD:242905190, RGD:13825261, RGD:13792833 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfaip6
|
TNF alpha induced protein 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IMP
|
|
RGD |
PMID:15647744 |
RGD:13825261 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Trem1
|
triggering receptor expressed on myeloid cells 1
|
ameliorates
|
IDA
|
|
RGD |
PMID:32736673 |
RGD:127284860 |
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892
|
|
| G
|
Upp1
|
uridine phosphorylase 1
|
|
IEP
|
mRNA, protein:increased expression:brain (rat)
|
RGD |
PMID:18457515 |
RGD:2317094 |
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:88,023,351...88,043,034
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
treatment
|
IMP IEP
|
mRNA,protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:29497380 PMID:30531687 PMID:27035554 |
RGD:40925919, RGD:329849008, RGD:329337377 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12374626 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
| G
|
Xrcc1
|
X-ray repair cross complementing 1
|
|
IEP
|
associated with transient cerebral ischemia;protein:increased expression:brain
|
RGD |
PMID:17412650 |
RGD:2302580 |
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
|
|
|
|
| G
|
App
|
amyloid beta precursor protein
|
|
ISO
|
protein:decreased expression:cerebrospinal fluid:
|
RGD |
PMID:1677459 |
RGD:10054257 |
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:18938189 |
RGD:10054050 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:18938189 |
RGD:10054050 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:21279683 |
RGD:10449132 |
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Il2
|
interleukin 2
|
severity
|
ISO
|
protein:increased secretion:mononuclear cell:
|
RGD |
PMID:8586980 |
RGD:10047081 |
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
|
|
| G
|
Abcc9
|
ATP binding cassette subfamily C member 9
|
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction
|
ClinVar |
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
|
|
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
treatment susceptibility
|
ISO IEP IMP
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human) associated with Myocardial Reperfusion Injury
|
ClinVar CTD RGD |
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:25741868 PMID:28492532 PMID:15118671 PMID:23959549 PMID:15671045 PMID:7555560 PMID:21975128 More...
|
RGD:1331525, RGD:9685449, RGD:1558664, RGD:7829785, RGD:6893480 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Ace2
|
angiotensin converting enzyme 2
|
treatment
|
IEP IDA
|
mRNA:increased expression:myocardium
|
RGD |
PMID:15671045 PMID:23959549 |
RGD:1558664, RGD:9685449 |
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:33,925,458...33,971,596
|
|
| G
|
Acta2
|
actin alpha 2, smooth muscle
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24358288 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
|
|
| G
|
Acvr2a
|
activin A receptor type 2A
|
|
ISO
|
mRNA:decreased expression:myocardium (mouse)
|
RGD |
PMID:32427381 |
RGD:329849118 |
NCBI chr 3:53,614,143...53,701,933
Ensembl chr 3:53,614,171...53,701,941
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
|
ISO
|
mRNA:decreased expression:myocardium (mouse)
|
RGD |
PMID:32427381 |
RGD:329849118 |
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
IEP
|
|
RGD |
PMID:15625312 |
RGD:9681751 |
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Add1
|
adducin 1
|
no_association
|
ISO
|
DNA:missense mutation:cds:p.G460W (human)
|
RGD |
PMID:17082469 PMID:16420563 |
RGD:5147995, RGD:5148001 |
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:80,333,244...80,391,732
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
disease_progression
|
IEP
|
|
RGD |
PMID:21326342 |
RGD:5686351 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adipor1
|
adiponectin receptor 1
|
|
ISO
|
mRNA, protein:decreased expression:heart left ventricle
|
RGD |
PMID:16415076 |
RGD:1625764 |
NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255
|
|
| G
|
Adipor2
|
adiponectin receptor 2
|
|
ISO
|
mRNA, protein:decreased expression:heart left ventricle
|
RGD |
PMID:16415076 |
RGD:1625764 |
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12160945 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Adora3
|
adenosine A3 receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12160945 PMID:20132822 |
|
NCBI chr 2:196,077,042...196,080,686
Ensembl chr 2:196,077,042...196,080,686
|
|
| G
|
Adra2b
|
adrenoceptor alpha 2B
|
|
ISO
|
|
RGD |
PMID:12535806 |
RGD:1559314 |
NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
|
ISO IMP
|
|
GAD RGD |
PMID:15118671 PMID:17143192 |
RGD:1331525, RGD:7241557 |
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
susceptibility
|
ISO IEP
|
DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I mRNA:decreased expression:heart
|
RGD |
PMID:15520258 PMID:12400771 |
RGD:1601126, RGD:8548519 |
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
susceptibility
|
IEP ISO
|
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
|
RGD |
PMID:19910580 PMID:16728681 |
RGD:2325647, RGD:1625333 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agt
|
angiotensinogen
|
susceptibility
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human) associated with hypertension;DNA:polymorphism: :p.M235T
|
CTD RGD |
PMID:1668233 PMID:16413583 PMID:21167013 PMID:15118671 PMID:11393670 PMID:17299437 More...
|
RGD:5129191, RGD:1331525, RGD:1566452, RGD:1601132 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
susceptibility no_association
|
ISO IEP
|
DNA:polymorphism:3' utr:1166A>C DNA:polymorphism:3' utr:1166A>C (human)
|
RGD GAD |
PMID:16061119 PMID:9652322 PMID:15118671 PMID:9857918 |
RGD:1601150, RGD:10047101, RGD:1331525, RGD:1566499 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Ahsg
|
alpha-2-HS-glycoprotein
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:19029462 |
RGD:2313810 |
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
|
|
| G
|
Aimp1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
IEP
|
|
RGD |
PMID:14732363 |
RGD:1580021 |
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994
|
|
| G
|
Ak1
|
adenylate kinase 1
|
treatment
|
IEP
|
|
RGD |
PMID:22229508 |
RGD:11100025 |
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
ISO IDA
|
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
|
RGD |
PMID:20467748 PMID:20352476 |
RGD:5509094, RGD:10041035 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
|
ISO
|
DNA:missense mutation: :p.E487K (human)
|
RGD |
PMID:12452318 |
RGD:2311152 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Alox5ap
|
arachidonate 5-lipoxygenase activating protein
|
no_association
|
ISO
|
DNA:snps:multiple (human)
|
RGD GAD |
PMID:14770184 PMID:15118671 PMID:19046748 |
RGD:1578317, RGD:1331525, RGD:2313891 |
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
|
|
| G
|
Ang
|
angiogenin
|
|
ISO
|
|
RGD |
PMID:18462761 |
RGD:2325719 |
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Angpt1
|
angiopoietin 1
|
|
IEP
|
mRNA, protein:decreased expression:myocardium
|
RGD |
PMID:15364619 |
RGD:1626168 |
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Angpt2
|
angiopoietin 2
|
|
IEP
|
protein:increased expression:left ventricular wall, heart septum (rat)
|
RGD |
PMID:16714360 |
RGD:1601493 |
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Anxa5
|
annexin A5
|
susceptibility no_association
|
ISO IEP
|
DNA:polymorphism: :-1C>T (human) protein:altered localization:cardiac muscle cell, sarcolemma protein:increased expression:plasma
|
RGD |
PMID:12200370 PMID:16501019 PMID:8814351 PMID:16025836 |
RGD:2317542, RGD:2317541, RGD:2317543, RGD:1578384 |
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
susceptibility
|
ISO
|
DNA:polymorphism:exon 5: G>A (human)
|
RGD |
PMID:18712175 |
RGD:401827276 |
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Apoa1
|
apolipoprotein A1
|
treatment no_association
|
ISO IEP
|
DNA:polymorphisms
|
RGD GAD |
PMID:20176799 PMID:31734577 PMID:15118671 PMID:10428310 |
RGD:2325759, RGD:408418726, RGD:1331525, RGD:1578442 |
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:55,423,825...55,425,729
|
|
| G
|
Apoa4
|
apolipoprotein A4
|
no_association susceptibility
|
ISO
|
DNA:mutation:intron:IVS2 (human) associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human)
|
RGD GAD |
PMID:10428310 PMID:7958503 PMID:15118671 |
RGD:1578442, RGD:5685678, RGD:1331525 |
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
|
|
| G
|
Apob
|
apolipoprotein B
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoc3
|
apolipoprotein C3
|
no_association
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
|
ClinVar RGD |
PMID:25741868 PMID:10428310 PMID:15118671 |
RGD:1578442, RGD:1331525 |
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679
|
|
| G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO
|
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
|
CTD RGD |
PMID:10587578 PMID:17217375 PMID:10090925 PMID:15118671 |
RGD:1601229, RGD:10449412, RGD:1331525 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Apoh
|
apolipoprotein H
|
|
ISO IDA
|
|
RGD |
PMID:15322656 PMID:12826288 |
RGD:2313985, RGD:10054111 |
NCBI chr10:93,841,992...93,855,897
Ensembl chr10:93,841,966...93,857,127
|
|
| G
|
Atg7
|
autophagy related 7
|
|
IEP
|
mRNA:increased expression:plantaris
|
RGD |
PMID:24427319 |
RGD:11557988 |
NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319
|
|
| G
|
Atm
|
ATM serine/threonine kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:24358288 PMID:24358288 |
RGD:10053570 |
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:29702141 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
treatment
|
IEP
|
protein:decreased expression:myocardium (rat)
|
RGD |
PMID:29300489 PMID:23809007 |
RGD:13792656, RGD:13792681 |
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
|
|
| G
|
Atp5po
|
ATP synthase peripheral stalk subunit OSCP
|
treatment
|
ISO
|
|
RGD |
PMID:24692845 |
RGD:13801194 |
NCBI chr11:44,651,171...44,657,483
Ensembl chr11:44,651,173...44,657,520
|
|
| G
|
Avpr1a
|
arginine vasopressin receptor 1A
|
|
IMP
|
|
RGD |
PMID:16423716 |
RGD:2300376 |
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
|
|
| G
|
Bak1
|
BCL2-antagonist/killer 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29122578 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20079142 PMID:25450231 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19027736 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
|
IMP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20079142 PMID:17467744 |
RGD:1643494 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bdkrb1
|
bradykinin receptor B1
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:12489796 |
RGD:704379 |
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
|
|
| G
|
Bdkrb2
|
bradykinin receptor B2
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:12489796 |
RGD:704379 |
NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20079142 PMID:20079142 |
RGD:11561913 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
|
IEP
|
|
RGD |
PMID:15081314 |
RGD:2293137 |
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
|
IEP
|
mRNA:increased expression:plantaris
|
RGD |
PMID:24427319 |
RGD:11557988 |
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Brap
|
BRCA1 associated protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19198608 |
|
NCBI chr12:40,535,232...40,561,726
Ensembl chr12:40,535,232...40,561,726
|
|
| G
|
Brinp3
|
BMP/retinoic acid inducible neural specific 3
|
susceptibility
|
ISO
|
DNA:SNPs:3' end:
|
RGD |
PMID:18430236 |
RGD:14398488 |
NCBI chr13:60,964,127...61,397,044
Ensembl chr13:60,966,100...61,397,039
|
|
| G
|
C1qtnf6
|
C1q and TNF related 6
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:25962701 |
RGD:529435444 |
NCBI chr 7:111,958,348...111,964,948
Ensembl chr 7:111,958,350...111,966,871
|
|
| G
|
C3
|
complement C3
|
treatment
|
IEP
|
mRNA, protein:increased expression:myocardium
|
RGD |
PMID:16996480 PMID:31734577 |
RGD:1600605, RGD:408418726 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
C7
|
complement C7
|
|
IEP
|
Protein:increased activity:serum, myocardium
|
RGD |
PMID:15724448 |
RGD:1599522 |
NCBI chr 2:55,815,687...55,892,605
Ensembl chr 2:55,816,807...55,892,672
|
|
| G
|
C8a
|
complement C8 alpha chain
|
|
IEP
|
|
RGD |
PMID:7515561 |
RGD:1600501 |
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:124,812,131...124,866,710
|
|
| G
|
C8b
|
complement C8 beta chain
|
|
IEP
|
|
RGD |
PMID:7515561 |
RGD:1600501 |
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:124,761,790...124,801,516
|
|
| G
|
Cacybp
|
calcyclin binding protein
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:16440310 |
RGD:2326117 |
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505
|
|
| G
|
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta
|
treatment
|
IEP
|
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
|
RGD |
PMID:26067684 |
RGD:11097969 |
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
|
|
| G
|
Casp1
|
caspase 1
|
severity ameliorates
|
ISO IEP
|
|
RGD |
PMID:17303764 PMID:33389498 |
RGD:2315913, RGD:242905187 |
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp3
|
caspase 3
|
ameliorates treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25450231 PMID:28622474 PMID:27904666 |
RGD:329333030, RGD:13782309 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casr
|
calcium-sensing receptor
|
|
IEP
|
protein:increased expression:myocardium (rat)
|
RGD |
PMID:22527939 |
RGD:7205672 |
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
|
|
| G
|
Cat
|
catalase
|
|
IEP ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:21600015 PMID:14575298 |
RGD:1581148 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cav3
|
caveolin 3
|
|
IEP
|
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
|
RGD |
PMID:12566108 PMID:29438664 |
RGD:1599542, RGD:126925221 |
NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:147,137,797...147,153,967
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
treatment
|
IEP IDA ISO
|
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
|
RGD |
PMID:18459941 PMID:18753699 PMID:16116069 |
RGD:2307033, RGD:8549616, RGD:1581161 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
|
IEP
|
mRNA:increased expression:heart (rat)
|
RGD |
PMID:18954648 |
RGD:4890013 |
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
|
ISO
|
mRNA,protein:increased expression:myocardium (mouse)
|
RGD |
PMID:15117851 |
RGD:329845570 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
treatment
|
IEP
|
mRNA:increased expression:left ventricle (rat)
|
RGD |
PMID:18167060 PMID:29849775 |
RGD:2314623, RGD:35673318 |
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Ccna2
|
cyclin A2
|
|
IEP
|
protein:increased expression:cardiomyocyte:
|
RGD |
PMID:23634243 |
RGD:10054471 |
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
|
ISO
|
|
RGD |
PMID:12719858 PMID:12853162 |
RGD:1581177, RGD:1581174 |
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr3
|
C-C motif chemokine receptor 3
|
|
IDA
|
|
RGD |
PMID:18954648 |
RGD:4890013 |
NCBI chr 8:132,463,533...132,511,601
Ensembl chr 8:132,463,788...132,511,593
|
|
| G
|
Cct7
|
chaperonin containing TCP1 subunit 7
|
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
|
ClinVar |
PMID:24213632 |
|
NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:119,546,730...119,563,973
|
|
| G
|
Cd14
|
CD14 molecule
|
no_association
|
ISO
|
associated with Coronary Artery Disease;DNA:SNP:promoter
|
RGD |
PMID:10195920 PMID:14587643 PMID:17436151 |
RGD:1580252, RGD:1580255, RGD:2314155 |
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cd36
|
CD36 molecule
|
severity
|
IMP
|
|
RGD |
PMID:22128087 |
RGD:6893560 |
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd40lg
|
CD40 ligand
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:17635572 |
RGD:2314209 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cd59b
|
CD59b molecule
|
|
IEP
|
protein:decreased expression:myocardium
|
RGD |
PMID:7515561 |
RGD:1600501 |
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
treatment
|
IMP ISO
|
|
RGD |
PMID:22492676 PMID:22492676 |
RGD:10045366, RGD:10045366 |
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cfl1
|
cofilin 1
|
treatment
|
IDA
|
|
RGD |
PMID:24292258 |
RGD:11570534 |
NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
|
|
| G
|
Cftr
|
CF transmembrane conductance regulator
|
|
ISO
|
associated with Myocardial Reperfusion Injury
|
RGD |
PMID:23221371 |
RGD:11566046 |
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:47,526,735...47,694,643
|
|
| G
|
Chi3l1
|
chitinase 3 like 1
|
|
ISO
|
protein:increased secretion:serum (human)
|
RGD |
PMID:18480670 |
RGD:4892633 |
NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825
|
|
| G
|
Ciita
|
class II, major histocompatibility complex, transactivator
|
susceptibility no_association
|
ISO
|
DNA:polymorphism:promoter:-168A>G (human)
|
RGD |
PMID:15821736 PMID:17183695 |
RGD:1358146, RGD:5491201 |
NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342
|
|
| G
|
Ckb
|
creatine kinase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12359538 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478
|
|
| G
|
Ckm
|
creatine kinase, M-type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:3279722 PMID:12359538 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719
|
|
| G
|
Clu
|
clusterin
|
treatment
|
ISO
|
|
RGD |
PMID:20854280 |
RGD:9068409 |
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Col1a1
|
collagen type I alpha 1 chain
|
treatment
|
IEP
|
|
RGD |
PMID:25636075 |
RGD:11041598 |
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
| G
|
Col3a1
|
collagen type III alpha 1 chain
|
treatment
|
IEP
|
|
RGD |
PMID:25636075 |
RGD:11041598 |
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
|
|
| G
|
Col4a1
|
collagen type IV alpha 1 chain
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.Q1334H (human)
|
RGD |
PMID:18077766 |
RGD:2311341 |
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:84,885,597...84,996,482
|
|
| G
|
Col6a2
|
collagen type VI alpha 2 chain
|
|
ISO
|
mRNA:increased expression:blood
|
RGD |
PMID:29399125 |
RGD:626469561 |
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,265...12,057,042
|
|
| G
|
Col6a3
|
collagen type VI alpha 3 chain
|
|
ISO
|
DNA:SNP:CDS:E1386K (rs146092501) (human)
|
RGD |
PMID:30226566 |
RGD:401851058 |
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19027736 |
|
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19027736 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Crp
|
C-reactive protein
|
|
IEP ISO
|
protein:increased expression:serum associated with Angina, Unstable;
|
RGD |
PMID:21046814 PMID:9761079 PMID:22446866 |
RGD:5131456, RGD:9491780, RGD:6482304 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cs
|
citrate synthase
|
severity
|
IDA ISO
|
protein:decreased expression:diaphragm, mitochondrion
|
RGD |
PMID:1877670 PMID:34416105 |
RGD:243048469, RGD:243048471 |
NCBI chr 7:1,348,389...1,374,624
Ensembl chr 7:1,342,942...1,375,938
|
|
| G
|
Csf2
|
colony stimulating factor 2
|
|
IMP
|
|
RGD |
PMID:21326109 |
RGD:5131507 |
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
|
RGD |
PMID:15639484 |
RGD:11039417 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Csnk2a1
|
casein kinase 2 alpha 1
|
|
IEP
|
|
RGD |
PMID:15090263 |
RGD:11565830 |
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:161,170,405...161,215,698
|
|
| G
|
Csnk2b
|
casein kinase 2 beta
|
|
IEP
|
|
RGD |
PMID:15090263 |
RGD:11565830 |
NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,704,904...3,710,525
|
|
| G
|
Ctla4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
ISO
|
DNA:SNP:CDS:49A>G (human)
|
RGD |
PMID:17652883 |
RGD:2301976 |
NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973
|
|
| G
|
Ctsb
|
cathepsin B
|
|
IEP
|
protein:increased activity:serum, heart (rat)
|
RGD |
PMID:19958779 |
RGD:2315501 |
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
IEP IMP
|
mRNA:increased expression:heart left ventricle
|
RGD |
PMID:11820456 PMID:19187644 |
RGD:632503, RGD:2306567 |
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
|
IEP
|
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
|
RGD |
PMID:18762777 PMID:11243862 |
RGD:2317860, RGD:1599690 |
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
|
IEP
|
mRNA:increase expression:ventricle myocardium
|
RGD |
PMID:11243862 |
RGD:1599690 |
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyp11b2
|
cytochrome P450, family 11, subfamily b, polypeptide 2
|
|
IMP
|
|
RGD |
PMID:18689429 |
RGD:2307303 |
NCBI chr 7:108,719,349...108,726,024
Ensembl chr 7:108,719,349...108,725,763
|
|
| G
|
Cyp1b1
|
cytochrome P450, family 1, subfamily b, polypeptide 1
|
ameliorates
|
IMP
|
|
RGD |
PMID:33389498 |
RGD:242905187 |
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
|
|
| G
|
Cyp2j4
|
cytochrome P450, family 2, subfamily j, polypeptide 4
|
susceptibility
|
ISO
|
DNA:polymorphism
|
RGD |
PMID:17126841 |
RGD:1625380 |
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042
|
|
| G
|
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1
|
|
ISO
|
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
|
RGD |
PMID:29804528 |
RGD:401901167 |
NCBI chr 1:178,166,984...178,232,191
Ensembl chr 1:178,219,704...178,232,423
|
|
| G
|
Dab2
|
DAB adaptor protein 2
|
|
IEP IMP
|
protein:increased expression:cardiomyocyte
|
RGD |
PMID:21762377 PMID:20666606 |
RGD:7243156, RGD:7243158 |
NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888
|
|
| G
|
Dab2ip
|
DAB2 interacting protein
|
onset
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
|
CTD RGD |
PMID:20622881 PMID:20622881 |
RGD:401901599 |
NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730
|
|
| G
|
Dag1
|
dystroglycan 1
|
treatment
|
IDA
|
|
RGD |
PMID:12034665 |
RGD:11541047 |
NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199
|
|
| G
|
Dcn
|
decorin
|
|
IEP
|
|
RGD |
PMID:16311904 |
RGD:1598497 |
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25450231 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Dgkz
|
diacylglycerol kinase zeta
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:17071729 |
|
NCBI chr 3:98,359,804...98,401,847
Ensembl chr 3:98,359,804...98,401,951
|
|
| G
|
Dvl1
|
dishevelled segment polarity protein 1
|
|
IEP
|
|
RGD |
PMID:15256074 |
RGD:1580899 |
NCBI chr 5:171,738,911...171,750,967
Ensembl chr 5:171,739,133...171,750,966
|
|
| G
|
Dyrk1a
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
treatment
|
IEP
|
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
|
RGD |
PMID:26067684 |
RGD:11097969 |
NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
|
ISO
|
|
RGD |
PMID:9607404 |
RGD:1580912 |
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Edn1
|
endothelin 1
|
severity
|
ISO IEP
|
protein:increased secretion:plasma (human) mRNA:increased expression:heart left ventricle (rat)
|
RGD |
PMID:17893002 PMID:10573185 |
RGD:4144880, RGD:1580921 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Edn2
|
endothelin 2
|
|
IEP
|
|
RGD |
PMID:10573185 |
RGD:1580921 |
NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070
|
|
| G
|
Ednra
|
endothelin receptor type A
|
|
IDA
|
|
RGD |
PMID:12524016 |
RGD:1580948 |
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
|
IDA
|
|
RGD |
PMID:12524016 |
RGD:1580948 |
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Egln1
|
egl-9 family hypoxia-inducible factor 1
|
|
IEP
|
|
RGD |
PMID:16765982 |
RGD:11252084 |
NCBI chr19:69,765,276...69,804,681
|
|
| G
|
Egln3
|
egl-9 family hypoxia-inducible factor 3
|
|
IEP
|
|
RGD |
PMID:16765982 |
RGD:11252084 |
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
|
|
| G
|
Epas1
|
endothelial PAS domain protein 1
|
|
IEP
|
|
RGD |
PMID:15247145 PMID:18484163 |
RGD:1580977, RGD:5147886 |
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
|
|
| G
|
Ephb1
|
Eph receptor B1
|
ameliorates
|
IEP
|
|
RGD |
PMID:28622474 |
RGD:329333030 |
NCBI chr 8:111,386,432...111,823,759
Ensembl chr 8:111,386,432...111,823,759
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
|
RGD |
PMID:19716829 |
RGD:5688358 |
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:19337937 PMID:21415704 |
RGD:10400907 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Epor
|
erythropoietin receptor
|
|
IEP
|
|
RGD |
PMID:21415704 |
RGD:10400907 |
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
treatment
|
IEP
|
|
RGD |
PMID:26892146 |
RGD:11522702 |
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
Erbb4
|
erb-b2 receptor tyrosine kinase 4
|
treatment
|
IEP
|
|
RGD |
PMID:26892146 |
RGD:11522702 |
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772
|
|
| G
|
Esr1
|
estrogen receptor 1
|
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD |
PMID:11894143 PMID:11919305 PMID:14600184 PMID:15133719 PMID:25741868 PMID:15118671 More...
|
RGD:1331525 |
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
F12
|
coagulation factor XII
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-46C>T(human)
|
RGD |
PMID:16411408 |
RGD:11041803 |
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
F13a1
|
coagulation factor XIII A1 chain
|
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, protection against CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD RGD |
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 PMID:12480694 More...
|
RGD:1581022 |
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:polymorphism::20210G>A(human)
|
CTD RGD |
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694 |
RGD:1581022 |
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
treatment
|
IEP
|
|
RGD |
PMID:21229253 |
RGD:11062083 |
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
F5
|
coagulation factor V
|
no_association susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism DNA:mutation:cds:1691G>A (human)
|
CTD RGD |
PMID:9531249 PMID:10590188 PMID:15131548 |
RGD:11564337, RGD:11564335 |
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
F7
|
coagulation factor VII
|
susceptibility
|
ISO
|
protein:increased activity:plasma (human) ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation, repeat:cds, intron:p.R353Q, (human)
|
OMIM ClinVar CTD RGD |
PMID:627745 PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7974346 PMID:7981691 PMID:8043443 PMID:8242057 PMID:8448207 PMID:8844208 PMID:8883260 PMID:9657438 PMID:9949166 PMID:10554827 PMID:10862079 PMID:10959697 PMID:10984565 PMID:11091194 PMID:11092214 PMID:11129332 PMID:11225604 PMID:11313743 PMID:11918550 PMID:11931672 PMID:12632035 PMID:12695753 PMID:12903033 PMID:12935978 PMID:14521598 PMID:15142120 PMID:15194538 PMID:15456489 PMID:15590402 PMID:15735798 PMID:15741795 PMID:15907525 PMID:16732384 PMID:16753603 PMID:16807660 PMID:18282149 PMID:18669152 PMID:18976247 PMID:19601987 PMID:19751712 PMID:19780835 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21206266 PMID:21902896 PMID:22180436 PMID:22327826 PMID:22353194 PMID:23731332 PMID:24533960 PMID:24711753 PMID:25275492 PMID:25582404 PMID:25741868 PMID:25828579 PMID:25952977 PMID:26105150 PMID:27227566 PMID:27848944 PMID:28447100 PMID:28492532 PMID:29104756 PMID:29246447 PMID:29318701 PMID:29618153 PMID:31064749 PMID:31273093 PMID:31467667 PMID:31589614 PMID:32333443 PMID:33477601 PMID:34342048 PMID:34355501 PMID:35356632 PMID:35552711 PMID:35802509 PMID:36571800 PMID:36696193 PMID:36719811 PMID:36760778 PMID:37055848 PMID:37091489 PMID:37312209 PMID:37521340 PMID:37761907 PMID:38202056 PMID:38387429 PMID:38397060 PMID:7495060 PMID:9420338 PMID:16116695 More...
|
RGD:2312409, RGD:11049521, RGD:1580374 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Fabp3
|
fatty acid binding protein 3
|
|
ISO
|
|
RGD |
PMID:8326460 |
RGD:1582401 |
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
| G
|
Fga
|
fibrinogen alpha chain
|
treatment
|
IEP
|
|
RGD |
PMID:31734577 |
RGD:408418726 |
NCBI chr 2:170,672,169...170,679,572
Ensembl chr 2:170,672,012...170,679,577
|
|
| G
|
Fgb
|
fibrinogen beta chain
|
|
ISO
|
|
GAD RGD |
PMID:15118671 PMID:9437197 |
RGD:1331525, RGD:1580381 |
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:170,692,965...170,705,434
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
treatment
|
ISO
|
|
RGD |
PMID:24200746 |
RGD:10449026 |
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
|
ISO
|
|
RGD |
PMID:17439742 |
RGD:10402087 |
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
ameliorates
|
ISO
|
|
RGD |
PMID:19358330 |
RGD:155663664 |
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Fgg
|
fibrinogen gamma chain
|
treatment
|
IEP
|
|
RGD |
PMID:31734577 |
RGD:408418726 |
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:170,652,234...170,661,170
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
|
IEP
|
protein:increased expression:plantaris (rat)
|
RGD |
PMID:24427319 |
RGD:11557988 |
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
|
IEP
|
|
RGD |
PMID:16714360 |
RGD:1601493 |
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Flt3lg
|
Fms related receptor tyrosine kinase 3 ligand
|
treatment
|
ISO
|
|
RGD |
PMID:24184252 |
RGD:11049498 |
NCBI chr 1:104,751,518...104,756,925
Ensembl chr 1:104,749,983...104,757,038
|
|
| G
|
Fn1
|
fibronectin 1
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:19695229 |
RGD:2325720 |
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
IEP
|
protein:increased expression:paraventricular nucleus hypothalamus, paraventricular nucleus thalamus
|
RGD |
PMID:27601012 |
RGD:405649741 |
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
treatment
|
ISO
|
mRNA, protein:decreased expression:heart DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human)
|
RGD |
PMID:29997116 PMID:26772723 PMID:20031593 PMID:29997116 |
RGD:329812009, RGD:11555187, RGD:329901766, RGD:329812009 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
Fzd2
|
frizzled class receptor 2
|
|
IEP
|
mRNA:increased expression:heart left ventricle
|
RGD |
PMID:9142123 |
RGD:4107058 |
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:88,061,667...88,065,396
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:20462747 |
RGD:10449173 |
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gata4
|
GATA binding protein 4
|
treatment
|
IMP ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:20200331 PMID:23948075 |
RGD:7327215 |
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
|
ISO
|
|
RGD |
PMID:31972362 |
RGD:329961305 |
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
treatment
|
IDA IEP
|
|
RGD |
PMID:32782412 PMID:26192027 |
RGD:329961570, RGD:329970290 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
|
ISO
|
DNA:snp:promoter:c.-129C>T (human) ClinVar Annotator: match by term: GCLC-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD RGD |
PMID:12598062 PMID:25741868 PMID:28492532 PMID:12598062 |
RGD:1302515 |
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
|
CTD ClinVar OMIM |
PMID:12081989 PMID:12975258 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Ggt1
|
gamma-glutamyltransferase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19419996 |
|
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050
|
|
| G
|
Gh1
|
growth hormone 1
|
treatment
|
ISO
|
|
RGD |
PMID:12500159 |
RGD:11352745 |
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Ghrh
|
growth hormone releasing hormone
|
treatment
|
IDA
|
|
RGD |
PMID:24373935 |
RGD:10401242 |
NCBI chr 3:166,412,763...166,432,519
Ensembl chr 3:166,412,764...166,431,880
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
treatment
|
IEP IMP
|
protein:decreased phosphorylation
|
RGD |
PMID:22969867 PMID:29428663 PMID:22841862 |
RGD:7207261, RGD:13592597, RGD:7207262 |
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gja4
|
gap junction protein, alpha 4
|
|
ISO
|
|
RGD |
PMID:15982495 |
RGD:1580400 |
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216
|
|
| G
|
Gja5
|
gap junction protein, alpha 5
|
treatment
|
IEP
|
|
RGD |
PMID:29428663 |
RGD:13592597 |
NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512
|
|
| G
|
Gp1ba
|
glycoprotein Ib platelet subunit alpha
|
|
ISO
|
|
RGD |
PMID:15269835 |
RGD:1580432 |
NCBI chr10:55,831,901...55,856,729
Ensembl chr10:55,829,832...55,854,560
|
|
| G
|
Gp6
|
glycoprotein 6
|
sexual_dimorphism treatment no_association susceptibility onset
|
ISO
|
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) human protein in a mouse model DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
|
RGD |
PMID:11571236 PMID:22814400 PMID:20723028 PMID:12417295 PMID:11571236 PMID:11571236 More...
|
RGD:401793749, RGD:401824647, RGD:401794407, RGD:401793754, RGD:401793749, RGD:401793749 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
treatment
|
IEP
|
|
RGD |
PMID:32026788 |
RGD:401793703 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:14573732 |
RGD:1600662 |
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
treatment
|
IMP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16716347 PMID:16565311 |
RGD:10045368 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsn
|
gelsolin
|
ameliorates
|
ISO IEP
|
protein:decreased expression:blood serum (human)
|
RGD |
PMID:9142022 PMID:28622474 |
RGD:329333022, RGD:329333030 |
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
treatment
|
IEP
|
|
RGD |
PMID:25119867 |
RGD:10401898 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstk1
|
glutathione S-transferase kappa 1
|
|
HEP
|
mRNA:decreased expression:heart
|
RGD |
PMID:33762941 |
RGD:626469577 |
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:72,085,531...72,089,927
|
|
| G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
|
ClinVar |
PMID:24213632 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
ameliorates
|
IMP
|
|
RGD |
PMID:33389498 |
RGD:242905187 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hadh
|
hydroxyacyl-CoA dehydrogenase
|
|
IEP
|
|
RGD |
PMID:11481570 |
RGD:2302229 |
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:19615879 |
RGD:11041636 |
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hfe
|
homeostatic iron regulator
|
no_association susceptibility
|
ISO
|
|
RGD |
PMID:12850485 PMID:10491370 |
RGD:1582672, RGD:1582697 |
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
treatment
|
ISO
|
protein:increased expression:serum:
|
RGD |
PMID:12419930 PMID:16570015 |
RGD:8548609, RGD:8548632 |
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
ameliorates treatment
|
IEP ISO
|
mRNA:increased expression:heart left ventricle human gene in a rat model
|
RGD |
PMID:18484163 PMID:28622474 PMID:15247145 PMID:15999059 |
RGD:5147886, RGD:329333030, RGD:1580977, RGD:9068466 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21113057 PMID:23188125 |
RGD:10402174 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IEP IDA
|
|
RGD |
PMID:12392996 PMID:20925964 |
RGD:1598393, RGD:4145134 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hp
|
haptoglobin
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16597321 PMID:17068284 PMID:17207726 PMID:3990081 PMID:2613263 |
RGD:1626360, RGD:1626354 |
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
|
|
| G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:28522730 PMID:26465199 |
RGD:329902054, RGD:11087531 |
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
|
|
| G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
|
IEP ISO
|
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17587755 PMID:17587755 |
RGD:2308939 |
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25450231 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
|
IEP
|
|
RGD |
PMID:17202668 |
RGD:1624230 |
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10070497 PMID:23139358 |
RGD:8547733 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
severity
|
IEP ISO
|
mRNA, protein:increased expression:myocardium
|
RGD |
PMID:19295919 PMID:16635594 |
RGD:2306696, RGD:1598421 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
|
IEP
|
mRNA,protein:increased expression:myocyte:
|
RGD |
PMID:8682060 |
RGD:10046050 |
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
| G
|
Il10
|
interleukin 10
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15883752 PMID:16310260 PMID:15466015 |
RGD:1598480 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il17a
|
interleukin 17A
|
|
IEP
|
mRNA, protein:increased expression:heart left ventricle (rat)
|
RGD |
PMID:23096364 |
RGD:9095344 |
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il18
|
interleukin 18
|
ameliorates
|
IEP
|
|
RGD |
PMID:33389498 |
RGD:242905187 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18bp
|
interleukin 18 binding protein
|
|
ISO
|
|
RGD |
PMID:19805173 |
RGD:4889400 |
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955
|
|
| G
|
Il1b
|
interleukin 1 beta
|
ameliorates
|
IDA IEP ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
|
CTD RGD |
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:33389498 PMID:23237935 More...
|
RGD:7175553, RGD:242905187, RGD:7204425 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:18474815 PMID:19005744 |
|
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il4r
|
interleukin 4 receptor
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:10807530 |
RGD:4889985 |
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15883752 PMID:16310260 PMID:31734577 |
RGD:408418726 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
|
IEP
|
|
RGD |
PMID:12123772 |
RGD:1625444 |
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
|
IEP ISO
|
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
|
RGD |
PMID:14993131 PMID:32427381 |
RGD:1580888, RGD:329849118 |
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Inhbb
|
inhibin subunit beta B
|
|
ISO
|
mRNA:increased expression:myocardium (mouse)
|
RGD |
PMID:32427381 |
RGD:329849118 |
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609
|
|
| G
|
Isl1
|
ISL LIM homeobox 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:29482621 PMID:22727192 |
RGD:243048463, RGD:243048464 |
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442
|
|
| G
|
Itga2
|
integrin subunit alpha 2
|
susceptibility no_association
|
ISO
|
|
RGD |
PMID:16697311 PMID:10194421 PMID:15227729 |
RGD:1582296, RGD:1581029, RGD:1582294 |
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
|
|
| G
|
Itga3
|
integrin subunit alpha 3
|
|
IEP
|
protein:increased expression:myocardium (rat)
|
RGD |
PMID:19041328 |
RGD:2325287 |
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
treatment
|
ISO
|
|
RGD |
PMID:29933226 |
RGD:329853753 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgb1
|
integrin subunit beta 1
|
treatment
|
IMP
|
|
RGD |
PMID:28367125 |
RGD:13602094 |
NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
no_association susceptibility
|
ISO IEP
|
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to mRNA, protein:increased expression:myocardium CTD Direct Evidence: marker/mechanism associated with arteriosclerosis; DNA:polymorphism:exon
|
ClinVar CTD RGD |
PMID:1371279 PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9215749 PMID:9376589 PMID:9450787 PMID:9536098 PMID:9700201 PMID:9790984 PMID:10583927 PMID:10727448 PMID:11723016 PMID:11806996 PMID:14629479 PMID:16199547 PMID:16463284 PMID:17264806 PMID:17576681 PMID:19691478 PMID:20020534 PMID:21781244 PMID:21917754 PMID:22250950 PMID:24236036 PMID:25373348 PMID:25539746 PMID:25728920 PMID:25741868 PMID:26096001 PMID:27469266 PMID:28492532 PMID:28748566 PMID:28983057 PMID:31565851 PMID:32237906 PMID:32581362 PMID:32757236 PMID:34066320 PMID:36122578 PMID:9716140 PMID:12600920 PMID:10531147 PMID:20846430 More...
|
RGD:5128498, RGD:633129, RGD:5128481, RGD:5128476 |
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Itih4
|
inter-alpha-trypsin inhibitor heavy chain 4
|
|
ISO
|
|
RGD |
PMID:10486281 |
RGD:1582334 |
NCBI chr16:6,086,985...6,102,162
Ensembl chr16:6,086,973...6,102,160
|
|
| G
|
Jak2
|
Janus kinase 2
|
susceptibility
|
IMP
|
associated with Myocardial Reperfusion Injury
|
RGD |
PMID:22749532 |
RGD:10403083 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Kcnj2
|
potassium inwardly-rectifying channel, subfamily J, member 2
|
treatment
|
IDA
|
|
RGD |
PMID:23647964 |
RGD:7247426 |
NCBI chr10:96,560,225...96,570,788
Ensembl chr10:96,565,600...96,570,901
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
|
IEP
|
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
|
RGD |
PMID:21683547 |
RGD:9831182 |
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kcnn4
|
potassium calcium-activated channel subfamily N member 4
|
susceptibility
|
ISO
|
DNA:SNPs,haplotypes:introns:multiple
|
RGD |
PMID:19644414 |
RGD:329969896 |
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:89,086,814...89,102,275
|
|
| G
|
Kdm5b
|
lysine demethylase 5B
|
ameliorates
|
ISO
|
|
RGD |
PMID:36481938 |
RGD:329901769 |
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:48,554,420...48,626,423
|
|
| G
|
Kdm6a
|
lysine demethylase 6A
|
|
IEP
|
mRNA:increased expression:myocardium (rat)
|
RGD |
PMID:30887465 |
RGD:151665136 |
NCBI chr X:6,920,374...7,060,027
Ensembl chr X:6,920,343...7,059,960
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
treatment
|
ISO IDA
|
|
RGD |
PMID:16698275 PMID:25936512 |
RGD:1581717, RGD:126925214 |
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Kif6
|
kinesin family member 6
|
no_association treatment
|
ISO
|
DNA:SNP: :rs20455 (human) CTD Direct Evidence: marker/mechanism DNA:SNP: :p.W719R (rs20455) (human)
|
CTD RGD |
PMID:21943003 PMID:18222354 PMID:20927332 PMID:26997531 PMID:19371834 PMID:20403483 More...
|
RGD:243048446, RGD:243048450, RGD:243048449, RGD:243048447, RGD:11097528 |
NCBI chr 9:18,573,925...18,870,789
Ensembl chr 9:18,573,789...18,870,729
|
|
| G
|
Klf13
|
KLF transcription factor 13
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29122578 |
|
NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:126,916,781...126,961,056
|
|
| G
|
Klk1
|
kallikrein 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12411458 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
|
|
| G
|
Klk1c12
|
kallikrein 1-related peptidase C12
|
|
ISO
|
|
RGD |
PMID:17022964 |
RGD:1641799 |
NCBI chr 1:103,514,639...103,518,676
Ensembl chr 1:103,514,590...103,518,712
|
|
| G
|
Lamp2
|
lysosomal-associated membrane protein 2
|
|
IEP
|
mRNA:increased expression:plantaris
|
RGD |
PMID:24427319 |
RGD:11557988 |
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
|
|
| G
|
Lcat
|
lecithin cholesterol acyltransferase
|
|
IDA
|
|
RGD |
PMID:16640830 |
RGD:1581773 |
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
| G
|
Lcn2
|
lipocalin 2
|
ameliorates
|
ISO
|
|
RGD |
PMID:27800610 |
RGD:126790572 |
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Ldha
|
lactate dehydrogenase A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:3279722 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
|
ISO
|
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lefty1
|
left right determination factor 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:33409963 |
RGD:401794430 |
NCBI chr13:95,188,091...95,191,488
Ensembl chr13:95,188,091...95,191,488
|
|
| G
|
Lgals2
|
galectin 2
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
|
OMIM CTD ClinVar RGD |
PMID:15129282 PMID:15129282 |
RGD:1581852 |
NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:112,282,822...112,285,392
|
|
| G
|
Lgals3
|
galectin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29769800 |
|
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Lipg
|
lipase G, endothelial type
|
susceptibility
|
ISO
|
DNA:polymorphism: :584C>T
|
RGD |
PMID:17526978 |
RGD:1641818 |
NCBI chr18:70,790,077...70,811,259
Ensembl chr18:70,790,077...70,812,260
|
|
| G
|
Lox
|
lysyl oxidase
|
|
ISO
|
|
RGD |
PMID:14553832 |
RGD:1581883 |
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
|
|
| G
|
Lpl
|
lipoprotein lipase
|
susceptibility
|
ISO
|
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
|
RGD |
PMID:18823627 |
RGD:2313302 |
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
|
|
| G
|
Lrp1
|
LDL receptor related protein 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:12402342 |
RGD:1581913 |
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196
|
|
| G
|
Lrp8
|
LDL receptor related protein 8
|
no_association susceptibility onset
|
ISO
|
DNA:missense mutation:cds:p.R952Q (human) ClinVar Annotator: match by term: LRP8-related condition | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1 CTD Direct Evidence: marker/mechanism
|
ClinVar CTD OMIM RGD |
PMID:17847002 PMID:25741868 PMID:28492532 PMID:18592168 PMID:17847002 |
RGD:2306125, RGD:2306124 |
NCBI chr 5:127,792,236...127,864,207
Ensembl chr 5:127,792,299...127,864,207
|
|
| G
|
Lrpap1
|
LDL receptor related protein associated protein 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:12394648 |
RGD:1581922 |
NCBI chr14:79,876,002...79,888,011
Ensembl chr14:79,875,708...79,890,034
|
|
| G
|
Lta
|
lymphotoxin alpha
|
no_association susceptibility severity
|
ISO
|
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:SNP:exon:804C>A (p.T26N) (human)
|
ClinVar OMIM CTD RGD |
PMID:12426569 PMID:15129282 PMID:15266304 PMID:15175864 PMID:23398946 PMID:12426569 More...
|
RGD:1581940, RGD:8548841, RGD:1580417 |
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
treatment
|
IEP
|
|
RGD |
PMID:20079142 |
RGD:11561913 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
treatment
|
IMP
|
|
RGD |
PMID:22635076 |
RGD:10412335 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
treatment
|
IEP
|
mRNA, protein:increased expression:myocardium (rat)
|
RGD |
PMID:16183734 PMID:27121011 |
RGD:2298758, RGD:11073666 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
|
IDA
|
|
RGD |
PMID:15653762 |
RGD:1582282 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
ameliorates
|
ISO
|
|
RGD |
PMID:33409963 |
RGD:401794430 |
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
ameliorates
|
IEP
|
|
RGD |
PMID:28622474 |
RGD:329333030 |
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mdh2
|
malate dehydrogenase 2
|
|
IDA
|
|
RGD |
PMID:9753871 |
RGD:1582468 |
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:26,530,881...26,543,841
|
|
| G
|
Mdk
|
midkine
|
|
IEP
|
|
RGD |
PMID:9568069 |
RGD:1582488 |
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Mef2a
|
myocyte enhancer factor 2a
|
|
ISO
|
|
RGD |
PMID:15811259 |
RGD:1580548 |
NCBI chr 1:130,258,083...130,392,819
Ensembl chr 1:130,260,339...130,392,162
|
|
| G
|
Mef2c
|
myocyte enhancer factor 2C
|
treatment
|
IMP
|
|
RGD |
PMID:23948075 |
RGD:7327215 |
NCBI chr 2:15,708,732...15,871,639
Ensembl chr 2:15,708,924...15,871,640
|
|
| G
|
Meox2
|
mesenchyme homeobox 2
|
|
IEP
|
protein:decreased expression:heart (rat)
|
RGD |
PMID:24155330 |
RGD:155882536 |
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700
|
|
| G
|
Mesp1
|
mesoderm posterior bHLH transcription factor 1
|
treatment
|
ISO
|
human gene and cell line in a rat model
|
RGD |
PMID:32550911 |
RGD:242905196 |
NCBI chr 1:143,147,671...143,149,189
Ensembl chr 1:143,147,671...143,149,189
|
|
| G
|
Mff
|
mitochondrial fission factor
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:23867156 PMID:23867156 |
RGD:12879458 |
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171
|
|
| G
|
Mfn2
|
mitofusin 2
|
treatment
|
IEP
|
|
RGD |
PMID:20886221 |
RGD:12738232 |
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mgp
|
matrix Gla protein
|
susceptibility
|
ISO
|
|
RGD |
PMID:11073842 |
RGD:1582503 |
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
|
|
| G
|
Mia3
|
MIA SH3 domain ER export factor 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19198609 |
|
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:97,494,275...97,543,587
|
|
| G
|
Miat
|
myocardial infarction associated transcript
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD OMIM |
PMID:17066261 |
|
NCBI chr12:50,075,026...50,090,259
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
|
ISO IEP
|
protein:increased expression:plasma mRNA, protein:increased expression:myocardium
|
RGD |
PMID:11589847 PMID:12704210 |
RGD:1642008, RGD:1642003 |
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mir125b2
|
microRNA 125b-2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:29122578 |
|
NCBI chr11:29,732,572...29,732,659
|
|
| G
|
Mir143
|
microRNA 143
|
|
ISO IEP
|
RNA:increased expression:myocardium: RNA:increased expression:plasma, left ventricle:
|
RGD |
PMID:28887629 PMID:29728596 |
RGD:155882580, RGD:155882581 |
NCBI chr18:57,371,349...57,371,453
|
|
| G
|
Mir145
|
microRNA 145
|
treatment ameliorates
|
ISO IMP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:29956747 PMID:30146700 PMID:32890431 |
RGD:155260296, RGD:155260294 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mir155
|
microRNA 155
|
treatment
|
ISO
|
|
RGD |
PMID:31207208 |
RGD:21066347 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir208a
|
microRNA 208a
|
treatment
|
ISO IEP
|
miRNA:increased expression:heart
|
RGD |
PMID:26688617 PMID:26861724 |
RGD:11536862, RGD:242905213 |
NCBI chr15:32,395,552...32,395,634
|
|
| G
|
Mir223
|
microRNA 223
|
|
IEP
|
RNA:increased expression:heart
|
RGD |
PMID:29608885 |
RGD:21408565 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mir25
|
microRNA 25
|
|
ISO
|
RNA:increased expression:myocardium:
|
RGD |
PMID:28887629 |
RGD:155882580 |
NCBI chr12:22,156,641...22,156,724
|
|
| G
|
Mir30a
|
microRNA 30a
|
treatment
|
IDA
|
|
RGD |
PMID:29849775 |
RGD:35673318 |
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011
|
|
| G
|
Mir30c1
|
microRNA 30c-1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:34217758 |
|
NCBI chr 5:139,634,455...139,634,543
|
|
| G
|
Mir30e
|
microRNA 30e
|
|
IEP
|
miRNA:decreased expression:heart (rat)
|
RGD |
PMID:25950484 |
RGD:11541106 |
NCBI chr 5:139,637,450...139,637,541
Ensembl chr 5:139,637,450...139,637,541
|
|
| G
|
Mir320a
|
microRNA 320a
|
treatment
|
ISO
|
|
RGD |
PMID:19380620 |
RGD:155882541 |
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
| G
|
Mir423
|
microRNA 423
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24253456 |
|
NCBI chr10:62,412,272...62,412,350
|
|
| G
|
Mir761
|
microRNA 761
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23867156 |
|
NCBI chr 5:129,005,205...129,005,280
Ensembl chr 5:129,005,205...129,005,280
|
|
| G
|
Mlxipl
|
MLX interacting protein-like
|
susceptibility
|
ISO
|
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
|
RGD |
PMID:24448738 |
RGD:401799621 |
NCBI chr12:27,178,158...27,213,675
Ensembl chr12:27,178,158...27,213,660
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
susceptibility
|
ISO IEP IDA
|
protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human)
|
RGD |
PMID:15009768 PMID:8531210 PMID:11179039 PMID:19797822 PMID:16210545 |
RGD:1582535, RGD:7207198, RGD:7207136, RGD:7207135, RGD:1582520 |
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp13
|
matrix metallopeptidase 13
|
|
IDA
|
|
RGD |
PMID:15782494 |
RGD:1582556 |
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
| G
|
Mmp14
|
matrix metallopeptidase 14
|
|
IEP ISO
|
|
RGD |
PMID:10773235 PMID:16461815 |
RGD:1582587, RGD:1582569 |
NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
|
IEP ISO IDA
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16310260 PMID:24358288 PMID:10773235 PMID:11179039 |
RGD:1582587, RGD:7207136 |
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
|
ISO
|
|
RGD |
PMID:15467919 |
RGD:1580551 |
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp7
|
matrix metallopeptidase 7
|
|
ISO
|
|
RGD |
PMID:16769909 |
RGD:1582373 |
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
susceptibility
|
ISO IEP IDA
|
protein:increased expression:coronary artery, plasma (human) protein:increased expression:heart left ventricle CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:heart left ventricle (rat) DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human)
|
CTD RGD |
PMID:16310260 PMID:24358288 PMID:15118287 PMID:25520329 PMID:8531210 PMID:17893005 PMID:14729404 PMID:16845718 More...
|
RGD:1582645, RGD:13204799, RGD:7207198, RGD:7207049, RGD:1582639, RGD:1582653 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mstn
|
myostatin
|
|
ISO
|
mRNA:decreased expression:myocardium (mouse)
|
RGD |
PMID:32427381 |
RGD:329849118 |
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:55,944,513...55,950,913
|
|
| G
|
Mt-nd2
|
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
|
|
ISO
|
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
|
RGD |
PMID:15262184 |
RGD:1581054 |
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,892...4,929
|
|
| G
|
Mthfr
|
methylenetetrahydrofolate reductase
|
susceptibility
|
ISO
|
associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human) DNA:SNP: :677C>T (human)
|
RGD |
PMID:19272686 PMID:10090925 |
RGD:6893548, RGD:10449412 |
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
treatment
|
IDA
|
protein:decreased serine phosphorylation:heart associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:20352476 PMID:23773982 |
RGD:10041035, RGD:10041040 |
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Mx1
|
MX dynamin like GTPase 1
|
|
ISO
|
mRNA:increased expression:blood
|
RGD |
PMID:29399125 |
RGD:626469561 |
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
| G
|
Myh6
|
myosin heavy chain 6
|
|
IEP
|
|
RGD |
PMID:15090263 |
RGD:11565830 |
NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333
|
|
| G
|
Myh7
|
myosin heavy chain 7
|
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11743230 PMID:15090263 |
RGD:11565830 |
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194
|
|
| G
|
Ncam1
|
neural cell adhesion molecule 1
|
|
ISO IEP
|
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
|
RGD |
PMID:19853610 PMID:23462508 |
RGD:2325979, RGD:40924663 |
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:58,762,116...59,061,971
|
|
| G
|
Ndufb5
|
NADH:ubiquinone oxidoreductase subunit B5
|
treatment
|
ISO
|
|
RGD |
PMID:24692845 |
RGD:13801194 |
NCBI chr 2:117,447,605...117,461,943
Ensembl chr 2:117,447,035...117,461,590
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
treatment
|
IDA ISO
|
|
RGD |
PMID:23290949 PMID:24915518 |
RGD:10412734, RGD:10412738 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
treatment
|
IEP
|
|
RGD |
PMID:19616538 |
RGD:10413879 |
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Ngf
|
nerve growth factor
|
treatment
|
ISO
|
protein:increased expression:myocardium
|
RGD |
PMID:20360245 PMID:20360245 |
RGD:405100231, RGD:405100231 |
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
| G
|
Nlk
|
nemo like kinase
|
|
IEP
|
mRNA, protein:decreased expression:heart
|
RGD |
PMID:26861724 |
RGD:242905213 |
NCBI chr10:63,965,432...64,089,006
|
|
| G
|
Nlrp3
|
NLR family, pyrin domain containing 3
|
ameliorates
|
IEP
|
|
RGD |
PMID:33389498 |
RGD:242905187 |
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
|
|
| G
|
Nono
|
non-POU domain containing, octamer-binding
|
ameliorates
|
ISO
|
|
RGD |
PMID:35247074 |
RGD:155882458 |
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:70,593,888...70,611,979
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10090345 PMID:11489778 PMID:26192027 |
RGD:329970290 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
susceptibility treatment
|
ISO IEP IDA
|
DNA:repeats:intron protein:decreased expression:aorta (rat) CTD Direct Evidence: marker/mechanism human gene in rat model DNA:duplication:intron:IVS4?-?+27 (human)
|
CTD RGD |
PMID:10510054 PMID:16337503 PMID:10531147 PMID:29311930 PMID:28980197 PMID:22012955 PMID:17637430 PMID:11903359 PMID:12362496 More...
|
RGD:5128481, RGD:13503346, RGD:13450930, RGD:7771563, RGD:7771561, RGD:1580284, RGD:1580283 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Npm1
|
nucleophosmin 1
|
|
ISO
|
protein:increased expression:cardiomyocyte:
|
RGD |
PMID:21444791 |
RGD:11535018 |
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
|
|
| G
|
Nppa
|
natriuretic peptide A
|
|
ISO IEP
|
DNA:snp:cds:c.2238T>C (human) CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130 |
RGD:1579982, RGD:1580000 |
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nppb
|
natriuretic peptide B
|
|
IMP ISO IEP
|
|
RGD |
PMID:19858735 PMID:17639095 PMID:17256064 |
RGD:2324680, RGD:7247724, RGD:1642266 |
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Npr1
|
natriuretic peptide receptor 1
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.M341I (human)
|
RGD |
PMID:14646971 |
RGD:1580174 |
NCBI chr 2:178,231,766...178,247,591
Ensembl chr 2:178,231,766...178,247,088
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
susceptibility
|
ISO
|
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
|
RGD |
PMID:21903943 |
RGD:401842365 |
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16413583 PMID:17587755 |
|
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
|
|
| G
|
Nrg1
|
neuregulin 1
|
treatment
|
ISO IEP
|
|
RGD |
PMID:24200746 PMID:26892146 PMID:27993643 |
RGD:10449026, RGD:11522702, RGD:405145704 |
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Nrip1
|
nuclear receptor interacting protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22503866 |
|
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353
|
|
| G
|
Olr1
|
oxidized low density lipoprotein receptor 1
|
susceptibility
|
ISO
|
DNA:missense mutation:cds:p.K167N (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to | ClinVar Annotator: match by term: OLR1-related condition CTD Direct Evidence: marker/mechanism
|
ClinVar OMIM CTD RGD |
PMID:12646194 PMID:12810610 PMID:14684693 PMID:12646194 |
RGD:1580996 |
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
treatment
|
IEP
|
|
RGD |
PMID:20886221 |
RGD:12738232 |
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Oprd1
|
opioid receptor, delta 1
|
|
IDA IMP
|
|
RGD |
PMID:12798419 PMID:15076225 |
RGD:2316587, RGD:9831425 |
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:149,590,244...149,624,999
|
|
| G
|
Oprk1
|
opioid receptor, kappa 1
|
|
IMP
|
|
RGD |
PMID:15076225 |
RGD:9831425 |
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:18,657,871...18,675,671
|
|
| G
|
P2ry12
|
purinergic receptor P2Y12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19334620 |
|
NCBI chr 2:145,631,487...145,673,194
Ensembl chr 2:145,629,967...145,633,410
|
|
| G
|
Pappa
|
pappalysin 1
|
susceptibility
|
ISO
|
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11586954 PMID:17700210 |
RGD:1642324 |
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
|
ISO
|
protein:altered processing:left ventricle (mouse)
|
RGD |
PMID:21282286 |
RGD:5684012 |
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2
|
|
ISO
|
DNA:SNP:intron: (rs6080699) (human)
|
RGD |
PMID:20036365 |
RGD:6483554 |
NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:151,333,234...151,638,849
|
|
| G
|
Pde3a
|
phosphodiesterase 3A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19027736 |
|
NCBI chr 4:175,904,276...176,170,531
Ensembl chr 4:175,904,077...176,169,270
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
|
IMP
|
|
RGD |
PMID:17339532 |
RGD:2314468 |
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pdgfd
|
platelet derived growth factor D
|
|
IEP
|
mRNA,protein:altered expression:myocardium:
|
RGD |
PMID:21767547 |
RGD:9854703 |
NCBI chr 8:11,773,335...12,007,277
Ensembl chr 8:11,773,475...12,007,271
|
|
| G
|
Pebp1
|
phosphatidylethanolamine binding protein 1
|
|
IEP
|
protein:decreased expression:right heart ventricle, ventricular septum
|
RGD |
PMID:17089028 |
RGD:2302667 |
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
onset no_association
|
ISO
|
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutation:cds:p.R643G (human) DNA:missense mutations:cds:p.L125V, p.S563N (human)
|
RGD |
PMID:11795274 PMID:15488875 PMID:15265022 |
RGD:2311656, RGD:6771224, RGD:1581009 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Pgf
|
placental growth factor
|
|
ISO IMP
|
|
RGD |
PMID:20649603 PMID:21329947 PMID:22114497 |
RGD:6483584, RGD:6483777, RGD:6483773 |
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Phactr1
|
phosphatase and actin regulator 1
|
susceptibility severity no_association
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNP:intron:(rs12526453) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
|
CTD RGD |
PMID:19198609 PMID:26098115 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763 PMID:33460763 PMID:19198609 PMID:26098115 More...
|
RGD:11052994, RGD:11052493, RGD:11056926, RGD:401900171, RGD:401900171, RGD:401851907, RGD:11053274 |
NCBI chr17:21,769,006...22,246,227
Ensembl chr17:21,768,662...22,244,586
|
|
| G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34351043 |
|
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621
|
|
| G
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
ISO
|
|
RGD |
PMID:20056919 |
RGD:6482688 |
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509
|
|
| G
|
Pla2g7
|
phospholipase A2 group VII
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:19644070 |
RGD:6482786 |
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:24,859,502...24,901,747
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
treatment
|
ISO
|
DNA:snp:enhancer:g.-7351C>T (human) CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 PMID:11848437 PMID:7994806 More...
|
RGD:1580881, RGD:11541077 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
ISO IEP
|
DNA:SNP:3' utr:c.*141C>T (rs4065) (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA, protein:increased expression:myocardium
|
CTD RGD |
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:20518747 PMID:17653104 PMID:20952728 More...
|
RGD:6484126, RGD:6484145, RGD:6484133 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
|
ISO IEP
|
mRNA, protein:increased expression:myocardium
|
RGD |
PMID:12393744 PMID:20952728 |
RGD:1580897, RGD:6484133 |
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Plcb1
|
phospholipase C beta 1
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:9521338 |
RGD:2314514 |
NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646
|
|
| G
|
Plcb3
|
phospholipase C beta 3
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:9521338 |
RGD:2314514 |
NCBI chr 1:213,572,499...213,589,585
Ensembl chr 1:213,574,166...213,589,583
|
|
| G
|
Pln
|
phospholamban
|
treatment
|
IDA IEP ISO
|
protein:decreased expression:heart left ventricle (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684 |
RGD:7327176, RGD:11097969 |
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
|
|
| G
|
Pon1
|
paraoxonase 1
|
|
ISO
|
|
RGD |
PMID:10978258 PMID:10610741 |
RGD:1580202, RGD:1580198 |
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Postn
|
periostin
|
|
IEP
|
protein:increased expression:heart:
|
RGD |
PMID:24212842 |
RGD:10041024 |
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
|
ISO
|
DNA:SNP:intron:rs4253623, minor allele associated with increased risk (human)
|
RGD |
PMID:18549840 |
RGD:5562819 |
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
|
IEP ISO
|
protein:decreased expression:heart (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:22503866 PMID:22503866 PMID:22087236 |
RGD:7242181, RGD:6484266 |
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Prkce
|
protein kinase C, epsilon
|
|
ISO
|
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
|
CTD RGD |
PMID:16782078 PMID:28887629 |
RGD:155882580 |
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
| G
|
Prkd1
|
protein kinase D1
|
treatment
|
IEP
|
|
RGD |
PMID:26064267 |
RGD:289474908 |
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
|
ISO
|
|
RGD |
PMID:10936861 |
RGD:11100014 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Psma6
|
proteasome 20S subunit alpha 6
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD OMIM |
PMID:16845397 |
|
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:78,500,736...78,531,717
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
susceptibility
|
ISO
|
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
|
RGD |
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748 |
RGD:401901147, RGD:401901268, RGD:401901155, RGD:2313891 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
ISO
|
|
RGD |
PMID:15138244 |
RGD:1581289 |
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptn
|
pleiotrophin
|
|
IEP
|
protein:increased expression:myocardium (rat)
|
RGD |
PMID:17925408 |
RGD:10044023 |
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Rad50
|
RAD50 double strand break repair protein
|
treatment
|
IDA
|
|
RGD |
PMID:15623426 |
RGD:9831390 |
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
|
|
| G
|
Ranbp1
|
RAN binding protein 1
|
|
IEP
|
protein:decreased expression:heart ventricle, cytoplasm (rat)
|
RGD |
PMID:25341891 |
RGD:9835001 |
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:25142320 |
RGD:329845867 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
Reg1a
|
regenerating family member 1 alpha
|
|
IEP
|
mRNA:increased expression:heart left ventricle (rat)
|
RGD |
PMID:15778284 |
RGD:9850130 |
NCBI chr 4:112,450,466...112,453,130
Ensembl chr 4:112,450,468...112,453,585
|
|
| G
|
Ren
|
renin
|
susceptibility
|
ISO
|
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:1668233 PMID:1759997 |
RGD:6892687 |
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
Retn
|
resistin
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:18997620 |
RGD:7207152 |
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116
|
|
| G
|
Rora
|
RAR-related orphan receptor A
|
|
ISO
|
mRNA:decreased expression:blood
|
RGD |
PMID:29399125 |
RGD:626469561 |
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
|
|
| G
|
Rps6kb1
|
ribosomal protein S6 kinase B1
|
|
IEP
|
protein:increased threonine phosphorylation:heart left ventricle
|
RGD |
PMID:16540832 |
RGD:1642998 |
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
|
|
| G
|
Ryr1
|
ryanodine receptor 1
|
|
IDA
|
protein:hyperphosphorylation:extensor digitorum longus:
|
RGD |
PMID:12824280 |
RGD:329813076 |
NCBI chr 1:93,420,078...93,551,305
Ensembl chr 1:93,420,078...93,551,305
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
IEP ISO
|
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:9788975 PMID:19910580 |
RGD:2325647 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Sdc1
|
syndecan 1
|
|
IEP
|
mRNA:increased expression:myocardium
|
RGD |
PMID:9237025 |
RGD:2311712 |
NCBI chr 6:37,282,041...37,304,503
Ensembl chr 6:37,297,010...37,304,500
|
|
| G
|
Sdc4
|
syndecan 4
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:11372670 |
RGD:2312328 |
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670
|
|
| G
|
Sell
|
selectin L
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10070497 |
|
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
|
|
| G
|
Selp
|
selectin P
|
susceptibility
|
ISO IEP
|
associated with Hypertension;protein:increased expression:plasma protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human)
|
RGD |
PMID:17391113 PMID:21162967 PMID:21567088 PMID:12165563 |
RGD:2312304, RGD:6219003, RGD:6218991, RGD:1580075 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpine1
|
serpin family E member 1
|
susceptibility
|
ISO IMP
|
DNA:deletion:promoter:g.-676_-674delG (human)
|
RGD |
PMID:12477941 PMID:16053971 |
RGD:1626626, RGD:8547882 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Sfrp2
|
secreted frizzled-related protein 2
|
|
IEP ISO
|
|
RGD |
PMID:19109969 PMID:19079247 |
RGD:4107088, RGD:155883169 |
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
|
|
| G
|
Sh2b3
|
SH2B adaptor protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19198610 |
|
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335
|
|
| G
|
Shh
|
sonic hedgehog signaling molecule
|
treatment
|
IMP
|
|
RGD |
PMID:20052412 |
RGD:12879408 |
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901
|
|
| G
|
Sirt1
|
sirtuin 1
|
|
IEP
|
protein:altered localization:nucleus
|
RGD |
PMID:20089851 |
RGD:2316169 |
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Sirt3
|
sirtuin 3
|
treatment
|
IEP
|
|
RGD |
PMID:24471974 |
RGD:9586050 |
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:205,371,710...205,394,076
|
|
| G
|
Slc27a1
|
solute carrier family 27 member 1
|
|
IEP
|
protein:decreased expression:infarcted heart
|
RGD |
PMID:17034771 |
RGD:1642800 |
NCBI chr16:18,311,859...18,337,024
Ensembl chr16:18,313,015...18,330,045
|
|
| G
|
Slc27a6
|
solute carrier family 27 member 6
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:17034771 |
RGD:1642800 |
NCBI chr18:54,238,697...54,297,595
Ensembl chr18:54,238,729...54,312,632
|
|
| G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
treatment
|
IEP
|
|
RGD |
PMID:23361363 |
RGD:9999400 |
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
| G
|
Smad2
|
SMAD family member 2
|
treatment ameliorates
|
IEP ISO
|
|
RGD |
PMID:11087260 PMID:33409963 |
RGD:12903276, RGD:401794430 |
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Smad3
|
SMAD family member 3
|
ameliorates
|
ISO
|
|
RGD |
PMID:33409963 |
RGD:401794430 |
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad4
|
SMAD family member 4
|
treatment
|
IEP
|
|
RGD |
PMID:11087260 |
RGD:12903276 |
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
|
|
| G
|
Socs1
|
suppressor of cytokine signaling 1
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:16377761 |
RGD:2298918 |
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
treatment
|
ISO
|
CTD Direct Evidence: therapeutic human gene in a rat model
|
CTD RGD |
PMID:21600015 PMID:11864929 PMID:22006090 |
RGD:1581222, RGD:8655953 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
IDA ISO IEP
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:12160945 PMID:14575298 PMID:9250167 |
RGD:1581148, RGD:1580839 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
ISO
|
|
RGD |
PMID:14592844 |
RGD:1580841 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sparc
|
secreted protein acidic and cysteine rich
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:12826287 |
RGD:2300056 |
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
|
RGD |
PMID:12939547 PMID:14500723 |
RGD:1581386, RGD:1581325 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Srsf1
|
serine and arginine rich splicing factor 1
|
treatment
|
IDA
|
protein:increased phosphorylation:heart left ventricle(rat)
|
RGD |
PMID:26067684 |
RGD:11097969 |
NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548
|
|
| G
|
Tbx3
|
T-box transcription factor 3
|
|
IEP
|
|
RGD |
PMID:19341743 |
RGD:5132891 |
NCBI chr12:42,540,378...42,555,490
Ensembl chr12:42,540,378...42,554,171
|
|
| G
|
Tbx5
|
T-box transcription factor 5
|
treatment
|
IMP
|
|
RGD |
PMID:23948075 |
RGD:7327215 |
NCBI chr12:42,342,926...42,399,723
Ensembl chr12:42,348,485...42,395,359
|
|
| G
|
Tek
|
TEK receptor tyrosine kinase
|
|
IEP
|
protein:increased expression:ventricle myocardium
|
RGD |
PMID:16714360 |
RGD:1601493 |
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
|
|
| G
|
Tfpi
|
tissue factor pathway inhibitor
|
treatment
|
ISO IEP
|
mRNA,protein:increased expression:heart:
|
RGD |
PMID:15630488 PMID:21229253 PMID:14656922 |
RGD:11060131, RGD:11062083, RGD:11060139 |
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:89,939,868...89,980,742
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
susceptibility
|
ISO IEP
|
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
|
CTD RGD |
PMID:16310260 PMID:16543493 PMID:27121011 PMID:15118671 |
RGD:1601560, RGD:11073666, RGD:1331525 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
|
IEP
|
|
RGD |
PMID:14575314 |
RGD:2302107 |
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tgfbr1
|
transforming growth factor, beta receptor 1
|
|
IEP
|
|
RGD |
PMID:10198196 |
RGD:1601617 |
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260
|
|
| G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
|
IEP
|
protein:increased expression:myocardium
|
RGD |
PMID:10198196 |
RGD:1601617 |
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
| G
|
Th
|
tyrosine hydroxylase
|
no_association
|
ISO
|
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
|
RGD |
PMID:16139102 |
RGD:1580048 |
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Thbd
|
thrombomodulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9843165 PMID:10627464 |
|
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Thbs1
|
thrombospondin 1
|
|
IEP
|
mRNA, protein:increased expression:myocardium
|
RGD |
PMID:16179730 |
RGD:2317960 |
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Timp2
|
TIMP metallopeptidase inhibitor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24358288 |
|
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
ISO
|
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk (human)
|
RGD |
PMID:15864121 PMID:18549840 |
RGD:1580734, RGD:5562819 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tm6sf2
|
transmembrane 6 superfamily member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24633158 |
|
NCBI chr16:19,378,148...19,385,360
Ensembl chr16:19,378,152...19,385,467
|
|
| G
|
Tnc
|
tenascin C
|
|
IEP
|
protein:increased expression:heart, fibroblast
|
RGD |
PMID:11454990 |
RGD:4889618 |
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
IEP ISO
|
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15883752 PMID:16310260 PMID:21362018 |
RGD:5130892 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
|
ISO
|
|
RGD |
PMID:15926884 |
RGD:1620893 |
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
|
|
| G
|
Tnfrsf12a
|
TNF receptor superfamily member 12A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20082609 |
|
NCBI chr10:13,211,670...13,213,666
Ensembl chr10:13,211,673...13,213,704
|
|
| G
|
Tnfrsf14
|
TNF receptor superfamily member 14
|
|
IEP
|
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
|
RGD |
PMID:18353719 |
RGD:2317281 |
NCBI chr 5:170,768,413...170,776,749
Ensembl chr 5:170,768,416...170,776,046
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IEP IMP IDA
|
mRNA, protein:increased expression:left ventricle myocardium (rat)
|
RGD |
PMID:21362018 PMID:20651834 PMID:15117889 |
RGD:5130892, RGD:5130975, RGD:1624194 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tnfrsf1b
|
TNF receptor superfamily member 1B
|
|
IEP
|
mRNA, protein:decreased expression:left ventricle myocardium (rat)
|
RGD |
PMID:21362018 |
RGD:5130892 |
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
|
|
| G
|
Tnfsf11
|
TNF superfamily member 11
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:18298349 |
RGD:2302363 |
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
| G
|
Tnfsf4
|
TNF superfamily member 4
|
susceptibility
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD OMIM RGD |
PMID:15750594 |
RGD:1580396 |
NCBI chr13:76,256,654...76,280,133
Ensembl chr13:76,256,654...76,280,133
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12359538 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
|
ISO
|
|
RGD |
PMID:15226628 |
RGD:1580441 |
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tp53
|
tumor protein p53
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:24358288 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Trem1
|
triggering receptor expressed on myeloid cells 1
|
ameliorates disease_progression
|
ISO IMP
|
|
RGD |
PMID:25840803 PMID:25840803 PMID:25840803 |
RGD:127284842, RGD:127284842, RGD:127284842 |
NCBI chr 9:20,259,227...20,276,879
Ensembl chr 9:20,261,408...20,276,892
|
|
| G
|
Trpv1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
IMP
|
|
RGD |
PMID:27671317 |
RGD:13792689 |
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021
|
|
| G
|
Trpv1em1Sage
|
transient receptor potential cation channel, subfamily V, member 1; ZFN induced mutant 1, Sage
|
|
IMP
|
|
RGD |
PMID:27671317 |
RGD:13792689 |
|
|
| G
|
Ttn
|
titin
|
|
IEP
|
|
RGD |
PMID:12221049 |
RGD:1580780 |
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:82,059,648...82,332,171
|
|
| G
|
Txn1
|
thioredoxin 1
|
|
ISO
|
|
RGD |
PMID:14677813 |
RGD:1580785 |
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
|
IEP
|
mRNA:decreased expression:heart left ventricle (rat)
|
RGD |
PMID:18515646 |
RGD:5134341 |
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Ubd
|
ubiquitin D
|
|
IEP IMP
|
mRNA, protein; increased expression; myocardium (rat) associated with induced myocardial infarction
|
RGD |
PMID:29438664 PMID:29438664 |
RGD:126925221, RGD:126925221 |
NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965
|
|
| G
|
Ubdem1
|
ubiquitin D; CRISPR/Cas9 induced mutant1
|
|
IMP
|
associated with induced myocardial infarction
|
RGD |
PMID:29438664 |
RGD:126925221 |
|
|
| G
|
Uts2
|
urotensin 2
|
|
IEP
|
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
|
RGD |
PMID:15549273 |
RGD:2306846 |
NCBI chr 5:166,725,471...166,739,063
Ensembl chr 5:166,733,671...166,739,059
|
|
| G
|
Uts2r
|
urotensin 2 receptor
|
|
IEP
|
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
|
RGD |
PMID:15549273 |
RGD:2306846 |
NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,932,325...106,938,056
|
|
| G
|
Vcan
|
versican
|
|
IEP
|
|
RGD |
PMID:16311904 |
RGD:1598497 |
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25488258 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdac2
|
voltage-dependent anion channel 2
|
treatment
|
IDA
|
|
RGD |
PMID:20601275 |
RGD:10003049 |
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,512,216...2,532,229
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
treatment
|
ISO IDA
|
protein:increased expression:serum,platelet:
|
RGD |
PMID:10652191 PMID:25936512 |
RGD:7483604, RGD:126925214 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vegfb
|
vascular endothelial growth factor B
|
|
ISO
|
|
RGD |
PMID:17975666 |
RGD:2314324 |
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152
|
|
| G
|
Vwf
|
von Willebrand factor
|
|
IEP
|
protein:increased expression:heart:
|
RGD |
PMID:19435557 |
RGD:11080745 |
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:160,047,982...160,177,757
|
|
| G
|
Wdr12
|
WD repeat domain 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19198609 PMID:25915632 |
|
NCBI chr 9:68,969,547...68,996,811
Ensembl chr 9:68,969,547...68,996,811
|
|
| G
|
Wrn
|
WRN RecQ like helicase
|
|
ISO
|
|
RGD |
PMID:9021029 |
RGD:1580821 |
NCBI chr16:65,466,552...65,602,951
Ensembl chr16:65,456,254...65,602,951
|
|
| G
|
Xrcc3
|
X-ray repair cross complementing 3
|
susceptibility
|
ISO
|
DNA:polymorphism:: (human)
|
RGD |
PMID:18712175 |
RGD:401827276 |
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822
|
|
| G
|
Ybx1
|
Y box binding protein 1
|
|
IEP
|
|
RGD |
PMID:16002047 |
RGD:1580630 |
NCBI chr 5:138,167,444...138,188,155
Ensembl chr 5:138,167,444...138,184,188
|
|
| G
|
Zeb2
|
zinc finger E-box binding homeobox 2
|
|
IEP
|
protein:increased expression:heart (rat)
|
RGD |
PMID:24155330 |
RGD:155882536 |
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
|
|
|
|
| G
|
Acot2
|
acyl-CoA thioesterase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
|
|
| G
|
Actb
|
actin, beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242
|
|
| G
|
Acvr1b
|
activin A receptor type 1B
|
|
IEP
|
|
RGD |
PMID:14993131 |
RGD:1580888 |
NCBI chr 7:134,164,987...134,208,389
Ensembl chr 7:134,164,991...134,208,388
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16155579 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adm
|
adrenomedullin
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:15350700 |
RGD:1625302 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adm2
|
adrenomedullin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16987513 |
|
NCBI chr 7:122,272,808...122,274,594
Ensembl chr 7:122,272,808...122,274,594
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9554809 |
|
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9554809 |
|
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
ISO
|
associated with Diabetes Mellitus, Type 2;DNA:SNP:promoter:-374T>A (human)
|
RGD |
PMID:15896660 |
RGD:8695969 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agt
|
angiotensinogen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16775501 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Ak1
|
adenylate kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:36,310,197...36,320,757
|
|
| G
|
Akr1b1
|
aldo-keto reductase family 1 member B1
|
|
IDA
|
protein:increased activity:heart
|
RGD |
PMID:16567803 |
RGD:1626092 |
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
|
IDA
|
|
RGD |
PMID:18787169 |
RGD:7241592 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Aldh6a1
|
aldehyde dehydrogenase 6 family, member A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Ampd1
|
adenosine monophosphate deaminase 1
|
susceptibility
|
ISO
|
associated with congestive heart failure; DNA:SNP:exon 2:34C>T (human)
|
RGD |
PMID:16875916 |
RGD:329412475 |
NCBI chr 2:193,287,219...193,308,446
Ensembl chr 2:193,287,265...193,308,443
|
|
| G
|
Anxa5
|
annexin A5
|
|
IEP
|
|
RGD |
PMID:8056721 |
RGD:7241858 |
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
|
|
| G
|
Aplp2
|
amyloid beta precursor like protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031
|
|
| G
|
Apob
|
apolipoprotein B
|
|
ISO
|
|
RGD |
PMID:9603795 |
RGD:1578415 |
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
|
|
| G
|
Apoe
|
apolipoprotein E
|
susceptibility
|
ISO
|
DNA:polymorphism:promoter:-219G>T (human)
|
RGD |
PMID:17006673 |
RGD:1601238 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Areg
|
amphiregulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:17,256,384...17,265,641
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Axin2
|
axin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29394407 |
|
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:22014268 |
RGD:10054500 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:22014268 |
RGD:10054500 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bhlhe40
|
basic helix-loop-helix family, member e40
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
|
|
| G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
| G
|
C1qb
|
complement C1q B chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
|
|
| G
|
Cacna2d2
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:28469787 |
RGD:13513983 |
NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:116,950,907...117,081,759
|
|
| G
|
Calr
|
calreticulin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
|
|
| G
|
Camk2d
|
calcium/calmodulin-dependent protein kinase II delta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276
|
|
| G
|
Canx
|
calnexin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP ISO
|
protein:increased expression:plasma, heart (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:10068207 |
RGD:8549542 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl4
|
C-C motif chemokine ligand 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
|
|
| G
|
Ccna2
|
cyclin A2
|
|
ISO
|
|
RGD |
PMID:17382628 |
RGD:10054468 |
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
| G
|
Ccnd1
|
cyclin D1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccnd2
|
cyclin D2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
|
|
| G
|
Cd36
|
CD36 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd38
|
CD38 molecule
|
|
IDA ISO
|
protein:increased activity:ventricle myocardium CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:12111041 |
RGD:2307243 |
NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505
|
|
| G
|
Cd40
|
CD40 molecule
|
treatment
|
IDA
|
|
RGD |
PMID:19565716 |
RGD:11352677 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
treatment
|
IDA IEP
|
protein:increased expression:myocardium (rat)
|
RGD |
PMID:19565716 PMID:19204010 |
RGD:11352677, RGD:11352684 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cdh2
|
cadherin 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288
|
|
| G
|
Cebpd
|
CCAAT/enhancer binding protein delta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824
|
|
| G
|
Ces3a
|
carboxylesterase 3a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr19:49,902,312...49,910,484
|
|
| G
|
Cirbp
|
cold inducible RNA binding protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:10,184,515...10,189,623
|
|
| G
|
Clec10a
|
C-type lectin domain containing 10A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108
|
|
| G
|
Cox5b
|
cytochrome c oxidase subunit 5B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:46,417,735...46,419,664
Ensembl chr 9:46,417,838...46,420,403
|
|
| G
|
Cpt1b
|
carnitine palmitoyltransferase 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
|
|
| G
|
Crk
|
CRK proto-oncogene, adaptor protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:61,028,736...61,054,971
Ensembl chr10:61,028,757...61,082,988
|
|
| G
|
Crp
|
C-reactive protein
|
|
IEP ISO
|
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11840375 PMID:21122204 |
RGD:5128547 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cryab
|
crystallin, alpha B
|
|
IDA
|
|
RGD |
PMID:11945023 |
RGD:704398 |
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29394407 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Ctsc
|
cathepsin C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
|
|
| G
|
Cttnbp2
|
cortactin binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:47,766,867...47,930,598
Ensembl chr 4:47,766,870...47,930,540
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Dcn
|
decorin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
|
|
| G
|
Dlat
|
dihydrolipoamide S-acetyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:59,868,214...59,900,818 Ensembl chr 1:59,868,214...59,900,818
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
treatment
|
IEP
|
|
RGD |
PMID:32089723 |
RGD:155641250 |
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp6
|
dual specificity phosphatase 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
|
|
| G
|
Edn1
|
endothelin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10462014 PMID:11707688 PMID:16306806 |
|
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Ednra
|
endothelin receptor type A
|
|
ISO
|
|
RGD |
PMID:14729387 |
RGD:1580946 |
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
|
ISO
|
|
RGD |
PMID:14729387 |
RGD:1580946 |
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Egr2
|
early growth response 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19041636 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19041636 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif4e
|
eukaryotic translation initiation factor 4E
|
|
IDA
|
|
RGD |
PMID:16439989 |
RGD:10401145 |
NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105
|
|
| G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
IDA
|
|
RGD |
PMID:16439989 |
RGD:10401145 |
NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
|
|
| G
|
Eif4g1
|
eukaryotic translation initiation factor 4 gamma 1
|
|
IEP
|
|
RGD |
PMID:16439989 |
RGD:10401145 |
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367
|
|
| G
|
Eln
|
elastin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:27,604,983...27,648,413
Ensembl chr12:27,604,680...27,648,413
|
|
| G
|
Ensa
|
endosulfine alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:185,874,500...185,881,838
Ensembl chr 2:185,874,500...185,881,838
|
|
| G
|
Ephx1
|
epoxide hydrolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29298899 |
|
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29298899 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
|
ISO
|
|
RGD |
PMID:15685397 |
RGD:1580988 |
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
| G
|
F2rl1
|
F2R like trypsin receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16286589 |
|
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
| G
|
F5
|
coagulation factor V
|
|
ISO
|
DNA:mutation, haplotype: :1691G>A (human)
|
RGD |
PMID:19524925 |
RGD:4892673 |
NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247
|
|
| G
|
Fabp5
|
fatty acid binding protein 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
|
|
| G
|
Fev
|
FEV transcription factor, ETS family member
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:83,887,844...83,891,718
Ensembl chr 9:83,887,844...83,891,737
|
|
| G
|
Fez2
|
fasciculation and elongation protein zeta 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:22,406,685...22,446,745
Ensembl chr 6:22,406,632...22,447,041
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12173832 PMID:14583313 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1
|
|
IDA
|
|
RGD |
PMID:14597563 |
RGD:9685466 |
NCBI chr 1:95,414,556...95,418,645
Ensembl chr 1:95,414,557...95,418,591
|
|
| G
|
Gas5
|
growth arrest specific 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr13:75,836,963...75,840,284
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gbp2
|
guanylate binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
|
|
| G
|
Gdf1
|
growth differentiation factor 1
|
|
ISO
|
protein:increased expression:Left ventricle (human)
|
RGD |
PMID:25726944 |
RGD:11252030 |
NCBI chr16:19,131,271...19,146,480
Ensembl chr16:19,131,276...19,146,480
|
|
| G
|
Gdf15
|
growth differentiation factor 15
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
|
|
| G
|
Ghr
|
growth hormone receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:54,269,066...54,532,595
Ensembl chr 2:54,270,206...54,532,331
|
|
| G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
disease_progression treatment
|
IEP ISO
|
mRNA,protein:increased expression:plasma,myocardia:
|
RGD |
PMID:16626506 PMID:16626506 |
RGD:12907503, RGD:12907503 |
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969
|
|
| G
|
Ghsr
|
growth hormone secretagogue receptor
|
|
IEP
|
mRNA,protein:increased expression,increased activity:myocardia:
|
RGD |
PMID:16626506 |
RGD:12907503 |
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:112,196,767...112,201,181
|
|
| G
|
Gk
|
glycerol kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr X:54,106,708...54,189,940
Ensembl chr X:54,112,214...54,196,701
|
|
| G
|
Gna12
|
G protein subunit alpha 12
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
|
IEP
|
|
RGD |
PMID:30841448 |
RGD:401717562 |
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gsta1
|
glutathione S-transferase alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528
|
|
| G
|
Gstm2
|
glutathione S-transferase mu 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:198,312,179...198,316,962
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Gyg1
|
glycogenin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:104,540,927...104,583,038
Ensembl chr 2:104,540,533...104,582,818
|
|
| G
|
Hadha
|
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
|
|
| G
|
Hfe
|
homeostatic iron regulator
|
susceptibility
|
ISO
|
|
RGD |
PMID:11545759 |
RGD:1582695 |
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12447174 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
IEP
|
mRNA, protein:increased expression:myocardium (rat)
|
RGD |
PMID:17335664 |
RGD:9068465 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hivep2
|
HIVEP zinc finger 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:10,176,880...10,376,089
Ensembl chr 1:10,179,402...10,376,089
|
|
| G
|
Hk1
|
hexokinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814
|
|
| G
|
Hk2
|
hexokinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgcs2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
susceptibility
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:15064108 PMID:15734859 |
RGD:1598399, RGD:1582713 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Hspa9
|
heat shock protein family A (Hsp70) member 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
|
|
| G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:12872233 |
RGD:1624250 |
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Id1
|
inhibitor of DNA binding 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
|
|
| G
|
Id3
|
inhibitor of DNA binding 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856
|
|
| G
|
Ifngr1
|
interferon gamma receptor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:16,152,879...16,171,437
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
severity
|
ISO IDA
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:16793032 PMID:16698918 |
RGD:1598425, RGD:1598426 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Igfbp3
|
insulin-like growth factor binding protein 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16286589 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Irf1
|
interferon regulatory factor 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
|
|
| G
|
Itgav
|
integrin subunit alpha V
|
|
ISO
|
|
RGD |
PMID:11997283 |
RGD:1582453 |
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
|
|
| G
|
Jak2
|
Janus kinase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15746188 PMID:16214533 |
|
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Junb
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
|
IEP
|
|
RGD |
PMID:26591689 |
RGD:12790977 |
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:9399952 PMID:26591689 |
RGD:1598652, RGD:12790977 |
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
|
IEP
|
mRNA:increased expression:heart left ventricle, epicardium, endocardium (rat)
|
RGD |
PMID:24705172 |
RGD:9831164 |
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kcnmb1
|
potassium calcium-activated channel subfamily M regulatory beta subunit 1
|
no_association
|
ISO
|
|
RGD |
PMID:16155733 |
RGD:1581719 |
NCBI chr10:19,062,014...19,119,005
Ensembl chr10:19,062,291...19,073,204
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Kitlg
|
KIT ligand
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
| G
|
Klf4
|
KLF transcription factor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592
|
|
| G
|
Lepr
|
leptin receptor
|
susceptibility
|
ISO
|
DNA:polymorphism: :p.Q223R (human)
|
RGD |
PMID:19337797 |
RGD:2311129 |
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Ltbp2
|
latent transforming growth factor beta binding protein 2
|
|
ISO
|
mRNA:increased expression:myocardium (human)
|
RGD |
PMID:17343875 |
RGD:156451374 |
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:110,161,029...110,257,298
|
|
| G
|
Map1lc3b
|
microtubule-associated protein 1 light chain 3 beta
|
|
IDA
|
|
RGD |
PMID:12371906 |
RGD:629541 |
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358 Ensembl chr16:66,574,407...66,584,358
|
|
| G
|
Map2k3
|
mitogen activated protein kinase kinase 3
|
|
IDA
|
|
RGD |
PMID:20550965 |
RGD:7243113 |
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004
|
|
| G
|
Map3k8
|
mitogen-activated protein kinase kinase kinase 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:58,078,320...58,098,452
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapre1
|
microtubule-associated protein, RP/EB family, member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:162,679,020...162,707,167
Ensembl chr 3:162,673,195...162,711,210
|
|
| G
|
Mb
|
myoglobin
|
susceptibility
|
IDA IEP ISO
|
protein:decreased expression:subendocardium
|
RGD |
PMID:12935692 PMID:3315739 PMID:15762290 |
RGD:1582426, RGD:485874381, RGD:1582393 |
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Meox2
|
mesenchyme homeobox 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700
|
|
| G
|
Mfn1
|
mitofusin 1
|
treatment
|
IEP
|
|
RGD |
PMID:27491814 |
RGD:12910831 |
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
| G
|
Mfn2
|
mitofusin 2
|
treatment
|
IEP
|
|
RGD |
PMID:27491814 |
RGD:12910831 |
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mir145
|
microRNA 145
|
|
ISO
|
miRNA:decreased expression:myocardium (mouse)
|
RGD |
PMID:23028672 |
RGD:10047368 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mpo
|
myeloperoxidase
|
|
ISO
|
Acute Coronary Syndrome; protein:increased expression:plasma
|
RGD |
PMID:21226709 |
RGD:5130961 |
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Msn
|
moesin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
|
|
| G
|
Msr1
|
macrophage scavenger receptor 1
|
disease_progression
|
ISO
|
mRNA:increased expression:blood, mononuclear cell
|
RGD |
PMID:17945237 |
RGD:2306126 |
NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070
|
|
| G
|
Mx1
|
MX dynamin like GTPase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904
|
|
| G
|
Ncl
|
nucleolin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Nedd4
|
NEDD4 E3 ubiquitin protein ligase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:82,264,751...82,349,642
Ensembl chr 8:82,264,649...82,349,633
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
susceptibility
|
ISO
|
DNA:duplication, snp:intron, cds:g.IVS4?-?+27, p.E298D (human) ClinVar Annotator: match by term: Ischemic heart disease, susceptibility to CTD Direct Evidence: therapeutic
|
ClinVar CTD RGD |
PMID:9737779 PMID:9894802 PMID:10475066 PMID:10510054 PMID:10514107 PMID:11026457 PMID:11354626 PMID:11394896 PMID:11745998 PMID:12354446 PMID:15007011 PMID:16059745 PMID:16813604 PMID:17165044 PMID:24033266 PMID:25741868 PMID:15007011 More...
|
RGD:7777100 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch1
|
notch receptor 1
|
treatment
|
IEP
|
|
RGD |
PMID:32089723 |
RGD:155641250 |
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
| G
|
Nppa
|
natriuretic peptide A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:1830552 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
Nptn
|
neuroplastin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 8:67,892,678...67,959,231
Ensembl chr 8:67,892,702...67,959,236
|
|
| G
|
Nr1h3
|
nuclear receptor subfamily 1, group H, member 3
|
susceptibility
|
ISO
|
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
|
RGD |
PMID:21903943 |
RGD:401842365 |
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
|
|
| G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
treatment
|
IEP
|
|
RGD |
PMID:27491814 |
RGD:12910831 |
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
P4hb
|
prolyl 4-hydroxylase subunit beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
|
|
| G
|
Pde4b
|
phosphodiesterase 4B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267
|
|
| G
|
Pdha1
|
pyruvate dehydrogenase E1 subunit alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr X:38,509,158...38,522,986
Ensembl chr X:38,509,084...38,522,536
|
|
| G
|
Pdk4
|
pyruvate dehydrogenase kinase 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
|
|
| G
|
Pdlim5
|
PDZ and LIM domain 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:233,628,503...233,793,528
|
|
| G
|
Pebp1
|
phosphatidylethanolamine binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:44,963,675...44,971,780
|
|
| G
|
Penk
|
proenkephalin
|
treatment
|
IEP
|
|
RGD |
PMID:21247719 |
RGD:10003103 |
NCBI chr 5:21,981,381...21,987,074
Ensembl chr 5:21,981,382...21,986,705
|
|
| G
|
Pfkfb3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:71,893,416...71,975,052
|
|
| G
|
Pfkm
|
phosphofructokinase, muscle
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:131,100,753...131,138,248
|
|
| G
|
Pgf
|
placental growth factor
|
|
ISO
|
|
RGD |
PMID:18192038 |
RGD:6483613 |
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
| G
|
Pgm1
|
phosphoglucomutase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159
|
|
| G
|
Pla2g2a
|
phospholipase A2 group IIA
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
|
|
| G
|
Plcd1
|
phospholipase C, delta 1
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:15276620 |
RGD:2300429 |
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939
|
|
| G
|
Pomc
|
proopiomelanocortin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10908253 |
|
NCBI chr 6:32,659,137...32,665,175
Ensembl chr 6:32,659,346...32,665,173
|
|
| G
|
Ppat
|
phosphoribosyl pyrophosphate amidotransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405
|
|
| G
|
Ppm1b
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:15,399,562...15,460,756
|
|
| G
|
Ppp2ca
|
protein phosphatase 2 catalytic subunit alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:36,856,534...36,878,789
|
|
| G
|
Ppp3r1
|
protein phosphatase 3, regulatory subunit B, alpha
|
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:16214533 |
RGD:1580707 |
NCBI chr14:95,758,333...95,808,015
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
|
IEP
|
mRNA, protein:increased expression, altered phosphorylation:heart
|
RGD |
PMID:16924416 |
RGD:1642550 |
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkce
|
protein kinase C, epsilon
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
| G
|
Psmb5
|
proteasome 20S subunit beta 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:32,042,787...32,047,379
|
|
| G
|
Ptpra
|
protein tyrosine phosphatase, receptor type, A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:138,103,261...138,212,835
Ensembl chr 3:138,098,110...138,213,126
|
|
| G
|
Pygb
|
glycogen phosphorylase B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:160,072,115...160,123,961
|
|
| G
|
Pygm
|
glycogen phosphorylase, muscle associated
|
|
IDA
|
|
RGD |
PMID:10498852 |
RGD:1599991 |
NCBI chr 1:213,119,805...213,134,622
Ensembl chr 1:213,119,791...213,134,612
|
|
| G
|
Rab12
|
RAB12, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:113,927,119...113,953,722
Ensembl chr 9:113,927,119...113,953,695
|
|
| G
|
Rab1b
|
RAB1B, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:211,835,133...211,843,408
Ensembl chr 1:211,835,073...211,843,337 Ensembl chr X:211,835,073...211,843,337
|
|
| G
|
Rab5a
|
RAB5A, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,721,122...6,749,447
|
|
| G
|
Rab7a
|
RAB7A, member RAS oncogene family
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185
|
|
| G
|
Ralbp1
|
ralA binding protein 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 9:112,903,289...112,940,093
Ensembl chr 9:112,903,302...112,939,659
|
|
| G
|
Ramp2
|
receptor activity modifying protein 2
|
|
IEP
|
mRNA:increased expression:ventricle myocardium
|
RGD |
PMID:16987513 |
RGD:1642684 |
NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,688,703...86,691,231
|
|
| G
|
Rgcc
|
regulator of cell cycle
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408
|
|
| G
|
Rhoc
|
ras homolog family member C
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745
|
|
| G
|
Rln3
|
relaxin 3
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16112403 |
|
NCBI chr19:41,012,168...41,014,199
Ensembl chr19:41,012,168...41,014,653
|
|
| G
|
Rpl17
|
ribosomal protein L17
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr18:70,856,275...70,859,388
Ensembl chr 3:111,722,010...111,722,638 Ensembl chr18:111,722,010...111,722,638
|
|
| G
|
Rsad2
|
radical S-adenosyl methionine domain containing 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
|
|
| G
|
RT1-A2
|
RT1 class Ia, locus A2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:4,872,720...4,876,425
|
|
| G
|
RT1-N3
|
RT1 class Ib, locus N3
|
|
EXP
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:2,666,469...2,670,355
Ensembl chr20:2,666,464...2,670,348
|
|
| G
|
Rtn1
|
reticulon 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:96,499,137...96,719,340
Ensembl chr 6:96,499,134...96,719,340
|
|
| G
|
Rxrg
|
retinoid X receptor gamma
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr13:82,276,330...82,318,097
Ensembl chr13:82,276,291...82,318,095
|
|
| G
|
Ryr2
|
ryanodine receptor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr17:63,081,527...63,667,141
Ensembl chr17:63,081,527...63,666,705
|
|
| G
|
S100a1
|
S100 calcium binding protein A1
|
|
ISO
|
protein:increased expression:serum (human)
|
RGD |
PMID:10924368 |
RGD:1579977 |
NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:178,291,503...178,296,346
|
|
| G
|
Sele
|
selectin E
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpina1
|
serpin family A member 1
|
|
ISO
|
associated with Aortic Aneurysm, Abdominal;DNA:polymorphism: :p.E342K (human)
|
RGD |
PMID:10063411 |
RGD:1643148 |
NCBI chr 6:128,631,101...128,653,125
Ensembl chr 6:128,619,382...128,660,703
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
|
ISO
|
associated with chronic kidney disease;protein:increased expression:blood (human)
|
RGD |
PMID:11045282 |
RGD:30296653 |
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Sfrp4
|
secreted frizzled-related protein 4
|
|
IEP
|
|
RGD |
PMID:20528676 |
RGD:4107721 |
NCBI chr17:49,974,532...50,026,448
Ensembl chr17:50,015,812...50,026,395
|
|
| G
|
Slc6a6
|
solute carrier family 6 member 6
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:125,752,340...125,826,033
Ensembl chr 4:125,752,372...125,826,032
|
|
| G
|
Slc8a1
|
solute carrier family 8 member A1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
|
IDA
|
|
RGD |
PMID:17356886 |
RGD:1625560 |
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Snap23
|
synaptosome associated protein 23
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067
|
|
| G
|
Socs3
|
suppressor of cytokine signaling 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16214533 PMID:15681709 |
RGD:1581233 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
IDA ISO
|
ClinVar Annotator: match by term: Superoxide dismutase, elevated extracellular
|
ClinVar RGD |
PMID:7662997 PMID:8034674 PMID:14662715 PMID:25741868 PMID:16840738 |
RGD:1580843 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Sox2
|
SRY-box transcription factor 2
|
|
IMP
|
|
RGD |
PMID:34321385 |
RGD:155882552 |
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350
|
|
| G
|
Sparc
|
secreted protein acidic and cysteine rich
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
| G
|
Stat5a
|
signal transducer and activator of transcription 5A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15746188 |
|
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184
|
|
| G
|
Sult1a1
|
sulfotransferase family 1A member 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
|
|
| G
|
Tap1
|
transporter 1, ATP binding cassette subfamily B member
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,658,172...4,668,810
|
|
| G
|
Tcf7l2
|
transcription factor 7 like 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29394407 |
|
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:264,791,335...264,984,225
|
|
| G
|
Tfrc
|
transferrin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Tgoln2
|
trans-golgi network protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 4:106,221,503...106,229,360
Ensembl chr 4:106,221,509...106,229,262
|
|
| G
|
Tle4
|
TLE family member 4, transcriptional corepressor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:221,086,250...221,222,826
Ensembl chr 1:221,086,253...221,222,826
|
|
| G
|
Tle5
|
TLE family member 5, transcriptional modulator
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:8,794,123...8,801,056
Ensembl chr 7:8,793,796...8,801,054
|
|
| G
|
Tmed2
|
transmembrane p24 trafficking protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr12:37,713,522...37,722,606
Ensembl chr12:37,713,529...37,722,606
|
|
| G
|
Tmpo
|
thymopoietin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 PMID:16775501 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10789933 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Ttn
|
titin
|
|
IDA
|
|
RGD |
PMID:12221049 |
RGD:1580780 |
NCBI chr 3:82,059,648...82,332,130
Ensembl chr 3:82,059,648...82,332,171
|
|
| G
|
Tuba1a
|
tubulin, alpha 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035
|
|
| G
|
Txnip
|
thioredoxin interacting protein
|
|
IDA
|
|
RGD |
PMID:16172122 |
RGD:1580789 |
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Ugcg
|
UDP-glucose ceramide glucosyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:78,828,006...78,860,417
|
|
| G
|
Uqcrfs1
|
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:34,173,833...34,190,950
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:9860779 PMID:11289497 PMID:14503966 PMID:14583313 PMID:15347709 PMID:16214533 More...
|
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Vegfb
|
vascular endothelial growth factor B
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11289497 |
|
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152
|
|
| G
|
Zeb1
|
zinc finger E-box binding homeobox 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:56,644,397...56,810,745
|
|
| G
|
Zfp36
|
zinc finger protein 36
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16214533 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
|
|
| G
|
Abcc8
|
ATP binding cassette subfamily C member 8
|
|
ISO
|
|
RGD |
PMID:18316485 |
RGD:2301903 |
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
|
|
| G
|
Acvr2b
|
activin A receptor type 2B
|
treatment
|
ISO
|
human construct in mouse model mRNA, protein:decreased expression:heart (mouse)
|
RGD |
PMID:30765322 PMID:30765322 |
RGD:329849112, RGD:329849112 |
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
|
|
| G
|
Ada
|
adenosine deaminase
|
|
IDA
|
protein:increased expression
|
RGD |
PMID:16641873 |
RGD:1624305 |
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16155579 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
|
IMP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10900253 PMID:17201736 |
RGD:5129149 |
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
|
IDA
|
|
RGD |
PMID:16269402 |
RGD:1598746 |
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
IEP
|
protein:increased expression:heart (rat)
|
RGD |
PMID:16505177 |
RGD:1625342 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agl
|
amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
|
|
IMP
|
|
RGD |
PMID:9281456 |
RGD:1598779 |
NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724
|
|
| G
|
Agt
|
angiotensinogen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD |
PMID:2535056 PMID:19166939 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr1a
|
angiotensin II receptor, type 1a
|
|
IEP
|
protein:increased expression:myocardium
|
RGD |
PMID:21078800 |
RGD:5129194 |
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
treatment
|
IMP
|
|
RGD |
PMID:35788946 |
RGD:401793705 |
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
|
IEP ISO
|
protein:decreased expression:mitochondrion:
|
RGD |
PMID:23685150 PMID:23685150 |
RGD:10053560, RGD:10053560 |
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
IDA
|
protein:increased phosphorylation:heart left ventricle
|
RGD |
PMID:20217242 |
RGD:5509104 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt2
|
AKT serine/threonine kinase 2
|
|
IDA
|
|
RGD |
PMID:16418318 |
RGD:2313347 |
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420
|
|
| G
|
Alb
|
albumin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:9572063 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldh2
|
aldehyde dehydrogenase 2 family member
|
|
IDA
|
|
RGD |
PMID:23468836 |
RGD:7241598 |
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
IMP
|
|
RGD |
PMID:20011686 |
RGD:2317527 |
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Angpt2
|
angiopoietin 2
|
|
IEP
|
mRNA, protein:increased expression:myocardium (rat)
|
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
|
|
| G
|
Ank1
|
ankyrin 1
|
|
IDA
|
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ank2
|
ankyrin 2
|
|
IDA
|
|
RGD |
PMID:9378703 |
RGD:1599110 |
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259
|
|
| G
|
Ankrd1
|
ankyrin repeat domain 1
|
|
IEP
|
protein:decreased expression:myocardium
|
RGD |
PMID:19299913 |
RGD:5133278 |
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751
|
|
| G
|
Anxa1
|
annexin A1
|
treatment
|
IEP ISO
|
protein:increased expression:heart, leukocyte
|
RGD |
PMID:11641252 PMID:22924634 PMID:22924634 |
RGD:2306910, RGD:7421655, RGD:7421655 |
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
IEP
|
protein:altered localization:cytoplasm
|
RGD |
PMID:17602955 |
RGD:2315672 |
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Arrb2
|
arrestin, beta 2
|
|
IEP
|
|
RGD |
PMID:29016703 |
RGD:13506827 |
NCBI chr10:55,645,539...55,653,485
Ensembl chr10:55,645,357...55,653,487
|
|
| G
|
Atf3
|
activating transcription factor 3
|
|
IEP
|
|
RGD |
PMID:11485922 |
RGD:7327201 |
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
|
|
| G
|
Atp1a1
|
ATPase Na+/K+ transporting subunit alpha 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:29702141 |
|
NCBI chr 2:191,709,311...191,737,414
Ensembl chr 2:191,709,311...191,737,425
|
|
| G
|
Atp2a1
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
|
|
IMP
|
|
RGD |
PMID:17630344 |
RGD:13782075 |
NCBI chr 1:190,457,198...190,475,410
Ensembl chr 1:190,457,198...190,475,423
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10734148 PMID:28637456 |
RGD:13782080 |
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Atp5f1d
|
ATP synthase F1 subunit delta
|
treatment
|
IEP
|
protein:decreased expression:myocardium (rat)
|
RGD |
PMID:26109848 PMID:25305180 |
RGD:13792666, RGD:13792676 |
NCBI chr 7:10,211,260...10,218,989
Ensembl chr 7:10,211,262...10,216,583
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
treatment
|
IEP IDA
|
protein:increased expression, decreased serine phosphorylation:heart
|
RGD |
PMID:15339931 PMID:23364609 |
RGD:2292700, RGD:10053674 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20026869 PMID:21223820 PMID:31583047 PMID:25547710 |
RGD:10054103, RGD:155230831, RGD:13782178 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP IDA
|
|
RGD |
PMID:16289365 PMID:31583047 PMID:20821058 PMID:23364609 |
RGD:1599484, RGD:155230831, RGD:11561911, RGD:10053674 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
treatment
|
IDA
|
|
RGD |
PMID:12668130 |
RGD:11035287 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
IDA ISO
|
|
RGD |
PMID:20821058 PMID:20812860 |
RGD:11561911, RGD:11561944 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
|
IDA IEP
|
protein:increased cleavage:heart:
|
RGD |
PMID:19940077 PMID:11934844 |
RGD:2317561, RGD:13782263 |
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Blk
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
IEP
|
mRNA:increased expression:left ventricle (rat)
|
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chr15:41,802,701...41,841,004
Ensembl chr15:41,802,994...41,840,982
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
treatment
|
IMP IEP
|
protein:decreased expression:myocardium (human)
|
RGD |
PMID:16645637 PMID:28661226 |
RGD:11561983, RGD:155260328 |
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
Brd4
|
bromodomain containing 4
|
|
ISO
|
mRNA,protein:increased expression:heart
|
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:12909328 |
RGD:2289075 |
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
C3
|
complement C3
|
|
IEP
|
protein:increased expression:myocardium
|
RGD |
PMID:11560858 |
RGD:1582136 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
C5
|
complement C5
|
treatment
|
IDA IMP
|
|
RGD |
PMID:9631876 PMID:23067403 |
RGD:1600666, RGD:7411626 |
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
| G
|
Casp1
|
caspase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14998631 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
treatment
|
IEP ISO
|
protein:increased activity:myocardium CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:14998631 PMID:19406177 PMID:25547710 |
RGD:2311458, RGD:13782178 |
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
ameliorates treatment
|
IMP ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:14998631 PMID:18470603 PMID:30259997 PMID:29538428 |
RGD:2293314, RGD:329337366, RGD:13782276 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:14998631 PMID:29538428 |
RGD:13782276 |
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte
|
CTD RGD |
PMID:14998631 PMID:11934844 |
RGD:13782263 |
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
ameliorates treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiomyocyte,endothelial cell
|
CTD RGD |
PMID:14998631 PMID:30259997 PMID:29538428 PMID:11934844 |
RGD:329337366, RGD:13782276, RGD:13782263 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Casr
|
calcium-sensing receptor
|
|
IEP
|
protein:increased expression:ventricular myocardium (rat)
|
RGD |
PMID:21766206 |
RGD:7205698 |
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
|
|
| G
|
Cast
|
calpastatin
|
ameliorates
|
IEP ISO
|
human transcript overexpression in rat model
|
RGD |
PMID:12482022 PMID:14519437 |
RGD:5683872, RGD:405101692 |
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
| G
|
Cat
|
catalase
|
|
IEP ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:21600015 PMID:11510883 |
RGD:1581149 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cbl
|
Cbl proto-oncogene
|
severity
|
ISO
|
|
RGD |
PMID:24583314 |
RGD:11251947 |
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
|
IEP ISO
|
mRNA:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12087064 PMID:10908159 |
RGD:8549625 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccr2
|
C-C motif chemokine receptor 2
|
|
ISO
|
protein:decreased expression:monocyte:
|
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
|
|
| G
|
Ccr5
|
C-C motif chemokine receptor 5
|
treatment
|
ISO IEP
|
protein:decreased expression:blood, monocyte (human)
|
RGD |
PMID:15786508 PMID:23456481 |
RGD:4892017, RGD:8552227 |
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
|
|
| G
|
Cflar
|
CASP8 and FADD-like apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:18466417 |
RGD:11341714 |
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
|
IMP
|
|
RGD |
PMID:18771032 |
RGD:2316217 |
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cnr2
|
cannabinoid receptor 2
|
|
IMP
|
|
RGD |
PMID:17950273 |
RGD:2316224 |
NCBI chr 5:153,408,968...153,435,092
Ensembl chr 5:153,409,147...153,435,961
|
|
| G
|
Cobll1
|
cordon-bleu WH2 repeat protein-like 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34355838 |
|
NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460
|
|
| G
|
Crebbp
|
CREB binding protein
|
treatment
|
IEP
|
|
RGD |
PMID:24338162 |
RGD:153352322 |
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
|
|
| G
|
Crp
|
C-reactive protein
|
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
|
ISO
|
protein:decreased expression:blood, monocyte
|
RGD |
PMID:15786508 |
RGD:4892017 |
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
|
IMP
|
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
|
IMP
|
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl6
|
C-X-C motif chemokine ligand 6
|
|
IMP
|
|
RGD |
PMID:11342480 |
RGD:5135269 |
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19207477 |
|
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Diablo
|
diablo, IAP-binding mitochondrial protein
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:14998631 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265
|
|
| G
|
Dnm1l
|
dynamin 1-like
|
ameliorates
|
ISO
|
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
|
|
| G
|
Ece1
|
endothelin converting enzyme 1
|
|
IMP IEP
|
|
RGD |
PMID:18586023 PMID:12193087 |
RGD:4892580, RGD:7244160 |
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
|
|
| G
|
Edn1
|
endothelin 1
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15642760 PMID:16700825 PMID:18586023 |
RGD:4892580 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Ednra
|
endothelin receptor type A
|
|
IMP
|
|
RGD |
PMID:18586023 |
RGD:4892580 |
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:47,137,771...47,201,284
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
|
IMP
|
|
RGD |
PMID:21048781 |
RGD:4892332 |
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Egln1
|
egl-9 family hypoxia-inducible factor 1
|
susceptibility
|
ISO
|
|
RGD |
PMID:20185832 |
RGD:11251775 |
NCBI chr19:69,765,276...69,804,681
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19834332 |
|
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Esr1
|
estrogen receptor 1
|
|
IMP
|
|
RGD |
PMID:18314151 |
RGD:4892299 |
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
|
ISO
|
|
RGD |
PMID:18656630 |
RGD:5508820 |
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fadd
|
Fas associated via death domain
|
treatment
|
ISO IEP
|
|
RGD |
PMID:26038570 PMID:26948086 |
RGD:11341801, RGD:13792504 |
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
IDA
|
|
RGD |
PMID:21316771 |
RGD:8686424 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fis1
|
fission, mitochondrial 1
|
ameliorates
|
ISO
|
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:25,345,239...25,349,335
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:27129213 |
RGD:11574725 |
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Gcg
|
glucagon
|
treatment
|
ISO
|
|
RGD |
PMID:24125539 |
RGD:10402369 |
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533
|
|
| G
|
Gdf11
|
growth differentiation factor 11
|
|
ISO
|
mRNA, protein:decreased expression:heart (mouse)
|
RGD |
PMID:30765322 |
RGD:329849112 |
NCBI chr 7:1,896,229...1,909,147
Ensembl chr 7:1,896,229...1,905,222
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:17445419 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Glrx
|
glutaredoxin
|
|
IEP
|
mRNA:decreased expression:heart:
|
RGD |
PMID:18163565 |
RGD:2306160 |
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
|
ISO
|
|
RGD |
PMID:11043918 |
RGD:401827843 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Grk2
|
G protein-coupled receptor kinase 2
|
treatment susceptibility severity
|
IMP ISO IDA
|
associated with Diabetes Mellitus, Experimental associated with Hypertension protein:increased expression:heart, mitochondrion (mouse)
|
RGD |
PMID:27865836 PMID:27601479 PMID:27296507 PMID:24170934 PMID:23467820 |
RGD:13513990, RGD:13513993, RGD:13513995, RGD:13792704, RGD:13792779 |
NCBI chr 1:211,010,259...211,031,013
Ensembl chr 1:211,009,978...211,031,015
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
treatment
|
IDA IEP
|
|
RGD |
PMID:20217242 PMID:26918336 PMID:29978610 |
RGD:5509104, RGD:13792772, RGD:13792725 |
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
treatment
|
IEP
|
|
RGD |
PMID:24769323 |
RGD:10401892 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
ameliorates
|
ISO
|
|
RGD |
PMID:31284127 |
RGD:158013771 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
H2ax
|
H2A.X variant histone
|
treatment
|
IDA
|
|
RGD |
PMID:23108649 |
RGD:8693739 |
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hdac3
|
histone deacetylase 3
|
ameliorates
|
ISO
|
|
RGD |
PMID:33982231 |
RGD:155883171 |
NCBI chr18:30,021,847...30,041,061
Ensembl chr18:30,021,941...30,041,025
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IEP ISO IDA
|
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism protein:increased expression:myocardium
|
CTD RGD |
PMID:18549825 PMID:22050707 PMID:12189448 PMID:20170615 PMID:19727523 |
RGD:1626327, RGD:9068872, RGD:5147885 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IEP ISO IDA
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:21113057 PMID:23531454 PMID:19540007 |
RGD:10402066, RGD:10402170 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IDA ISO IEP
|
|
RGD |
PMID:12709584 PMID:23921302 PMID:22179023 |
RGD:1598392, RGD:10755585, RGD:10755573 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hrh2
|
histamine receptor H 2
|
susceptibility
|
ISO
|
|
RGD |
PMID:23467745 |
RGD:9685524 |
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041
|
|
| G
|
Hrh3
|
histamine receptor H3
|
|
IDA
|
|
RGD |
PMID:15076218 |
RGD:1626433 |
NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:187,569,175...187,574,259
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
|
ISO
|
|
RGD |
PMID:22426029 |
RGD:10402789 |
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
treatment
|
IEP
|
|
RGD |
PMID:20501665 |
RGD:10003160 |
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
treatment
|
IEP
|
|
RGD |
PMID:24129401 PMID:25547710 |
RGD:11354962, RGD:13782178 |
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Htra2
|
HtrA serine peptidase 2
|
|
ISO
|
protein:increased expression:myocardium, cytosol (mouse)
|
RGD |
PMID:15611365 |
RGD:5688376 |
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
IEP ISO
|
protein:increased expression:heart (rat) CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12087064 PMID:20851484 |
RGD:4145348 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
IEP IDA
|
protein:increased expression:plasma
|
RGD |
PMID:19275881 PMID:23840272 |
RGD:2311056, RGD:7365001 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il17a
|
interleukin 17A
|
treatment
|
IMP
|
|
RGD |
PMID:22030025 |
RGD:9068944 |
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331
|
|
| G
|
Il18
|
interleukin 18
|
|
ISO IDA
|
|
RGD |
PMID:19164288 PMID:19805173 |
RGD:4889578, RGD:4889400 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il18bp
|
interleukin 18 binding protein
|
|
ISO
|
mRNA:increased expression:heart
|
RGD |
PMID:19164288 PMID:19805173 |
RGD:4889578, RGD:4889400 |
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:165,784,069...165,786,955
|
|
| G
|
Il18rap
|
interleukin 18 receptor accessory protein
|
|
ISO
|
|
RGD |
PMID:19164288 |
RGD:4889578 |
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
treatment
|
ISO IEP
|
|
RGD |
PMID:8576926 PMID:7622355 |
RGD:7794741, RGD:7794764 |
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
treatment
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:17134725 PMID:31583047 |
RGD:1626628, RGD:155230831 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rl2
|
interleukin 1 receptor-like 2
|
|
IMP
|
compared to Wild Type in cardiopulmonary bypass model
|
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 9:50,087,271...50,134,225
Ensembl chr 9:50,083,903...50,204,607
|
|
| G
|
Il1rl2tm1(Myh6-cre)Mhzh
|
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh
|
|
IMP
|
compared to Wild Type in cardiopulmonary bypass model
|
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
rat model treated with human protein
|
RGD |
PMID:22649318 |
RGD:7174360 |
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Il36rn
|
interleukin 36 receptor antagonist
|
|
IMP
|
|
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 3:27,442,679...27,449,306
Ensembl chr 3:27,442,709...27,449,306
|
|
| G
|
Il36rntm1(Myh6-cre)Mhzh
|
interleukin 36 receptor antagonist; tm1, Mhzh
|
|
IMP
|
|
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
| G
|
Il6
|
interleukin 6
|
treatment
|
IDA IEP
|
|
RGD |
PMID:27087891 PMID:31583047 |
RGD:11062149, RGD:155230831 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
|
ISO
|
|
RGD |
PMID:16056242 |
RGD:1625435 |
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Inhba
|
inhibin subunit beta A
|
|
ISO
|
mRNA, protein:increased expression:heart (mouse)
|
RGD |
PMID:30765322 |
RGD:329849112 |
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508
|
|
| G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
|
IEP
|
protein:increased activity:ventricle myocardium (rat)
|
RGD |
PMID:15793310 |
RGD:1579809 |
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
| G
|
Irf9
|
interferon regulatory factor 9
|
exacerbates ameliorates
|
ISO
|
protein:increased expression:left ventricular free wall
|
RGD |
PMID:25150882 PMID:25150882 PMID:25150882 |
RGD:125093742, RGD:125093742, RGD:125093742 |
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:33,065,659...33,071,879
|
|
| G
|
Jak2
|
Janus kinase 2
|
treatment
|
IMP
|
associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:23796350 PMID:23747931 |
RGD:8694332, RGD:10403071 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Kcnj11
|
potassium inwardly-rectifying channel, subfamily J, member 11
|
|
ISO
|
|
RGD |
PMID:17906066 |
RGD:7297046 |
NCBI chr 1:105,727,473...105,731,167
Ensembl chr 1:105,727,570...105,731,169
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
|
IDA
|
|
RGD |
PMID:12234964 |
RGD:729109 |
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Klrk1
|
killer cell lectin like receptor K1
|
treatment
|
IMP
|
|
RGD |
PMID:23953572 |
RGD:9685183 |
NCBI chr 4:164,767,377...164,778,453
Ensembl chr 4:164,767,946...164,778,382
|
|
| G
|
Kng1
|
kininogen 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:2535056 PMID:7856280 |
|
NCBI chr11:91,317,354...91,340,148
Ensembl chr11:91,317,355...91,340,148
|
|
| G
|
Lep
|
leptin
|
|
IEP
|
|
RGD |
PMID:21122204 |
RGD:5128547 |
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lepr
|
leptin receptor
|
|
IEP
|
mRNA:decreased expression:heart mRNA:altered expression:heart
|
RGD |
PMID:15284063 PMID:17134725 |
RGD:5129123, RGD:1626628 |
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Lum
|
lumican
|
|
IDA
|
|
RGD |
PMID:11348051 |
RGD:1582122 |
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
treatment
|
IEP ISO
|
protein:increased expression:heart
|
RGD |
PMID:20821058 PMID:20812860 |
RGD:11561911, RGD:11561944 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map2k6
|
mitogen-activated protein kinase kinase 6
|
|
ISO
|
|
RGD |
PMID:14749328 PMID:15492008 |
RGD:7495840, RGD:1582277 |
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
treatment
|
IEP
|
|
RGD |
PMID:31583047 |
RGD:155230831 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
treatment
|
IDA
|
|
RGD |
PMID:15653762 PMID:25345742 |
RGD:1582282, RGD:13800900 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk14
|
mitogen activated protein kinase 14
|
|
ISO
|
|
RGD |
PMID:14749328 |
RGD:7495840 |
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
treatment
|
IEP IDA
|
|
RGD |
PMID:29741915 PMID:25345742 PMID:28814571 |
RGD:13800564, RGD:13800900, RGD:13800874 |
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
treatment
|
IDA IEP
|
|
RGD |
PMID:15309413 PMID:31583047 PMID:12883833 |
RGD:1582311, RGD:155230831, RGD:1582312 |
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mb
|
myoglobin
|
treatment
|
ISO IEP IDA
|
|
RGD |
PMID:15132981 PMID:31455109 PMID:11972171 |
RGD:1582385, RGD:487982219, RGD:1582431 |
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Mbl1
|
mannose binding lectin 1
|
|
IDA IMP ISO
|
|
RGD |
PMID:11560858 PMID:20216929 PMID:15972690 |
RGD:1582136, RGD:4889154, RGD:1582131 |
NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,060,703...17,069,271
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
treatment
|
ISO
|
|
RGD |
PMID:25482922 |
RGD:11530049 |
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
|
IEP
|
protein:increased serine phosphorylation:heart ventricle (rat)
|
RGD |
PMID:14644432 |
RGD:2317401 |
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mfn2
|
mitofusin 2
|
treatment
|
IEP
|
|
RGD |
PMID:24721408 |
RGD:13204835 |
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mir1
|
microRNA 1
|
treatment
|
IMP
|
|
RGD |
PMID:29741915 |
RGD:13800564 |
NCBI chr18:2,160,327...2,160,413
|
|
| G
|
Mir10a
|
microRNA 10a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,779,709...81,779,818
|
|
| G
|
Mir10b
|
microRNA 10b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 3:80,035,859...80,035,967
Ensembl chr 3:80,035,859...80,035,967
|
|
| G
|
Mir126a
|
microRNA 126a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir134
|
microRNA 134
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 6:134,570,313...134,570,385
|
|
| G
|
Mir137
|
microRNA 137
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 2:209,165,709...209,165,810
Ensembl chr 2:209,165,712...209,165,813
|
|
| G
|
Mir140
|
microRNA 140
|
exacerbates
|
ISO
|
miRNA:increased expression:heart, endothelial cells (mouse)
|
RGD |
PMID:30259997 PMID:31792649 |
RGD:329337366, RGD:329337374 |
NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391
|
|
| G
|
Mir142
|
microRNA 142
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr10:73,055,104...73,055,190
Ensembl chr10:73,055,097...73,055,207
|
|
| G
|
Mir145
|
microRNA 145
|
treatment
|
IEP
|
RNA:decreased expression:heart
|
RGD |
PMID:31583047 PMID:33658472 |
RGD:155230831, RGD:329955358 |
NCBI chr18:57,369,983...57,370,070
|
|
| G
|
Mir146b
|
microRNA 146b
|
|
IEP
|
miRNA:increased expression:heart (rat)
|
RGD |
PMID:19380620 |
RGD:155882541 |
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947
|
|
| G
|
Mir181c
|
microRNA 181c
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr19:40,888,291...40,888,396
Ensembl chr19:40,888,291...40,888,396
|
|
| G
|
Mir183
|
microRNA 183
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 4:59,756,044...59,756,153
|
|
| G
|
Mir186
|
microRNA 186
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 2:249,241,650...249,241,735
Ensembl chr 2:249,241,650...249,241,735
|
|
| G
|
Mir188
|
microRNA 188
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:17,919,585...17,919,664
Ensembl chr X:17,919,585...17,919,664
|
|
| G
|
Mir193a
|
microRNA 193a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr10:65,170,306...65,170,417
|
|
| G
|
Mir196b
|
microRNA 196b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 4:82,661,101...82,661,185
|
|
| G
|
Mir206
|
microRNA 206
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 9:30,590,697...30,590,780
Ensembl chr 9:30,590,697...30,590,780
|
|
| G
|
Mir20b
|
microRNA 20b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:137,343,197...137,343,268
|
|
| G
|
Mir21
|
microRNA 21
|
exacerbates
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism miRNA:increased expression:heart (rat)
|
CTD RGD |
PMID:22050707 PMID:19380620 PMID:24825878 |
RGD:155882541, RGD:41404665 |
NCBI chr10:71,902,600...71,902,691
|
|
| G
|
Mir210
|
microRNA 210
|
sexual_dimorphism
|
IEP ISO
|
miRNA:increased expression:myocardium (human)
|
RGD |
PMID:28661226 PMID:35296158 |
RGD:155260328, RGD:155663666 |
NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034
|
|
| G
|
Mir222
|
microRNA 222
|
ameliorates
|
ISO
|
|
RGD |
PMID:25863248 |
RGD:152025190 |
NCBI chr X:6,022,621...6,022,723
Ensembl chr X:6,022,621...6,022,723
|
|
| G
|
Mir23b
|
microRNA 23b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr17:1,819,386...1,819,482
|
|
| G
|
Mir26a1
|
microRNA 26a-1
|
treatment
|
IEP
|
|
RGD |
PMID:29978610 |
RGD:13792725 |
NCBI chr 8:127,633,048...127,633,137
Ensembl chr 8:127,633,048...127,633,137
|
|
| G
|
Mir27a
|
microRNA 27a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr19:40,859,603...40,859,689
|
|
| G
|
Mir27b
|
microRNA 27b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr17:1,819,147...1,819,243
|
|
| G
|
Mir28
|
microRNA 28
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr11:89,480,252...89,480,337
|
|
| G
|
Mir296
|
microRNA 296
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 3:183,470,069...183,470,146
|
|
| G
|
Mir301b
|
microRNA 301b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr11:97,384,033...97,384,110
Ensembl chr11:97,384,033...97,384,110
|
|
| G
|
Mir30a
|
microRNA 30a
|
treatment
|
IEP
|
|
RGD |
PMID:25137026 |
RGD:35673319 |
NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011
|
|
| G
|
Mir30c1
|
microRNA 30c-1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:34217758 |
|
NCBI chr 5:139,634,455...139,634,543
|
|
| G
|
Mir320a
|
microRNA 320a
|
treatment ameliorates
|
IMP ISO
|
|
RGD |
PMID:27175593 PMID:25268616 PMID:30840298 PMID:19380620 |
RGD:155882540, RGD:155882578, RGD:155882546, RGD:155882541 |
NCBI chr15:51,926,088...51,926,169
Ensembl chr15:51,926,088...51,926,169
|
|
| G
|
Mir330
|
microRNA 330
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 1:87,961,207...87,961,303
Ensembl chr 1:87,961,207...87,961,303
|
|
| G
|
Mir331
|
microRNA 331
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 7:30,414,386...30,414,481
|
|
| G
|
Mir337
|
microRNA 337
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 6:134,321,142...134,321,238
Ensembl chr 6:134,321,141...134,321,237
|
|
| G
|
Mir346
|
microRNA 346
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr16:10,224,300...10,224,397
Ensembl chr16:10,224,300...10,224,397
|
|
| G
|
Mir34c
|
microRNA 34c
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 8:60,306,091...60,306,167
|
|
| G
|
Mir361
|
microRNA 361
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:82,438,463...82,438,532
|
|
| G
|
Mir375
|
microRNA 375
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 9:83,906,582...83,906,656
|
|
| G
|
Mir411
|
microRNA 411
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 6:134,544,594...134,544,669
Ensembl chr 6:134,544,589...134,544,684
|
|
| G
|
Mir429
|
microRNA 429
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 5:171,929,682...171,929,766
|
|
| G
|
Mir433
|
microRNA 433
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 6:134,327,358...134,327,450
Ensembl chr 6:134,327,351...134,327,456
|
|
| G
|
Mir451a
|
microRNA 451a
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr10:63,459,569...63,459,640
Ensembl chr10:63,459,569...63,459,640
|
|
| G
|
Mir494
|
microRNA 494
|
ameliorates
|
ISO
|
|
RGD |
PMID:33982231 PMID:20837890 PMID:20837890 |
RGD:155883171, RGD:155883174, RGD:155883174 |
NCBI chr 6:134,550,115...134,550,197
Ensembl chr 6:134,550,114...134,550,198
|
|
| G
|
Mir500
|
microRNA 500
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:17,930,647...17,930,726
Ensembl chr X:17,930,637...17,930,728
|
|
| G
|
Mir503
|
microRNA 503
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:137,725,856...137,725,926
|
|
| G
|
Mir532
|
microRNA 532
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:17,919,185...17,919,263
Ensembl chr X:17,919,185...17,919,263
|
|
| G
|
Mir542
|
microRNA 542
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:137,722,176...137,722,254
|
|
| G
|
Mir582
|
microRNA 582
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 2:42,661,954...42,662,034
Ensembl chr 2:42,661,954...42,662,034
|
|
| G
|
Mir598
|
microRNA 598
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr15:42,138,609...42,138,687
Ensembl chr15:42,138,609...42,138,688
|
|
| G
|
Mir743a
|
microRNA 743a
|
|
EXP
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr X:150,444,088...150,444,163
|
|
| G
|
Mirlet7i
|
microRNA let-7i
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 7:60,527,877...60,527,961
|
|
| G
|
Mki67
|
marker of proliferation Ki-67
|
|
IDA
|
|
RGD |
PMID:22405128 |
RGD:6483543 |
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
| G
|
Mmp1
|
matrix metallopeptidase 1
|
|
ISO IEP
|
|
RGD |
PMID:12892382 PMID:17996137 |
RGD:1582539, RGD:7207397 |
NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
treatment
|
ISO IEP
|
|
RGD |
PMID:16699069 PMID:23889688 |
RGD:1582614, RGD:8657084 |
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mstn
|
myostatin
|
|
ISO
|
mRNA, protein:increased expression:heart (mouse)
|
RGD |
PMID:30765322 |
RGD:329849112 |
NCBI chr 9:55,944,513...55,950,913
Ensembl chr 9:55,944,513...55,950,913
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
|
IDA
|
|
RGD |
PMID:14962484 |
RGD:1302746 |
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Ncl
|
nucleolin
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:23594402 |
RGD:9686384 |
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
|
|
| G
|
Ndufs1
|
NADH:ubiquinone oxidoreductase core subunit S1
|
treatment
|
IDA
|
|
RGD |
PMID:21700931 |
RGD:13801200 |
NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:72,040,090...72,073,605
|
|
| G
|
Nfe2l1
|
NFE2 like bZIP transcription factor 1
|
treatment
|
IEP
|
|
RGD |
PMID:20501665 |
RGD:10003160 |
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
|
ISO
|
|
RGD |
PMID:24915518 |
RGD:10412738 |
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Nfkbia
|
NFKB inhibitor alpha
|
treatment
|
IDA
|
|
RGD |
PMID:19304943 |
RGD:10413871 |
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
IEP ISO
|
mRNA:decreased expression:heart (rat) CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:12003803 PMID:12087064 PMID:14990356 PMID:19207477 PMID:20828608 PMID:21844074 More...
|
RGD:5509098 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IEP IDA ISO IMP
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:12354446 PMID:20828747 PMID:29274587 PMID:29299201 PMID:18390819 |
RGD:4891991, RGD:13504684, RGD:13503347, RGD:2292091 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:33658472 |
RGD:329955358 |
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nppb
|
natriuretic peptide B
|
|
IDA
|
|
RGD |
PMID:21168723 |
RGD:5685663 |
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
|
|
| G
|
Nppc
|
natriuretic peptide C
|
|
IDA
|
|
RGD |
PMID:15337698 |
RGD:1580149 |
NCBI chr 9:94,767,986...94,772,186
Ensembl chr 9:94,767,986...94,772,186
|
|
| G
|
Npr3
|
natriuretic peptide receptor 3
|
|
IDA
|
|
RGD |
PMID:15337698 |
RGD:1580149 |
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066
|
|
| G
|
Npy1r
|
neuropeptide Y receptor Y1
|
|
IEP
|
mRNA:decreased expression:heart left ventricle
|
RGD |
PMID:17562528 |
RGD:1642307 |
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387
|
|
| G
|
Olr1
|
oxidized low density lipoprotein receptor 1
|
treatment
|
IMP
|
|
RGD |
PMID:12384456 |
RGD:628368 |
NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598
|
|
| G
|
Oprd1
|
opioid receptor, delta 1
|
|
IDA
|
|
RGD |
PMID:12136724 |
RGD:2316590 |
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:149,590,244...149,624,999
|
|
| G
|
Oxt
|
oxytocin/neurophysin I prepropeptide
|
|
IMP
|
|
RGD |
PMID:19234577 |
RGD:2304087 |
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594
|
|
| G
|
P2ry12
|
purinergic receptor P2Y12
|
|
ISO
|
|
RGD |
PMID:20431845 |
RGD:6480645 |
NCBI chr 2:145,631,487...145,673,194
Ensembl chr 2:145,629,967...145,633,410
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
|
ISO
|
|
RGD |
PMID:9670921 PMID:23598272 |
RGD:5683917, RGD:11073735 |
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pawr
|
pro-apoptotic WT1 regulator
|
treatment
|
IMP
|
|
RGD |
PMID:18055876 |
RGD:9835369 |
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492
|
|
| G
|
Pdia3
|
protein disulfide isomerase family A, member 3
|
|
IEP
|
|
RGD |
PMID:12872233 |
RGD:1624250 |
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
IMP
|
|
RGD |
PMID:8989147 |
RGD:2311662 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Phlda3
|
pleckstrin homology-like domain, family A, member 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:34351043 |
|
NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621
|
|
| G
|
Pik3cg
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
ISO
|
|
RGD |
PMID:20179753 |
RGD:6482687 |
NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509
|
|
| G
|
Plcd1
|
phospholipase C, delta 1
|
|
IDA
|
protein:altered activity
|
RGD |
PMID:12623065 |
RGD:1304368 |
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939
|
|
| G
|
Pld2
|
phospholipase D2
|
|
IDA
|
protein:altered activity:sarcolemma, sarcoplasmic reticulum, heart left ventricle
|
RGD |
PMID:15752718 |
RGD:2299906 |
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,754,988...55,771,435
|
|
| G
|
Pln
|
phospholamban
|
treatment
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10734148 PMID:21934351 |
RGD:7327186 |
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16411023 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Ppard
|
peroxisome proliferator-activated receptor delta
|
|
IDA
|
|
RGD |
PMID:19997057 |
RGD:2324876 |
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,352,183...6,365,707
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
ISO
|
|
RGD |
PMID:18562925 |
RGD:2301853 |
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
treatment
|
ISO
|
|
RGD |
PMID:19096023 |
RGD:10059669 |
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
| G
|
Prkaa2
|
protein kinase AMP-activated catalytic subunit alpha 2
|
treatment
|
IEP
|
|
RGD |
PMID:20501665 |
RGD:10003160 |
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:125,042,179...125,108,324
|
|
| G
|
Prkcb
|
protein kinase C, beta
|
|
IDA
|
|
RGD |
PMID:15878997 |
RGD:1625520 |
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
|
|
| G
|
Prkcd
|
protein kinase C, delta
|
|
IEP
|
protein:decreased expression:heart
|
RGD |
PMID:17322024 |
RGD:1642542 |
NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839
|
|
| G
|
Prkd1
|
protein kinase D1
|
ameliorates
|
ISO
|
|
RGD |
PMID:24345679 |
RGD:307727199 |
NCBI chr 6:73,460,640...73,774,433
Ensembl chr 6:73,460,640...73,836,509
|
|
| G
|
Prkg1
|
protein kinase cGMP-dependent 1
|
treatment
|
IMP
|
|
RGD |
PMID:18332860 PMID:19845676 |
RGD:7777120, RGD:7777130 |
NCBI chr 1:237,818,950...239,052,184
Ensembl chr 1:237,823,053...239,103,005
|
|
| G
|
Procr
|
protein C receptor
|
treatment
|
IDA
|
|
RGD |
PMID:26994471 |
RGD:13515126 |
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:164,711,636...164,718,989
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
treatment
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:19038262 PMID:20951693 |
RGD:127285611 |
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptger3
|
prostaglandin E receptor 3
|
treatment
|
IMP
|
|
RGD |
PMID:10193764 |
RGD:10043342 |
NCBI chr 2:249,264,985...249,409,966
Ensembl chr 2:249,264,985...249,409,846
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
IMP
|
|
RGD |
PMID:17660401 |
RGD:2300261 |
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rap1a
|
RAP1A, member of RAS oncogene family
|
treatment
|
IDA
|
|
RGD |
PMID:20501665 |
RGD:10003160 |
NCBI chr 2:195,896,967...195,974,851
Ensembl chr 2:195,896,971...195,974,808
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
treatment
|
IDA IEP
|
protein:altered localization:nucleus
|
RGD |
PMID:18636044 PMID:31583047 |
RGD:2298773, RGD:155230831 |
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Rhoa
|
ras homolog family member A
|
|
IEP
|
protein:altered localization:heart
|
RGD |
PMID:17322412 |
RGD:1642967 |
NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302
|
|
| G
|
Rnf41
|
ring finger protein 41
|
severity
|
ISO
|
|
RGD |
PMID:21312039 |
RGD:401827146 |
NCBI chr 7:1,422,651...1,461,700
Ensembl chr 7:1,426,408...1,448,164
|
|
| G
|
Rnls
|
renalase, FAD-dependent amine oxidase
|
|
ISO
|
|
RGD |
PMID:21178975 PMID:21178975 |
RGD:7327174, RGD:7327174 |
NCBI chr 1:240,450,702...240,723,472
Ensembl chr 1:240,450,702...240,723,043
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
IEP
|
mRNA, protein:increased expression:myocardium
|
RGD |
PMID:21663912 |
RGD:5508825 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Selp
|
selectin P
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12087064 PMID:21146547 |
RGD:6480105 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpina3n
|
serpin family A member 3N
|
|
ISO
|
|
RGD |
PMID:7562495 |
RGD:5147423 |
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:129,088,398...129,097,415
|
|
| G
|
Serpine1
|
serpin family E member 1
|
treatment
|
IDA
|
|
RGD |
PMID:26958805 |
RGD:11073621 |
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Serping1
|
serpin family G member 1
|
treatment
|
ISO
|
|
RGD |
PMID:16942749 |
RGD:8661647 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Sfrp2
|
secreted frizzled-related protein 2
|
|
IEP
|
|
RGD |
PMID:19109969 |
RGD:4107088 |
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
|
|
| G
|
Sh2b3
|
SH2B adaptor protein 3
|
|
IMP
|
|
RGD |
PMID:25628389 |
RGD:12904914 |
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335
|
|
| G
|
Sh2b3em2Mcwi
|
SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
|
|
IMP
|
|
RGD |
PMID:25628389 |
RGD:12904914 |
|
|
| G
|
Shh
|
sonic hedgehog signaling molecule
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:18228117 |
RGD:2306299 |
NCBI chr 4:7,687,872...7,697,025
Ensembl chr 4:7,687,846...7,697,901
|
|
| G
|
Sirt1
|
sirtuin 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:21060073 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
| G
|
Slc25a4
|
solute carrier family 25 member 4
|
treatment
|
IEP
|
|
RGD |
PMID:24126566 |
RGD:9681554 |
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:52,805,523...52,811,700
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
|
IEP
|
|
RGD |
PMID:10336852 |
RGD:12879857 |
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc2a4
|
solute carrier family 2 member 4
|
|
IEP
|
|
RGD |
PMID:10336852 |
RGD:12879857 |
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
|
|
| G
|
Slc8a1
|
solute carrier family 8 member A1
|
|
IDA ISO IMP
|
CTD Direct Evidence: marker/mechanism protein:increased activity:cardiac muscle cell
|
CTD RGD |
PMID:15215644 PMID:17267548 PMID:17822695 |
RGD:1642729, RGD:1642716 |
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
|
IMP
|
|
RGD |
PMID:22803959 |
RGD:6771238 |
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Smad1
|
SMAD family member 1
|
|
ISO
|
|
RGD |
PMID:15911698 |
RGD:1643233 |
NCBI chr19:45,417,430...45,477,962
Ensembl chr19:45,417,433...45,477,957
|
|
| G
|
Smad3
|
SMAD family member 3
|
treatment
|
IDA
|
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad4
|
SMAD family member 4
|
treatment
|
IEP
|
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
treatment
|
ISO IDA
|
human protein in a rat model
|
RGD |
PMID:19277497 PMID:12668130 PMID:23629152 |
RGD:8655884, RGD:11035287, RGD:8655965 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
treatment
|
ISO
|
|
RGD |
PMID:11864929 PMID:12668130 |
RGD:1581222, RGD:11035287 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sord
|
sorbitol dehydrogenase
|
|
IEP ISO
|
protein:increased activity:heart CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:18549825 PMID:14525943 |
RGD:1601364 |
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
|
RGD |
PMID:15165989 |
RGD:1581342 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Stat1
|
signal transducer and activator of transcription 1
|
|
IDA
|
protein:increased phosphorylation:heart
|
RGD |
PMID:16935931 |
RGD:1600091 |
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
treatment
|
IDA
|
|
RGD |
PMID:23796350 |
RGD:8694332 |
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Suv39h1
|
SUV39H1 histone lysine methyltransferase
|
treatment
|
IDA
|
associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:24752040 |
RGD:9586740 |
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
|
|
| G
|
Tek
|
TEK receptor tyrosine kinase
|
|
IEP
|
mRNA, protein:increased expression:ventricle myocardium
|
RGD |
PMID:12737621 |
RGD:1601505 |
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
|
|
| G
|
Tfrc
|
transferrin receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:18549825 |
|
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
treatment
|
IEP
|
|
RGD |
PMID:22913380 |
RGD:12903950 |
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Thbs1
|
thrombospondin 1
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:16179730 |
RGD:2317960 |
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Timp4
|
TIMP metallopeptidase inhibitor 4
|
|
IEP
|
protein:increased expression:blood
|
RGD |
PMID:12707244 |
RGD:2290461 |
NCBI chr 4:149,978,667...149,985,350
Ensembl chr 4:149,978,685...149,985,452
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
treatment
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:19274437 PMID:32377693 PMID:32626996 PMID:22402367 |
RGD:2312688, RGD:597621678, RGD:597621676, RGD:597538502 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
IDA IEP
|
protein:increased expression:serum
|
RGD |
PMID:14962484 PMID:32626996 |
RGD:1302746, RGD:597621676 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnc
|
tenascin C
|
|
IEP
|
|
RGD |
PMID:20554738 |
RGD:4889599 |
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:82,391,340...82,476,131
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
IEP
|
protein:increased expression:serum, heart:
|
RGD |
PMID:24157164 PMID:31583047 |
RGD:7387274, RGD:155230831 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
ameliorates
|
ISO
|
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tp53
|
tumor protein p53
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:18317410 |
RGD:2290554 |
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Txn1
|
thioredoxin 1
|
|
IEP
|
mRNA:decreased expression:heart
|
RGD |
PMID:18045550 |
RGD:2306159 |
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Txn2
|
thioredoxin 2
|
|
IEP
|
mRNA, protein:decreased expression:heart
|
RGD |
PMID:18045550 |
RGD:2306159 |
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022
|
|
| G
|
Ucn
|
urocortin
|
|
IDA
|
|
RGD |
PMID:15806110 |
RGD:1642783 |
NCBI chr 6:30,958,086...30,958,916
Ensembl chr 6:30,957,383...30,959,422
|
|
| G
|
Ucp2
|
uncoupling protein 2
|
|
IEP
|
mRNA:increased expression:myocardium
|
RGD |
PMID:19526854 |
RGD:2313528 |
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
|
|
| G
|
Ucp3
|
uncoupling protein 3
|
|
IEP
|
mRNA:increased expression:myocardium
|
RGD |
PMID:19526854 |
RGD:2313528 |
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210
|
|
| G
|
Uts2
|
urotensin 2
|
|
IDA
|
|
RGD |
PMID:17900760 |
RGD:2306836 |
NCBI chr 5:166,725,471...166,739,063
Ensembl chr 5:166,733,671...166,739,059
|
|
| G
|
Uts2r
|
urotensin 2 receptor
|
|
IMP
|
|
RGD |
PMID:17900760 |
RGD:2306836 |
NCBI chr10:106,936,398...106,937,558
Ensembl chr10:106,932,325...106,938,056
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
IEP
|
protein:increased expression:heart
|
RGD |
PMID:23052973 |
RGD:7207792 |
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vcan
|
versican
|
|
IEP
|
mRNA:increased expression:heart
|
RGD |
PMID:16311904 |
RGD:1598497 |
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
| G
|
Vdac1
|
voltage-dependent anion channel 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25488258 |
|
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
|
|
| G
|
Vdr
|
vitamin D receptor
|
|
ISO
|
mRNA,protein:increased expression, activity:heart:
|
RGD |
PMID:25365634 |
RGD:13432076 |
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22050707 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
|
IEP
|
|
RGD |
PMID:3162724 |
RGD:13209131 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
| G
|
Xiap
|
X-linked inhibitor of apoptosis
|
treatment
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:14998631 PMID:20501665 |
RGD:10003160 |
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:125,737,971...125,803,978
|
|
| G
|
Yes1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ISO
|
mRNA,protein:increased expression:myocardium (mouse)
|
RGD |
PMID:30259997 |
RGD:329337366 |
NCBI chr 9:120,646,657...120,753,880
Ensembl chr 9:120,646,838...120,746,441
|
|
|
|
| G
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16317512 |
|
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11927517 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Pln
|
phospholamban
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16317512 |
|
NCBI chr20:33,166,512...33,182,241
Ensembl chr20:33,172,494...33,182,241
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11927517 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
|
| G
|
Cdh5
|
cadherin 5
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16824628 |
|
NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822
|
|
| G
|
Ctnnb1
|
catenin beta 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16824628 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
|
|
| G
|
Jup
|
junction plakoglobin
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16824628 |
|
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,800,814...85,827,429
|
|
|
|
| G
|
F3
|
coagulation factor III, tissue factor
|
treatment
|
IEP
|
|
RGD |
PMID:26370456 |
RGD:11341710 |
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369
|
|
|
|
| G
|
Ccn2
|
cellular communication network factor 2
|
exacerbates
|
IEP
|
protein:increased expression:urine (rat)
|
RGD |
PMID:19921985 |
RGD:150517553 |
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
|
|
| G
|
Cd40lg
|
CD40 ligand
|
treatment
|
ISO
|
|
RGD |
PMID:12244161 |
RGD:7248713 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Gata2
|
GATA binding protein 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28569748 |
|
NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
treatment
|
ISO
|
|
RGD |
PMID:29290803 |
RGD:401827126 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IMP
|
|
RGD |
PMID:22617707 PMID:10666412 |
RGD:8547722, RGD:11520779 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
IDA
|
|
RGD |
PMID:21911153 |
RGD:11049478 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Npy
|
neuropeptide Y
|
|
IEP
|
mRNA, protein:decreased expression:blood, mononuclear cell
|
RGD |
PMID:18981110 |
RGD:10448956 |
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
| G
|
Pf4
|
platelet factor 4
|
ameliorates
|
IDA
|
|
RGD |
PMID:24986443 |
RGD:329901907 |
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392
|
|
| G
|
Selp
|
selectin P
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28569748 |
|
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Senp1
|
SUMO specific peptidase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28569748 |
|
NCBI chr 7:131,042,237...131,105,826
Ensembl chr 7:131,044,818...131,100,851
|
|
| G
|
Tnf
|
tumor necrosis factor
|
treatment
|
IEP
|
liver
|
RGD |
PMID:18972563 |
RGD:15023490 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:28569748 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
protein:increased expression:plasma
|
RGD |
PMID:9415270 |
RGD:8547713 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
|
ISO
|
|
RGD |
PMID:11984590 |
RGD:1581700 |
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
|
|
| G
|
Pnpo
|
pyridoxamine 5'-phosphate oxidase
|
|
ISO
|
ClinVar Annotator: match by term: Pyridoxal phosphate-responsive seizures CTD Direct Evidence: marker/mechanism
|
OMIM ClinVar CTD |
PMID:9536098 PMID:15182361 PMID:15772097 PMID:16199547 PMID:17216302 PMID:17576681 PMID:18296573 PMID:18485777 PMID:19759001 PMID:20370816 PMID:21292558 PMID:22858719 PMID:23419474 PMID:23430561 PMID:23708187 PMID:24266778 PMID:24297574 PMID:24645144 PMID:24658933 PMID:24781210 PMID:25256445 PMID:25741868 PMID:25762494 PMID:25979913 PMID:26077850 PMID:26467025 PMID:27014579 PMID:27419045 PMID:27781031 PMID:28133863 PMID:28349276 PMID:28492532 PMID:28929476 PMID:28985901 PMID:29588952 PMID:29610166 PMID:30398534 PMID:31440721 PMID:32395712 PMID:32788630 PMID:32888189 PMID:33087887 PMID:33981986 PMID:34177756 PMID:34769443 PMID:35217610 PMID:35495162 PMID:35636100 PMID:35715422 PMID:36007526 PMID:36106796 PMID:36801247 More...
|
|
NCBI chr10:82,421,027...82,427,288
Ensembl chr10:82,421,027...82,427,288
|
|
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
treatment
|
IMP
|
|
RGD |
PMID:25330150 |
RGD:13703111 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Lcn2
|
lipocalin 2
|
|
ISO
|
protein:increased expression:urine
|
RGD |
PMID:27800610 |
RGD:126790572 |
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
|
IEP
|
protein:decreased expression:kidney
|
RGD |
PMID:2253787 |
RGD:13209019 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22749977 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Abcc5
|
ATP binding cassette subfamily C member 5
|
|
IEP
|
mRNA, protein:increased expression:brain, neuron
|
RGD |
PMID:16997484 |
RGD:2301088 |
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655
|
|
| G
|
Abcg2
|
ATP binding cassette subfamily G member 2
|
|
IEP
|
mRNA, protein:increased expression, altered localization:small intestine
|
RGD |
PMID:18451542 |
RGD:2315580 |
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
|
|
| G
|
Ace
|
angiotensin I converting enzyme
|
|
IMP
|
|
RGD |
PMID:20436217 |
RGD:2325213 |
NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
|
|
| G
|
Adcyap1
|
adenylate cyclase activating polypeptide 1
|
|
IEP
|
mRNA:increased expression:hippocampal granule cell
|
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 9:120,550,236...120,569,096
Ensembl chr 9:120,550,328...120,556,383
|
|
| G
|
Adcyap1r1
|
ADCYAP receptor type I
|
|
IEP
|
mRNA:decreased expression:dentate gyrus (rat)
|
RGD |
PMID:19647005 |
RGD:2315956 |
NCBI chr 4:85,924,171...85,972,973
Ensembl chr 4:85,924,100...85,972,973
|
|
| G
|
Adgrl1
|
adhesion G protein-coupled receptor L1
|
|
IEP
|
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr19:41,107,162...41,148,752
Ensembl chr19:41,109,117...41,148,896
|
|
| G
|
Adgrl3
|
adhesion G protein-coupled receptor L3
|
|
IEP
|
|
RGD |
PMID:12225880 |
RGD:2314400 |
NCBI chr14:26,690,891...27,458,132
Ensembl chr14:26,722,194...27,280,418
|
|
| G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
|
IMP
|
associated with Non-alcoholic Fatty Liver Disease;
|
RGD |
PMID:18098300 |
RGD:5686804 |
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
| G
|
Adm
|
adrenomedullin
|
|
IEP
|
protein:increased expression:plasma:
|
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
|
IDA ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:27757725 PMID:17937935 |
RGD:4890367 |
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Adora2b
|
adenosine A2B receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:27757725 |
|
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:47,439,701...47,456,091
|
|
| G
|
Adrb1
|
adrenoceptor beta 1
|
|
IMP
|
|
RGD |
PMID:20451506 |
RGD:5129116 |
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
|
|
| G
|
Adrb2
|
adrenoceptor beta 2
|
|
IDA
|
|
RGD |
PMID:14630341 PMID:18336819 |
RGD:1598754, RGD:4145097 |
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:57,911,348...57,914,803
|
|
| G
|
Agt
|
angiotensinogen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23875703 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Agtr2
|
angiotensin II receptor, type 2
|
|
IDA
|
|
RGD |
PMID:22920387 |
RGD:6903870 |
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:116,913,656...116,918,745
|
|
| G
|
Aif1
|
allograft inflammatory factor 1
|
|
IEP
|
protein:increased expression:Kupffer cell (rat)
|
RGD |
PMID:16500929 |
RGD:2313040 |
NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
|
ISO
|
|
RGD |
PMID:21351045 |
RGD:5509067 |
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Akt1s1
|
AKT1 substrate 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16397181 |
|
NCBI chr 1:104,469,823...104,476,168
Ensembl chr 1:104,469,803...104,476,167
|
|
| G
|
Alb
|
albumin
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:20193666 |
RGD:2325686 |
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Aldoa
|
aldolase, fructose-bisphosphate A
|
|
IEP
|
|
RGD |
PMID:10395295 |
RGD:1599061 |
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
|
|
| G
|
Alox12
|
arachidonate 12-lipoxygenase, 12S type
|
|
IEP
|
|
RGD |
PMID:15518705 |
RGD:5509617 |
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199
|
|
| G
|
Alox15
|
arachidonate 15-lipoxygenase
|
|
ISO
|
|
RGD |
PMID:18635843 |
RGD:5509608 |
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
| G
|
Alox5
|
arachidonate 5-lipoxygenase
|
|
IEP ISO IMP
|
protein:increased expression:cerebral hemisphere CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15266012 PMID:14769366 PMID:19816089 |
RGD:1626152, RGD:2317531 |
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
| G
|
Ang
|
angiogenin
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:19666176 |
RGD:2325717 |
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Angpt1
|
angiopoietin 1
|
|
ISO
|
|
RGD |
PMID:19885826 |
RGD:2316041 |
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696
|
|
| G
|
Aoc3
|
amine oxidase, copper containing 3
|
|
IMP
|
|
RGD |
PMID:16339390 |
RGD:2313821 |
NCBI chr10:86,773,018...86,780,961
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
|
IEP
|
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Apex1
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
IEP
|
protein:increased expression:placenta
|
RGD |
PMID:18373555 |
RGD:2315671 |
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:26,618,224...26,620,329
|
|
| G
|
Aqp4
|
aquaporin 4
|
|
IEP ISO
|
protein:increased expression:cerebral cortex mRNA, protein:increased expression:parietal cortex
|
RGD |
PMID:20979759 PMID:21718723 PMID:19806476 PMID:20924629 |
RGD:5148016, RGD:5684013, RGD:5148037, RGD:5148022 |
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Arg1
|
arginase 1
|
|
IEP
|
protein:increased expression:serum (rat)
|
RGD |
PMID:17023552 |
RGD:4143185 |
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
|
|
| G
|
Asl
|
argininosuccinate lyase
|
resistance
|
IEP
|
protein:increased expression:brain, neuron (rat)
|
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261
|
|
| G
|
Ass1
|
argininosuccinate synthase 1
|
resistance
|
IEP
|
protein:increased expression:brain, neuron (rat)
|
RGD |
PMID:17198704 |
RGD:1599263 |
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
|
IEP
|
protein:altered localization:brain, mitochondria
|
RGD |
PMID:18347331 |
RGD:2292679 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bag1
|
BAG cochaperone 1
|
|
IMP
|
|
RGD |
PMID:12215270 |
RGD:2296021 |
NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161
|
|
| G
|
Bag3
|
BAG cochaperone 3
|
|
IEP
|
protein:increased expression:hippocampus, astrocyte
|
RGD |
PMID:12061864 |
RGD:2325848 |
NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:18083315 PMID:18221257 |
RGD:2290557, RGD:2293026 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:15449323 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
|
IEP
|
mRNA:increased expression:retina
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:22306244 |
RGD:6483054 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bid
|
BH3 interacting domain death agonist
|
|
IDA
|
|
RGD |
PMID:19888517 |
RGD:2317562 |
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
| G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
|
IEP IMP
|
protein:increased expression:brain
|
RGD |
PMID:18159002 PMID:18053646 |
RGD:2293126, RGD:2293127 |
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
| G
|
Bmp6
|
bone morphogenetic protein 6
|
|
IEP
|
|
RGD |
PMID:11245809 |
RGD:2289024 |
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
|
|
| G
|
Bmpr2
|
bone morphogenetic protein receptor type 2
|
|
IEP
|
mRNA:increased expression:dentate gyrus, granule cell
|
RGD |
PMID:10996456 |
RGD:5129486 |
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350
|
|
| G
|
Bsg
|
basigin
|
|
IEP
|
protein:increased expression:basal ganglia
|
RGD |
PMID:16029217 |
RGD:2289063 |
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
| G
|
Btg2
|
BTG anti-proliferation factor 2
|
|
IEP
|
mRNA:increased expression:kidney
|
RGD |
PMID:9712737 |
RGD:2289078 |
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
|
|
| G
|
C3
|
complement C3
|
|
IEP
|
protein:increased expression:intestine
|
RGD |
PMID:17981193 |
RGD:5129536 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
C3ar1
|
complement C3a receptor 1
|
|
IMP
|
|
RGD |
PMID:15159277 |
RGD:5129702 |
NCBI chr 4:157,747,419...157,756,609
Ensembl chr 4:157,746,089...157,776,323
|
|
| G
|
C5
|
complement C5
|
|
IDA
|
|
RGD |
PMID:15158333 |
RGD:1600597 |
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
| G
|
C5ar1
|
complement C5a receptor 1
|
|
IMP
|
|
RGD |
PMID:15158333 PMID:15159277 |
RGD:1600597, RGD:5129702 |
NCBI chr 1:86,077,309...86,088,001
|
|
| G
|
Casp1
|
caspase 1
|
|
IMP
|
|
RGD |
PMID:17845807 |
RGD:2315890 |
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
| G
|
Casp12
|
caspase 12
|
|
IEP
|
|
RGD |
PMID:18273070 |
RGD:2311461 |
NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442
|
|
| G
|
Casp3
|
caspase 3
|
treatment
|
IMP IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:23875703 PMID:18490106 PMID:29568770 |
RGD:2293311, RGD:13792595 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp6
|
caspase 6
|
|
IEP
|
protein:increased expression, increased activity:small intestine mucosa
|
RGD |
PMID:15010362 |
RGD:2301320 |
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
| G
|
Casp8
|
caspase 8
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23875703 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
treatment
|
IDA
|
|
RGD |
PMID:29568770 |
RGD:13792595 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cast
|
calpastatin
|
|
IEP
|
|
RGD |
PMID:11035539 |
RGD:5509823 |
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180
|
|
| G
|
Cat
|
catalase
|
|
IDA ISO IEP
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:8215636 PMID:16682413 PMID:23743330 PMID:23875703 PMID:19196076 PMID:20888583 More...
|
RGD:5130760, RGD:5130200 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cav1
|
caveolin 1
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:17293479 |
RGD:2289123 |
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Ccl11
|
C-C motif chemokine ligand 11
|
|
IEP
|
mRNA:increased expression:aorta
|
RGD |
PMID:9665468 |
RGD:4145482 |
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
treatment
|
IDA ISO
|
Gastric Reperfusion Injury CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12468449 PMID:15829914 PMID:22611311 |
RGD:8549744 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl3
|
C-C motif chemokine ligand 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15829914 |
|
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
|
|
| G
|
Ccl5
|
C-C motif chemokine ligand 5
|
|
ISO IEP
|
protein:increased secretion:lung, secretion (mouse) protein:increased expression:gut
|
RGD |
PMID:19558673 PMID:15542513 |
RGD:4891479, RGD:2307184 |
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
| G
|
Ccnb1
|
cyclin B1
|
|
IEP
|
protein;altered expression:cerebral cortex, hippocampus CA1, neuron
|
RGD |
PMID:18278459 |
RGD:2315990 |
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
|
|
| G
|
Ccnd1
|
cyclin D1
|
|
IEP
|
|
RGD |
PMID:16718823 |
RGD:2289145 |
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccne1
|
cyclin E1
|
|
IEP
|
protein:decreased expression:liver
|
RGD |
PMID:17584601 |
RGD:2289275 |
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
|
|
| G
|
Ccng1
|
cyclin G1
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:9698156 |
RGD:2316027 |
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
|
ISO
|
mRNA:increased expression:kidney
|
RGD |
PMID:20410256 |
RGD:5688141 |
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Cd2ap
|
CD2-associated protein
|
|
IEP
|
|
RGD |
PMID:16088078 |
RGD:1581187 |
NCBI chr 9:25,580,071...25,679,968
Ensembl chr 9:25,583,975...25,679,968
|
|
| G
|
Cd36
|
CD36 molecule
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 4:18,209,088...18,302,142
|
|
| G
|
Cd40
|
CD40 molecule
|
|
IMP
|
|
RGD |
PMID:12388354 |
RGD:5508171 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
|
ISO IMP
|
|
RGD |
PMID:20659085 PMID:12388354 |
RGD:5490531, RGD:5508171 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cd44
|
CD44 molecule
|
|
IEP
|
protein:increased expression:kidney protein:increased expression:testis, macrophage
|
RGD |
PMID:16786159 PMID:16891795 |
RGD:2289354, RGD:2289369 |
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
|
|
| G
|
Cd55
|
CD55 molecule (Cromer blood group)
|
|
IEP
|
|
RGD |
PMID:20403613 |
RGD:2326175 |
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107
|
|
| G
|
Cd59b
|
CD59b molecule
|
|
IDA
|
|
RGD |
PMID:10530491 |
RGD:1600493 |
NCBI chr 3:110,914,008...110,932,489
Ensembl chr 3:110,914,091...110,935,310
|
|
| G
|
Cdc42
|
cell division cycle 42
|
|
IDA
|
protein:increased activation:hippocampus CA1
|
RGD |
PMID:17161586 |
RGD:2298583 |
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16968891 PMID:10451498 |
RGD:10043817 |
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
|
IEP
|
protein:increased expression:skeletal muscle
|
RGD |
PMID:15799773 |
RGD:2293627 |
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
| G
|
Cfh
|
complement factor H
|
|
IEP
|
protein:increased expression:plasma:
|
RGD |
PMID:17263982 |
RGD:7364988 |
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
|
|
| G
|
Chat
|
choline O-acetyltransferase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23075401 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416
|
|
| G
|
Cldn4
|
claudin 4
|
|
IEP
|
protein:increased expression, altered localization:small intestine epithelium
|
RGD |
PMID:17375208 |
RGD:2317600 |
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
|
IMP
|
|
RGD |
PMID:19372445 |
RGD:2314674 |
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Cspg4
|
chondroitin sulfate proteoglycan 4
|
|
IEP
|
|
RGD |
PMID:17565360 |
RGD:5686869 |
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:66,160,942...66,200,806
|
|
| G
|
Ctsb
|
cathepsin B
|
|
IEP
|
protein:increased expression:cerebral cortex, mitochondrion (rat)
|
RGD |
PMID:18938146 |
RGD:2315506 |
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
|
|
| G
|
Ctsg
|
cathepsin G
|
|
ISO
|
|
RGD |
PMID:17322378 |
RGD:7242055 |
NCBI chr15:33,901,230...33,907,596
Ensembl chr15:33,901,754...33,907,596
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:19563789 |
RGD:4891956 |
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
|
ISO IEP
|
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16526316 PMID:20160675 PMID:10655268 |
RGD:5134970, RGD:5135270 |
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
| G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
|
IEP ISO
|
mRNA:increased expression:liver protein:increased expression:respiratory system fluid/secretion associated with Anemia, Sickle Cell;protein:increased expression:lung
|
RGD |
PMID:18589091 PMID:16709871 PMID:19433855 |
RGD:2311376, RGD:5135441, RGD:5135307 |
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
IEP
|
protein:increased expression:retina
|
RGD |
PMID:18709383 |
RGD:2306570 |
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
|
IEP ISO
|
mRNA:increased expression:jejunum, lung CTD Direct Evidence: marker/mechanism protein:increased expression:liver mRNA:increased expression:liver
|
CTD RGD |
PMID:12468449 PMID:19691980 PMID:10655268 PMID:11580116 PMID:20160675 |
RGD:5134974, RGD:5135270, RGD:5135251, RGD:5134970 |
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cxcl3
|
C-X-C motif chemokine ligand 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
|
|
| G
|
Cxcl6
|
C-X-C motif chemokine ligand 6
|
|
IEP
|
protein:increased expression:liver
|
RGD |
PMID:11580116 PMID:10655268 |
RGD:5135251, RGD:5135270 |
NCBI chr14:17,594,959...17,596,417
Ensembl chr14:17,594,959...17,596,417
|
|
| G
|
Cxcl9
|
C-X-C motif chemokine ligand 9
|
|
ISO
|
associated with Anemia, Sickle Cell;protein:increased expression:lung
|
RGD |
PMID:19433855 |
RGD:5135307 |
NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
|
|
| G
|
Cxcr3
|
C-X-C motif chemokine receptor 3
|
|
IEP
|
mRNA:increased expression:liver
|
RGD |
PMID:18589091 |
RGD:2311376 |
NCBI chr X:70,884,293...70,886,944
Ensembl chr X:70,883,958...70,886,871
|
|
| G
|
Cyba
|
cytochrome b-245 alpha chain
|
|
IEP
|
|
RGD |
PMID:15148062 |
RGD:1599683 |
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
|
|
| G
|
Cybb
|
cytochrome b-245 beta chain
|
|
IEP ISO
|
Protein:increase expression:brain CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:19193722 PMID:16766636 |
RGD:1599677 |
NCBI chr X:16,030,596...16,065,065
Ensembl chr X:16,030,596...16,065,065
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
|
IEP
|
protein:increased expression:hippocampus (rat)
|
RGD |
PMID:21114983 |
RGD:4890041 |
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
|
IEP
|
protein:decreased expression:liver
|
RGD |
PMID:21094789 |
RGD:4892235 |
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a62
|
cytochrome P450, family 3, subfamily a, polypeptide 62
|
|
EXP
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22749977 |
|
NCBI chr12:21,511,763...21,547,598
Ensembl chr12:21,471,542...21,547,598
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
|
EXP
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:22749977 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Cysltr1
|
cysteinyl leukotriene receptor 1
|
|
IEP
|
protein:increased expression:kidney
|
RGD |
PMID:18790177 |
RGD:4781446 |
NCBI chr X:75,734,281...75,762,873
Ensembl chr X:75,734,270...75,763,050
|
|
| G
|
Cysltr2
|
cysteinyl leukotriene receptor 2
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:21664436 |
RGD:5144004 |
NCBI chr15:54,599,043...54,638,314
Ensembl chr15:54,598,818...54,713,597
|
|
| G
|
Dcc
|
DCC netrin 1 receptor
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:17574219 |
RGD:2314372 |
NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541
|
|
| G
|
Dsg1
|
desmoglein 1
|
|
IEP
|
protein:decreased expression:lung
|
RGD |
PMID:19500802 |
RGD:2316254 |
NCBI chr18:11,948,098...11,980,455
Ensembl chr18:11,949,488...11,980,451
|
|
| G
|
Edn1
|
endothelin 1
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17470888 PMID:18722366 |
RGD:4892577 |
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
|
|
| G
|
Edn2
|
endothelin 2
|
|
IEP
|
|
RGD |
PMID:1479622 |
RGD:1580920 |
NCBI chr 5:139,036,576...139,042,074
Ensembl chr 5:139,036,492...139,043,070
|
|
| G
|
Ednrb
|
endothelin receptor type B
|
|
IEP
|
|
RGD |
PMID:18722366 |
RGD:4892577 |
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
|
|
| G
|
Eef2
|
eukaryotic translation elongation factor 2
|
|
IEP
|
protein:hypophosphorylation:cortex, hippocampus:
|
RGD |
PMID:15211596 |
RGD:10401223 |
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544
|
|
| G
|
Efna5
|
ephrin A5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348
|
|
| G
|
Efnb2
|
ephrin B2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
|
|
| G
|
Egf
|
epidermal growth factor
|
resistance
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16526316 PMID:16417467 |
RGD:6906916 |
NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297
|
|
| G
|
Egr1
|
early growth response 1
|
|
ISO IEP
|
Lung Reperfusion Injury CTD Direct Evidence: marker/mechanism Lung Reperfusion Injury; protein:increased expression:lung, nucleus (rat) Lung Reperfusion Injury; protein:increased expression:lung, nucleus (mouse)
|
CTD RGD |
PMID:12468449 PMID:16551742 PMID:16488723 PMID:19342415 |
RGD:5131903, RGD:5131904, RGD:5131887 |
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
|
|
| G
|
Eif2a
|
eukaryotic translation initiation factor 2A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19041636 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201
|
|
| G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
|
IDA
|
protein:increased phosphorylation:kidney
|
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
|
IDA
|
protein:increased phosphorylation:kidney
|
RGD |
PMID:15936177 |
RGD:1581062 |
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Eno2
|
enolase 2
|
|
IDA
|
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:159,258,371...159,267,220
|
|
| G
|
Ep300
|
E1A binding protein p300
|
treatment
|
IDA IEP
|
retina retina; protein:altered localization:Hsp70, promoter (rat)
|
RGD |
PMID:22143029 PMID:22143029 |
RGD:5686888, RGD:5686888 |
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Epha2
|
Eph receptor A2
|
|
IDA
|
|
RGD |
PMID:16735461 |
RGD:1580976 |
NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
|
|
| G
|
Ephx2
|
epoxide hydrolase 2
|
|
ISO
|
|
RGD |
PMID:19471280 |
RGD:5688359 |
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
|
|
| G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
|
IMP
|
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
|
|
| G
|
Ets1
|
ETS proto-oncogene 1, transcription factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021
|
|
| G
|
F2
|
coagulation factor II, thrombin
|
|
IMP
|
|
RGD |
PMID:20705928 |
RGD:5147777 |
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
IDA
|
|
RGD |
PMID:29568770 |
RGD:13792595 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fgf1
|
fibroblast growth factor 1
|
|
IDA ISO
|
Rat model using human FGF1
|
RGD |
PMID:19497570 PMID:16635575 |
RGD:5509879, RGD:5509881 |
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fgf7
|
fibroblast growth factor 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
|
IEP ISO
|
protein:increased expression:brain CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:7922267 PMID:15121240 |
RGD:2293779 |
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:15306117 |
RGD:1642465 |
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Fosl2
|
FOS like 2, AP-1 transcription factor subunit
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:15121240 |
RGD:2293779 |
NCBI chr 6:30,017,952...30,039,269
Ensembl chr 6:30,021,916...30,039,406
|
|
| G
|
Gast
|
gastrin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10594344 |
|
NCBI chr10:85,765,216...85,767,881
Ensembl chr10:85,765,216...85,767,880
|
|
| G
|
Gh1
|
growth hormone 1
|
treatment
|
ISO
|
|
RGD |
PMID:21439711 |
RGD:10003153 |
NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859
|
|
| G
|
Ghrl
|
ghrelin and obestatin prepropeptide
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:16581065 |
|
NCBI chr 4:148,421,315...148,431,128
Ensembl chr 4:148,421,315...148,425,969
|
|
| G
|
Gjb1
|
gap junction protein, beta 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25530438 |
|
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
|
|
| G
|
Glud1
|
glutamate dehydrogenase 1
|
|
IEP
|
protein:decreased activity:brain
|
RGD |
PMID:7808037 |
RGD:6484655 |
NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210
|
|
| G
|
Gnai2
|
G protein subunit alpha i2
|
|
IEP
|
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:117,167,045...117,187,622
|
|
| G
|
Gnai3
|
G protein subunit alpha i3
|
|
IEP
|
|
RGD |
PMID:11367746 |
RGD:13513922 |
NCBI chr 2:198,430,920...198,468,874
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:8215636 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gpx1
|
glutathione peroxidase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23743330 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
| G
|
Gria1
|
glutamate ionotropic receptor AMPA type subunit 1
|
|
IEP
|
mRNA:decreased expression:hippocampus (rat)
|
RGD |
PMID:20408958 |
RGD:4107069 |
NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309
|
|
| G
|
Grik2
|
glutamate ionotropic receptor kainate type subunit 2
|
|
IMP
|
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr20:53,717,564...54,415,283
Ensembl chr20:53,716,090...54,415,202
|
|
| G
|
Grik5
|
glutamate ionotropic receptor kainate type subunit 5
|
|
IMP
|
|
RGD |
PMID:17639597 |
RGD:2316528 |
NCBI chr 1:89,733,736...89,795,769
Ensembl chr 1:89,733,741...89,794,962
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
|
IEP
|
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
|
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
|
IEP
|
mRNA, protein:decreased expression:cerebral cortex, hippocampus (rat)
|
RGD |
PMID:20350575 |
RGD:2325867 |
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
treatment
|
IEP
|
associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:24904723 |
RGD:10401882 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Gstp1
|
glutathione S-transferase pi 1
|
|
ISO
|
|
RGD |
PMID:17142801 |
RGD:6903953 |
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
| G
|
Hbegf
|
heparin-binding EGF-like growth factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7635938 |
|
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IDA
|
Spinal Cord Reperfusion Injury Limb Reperfusion Injury
|
RGD |
PMID:16465055 PMID:23816242 |
RGD:9068924, RGD:9068927 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
treatment
|
IMP
|
|
RGD |
PMID:22392147 |
RGD:10402071 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
IMP ISO
|
associated with Diabetes Mellitus, Experimental
|
RGD |
PMID:21724106 PMID:16009498 PMID:18398369 |
RGD:5508445, RGD:5508473, RGD:2315888 |
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IDA ISO IEP IMP
|
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum, Bronchoalveolar Lavage Fluid
|
CTD RGD |
PMID:12352873 PMID:16982915 PMID:17660127 PMID:23075401 PMID:25780291 PMID:16699460 PMID:19885035 PMID:12919086 More...
|
RGD:1582708, RGD:4145338, RGD:4145514 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hrh3
|
histamine receptor H3
|
|
IDA
|
|
RGD |
PMID:17169356 |
RGD:1626416 |
NCBI chr 3:187,569,174...187,575,263
Ensembl chr 3:187,569,175...187,574,259
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7922267 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa1b
|
heat shock protein family A (Hsp70) member 1B
|
|
ISO IEP
|
|
RGD |
PMID:10965299 PMID:10550516 |
RGD:7242748, RGD:7242749 |
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
|
IMP
|
associated with Diabetes Mellitus, experimental (D003921): protein:increased expression:brain
|
RGD |
PMID:22075494 |
RGD:5685650 |
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:10216529 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:19193722 |
|
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11557319 PMID:23743330 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Id3
|
inhibitor of DNA binding 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856
|
|
| G
|
Ifng
|
interferon gamma
|
|
IEP
|
protein:increased expression:plasma
|
RGD |
PMID:19514843 |
RGD:2308950 |
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
|
ISO
|
|
RGD |
PMID:16306169 |
RGD:1598442 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Il10
|
interleukin 10
|
|
IEP ISO IDA
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:18460982 PMID:19514843 PMID:12388354 PMID:16141682 |
RGD:2308950, RGD:5508171, RGD:1598625 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il12a
|
interleukin 12A
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:155,275,625...155,282,997
|
|
| G
|
Il13
|
interleukin 13
|
|
IEP ISO
|
protein:decreased expression:plasma
|
RGD |
PMID:18354382 PMID:18354382 |
RGD:2301685, RGD:2301685 |
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483
|
|
| G
|
Il18
|
interleukin 18
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:19394645 PMID:16052682 |
RGD:4889555, RGD:4889825 |
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23875703 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10594344 PMID:12468449 PMID:15829914 PMID:19058328 PMID:19673871 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism protein:increased expression:lung
|
CTD RGD |
PMID:15829914 PMID:17032661 PMID:18258783 PMID:19673871 PMID:21940958 PMID:20680426 PMID:20659747 More...
|
RGD:4143250, RGD:4143253 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Il6r
|
interleukin 6 receptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:177,582,164...177,645,221
|
|
| G
|
Il6st
|
interleukin 6 cytokine family signal transducer
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182
|
|
| G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:25780291 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
| G
|
Irak3
|
interleukin-1 receptor-associated kinase 3
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:25780291 |
|
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706
|
|
| G
|
Irf1
|
interferon regulatory factor 1
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
|
|
| G
|
Itga2b
|
integrin subunit alpha 2b
|
|
IMP
|
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,908,697...87,925,833
|
|
| G
|
Itga5
|
integrin subunit alpha 5
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
|
IMP
|
|
RGD |
PMID:11705748 |
RGD:2316361 |
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Jak2
|
Janus kinase 2
|
|
ISO
|
|
RGD |
PMID:20440769 |
RGD:6483026 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:7922267 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
| G
|
Kcnj8
|
potassium inwardly-rectifying channel, subfamily J, member 8
|
|
IDA
|
|
RGD |
PMID:10708603 |
RGD:1581697 |
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
|
|
| G
|
Kdr
|
kinase insert domain receptor
|
|
IEP ISO
|
mRNA:increased expression:hippocampus CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:16526316 PMID:17402857 |
RGD:5684415 |
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
|
ISO IEP
|
protein:decreased expression:brain, neuron, cytoplasm (mouse) protein:decreased expression:left coronary artery (rat)
|
RGD |
PMID:21075092 PMID:18078953 |
RGD:6893270, RGD:6902919 |
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Klk1
|
kallikrein 1
|
|
IEP
|
|
RGD |
PMID:12746231 |
RGD:1641806 |
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
|
IEP
|
|
RGD |
PMID:17288738 |
RGD:2324630 |
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lep
|
leptin
|
|
IDA
|
|
RGD |
PMID:21086559 |
RGD:5128549 |
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Manf
|
mesencephalic astrocyte-derived neurotrophic factor
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:19773801 |
RGD:2325809 |
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
|
IEP
|
protein:increased expression:serum
|
RGD |
PMID:21948028 |
RGD:6483082 |
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Mapk8
|
mitogen-activated protein kinase 8
|
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20302854 PMID:16699462 |
RGD:1582310 |
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
| G
|
Mapk8ip3
|
mitogen-activated protein kinase 8 interacting protein 3
|
|
IDA
|
protein:increased activity:hippocampus
|
RGD |
PMID:16805806 |
RGD:2293339 |
NCBI chr10:14,422,936...14,463,387
Ensembl chr10:14,422,936...14,462,812
|
|
| G
|
Mapk9
|
mitogen-activated protein kinase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:19667931 PMID:20302854 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
| G
|
Mb
|
myoglobin
|
|
ISO
|
|
RGD |
PMID:12788661 |
RGD:1582427 |
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:110,640,512...110,647,958
|
|
| G
|
Mbl1
|
mannose binding lectin 1
|
|
ISO
|
protein:decreased expression:serum
|
RGD |
PMID:16982912 PMID:15509537 |
RGD:1582132, RGD:6903263 |
NCBI chr16:17,063,232...17,069,271
Ensembl chr16:17,060,703...17,069,271
|
|
| G
|
Mbl2
|
mannose binding lectin 2
|
|
ISO
|
protein:increased expression:serum
|
RGD |
PMID:15882434 PMID:15509537 |
RGD:6903262, RGD:6903263 |
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
|
|
| G
|
Mc1r
|
melanocortin 1 receptor
|
no_association
|
ISO
|
|
RGD |
PMID:18757499 |
RGD:5687323 |
NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877
|
|
| G
|
Mdk
|
midkine
|
|
ISO
|
|
RGD |
PMID:15780085 |
RGD:1582475 |
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
|
|
| G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
|
IEP
|
mRNA:increased expression:retina (rat)
|
RGD |
PMID:17113948 |
RGD:2317505 |
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
| G
|
Mif
|
macrophage migration inhibitory factor
|
disease_progression
|
ISO
|
|
RGD |
PMID:18055556 |
RGD:4891010 |
NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121 Ensembl chr20:134,041,774...134,042,121
|
|
| G
|
Mir148b
|
microRNA 148b
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:30308185 |
|
NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:136,299,870...136,299,966
|
|
| G
|
Mmp3
|
matrix metallopeptidase 3
|
|
IEP
|
protein:increased protein, activity:brain
|
RGD |
PMID:15099024 |
RGD:2325962 |
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO IMP
|
CTD Direct Evidence: marker/mechanism associated with lung injury; mRNA, protein:increased expression:lung protein:increased expression:limb muscle (mouse)
|
CTD RGD |
PMID:23075401 PMID:16551680 PMID:19545667 PMID:16251419 |
RGD:1582618, RGD:5129531, RGD:1582631 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpo
|
myeloperoxidase
|
|
IEP ISO
|
protein:increased activity:lung CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:8869312 PMID:10706834 PMID:12024109 PMID:16971220 PMID:19058328 PMID:20863214 PMID:21470877 More...
|
RGD:5130958 |
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Mt-atp6
|
mitochondrially encoded ATP synthase membrane subunit 6
|
|
IEP
|
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,904...8,584
|
|
| G
|
Mt-atp8
|
mitochondrially encoded ATP synthase membrane subunit 8
|
|
IEP
|
|
RGD |
PMID:20450733 |
RGD:5490294 |
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,743...7,946
|
|
| G
|
Mt-cyb
|
mitochondrially encoded cytochrome b
|
|
IEP
|
mRNA:decreased expression:kidney
|
RGD |
PMID:7692737 |
RGD:2298967 |
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,124...15,266
|
|
| G
|
Mt2
|
metallothionein 2
|
|
ISO
|
mRNA:increased expression:cerebrum (mouse)
|
RGD |
PMID:12122050 |
RGD:6483850 |
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mt3
|
metallothionein 3
|
|
ISO
|
|
RGD |
PMID:19635467 |
RGD:6480529 |
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Muc1
|
mucin 1, cell surface associated
|
|
IEP
|
|
RGD |
PMID:23977093 |
RGD:7349380 |
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:176,933,047...176,938,491
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25780291 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Nes
|
nestin
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:17569338 |
RGD:1642074 |
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
|
IEP
|
protein:increased expression:small intestine
|
RGD |
PMID:20107953 |
RGD:5131440 |
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
|
IMP
|
|
RGD |
PMID:17451676 |
RGD:1642142 |
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
|
IEP ISO
|
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism protein:increased expression:venule, arteriole, endothelium (mouse) mRNA, protein:increased expression:liver
|
CTD RGD |
PMID:10383581 PMID:19673871 PMID:23061969 PMID:23075401 PMID:11592783 PMID:22019501 PMID:14599979 More...
|
RGD:2325259, RGD:5509100, RGD:1580938 |
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21968084 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Nox4
|
NADPH oxidase 4
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:18438942 |
RGD:2324666 |
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
|
|
| G
|
Oga
|
O-GlcNAcase
|
|
IMP
|
|
RGD |
PMID:16899550 |
RGD:2305957 |
NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:254,547,311...254,582,855
|
|
| G
|
Oprm1
|
opioid receptor, mu 1
|
|
IEP
|
mRNA, protein:decreased expression:hippocampus
|
RGD |
PMID:17360495 |
RGD:2316611 |
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:45,565,371...45,638,756
|
|
| G
|
Otc
|
ornithine transcarbamylase
|
|
IEP
|
protein:increased activity:serum
|
RGD |
PMID:1499453 |
RGD:4144083 |
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
|
|
| G
|
Oxt
|
oxytocin/neurophysin I prepropeptide
|
|
IMP
|
|
RGD |
PMID:18403049 |
RGD:2304111 |
NCBI chr 3:138,235,754...138,236,594
Ensembl chr 3:138,235,754...138,236,594
|
|
| G
|
P2rx7
|
purinergic receptor P2X 7
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26070527 |
|
NCBI chr12:39,550,531...39,594,984
Ensembl chr12:39,540,567...39,595,193
|
|
| G
|
P2ry2
|
purinergic receptor P2Y2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:26070527 |
|
NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
|
ISO IEP
|
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (rat)
|
CTD RGD |
PMID:15696051 PMID:16798486 PMID:9390645 PMID:21850691 |
RGD:5510018, RGD:5510020 |
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2
|
|
IEP ISO
|
|
RGD |
PMID:19142196 PMID:19142196 |
RGD:6483555, RGD:6483555 |
NCBI chr 3:151,333,938...151,636,628
Ensembl chr 3:151,333,234...151,638,849
|
|
| G
|
Pde5a
|
phosphodiesterase 5A
|
|
IMP
|
|
RGD |
PMID:19474186 |
RGD:2314462 |
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:213,542,923...213,684,298
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
IMP IEP ISO
|
protein:decreased expression:lung (rat) protein:increased expression:brain (mouse)
|
RGD |
PMID:12121711 PMID:21872880 PMID:22382321 |
RGD:2311660, RGD:6771206, RGD:6766379 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1
|
|
IEP
|
proetin:decreased dimerization:skeletal muscle (rat)
|
RGD |
PMID:19100383 |
RGD:4108481 |
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
|
|
| G
|
Pink1
|
PTEN induced kinase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:35312153 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
| G
|
Pklr
|
pyruvate kinase L/R
|
|
IEP
|
|
RGD |
PMID:17013507 |
RGD:1625588 |
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
|
|
| G
|
Pla2g2a
|
phospholipase A2 group IIA
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12967936 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:156,359,725...156,362,297
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
|
IDA
|
protein:increased activity:alveolar macrophage
|
RGD |
PMID:1642455 |
RGD:1642456 |
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
IDA ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:9472885 PMID:15223382 |
RGD:2311674 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
IEP ISO
|
protein:increased expression:spinal cord (rat) CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:15181847 PMID:19663807 PMID:18586014 |
RGD:6483808, RGD:6483830 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plaur
|
plasminogen activator, urokinase receptor
|
|
ISO
|
|
RGD |
PMID:18606671 |
RGD:6483829 |
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130
|
|
| G
|
Pld2
|
phospholipase D2
|
|
IEP
|
protein:increased expression:hippocampus CA1, hippocampus granule cell layer mRNA:decreased expression:brainstem, cerebellum
|
RGD |
PMID:17393174 PMID:17024567 |
RGD:2299901, RGD:2299902 |
NCBI chr10:55,754,957...55,772,819
Ensembl chr10:55,754,988...55,771,435
|
|
| G
|
Pnmt
|
phenylethanolamine-N-methyltransferase
|
|
ISO
|
protein:increased expression:medulla oblongata (human)
|
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr10:83,881,211...83,882,849
Ensembl chr10:83,881,185...83,882,849
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
|
IDA ISO
|
liver ischemia/reperfusion injury CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:19151258 PMID:21305343 |
RGD:5509942 |
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:12468449 PMID:24011919 PMID:24433871 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppp3ca
|
protein phosphatase 3 catalytic subunit alpha
|
|
IDA
|
|
RGD |
PMID:14762344 |
RGD:1580702 |
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
|
|
| G
|
Ppp3cb
|
protein phosphatase 3 catalytic subunit beta
|
|
ISO
|
|
RGD |
PMID:14615291 |
RGD:1580705 |
NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,809,262...3,854,203
|
|
| G
|
Prdx6
|
peroxiredoxin 6
|
|
ISO
|
|
RGD |
PMID:16766642 |
RGD:1580710 |
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:76,061,554...76,072,657
|
|
| G
|
Prkca
|
protein kinase C, alpha
|
|
IMP
|
|
RGD |
PMID:17905752 |
RGD:2292474 |
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572
|
|
| G
|
Prss1
|
serine protease 1
|
|
IEP
|
|
RGD |
PMID:11062314 |
RGD:1599961 |
NCBI chr 4:71,331,249...71,334,452
Ensembl chr 4:71,331,246...71,334,452
|
|
| G
|
Ptafr
|
platelet-activating factor receptor
|
treatment
|
ISO IMP
|
|
RGD |
PMID:12812996 PMID:11139461 |
RGD:1581279, RGD:10043168 |
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
|
IMP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:19038262 PMID:17239858 |
RGD:2292538 |
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptges
|
prostaglandin E synthase
|
|
IEP ISO
|
|
RGD |
PMID:12431630 PMID:16864802 |
RGD:2300116, RGD:2300094 |
NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995
|
|
| G
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10594344 PMID:16385084 |
RGD:5688223 |
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
|
IEP ISO IMP IDA
|
protein:decreased expression:kidney CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:10588920 PMID:10594344 PMID:11567657 PMID:16386242 PMID:18258783 PMID:19673871 PMID:21394482 PMID:21944479 PMID:16247333 More...
|
RGD:5135045, RGD:5508180, RGD:1580660 |
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Ptk2
|
protein tyrosine kinase 2
|
|
IEP
|
protein:increased tyrosine phosphorylation:kidney
|
RGD |
PMID:17620366 |
RGD:2292577 |
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
| G
|
Ptk2b
|
protein tyrosine kinase 2 beta
|
|
IDA
|
protein:increased phosphorylation:hippocampus
|
RGD |
PMID:15970382 |
RGD:1642621 |
NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
|
IEP ISO
|
protein:increased expression:nucleus, liver CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:20302854 PMID:23743330 PMID:18621400 |
RGD:2298777 |
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
|
IEP
|
|
RGD |
PMID:18840784 |
RGD:5508834 |
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
S1pr1
|
sphingosine-1-phosphate receptor 1
|
|
ISO
|
|
RGD |
PMID:16403835 |
RGD:1580913 |
NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:205,900,836...206,328,689
|
|
| G
|
Scfd1
|
sec1 family domain containing 1
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:9195952 |
RGD:633771 |
NCBI chr 6:74,531,225...74,609,463
Ensembl chr 6:74,531,276...74,633,750
|
|
| G
|
Sele
|
selectin E
|
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:17112405 PMID:23743330 PMID:19489247 |
RGD:2313598 |
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:78,936,036...78,945,903
|
|
| G
|
Sell
|
selectin L
|
|
IEP
|
|
RGD |
PMID:19489247 |
RGD:2313598 |
NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600
|
|
| G
|
Selp
|
selectin P
|
|
IEP ISO
|
|
RGD |
PMID:18521901 PMID:21701413 |
RGD:2312314, RGD:6218990 |
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
| G
|
Serpine2
|
serpin family E member 2
|
|
IEP
|
|
RGD |
PMID:8261109 |
RGD:2317936 |
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
|
|
| G
|
Serping1
|
serpin family G member 1
|
treatment
|
ISO
|
|
RGD |
PMID:23991040 |
RGD:8661644 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
| G
|
Sftpc
|
surfactant protein C
|
|
IDA
|
mRNA:decreased expression:lung
|
RGD |
PMID:20560845 |
RGD:4144062 |
NCBI chr15:52,006,274...52,009,324
Ensembl chr15:52,006,283...52,009,475
|
|
| G
|
Si
|
sucrase-isomaltase
|
|
IEP
|
|
RGD |
PMID:9724271 |
RGD:1625550 |
NCBI chr 2:159,804,568...159,884,902
Ensembl chr 2:159,804,568...159,883,934
|
|
| G
|
Sigmar1
|
sigma non-opioid intracellular receptor 1
|
ameliorates
|
IDA
|
associated with retinal ischemia;
|
RGD |
PMID:16580663 |
RGD:617212662 |
NCBI chr 5:61,700,021...61,702,799
Ensembl chr 5:61,700,021...61,702,855
|
|
| G
|
Sirt7
|
sirtuin 7
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:28675767 |
|
NCBI chr10:106,394,802...106,401,627
Ensembl chr10:106,394,802...106,401,498
|
|
| G
|
Slc2a1
|
solute carrier family 2 member 1
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
|
|
| G
|
Slc2a3
|
solute carrier family 2 member 3
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:19781384 |
RGD:2313601 |
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
|
|
| G
|
Slc30a4
|
solute carrier family 30 member 4
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:18289514 |
RGD:2299950 |
NCBI chr 3:130,206,852...130,228,888
Ensembl chr 3:130,206,852...130,228,888
|
|
| G
|
Slc34a1
|
solute carrier family 34 member 1
|
|
IEP
|
protein:decreased expression:renal proximal tubule
|
RGD |
PMID:15775707 |
RGD:2311304 |
NCBI chr17:9,224,010...9,238,983
Ensembl chr17:9,224,010...9,238,983
|
|
| G
|
Slc6a11
|
solute carrier family 6 member 11
|
|
IEP
|
|
RGD |
PMID:13678673 |
RGD:1299345 |
NCBI chr 4:148,853,557...148,968,895
Ensembl chr 4:148,853,554...148,969,019
|
|
| G
|
Slc8a1
|
solute carrier family 8 member A1
|
|
IEP
|
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:18,975,498...19,299,704
Ensembl chr 6:18,946,798...19,287,964
|
|
| G
|
Slc8a2
|
solute carrier family 8 member A2
|
|
IEP
|
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 1:85,944,752...85,982,900
Ensembl chr 1:85,947,204...85,981,889
|
|
| G
|
Slc8a3
|
solute carrier family 8 member A3
|
|
IEP
|
|
RGD |
PMID:18037393 |
RGD:2316975 |
NCBI chr 6:106,605,611...106,739,208
Ensembl chr 6:106,605,621...106,721,412
|
|
| G
|
Slc9a1
|
solute carrier family 9 member A1
|
|
IMP ISO
|
CTD Direct Evidence: therapeutic
|
CTD RGD |
PMID:19027022 PMID:20337040 |
RGD:6771332 |
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
|
|
| G
|
Slco1b2
|
solute carrier organic anion transporter family member 1B2
|
|
IEP
|
mRNA:decreased expression:liver
|
RGD |
PMID:16858290 |
RGD:2303111 |
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
|
|
| G
|
Slk
|
STE20-like kinase
|
|
IEP
|
protein:increased expression:kidney
|
RGD |
PMID:12965890 |
RGD:2304069 |
NCBI chr 1:256,415,013...256,470,942
Ensembl chr 1:256,415,013...256,467,829
|
|
| G
|
Slpi
|
secretory leukocyte peptidase inhibitor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:8215636 |
|
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
|
|
| G
|
Socs1
|
suppressor of cytokine signaling 1
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:25780291 |
|
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
|
|
| G
|
Socs3
|
suppressor of cytokine signaling 3
|
|
IDA
|
associated with Brain Ischemia;mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
|
|
| G
|
Socs4
|
suppressor of cytokine signaling 4
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr15:23,003,130...23,017,615
Ensembl chr15:23,002,883...23,022,499
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:15364863 PMID:16397181 PMID:23061969 PMID:23743330 PMID:15364863 |
RGD:1580834 |
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
|
IEP ISO
|
protein:increased expression:liver CTD Direct Evidence: marker/mechanism|therapeutic
|
CTD RGD |
PMID:8215636 PMID:16682413 PMID:19193722 PMID:19917352 PMID:21940958 PMID:23743330 PMID:15612529 PMID:15087276 More...
|
RGD:1582141, RGD:1581259 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Sod3
|
superoxide dismutase 3
|
|
ISO
|
|
RGD |
PMID:15778274 |
RGD:1581264 |
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
|
ISO
|
|
RGD |
PMID:20548025 |
RGD:6903275 |
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
IEP
|
protein:increased phosphorylation:hippocampus CA1 (rat)
|
RGD |
PMID:20197063 |
RGD:2325012 |
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
| G
|
Stat1
|
signal transducer and activator of transcription 1
|
|
IDA IEP
|
protein:increased serine phosphorylation:brain protein:increased phosphorylation:kidney
|
RGD |
PMID:15262323 PMID:17670769 |
RGD:1600103, RGD:2291900 |
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
| G
|
Stat2
|
signal transducer and activator of transcription 2
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:1,287,024...1,303,459
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:21940958 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Stat5a
|
signal transducer and activator of transcription 5A
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184
|
|
| G
|
Stat5b
|
signal transducer and activator of transcription 5B
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990
|
|
| G
|
Stat6
|
signal transducer and activator of transcription 6
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17880360 |
RGD:2303397 |
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:65,365,306...65,383,795
|
|
| G
|
Stc1
|
stanniocalcin 1
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082
|
|
| G
|
Stc2
|
stanniocalcin 2
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:15485913 |
RGD:2324700 |
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
|
|
| G
|
Sult1e1
|
sulfotransferase family 1E member 1
|
|
IEP ISO
|
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25922074 PMID:16908442 |
RGD:2302564 |
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,700,292...20,718,716
|
|
| G
|
Tbxas1
|
thromboxane A synthase 1
|
|
IDA
|
associated with Cholestasis, Extrahepatic
|
RGD |
PMID:15000260 PMID:8680115 |
RGD:1601451, RGD:1601475 |
NCBI chr 4:68,631,841...68,803,959
Ensembl chr 4:68,631,838...68,803,969
|
|
| G
|
Tert
|
telomerase reverse transcriptase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16968891 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
|
|
| G
|
Tfam
|
transcription factor A, mitochondrial
|
|
IDA
|
|
RGD |
PMID:22266265 |
RGD:6767573 |
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
|
|
| G
|
Tgfbr2
|
transforming growth factor, beta receptor 2
|
|
IEP
|
|
RGD |
PMID:15613744 |
RGD:1579926 |
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
|
|
| G
|
Th
|
tyrosine hydroxylase
|
|
ISO
|
protein:increased expression:medulla oblongata (human)
|
RGD |
PMID:21061149 |
RGD:5128821 |
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:207,500,962...207,557,227
|
|
| G
|
Thbd
|
thrombomodulin
|
|
ISO
|
|
RGD |
PMID:19342415 |
RGD:5131887 |
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
|
|
| G
|
Thbs1
|
thrombospondin 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:125,510,250...125,525,402
|
|
| G
|
Thy1
|
Thy-1 cell surface antigen
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23075401 |
|
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
| G
|
Ticam1
|
TIR domain containing adaptor molecule 1
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:25780291 |
|
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892
|
|
| G
|
Timp3
|
TIMP metallopeptidase inhibitor 3
|
|
IEP
|
protein:decreased expression:brain
|
RGD |
PMID:17551674 |
RGD:2290424 |
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:19,409,631...19,459,547
|
|
| G
|
Tjp1
|
tight junction protein 1
|
|
IEP
|
protein:decreased expression:brain, endothelial cell
|
RGD |
PMID:19374856 PMID:19929946 |
RGD:2325135, RGD:2325127 |
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
|
|
| G
|
Tlr2
|
toll-like receptor 2
|
|
IEP ISO
|
mRNA, protein:increased expression:kidney CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25780291 PMID:15912106 |
RGD:2312727 |
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
| G
|
Tlr3
|
toll-like receptor 3
|
|
IEP
|
protein:increased expression:liver (rat)
|
RGD |
PMID:21355876 |
RGD:5128693 |
NCBI chr16:53,554,916...53,572,321
Ensembl chr16:53,555,131...53,568,385
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
IEP ISO
|
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:25780291 PMID:27064547 PMID:19473433 PMID:17126102 |
RGD:2312503, RGD:4144169 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6
|
|
IEP
|
protein:increased expression:liver
|
RGD |
PMID:18005084 |
RGD:2291961 |
NCBI chr 7:132,405,217...132,422,492
Ensembl chr 7:132,386,134...132,422,492
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:10706834 PMID:12024109 PMID:15829914 PMID:16971220 PMID:17112405 PMID:18460982 PMID:19058328 PMID:23743330 PMID:23875703 PMID:24898700 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
|
IEP
|
|
RGD |
PMID:17109621 |
RGD:1624182 |
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
| G
|
Tp53
|
tumor protein p53
|
|
IEP
|
protein:increased expression:brain, mitochondrion
|
RGD |
PMID:17661174 |
RGD:2290568 |
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
treatment
|
IDA
|
|
RGD |
PMID:20554625 |
RGD:4891135 |
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304
|
|
| G
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
IEP
|
mRNA,protein:increased expression:hippocampus
|
RGD |
PMID:18395621 |
RGD:5684390 |
NCBI chr 3:134,499,617...134,588,113
Ensembl chr 3:134,499,617...134,588,113
|
|
| G
|
Txn1
|
thioredoxin 1
|
|
IEP
|
mRNA:decreased expression:cerebral cortex
|
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
|
|
| G
|
Txn2
|
thioredoxin 2
|
|
IEP
|
mRNA:decreased expression:cerebral cortex
|
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022
|
|
| G
|
Txnrd1
|
thioredoxin reductase 1
|
|
IEP
|
mRNA:decreased expression:cerebral cortex mRNA:decreased expression:spinal cord
|
RGD |
PMID:19128823 PMID:19409971 |
RGD:5685030, RGD:5685028 |
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
|
|
| G
|
Txnrd2
|
thioredoxin reductase 2
|
|
IEP
|
mRNA:decreased expression:cerebral cortex
|
RGD |
PMID:19128823 |
RGD:5685030 |
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:96,024,324...96,072,475
|
|
| G
|
Vcam1
|
vascular cell adhesion molecule 1
|
|
IEP
|
mRNA:increased expression:kidney
|
RGD |
PMID:18813897 |
RGD:2313108 |
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
| G
|
Vegfc
|
vascular endothelial growth factor C
|
|
IEP
|
|
RGD |
PMID:18704465 |
RGD:2315487 |
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
|
|
| G
|
Vegfd
|
vascular endothelial growth factor D
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:16526316 |
|
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:33,706,055...33,740,167
|
|
| G
|
Vim
|
vimentin
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23075401 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:81,568,272...81,585,746
|
|
| G
|
Vip
|
vasoactive intestinal peptide
|
|
ISO
|
|
RGD |
PMID:21693218 |
RGD:5685379 |
NCBI chr 1:44,470,232...44,478,561
Ensembl chr 1:44,470,462...44,478,558
|
|
| G
|
Wnt3a
|
Wnt family member 3A
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23875703 |
|
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,533,734...44,577,919
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IDA ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:12910483 PMID:23403765 |
RGD:7247700 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
| G
|
Zfp354a
|
zinc finger protein 354A
|
|
IEP
|
mRNA:decreased expression:kidney
|
RGD |
PMID:8382778 |
RGD:1300202 |
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,897,228...35,909,510
|
|
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
treatment
|
IDA
|
|
RGD |
PMID:22143029 |
RGD:5686888 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
treatment
|
IDA
|
|
RGD |
PMID:23056591 |
RGD:10053711 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:23056591 |
RGD:10053711 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IDA
|
|
RGD |
PMID:25535961 |
RGD:11522737 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l1
|
Bcl2-like 1
|
treatment
|
IEP
|
|
RGD |
PMID:23056591 |
RGD:10053711 |
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
|
ISO
|
|
RGD |
PMID:10549664 |
RGD:8655861 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Casp7
|
caspase 7
|
|
IEP
|
|
RGD |
PMID:20702827 |
RGD:5684535 |
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Cat
|
catalase
|
treatment
|
IEP
|
protein:decreased expression,decreased activity:retina:
|
RGD |
PMID:22509733 |
RGD:9068919 |
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
treatment
|
IDA
|
|
RGD |
PMID:24325836 |
RGD:11526144 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Clu
|
clusterin
|
|
IEP
|
|
RGD |
PMID:15139011 |
RGD:1581194 |
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
|
|
| G
|
Cntf
|
ciliary neurotrophic factor
|
treatment
|
IDA
|
|
RGD |
PMID:8125754 |
RGD:8655591 |
NCBI chr 1:219,312,512...219,314,535
Ensembl chr 1:219,312,512...219,314,488
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
treatment
|
IMP
|
|
RGD |
PMID:21094639 |
RGD:7495849 |
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Fgf2
|
fibroblast growth factor 2
|
treatment
|
IEP ISO
|
|
RGD |
PMID:9561364 PMID:8125754 PMID:14975212 |
RGD:8554857, RGD:8655591, RGD:8655585 |
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
| G
|
Fxn
|
frataxin
|
ameliorates
|
ISO
|
|
RGD |
PMID:27537261 PMID:27537261 |
RGD:401793704, RGD:401793704 |
NCBI chr 1:231,300,457...231,323,989
Ensembl chr 1:231,300,150...231,323,989
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
treatment
|
IEP
|
|
RGD |
PMID:22008240 |
RGD:401794422 |
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Hdac2
|
histone deacetylase 2
|
treatment
|
ISO
|
|
RGD |
PMID:23696608 |
RGD:9590210 |
NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311
|
|
| G
|
Hgf
|
hepatocyte growth factor
|
treatment
|
ISO IEP
|
mRNA,protein:increased expression:retina:
|
RGD |
PMID:11818401 PMID:11818401 |
RGD:8548551, RGD:8548551 |
NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
IDA
|
|
RGD |
PMID:21999229 |
RGD:10402064 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
|
IEP
|
associated with Glaucoma
|
RGD |
PMID:20357190 |
RGD:4145289 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
|
IDA
|
|
RGD |
PMID:21310899 |
RGD:10402767 |
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IMP IEP
|
associated with Hypertension
|
RGD |
PMID:10235552 PMID:15007035 |
RGD:8547704, RGD:8547707 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Il1a
|
interleukin 1 alpha
|
|
IEP
|
|
RGD |
PMID:7890488 |
RGD:7401191 |
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
IEP
|
|
RGD |
PMID:7890488 |
RGD:7401191 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il6
|
interleukin 6
|
|
IEP
|
mRNA:increased expression:retina:
|
RGD |
PMID:16530172 |
RGD:7829807 |
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10
|
|
IEP ISO
|
mRNA:decreased expression:retina protein:decreased expression:retina, blood vessel
|
RGD |
PMID:16330144 PMID:20132867 |
RGD:8662868, RGD:8662890 |
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678
|
|
| G
|
Lpar1
|
lysophosphatidic acid receptor 1
|
|
IEP
|
protein:increased expression:retina
|
RGD |
PMID:17026968 |
RGD:2317696 |
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188
|
|
| G
|
Map2k4
|
mitogen activated protein kinase kinase 4
|
|
IEP
|
|
RGD |
PMID:19668425 |
RGD:7495824 |
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IEP IDA
|
mRNA:altered expression:retina (rat) protein:increased expression:retinal vasculature, retinal ganglion cell layer (rat)
|
RGD |
PMID:9950605 PMID:11496119 PMID:12634478 |
RGD:7771570, RGD:7775036, RGD:7775037 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
|
IEP
|
protein:increased expression:retina, cytosol (rat)
|
RGD |
PMID:19122832 |
RGD:13208943 |
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Ren
|
renin
|
treatment
|
IMP
|
|
RGD |
PMID:24709336 |
RGD:11039406 |
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:47,348,143...47,359,543
|
|
| G
|
Rnf2
|
ring finger protein 2
|
|
IEP
|
|
RGD |
PMID:20740046 |
RGD:9491844 |
NCBI chr13:66,103,943...66,136,038
Ensembl chr13:66,083,653...66,133,161
|
|
| G
|
Serpinf1
|
serpin family F member 1
|
|
ISO
|
human protein in a mouse model
|
RGD |
PMID:16822505 |
RGD:8554871 |
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
|
|
| G
|
Sod2
|
superoxide dismutase 2
|
treatment
|
IEP ISO
|
protein:decreased activity:retina:
|
RGD |
PMID:22240151 PMID:22240151 |
RGD:8158043, RGD:8158043 |
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
treatment
|
IDA
|
|
RGD |
PMID:21858029 |
RGD:8694310 |
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
ISO
|
|
RGD |
PMID:21031135 |
RGD:7794771 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
IEP IMP IDA
|
protein:increased expression:retina:
|
RGD |
PMID:18660426 PMID:18660426 PMID:18660426 |
RGD:7387281, RGD:7387281, RGD:7387281 |
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
|
IDA
|
|
RGD |
PMID:17591953 |
RGD:7421609 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IMP
|
|
RGD |
PMID:9288448 |
RGD:13210506 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
H19
|
H19 imprinted maternally expressed transcript
|
ameliorates
|
ISO
|
|
RGD |
PMID:31127201 |
RGD:242905201 |
NCBI chr 1:207,160,175...207,162,851
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IEP
|
|
RGD |
PMID:23537149 |
RGD:10755711 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IEP
|
|
RGD |
PMID:23537149 |
RGD:10755711 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
treatment
|
IEP
|
|
RGD |
PMID:23537149 |
RGD:10755711 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Ngb
|
neuroglobin
|
|
IEP
|
associated with Ocular Hypertension;protein:increased expression:retina
|
RGD |
PMID:22553688 |
RGD:9854634 |
NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:112,475,332...112,480,786
|
|
| G
|
Ptger4
|
prostaglandin E receptor 4
|
|
IEP
|
protein:decreased expression:retina (rat)
|
RGD |
PMID:12821538 |
RGD:9850261 |
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135
|
|
| G
|
Thy1
|
Thy-1 cell surface antigen
|
treatment
|
IEP
|
|
RGD |
PMID:23537149 |
RGD:10755711 |
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:53,286,148...53,291,540
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
treatment
|
IEP
|
|
RGD |
PMID:23537149 |
RGD:10755711 |
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
|
IMP
|
|
RGD |
PMID:7858993 |
RGD:10450555 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
treatment
|
IEP
|
|
RGD |
PMID:26315464 PMID:19105227 |
RGD:329901918, RGD:329902055 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Serping1
|
serpin family G member 1
|
treatment
|
ISO
|
|
RGD |
PMID:29395422 PMID:24585935 |
RGD:13525001, RGD:13542089 |
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
|
|
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
treatment
|
IDA
|
|
RGD |
PMID:23643992 |
RGD:10053660 |
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
treatment
|
IEP
|
|
RGD |
PMID:24361987 |
RGD:10059358 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
IEP
|
|
RGD |
PMID:25374587 |
RGD:11561952 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
treatment
|
IDA
|
|
RGD |
PMID:25301568 |
RGD:13782374 |
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdk5r1
|
cyclin-dependent kinase 5 regulatory subunit 1
|
treatment
|
IEP
|
|
RGD |
PMID:25301568 |
RGD:13782374 |
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
treatment
|
IEP
|
|
RGD |
PMID:17368520 PMID:29310813 |
RGD:155226865, RGD:155226868 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
IMP
|
|
RGD |
PMID:27760212 |
RGD:12910551 |
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cxcr4
|
C-X-C motif chemokine receptor 4
|
|
IMP
|
|
RGD |
PMID:27760212 |
RGD:12910551 |
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
|
|
| G
|
Gapdh
|
glyceraldehyde-3-phosphate dehydrogenase
|
treatment
|
IEP
|
|
RGD |
PMID:30195603 |
RGD:13792615 |
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
treatment
|
IEP
|
protein:increased expression:spinal cord:
|
RGD |
PMID:24463125 |
RGD:11354961 |
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Proc
|
protein C, inactivator of coagulation factors Va and VIIIa
|
treatment
|
ISO
|
|
RGD |
PMID:10903607 |
RGD:11100044 |
NCBI chr18:24,038,596...24,049,061
Ensembl chr18:24,038,597...24,048,964
|
|
| G
|
Siah1
|
siah E3 ubiquitin protein ligase 1
|
treatment
|
IEP
|
|
RGD |
PMID:30195603 |
RGD:13792615 |
NCBI chr19:36,552,165...36,575,773
Ensembl chr19:36,540,947...36,581,541
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
IMP
|
|
RGD |
PMID:27760212 |
RGD:12910551 |
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
|
|
| G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
treatment
|
ISO
|
DNA:SNPs: :rs1045642,rs7779562(human)
|
RGD |
PMID:25217066 |
RGD:14700903 |
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
| G
|
Atp5mc2
|
ATP synthase membrane subunit c locus 2
|
severity
|
ISO
|
|
RGD |
PMID:27441480 |
RGD:14696800 |
NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:135,669,848...135,678,231
|
|
| G
|
Ccn1
|
cellular communication network factor 1
|
sexual_dimorphism
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:34597881 |
RGD:329845519 |
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
|
|
| G
|
Lgals3
|
galectin 3
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:29769800 |
|
NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737
|
|
| G
|
Mir208a
|
microRNA 208a
|
severity
|
IEP
|
miRNA:increased expression:blood
|
RGD |
PMID:32458401 |
RGD:213230165 |
NCBI chr15:32,395,552...32,395,634
|
|
|
|
| G
|
F7
|
coagulation factor VII
|
|
ISO
|
protein:increased activity:plasma (human)
|
RGD |
PMID:17357481 |
RGD:11049525 |
NCBI chr16:83,191,896...83,202,775
Ensembl chr16:83,191,914...83,202,738
|
|
| G
|
Mir126a
|
microRNA 126a
|
|
ISO
|
RNA:decreased expression:plasma
|
RGD |
PMID:27900989 |
RGD:401850572 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20981132 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Rbp4
|
retinol binding protein 4
|
|
ISO
|
protein:increased expression:blood serum (human)
|
RGD |
PMID:25142320 |
RGD:329845867 |
NCBI chr 1:245,306,349...245,313,551
Ensembl chr 1:245,306,349...245,313,898
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20981132 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:20981132 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
|
| G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
treatment
|
IEP
|
|
RGD |
PMID:27748062 |
RGD:13703108 |
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
|
IEP
|
|
RGD |
PMID:26754107 |
RGD:11555349 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
|
IEP
|
|
RGD |
PMID:26754107 |
RGD:11555349 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
|
IEP
|
|
RGD |
PMID:26754107 |
RGD:11555349 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
|
IEP
|
|
RGD |
PMID:26754107 |
RGD:11555349 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
|
IEP
|
protein:increased expression:testes (rat)
|
RGD |
PMID:12193413 |
RGD:632997 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
treatment
|
IMP
|
|
RGD |
PMID:23142244 |
RGD:10755740 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
treatment
|
IMP
|
|
RGD |
PMID:15944243 |
RGD:13800876 |
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
treatment
|
IMP
|
|
RGD |
PMID:15944243 |
RGD:13800876 |
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
|
IEP
|
protein:increased expression:testis
|
RGD |
PMID:18205898 |
RGD:2292105 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Uchl5
|
ubiquitin C-terminal hydrolase L5
|
|
IEP
|
mRNA, protein:decreased expression:testis
|
RGD |
PMID:24189580 |
RGD:9588240 |
NCBI chr13:58,070,947...58,106,825
Ensembl chr13:58,042,029...58,107,441
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
treatment
|
IDA
|
|
RGD |
PMID:23769121 |
RGD:7247698 |
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|
|
|
| G
|
Acvrl1
|
activin A receptor like type 1
|
|
IEP
|
|
RGD |
PMID:15781474 |
RGD:1579751 |
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305
|
|
| G
|
Adamts1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:16630594 |
RGD:9681747 |
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
|
|
| G
|
Adamts4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
IEP
|
|
RGD |
PMID:16630594 |
RGD:9681747 |
NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514
|
|
| G
|
Adarb1
|
adenosine deaminase, RNA-specific, B1
|
|
IMP
|
|
RGD |
PMID:16504947 |
RGD:10755337 |
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415
|
|
| G
|
Adora1
|
adenosine A1 receptor
|
|
ISO
|
CTD Direct Evidence: therapeutic
|
CTD |
PMID:23437309 |
|
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:48,213,273...48,247,190
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
|
IEP ISO
|
protein:altered expression:cerebral cortex, striatum (rat) protein:increased expression:brain, plasma
|
RGD |
PMID:22528836 PMID:23288172 |
RGD:7245542, RGD:8696004 |
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Agt
|
angiotensinogen
|
|
IEP
|
|
RGD |
PMID:21934531 |
RGD:8549480 |
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
treatment
|
IMP
|
|
RGD |
PMID:32913241 |
RGD:401793747 |
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Aifm1
|
apoptosis inducing factor, mitochondria associated 1
|
|
IEP ISO
|
mRNA:decreased expression, altered localization:CA1 pyramidal layer, nucleus: protein:increased expression:nucleus:
|
RGD |
PMID:14526224 PMID:15087715 |
RGD:10047409, RGD:10053562 |
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:132,528,107...132,567,237
|
|
| G
|
Ang
|
angiogenin
|
treatment
|
IEP
|
|
RGD |
PMID:30258350 |
RGD:155663419 |
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
|
|
| G
|
Ank1
|
ankyrin 1
|
|
IEP
|
|
RGD |
PMID:9202331 |
RGD:1599109 |
NCBI chr16:75,578,824...75,757,464
Ensembl chr16:75,578,824...75,757,464
|
|
| G
|
Ank2
|
ankyrin 2
|
|
IEP
|
|
RGD |
PMID:9202331 |
RGD:1599109 |
NCBI chr 2:218,052,555...218,628,414
Ensembl chr 2:218,052,555...218,537,259
|
|
| G
|
Apoe
|
apolipoprotein E
|
|
IEP
|
|
RGD |
PMID:19623195 |
RGD:6903926 |
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
|
|
| G
|
Aqp4
|
aquaporin 4
|
treatment
|
IEP
|
|
RGD |
PMID:24773551 PMID:28396190 |
RGD:13207320, RGD:597978119 |
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
|
|
| G
|
Atf2
|
activating transcription factor 2
|
|
IDA IEP
|
|
RGD |
PMID:10077326 PMID:9813301 |
RGD:10047405, RGD:10047413 |
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745
|
|
| G
|
Atp5f1b
|
ATP synthase F1 subunit beta
|
|
IEP
|
protein:increased expression:cerebrum (rat)
|
RGD |
PMID:21950801 |
RGD:13792582 |
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
|
|
| G
|
Axin2
|
axin 2
|
treatment
|
IEP
|
|
RGD |
PMID:31650542 |
RGD:151356749 |
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
|
|
| G
|
Bace1
|
beta-secretase 1
|
|
IEP
|
protein:increased activity,increased expression:brain cortex
|
RGD |
PMID:15120577 |
RGD:13782170 |
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
|
|
| G
|
Bad
|
BCL2-associated agonist of cell death
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:12629175 |
|
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
treatment
|
IEP
|
|
RGD |
PMID:21167243 |
RGD:10054102 |
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bbc3
|
Bcl-2 binding component 3
|
|
IEP
|
protein:increased expression:hippocampus CA1, pyramidal cell
|
RGD |
PMID:12913114 |
RGD:634629 |
NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
treatment
|
IEP IDA
|
protein:decreased expression:brain protein:increased expression:hippocampus:
|
RGD |
PMID:18083315 PMID:26607632 PMID:22509406 PMID:16732092 |
RGD:2290557, RGD:597538583, RGD:11561910, RGD:11522725 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Bcl2l2
|
Bcl2-like 2
|
treatment
|
IEP ISO
|
protein:increased expression:cortex and caudate putamen
|
RGD |
PMID:10724126 PMID:12571640 |
RGD:14394498, RGD:14394500 |
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
treatment
|
IDA
|
associated with middle cerebral artery infarction
|
RGD |
PMID:33227709 |
RGD:597015753 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Becn1
|
beclin 1
|
treatment
|
IEP
|
|
RGD |
PMID:22509406 |
RGD:11561910 |
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002
|
|
| G
|
Bex3
|
brain expressed X-linked 3
|
|
IEP
|
|
RGD |
PMID:11124986 |
RGD:9743974 |
NCBI chr X:104,064,896...104,066,425
Ensembl chr X:104,064,515...104,075,906
|
|
| G
|
Bnip3
|
BCL2 interacting protein 3
|
|
IEP
|
|
RGD |
PMID:14972662 |
RGD:2314028 |
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
|
|
| G
|
C3
|
complement C3
|
treatment
|
IEP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:23199288 PMID:22004711 |
RGD:7411628 |
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
| G
|
Cab39
|
calcium binding protein 39
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:27798271 |
RGD:14398833 |
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:93,911,054...93,972,542
|
|
| G
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
IEP ISO
|
protein:increased expression:hippocampus
|
RGD |
PMID:12951199 PMID:12199152 |
RGD:7241547, RGD:13681927 |
NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504
|
|
| G
|
Casp3
|
caspase 3
|
|
IDA
|
|
RGD |
PMID:21712070 |
RGD:10053706 |
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp7
|
caspase 7
|
treatment
|
IEP
|
|
RGD |
PMID:25872160 |
RGD:13782285 |
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
|
|
| G
|
Casp8
|
caspase 8
|
treatment
|
IEP
|
protein:increased expression:cerebral cortex:
|
RGD |
PMID:30148677 PMID:18096138 |
RGD:13782286, RGD:4142863 |
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
| G
|
Casp9
|
caspase 9
|
|
IEP ISO
|
associated with Diabetes Mellitus, Experimental;protein:increased expression:neocortex CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:11333366 PMID:15246841 PMID:21712070 |
RGD:2311321, RGD:10053706 |
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cav1
|
caveolin 1
|
treatment
|
IEP ISO
|
|
RGD |
PMID:22007835 PMID:22007835 |
RGD:8661794, RGD:8661794 |
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
|
|
| G
|
Cbl
|
Cbl proto-oncogene
|
treatment
|
IDA
|
|
RGD |
PMID:18773943 |
RGD:4108486 |
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067
|
|
| G
|
Cbs
|
cystathionine beta synthase
|
treatment
|
ISO
|
XCO:0000348 XCO:0000807
|
RGD |
PMID:22212488 PMID:22212488 |
RGD:41410880, RGD:41410880 |
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
treatment
|
IDA IEP
|
mRNA:increased expression:brain (rat)
|
RGD |
PMID:21487414 PMID:7860708 |
RGD:8549519, RGD:8549729 |
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Ccl20
|
C-C motif chemokine ligand 20
|
treatment
|
IMP
|
|
RGD |
PMID:19428685 |
RGD:7488896 |
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
|
|
| G
|
Ccnh
|
cyclin H
|
|
IEP
|
mRNA, protein:increased expression:hippocampus
|
RGD |
PMID:10501206 |
RGD:69371 |
NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860
|
|
| G
|
Ccr6
|
C-C motif chemokine receptor 6
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:19428685 |
RGD:7488896 |
NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059
|
|
| G
|
Cd40
|
CD40 molecule
|
severity
|
ISO
|
|
RGD |
PMID:15795333 |
RGD:11352234 |
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
| G
|
Cd40lg
|
CD40 ligand
|
severity
|
ISO
|
|
RGD |
PMID:15795333 |
RGD:11352234 |
NCBI chr X:140,164,341...140,176,057
Ensembl chr X:140,164,302...140,176,475
|
|
| G
|
Cdk5
|
cyclin-dependent kinase 5
|
treatment
|
IEP
|
|
RGD |
PMID:28254431 |
RGD:13506925 |
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
|
|
| G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
|
ISO
|
protein:decreased expression:striatum, neuron
|
RGD |
PMID:11438580 |
RGD:8552691 |
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
|
IEP
|
mRNA, protein:increased expression:hippocampal pyramidal cell layer (rat)
|
RGD |
PMID:9795105 |
RGD:10401192 |
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Chka
|
choline kinase alpha
|
|
IEP
|
mRNA:increased expression:cerebral cortex (rat)
|
RGD |
PMID:16300643 |
RGD:10401831 |
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752
|
|
| G
|
Cldn5
|
claudin 5
|
treatment
|
IEP
|
|
RGD |
PMID:28396190 |
RGD:597978119 |
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
|
|
| G
|
Coq7
|
coenzyme Q7, hydroxylase
|
severity
|
ISO
|
|
RGD |
PMID:20170652 |
RGD:10402096 |
NCBI chr 1:182,270,570...182,285,959
Ensembl chr 1:182,269,399...182,285,508
|
|
| G
|
Creb1
|
cAMP responsive element binding protein 1
|
|
IDA
|
|
RGD |
PMID:10077326 |
RGD:10047405 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
|
IEP
|
mRNA:increased expression:cerebral cortex (rat)
|
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
|
RGD |
PMID:12624302 |
RGD:10450512 |
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
|
|
| G
|
Cx3cl1
|
C-X3-C motif chemokine ligand 1
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:24447880 |
RGD:9491776 |
NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999
|
|
| G
|
Cx3cr1
|
C-X3-C motif chemokine receptor 1
|
|
IEP
|
mRNA,protein:decreased expression:hippocampus
|
RGD |
PMID:24447880 |
RGD:9491776 |
NCBI chr 8:128,661,294...128,679,048
Ensembl chr 8:128,654,833...128,685,983
|
|
| G
|
Cxcl12
|
C-X-C motif chemokine ligand 12
|
|
IEP
|
protein:increased expression:hippocampus:
|
RGD |
PMID:24924806 |
RGD:11352662 |
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
|
|
| G
|
Cycs
|
cytochrome c, somatic
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:11333366 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
|
|
| G
|
Daxx
|
death-domain associated protein
|
treatment
|
IDA IEP
|
mRNA,protein:increased expression:cerebral cortex:
|
RGD |
PMID:17967739 PMID:18096138 |
RGD:9587802, RGD:4142863 |
NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720
|
|
| G
|
Dbn1
|
drebrin 1
|
|
IEP
|
|
RGD |
PMID:8583659 |
RGD:10398814 |
NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122
|
|
| G
|
Dffb
|
DNA fragmentation factor subunit beta
|
|
IEP
|
mRNA, protein:increased expression:hippocampus CA1
|
RGD |
PMID:11425895 |
RGD:628524 |
NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225
|
|
| G
|
Dll4
|
delta like canonical Notch ligand 4
|
ameliorates treatment disease_progression
|
ISO IEP
|
|
RGD |
PMID:31927543 PMID:30258350 PMID:30653356 |
RGD:155663354, RGD:155663419, RGD:155663383 |
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
|
|
| G
|
Dusp1
|
dual specificity phosphatase 1
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:22197701 |
RGD:7771582 |
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
| G
|
Dusp16
|
dual specificity phosphatase 16
|
|
IEP
|
protein:increased expression, altered localization:hippocampus, cytosol, nucleus
|
RGD |
PMID:23280045 |
RGD:7775014 |
NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508
|
|
| G
|
Eed
|
embryonic ectoderm development
|
|
IDA
|
|
RGD |
PMID:24007266 |
RGD:9588303 |
NCBI chr 1:153,280,419...153,307,537
Ensembl chr 1:153,280,422...153,307,500
|
|
| G
|
Eif2s1
|
eukaryotic translation initiation factor 2 subunit alpha
|
|
ISO IEP
|
associated with Heart Arrest
|
RGD |
PMID:11520898 PMID:10541873 |
RGD:10395353, RGD:11041881 |
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
|
|
| G
|
Elane
|
elastase, neutrophil expressed
|
treatment
|
IMP
|
|
RGD |
PMID:19168036 |
RGD:10450558 |
NCBI chr 7:10,467,877...10,469,725
Ensembl chr 7:10,467,877...10,469,725
|
|
| G
|
Elk1
|
ETS transcription factor ELK1
|
treatment
|
IEP
|
|
RGD |
PMID:17091294 |
RGD:7488902 |
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:3,693,293...3,709,249
|
|
| G
|
Entpd1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
IEP
|
mRNA:increased expression:brain:
|
RGD |
PMID:9634555 |
RGD:9685492 |
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:249,374,836...249,502,317
|
|
| G
|
Ep300
|
E1A binding protein p300
|
disease_progression
|
IEP
|
mRNA:increased expression:cerebrum, ipsilateral side (rat)
|
RGD |
PMID:22196858 PMID:28230854 |
RGD:7349341, RGD:596933303 |
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
| G
|
Epo
|
erythropoietin
|
treatment
|
IEP ISO
|
|
RGD |
PMID:22282883 PMID:24702327 |
RGD:10401060, RGD:11041699 |
NCBI chr12:24,841,285...24,844,725
Ensembl chr12:24,841,285...24,844,725
|
|
| G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
treatment
|
ISO
|
human gene in a rat model
|
RGD |
PMID:19440222 |
RGD:2313668 |
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:88,118,891...88,139,120
|
|
| G
|
Ercc6
|
ERCC excision repair 6, chromatin remodeling factor
|
|
IEP
|
mRNA, protein:increased expression:cerebral cortex
|
RGD |
PMID:10437118 |
RGD:10401104 |
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895
|
|
| G
|
Esr1
|
estrogen receptor 1
|
treatment
|
IDA
|
|
RGD |
PMID:24548484 PMID:25098259 |
RGD:10045843, RGD:10045845 |
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
|
IMP
|
|
RGD |
PMID:23593292 |
RGD:7364962 |
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
F11r
|
F11 receptor
|
treatment
|
IEP
|
|
RGD |
PMID:22868201 |
RGD:7488943 |
NCBI chr13:86,406,229...86,429,819
Ensembl chr13:86,406,218...86,429,816
|
|
| G
|
F12
|
coagulation factor XII
|
treatment
|
ISO
|
|
RGD |
PMID:16533887 PMID:16533887 |
RGD:11041786, RGD:11041786 |
NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664
|
|
| G
|
Fadd
|
Fas associated via death domain
|
|
IEP
|
mRNA,protein:increased expression:cerebral cortex:
|
RGD |
PMID:18096138 |
RGD:4142863 |
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
|
|
| G
|
Fas
|
Fas cell surface death receptor
|
treatment
|
IEP IDA ISO
|
protein:increased expression:brain protein:increased expression:brain (rat)
|
RGD |
PMID:18410517 PMID:30301943 PMID:18981705 PMID:10972965 |
RGD:2311437, RGD:153297779, RGD:8686422, RGD:8662928 |
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
| G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
|
IEP
|
mRNA:increased expression:cerebral cortex:
|
RGD |
PMID:8858623 |
RGD:10402044 |
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
| G
|
Fgfr2
|
fibroblast growth factor receptor 2
|
treatment
|
IEP
|
associated with Experimental Diabetes Mellitus
|
RGD |
PMID:22432030 |
RGD:155882598 |
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
|
|
| G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
treatment
|
ISO
|
|
RGD |
PMID:17077813 |
RGD:10402150 |
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
| G
|
Fmr1
|
fragile X messenger ribonucleoprotein 1
|
|
IEP
|
mRNA, protein:increased expression:striatum (rat)
|
RGD |
PMID:22817682 |
RGD:11566024 |
NCBI chr X:152,284,857...152,322,686
Ensembl chr X:152,284,841...152,322,675
|
|
| G
|
Fto
|
FTO, alpha-ketoglutarate dependent dioxygenase
|
|
IEP ISO
|
protein:decreased expression:cerebral cortex mRNA:decreased expression:cerebral cortex mRNA:decreased expression:heart
|
RGD |
PMID:32426101 PMID:36479246 PMID:34413770 |
RGD:329901764, RGD:329951019, RGD:329901768 |
NCBI chr19:31,456,749...31,865,011
Ensembl chr19:31,522,293...31,864,957
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
|
IMP
|
|
RGD |
PMID:22580330 |
RGD:10449127 |
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gad1
|
glutamate decarboxylase 1
|
disease_progression
|
IEP
|
|
RGD |
PMID:20659561 |
RGD:401900597 |
NCBI chr 3:75,777,260...75,818,099
Ensembl chr 3:75,777,534...75,818,759
|
|
| G
|
Gad2
|
glutamate decarboxylase 2
|
disease_progression
|
IEP
|
|
RGD |
PMID:20659561 |
RGD:401900597 |
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Gamt
|
guanidinoacetate N-methyltransferase
|
ameliorates
|
ISO
|
DNA:deletion
|
RGD |
PMID:24004504 |
RGD:329955375 |
NCBI chr 7:10,099,267...10,102,083
Ensembl chr 7:10,098,571...10,102,083
|
|
| G
|
Gatm
|
glycine amidinotransferase
|
exacerbates
|
ISO
|
DNA:deletion
|
RGD |
PMID:24004504 |
RGD:329955375 |
NCBI chr 3:130,112,508...130,137,664
Ensembl chr 3:130,112,509...130,129,355
|
|
| G
|
Gch1
|
GTP cyclohydrolase 1
|
treatment
|
IMP
|
|
RGD |
PMID:9920651 |
RGD:329961573 |
NCBI chr15:22,884,006...22,917,412
Ensembl chr15:22,884,006...22,917,412
|
|
| G
|
Ghsr
|
growth hormone secretagogue receptor
|
|
IEP
|
mRNA,protein:decreased expression:brain:
|
RGD |
PMID:17560544 |
RGD:12907500 |
NCBI chr 2:112,196,158...112,201,666
Ensembl chr 2:112,196,767...112,201,181
|
|
| G
|
Gja1
|
gap junction protein, alpha 1
|
treatment
|
ISO IEP
|
protein:increased expression:brain
|
RGD |
PMID:22812228 PMID:23328809 |
RGD:7207263, RGD:8662426 |
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689
|
|
| G
|
Gjb6
|
gap junction protein, beta 6
|
|
IEP
|
protein:increased expression:hippocampus:
|
RGD |
PMID:21718970 |
RGD:6480433 |
NCBI chr15:35,400,147...35,410,649
Ensembl chr15:35,398,770...35,410,849
|
|
| G
|
Glrx
|
glutaredoxin
|
|
IEP
|
mRNA,protein:decreased expression:brain:
|
RGD |
PMID:10329397 |
RGD:9686043 |
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
|
|
| G
|
Glul
|
glutamate-ammonia ligase
|
treatment
|
IEP
|
associated with carotid artery occlusion protein:increased expression:hippocampus
|
RGD |
PMID:27664163 PMID:25365917 PMID:21272618 PMID:21371894 |
RGD:401794415, RGD:401794591, RGD:401794590, RGD:401794419 |
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
| G
|
Got1
|
glutamic-oxaloacetic transaminase 1
|
treatment
|
ISO IDA
|
human protein in a rat model
|
RGD |
PMID:24407245 PMID:21361730 PMID:20145654 |
RGD:13504852, RGD:13504855, RGD:13504854 |
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
|
|
| G
|
Gp6
|
glycoprotein 6
|
ameliorates
|
ISO
|
|
RGD |
PMID:34237320 |
RGD:401794450 |
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:78,508,468...78,535,374
|
|
| G
|
Gpx3
|
glutathione peroxidase 3
|
treatment
|
ISO
|
|
RGD |
PMID:30098076 |
RGD:401827833 |
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
|
|
| G
|
Grin2a
|
glutamate ionotropic receptor NMDA type subunit 2A
|
ameliorates treatment
|
IMP IDA ISO
|
associated with hyperhomocysteinemia
|
RGD |
PMID:30885791 PMID:12932824 PMID:30885791 |
RGD:401940141, RGD:401950480, RGD:401940141 |
NCBI chr10:6,136,458...6,560,003
Ensembl chr10:6,138,037...6,551,378
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
ameliorates
|
IMP
|
|
RGD |
PMID:30885791 |
RGD:401940141 |
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
treatment
|
IDA
|
|
RGD |
PMID:15525350 |
RGD:10401855 |
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
H2ax
|
H2A.X variant histone
|
treatment
|
IDA
|
|
RGD |
PMID:20830300 |
RGD:8693742 |
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Havcr2
|
hepatitis A virus cellular receptor 2
|
treatment
|
IEP
|
|
RGD |
PMID:24771108 |
RGD:9686115 |
NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872
|
|
| G
|
Hdac5
|
histone deacetylase 5
|
disease_progression
|
IEP
|
|
RGD |
PMID:28230854 |
RGD:596933303 |
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
|
|
| G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
treatment
|
IEP
|
protein:increased expression:cerebral cortex, caudoputamen (rat)
|
RGD |
PMID:20417628 PMID:30258350 |
RGD:9068877, RGD:155663419 |
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
|
ISO
|
protein:increased expression:brain, plasma
|
RGD |
PMID:23288172 |
RGD:8696004 |
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hnrnpa2b1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
IEP
|
protein:altered expression:cerebral cortex, hippocampus (rat)
|
RGD |
PMID:20421594 |
RGD:10041006 |
NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572
|
|
| G
|
Hnrnpab
|
heterogeneous nuclear ribonucleoprotein A/B
|
treatment
|
IDA
|
|
RGD |
PMID:22366221 |
RGD:9999181 |
NCBI chr10:36,358,004...36,363,898
Ensembl chr10:36,358,006...36,364,307
|
|
| G
|
Hrh2
|
histamine receptor H 2
|
|
IEP
|
protein:decreased expression:caudate putamen (rat)
|
RGD |
PMID:16181737 |
RGD:9685533 |
NCBI chr17:10,371,083...10,412,979
Ensembl chr17:10,371,083...10,391,041
|
|
| G
|
Hsf1
|
heat shock transcription factor 1
|
treatment
|
IEP IDA
|
protein:increased expression:brain, nucleus (rat) associated with Heart Arrest
|
RGD |
PMID:26070787 PMID:23528677 |
RGD:10402389, RGD:10402772 |
NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
treatment
|
IEP
|
|
RGD |
PMID:25632565 |
RGD:11354959 |
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
|
IEP
|
protein:increased expression:brain, postsynaptic density (rat)
|
RGD |
PMID:9425004 |
RGD:10059344 |
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspb1
|
heat shock protein family B (small) member 1
|
|
IEP
|
protein:increased expression:brain,astrocyte:
|
RGD |
PMID:10559386 |
RGD:10402577 |
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
|
|
| G
|
Htra2
|
HtrA serine peptidase 2
|
treatment
|
IMP ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD RGD |
PMID:15306124 PMID:19462455 |
RGD:10402932 |
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793
|
|
| G
|
Htt
|
huntingtin
|
|
IEP
|
protein:increased degradation:brain
|
RGD |
PMID:12957494 |
RGD:1304431 |
NCBI chr14:80,070,456...80,219,668
Ensembl chr14:80,070,456...80,219,668
|
|
| G
|
Icam1
|
intercellular adhesion molecule 1
|
treatment
|
IEP
|
|
RGD |
PMID:22379785 |
RGD:8547729 |
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
| G
|
Ifnb1
|
interferon beta 1
|
ameliorates
|
IDA
|
|
RGD |
PMID:12973019 |
RGD:401851924 |
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
severity
|
IEP
|
protein:decreased expression:serum (rat)
|
RGD |
PMID:25098324 |
RGD:12904924 |
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Ikbkb
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
treatment
|
IEP
|
|
RGD |
PMID:24261295 |
RGD:7495766 |
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
|
|
| G
|
Il10
|
interleukin 10
|
treatment
|
IDA
|
|
RGD |
PMID:24053818 |
RGD:7364868 |
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
| G
|
Il1b
|
interleukin 1 beta
|
|
IDA ISO
|
|
RGD |
PMID:23147509 PMID:22284622 |
RGD:7175551, RGD:7175554 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
IDA ISO
|
human protein in a rat model
|
RGD |
PMID:15837124 PMID:20412072 |
RGD:1626674, RGD:8551852 |
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
|
|
| G
|
Ilk
|
integrin-linked kinase
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:15472100 |
|
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:169,498,681...169,506,964
|
|
| G
|
Itgam
|
integrin subunit alpha M
|
treatment
|
ISO IEP IMP
|
mRNA:increased expression:cerebral cortex (mouse) mRNA:increased expression:brain (rat)
|
RGD |
PMID:30123113 PMID:23844255 PMID:22082476 PMID:32407868 PMID:19563786 PMID:8964796 PMID:8581506 PMID:8160235 More...
|
RGD:329853754, RGD:329902067, RGD:329902058, RGD:329901940, RGD:329901933, RGD:329901921, RGD:329901917, RGD:329901916 |
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
| G
|
Itgb3
|
integrin subunit beta 3
|
|
IEP
|
|
RGD |
PMID:18638458 |
RGD:6907424 |
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800
|
|
| G
|
Itpr1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
IEP
|
mRNA:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:7500836 |
RGD:6482813 |
NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504
|
|
| G
|
Jak1
|
Janus kinase 1
|
|
IEP
|
|
RGD |
PMID:10756075 |
RGD:19165138 |
NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758
|
|
| G
|
Jak2
|
Janus kinase 2
|
|
IDA
|
|
RGD |
PMID:23764464 |
RGD:8694326 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
|
|
| G
|
Jund
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
treatment
|
IEP
|
|
RGD |
PMID:9037518 |
RGD:617301926 |
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148
|
|
| G
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10
|
|
IEP
|
protein:decreased expression:CA1 field of hippocampus, astrocyte, astrocyte projection
|
RGD |
PMID:20833221 |
RGD:8662899 |
NCBI chr13:87,334,510...87,367,747
Ensembl chr13:87,334,216...87,368,678
|
|
| G
|
Kcnk2
|
potassium two pore domain channel subfamily K member 2
|
severity treatment
|
ISO IDA IEP
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:15175651 PMID:24154701 PMID:25062759 |
RGD:9831121, RGD:9831178, RGD:9831122 |
NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686
|
|
| G
|
Kdm1a
|
lysine demethylase 1A
|
|
IEP
|
protein:increased expression:cerebral cortex, hippocampus, dentate gyrus (rat)
|
RGD |
PMID:20542065 |
RGD:9588301 |
NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775
|
|
| G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
|
ISO
|
protein:decreased expression:brain (mouse)
|
RGD |
PMID:21075092 |
RGD:6893270 |
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
| G
|
Klf5
|
KLF transcription factor 5
|
ameliorates
|
IMP
|
|
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262
|
|
| G
|
Kmt2a
|
lysine methyltransferase 2A
|
treatment
|
IMP
|
|
RGD |
PMID:34694864 |
RGD:155888565 |
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317
|
|
| G
|
Lcn2
|
lipocalin 2
|
|
IEP
|
protein:increased expression:brain
|
RGD |
PMID:29122651 PMID:24916903 |
RGD:126781757, RGD:126790489 |
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
| G
|
Lmna
|
lamin A/C
|
|
IDA
|
|
RGD |
PMID:17683050 |
RGD:2293745 |
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072
|
|
| G
|
Lpar1
|
lysophosphatidic acid receptor 1
|
treatment
|
IDA
|
|
RGD |
PMID:17173873 |
RGD:9850154 |
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:78,024,139...78,142,188
|
|
| G
|
Ltbp1
|
latent transforming growth factor beta binding protein 1
|
treatment
|
IEP
|
|
RGD |
PMID:11720783 |
RGD:10412057 |
NCBI chr 6:25,781,625...26,177,346
Ensembl chr 6:25,781,638...26,454,036
|
|
| G
|
Ltc4s
|
leukotriene C4 synthase
|
|
ISO
|
DNA:SNPs:promoter:g.-444A>C, g.-1072G>A DNA:mutations:intron, exons:multiple
|
RGD |
PMID:19280718 PMID:20456754 |
RGD:626168270, RGD:626168272 |
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
|
|
| G
|
Madd
|
MAP-kinase activating death domain
|
|
IEP
|
|
RGD |
PMID:12625816 |
RGD:9588641 |
NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:97,570,787...97,613,509
|
|
| G
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha
|
treatment
|
IEP
|
|
RGD |
PMID:22509406 |
RGD:11561910 |
NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850
|
|
| G
|
Map2k4
|
mitogen activated protein kinase kinase 4
|
|
IDA
|
protein:increased threonine phosphorylation:heart, nucleus
|
RGD |
PMID:9195981 |
RGD:7495830 |
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185
|
|
| G
|
Map3k5
|
mitogen-activated protein kinase kinase kinase 5
|
|
IEP
|
protein:increased nitrosylation, activity:hippocampus:
|
RGD |
PMID:23137546 |
RGD:10412334 |
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
|
|
| G
|
Map3k7
|
mitogen activated protein kinase kinase kinase 7
|
ameliorates
|
ISO
|
|
RGD |
PMID:32078472 PMID:32349637 PMID:34628598 PMID:32382778 |
RGD:155791642, RGD:155804284, RGD:155804283, RGD:155804272 |
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
|
|
| G
|
Map4k1
|
mitogen activated protein kinase kinase kinase kinase 1
|
treatment
|
IDA
|
|
RGD |
PMID:18498770 PMID:18382279 |
RGD:7495845, RGD:7495847 |
NCBI chr 1:93,398,460...93,419,996
Ensembl chr 1:93,398,454...93,419,993
|
|
| G
|
Mbd1
|
methyl-CpG binding domain protein 1
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:12421618 |
RGD:9587846 |
NCBI chr18:70,145,093...70,159,744
Ensembl chr18:70,145,114...70,159,703
|
|
| G
|
Mbd2
|
methyl-CpG binding domain protein 2
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:12421618 |
RGD:9587846 |
NCBI chr18:66,449,196...66,516,112
Ensembl chr18:66,449,358...66,516,111
|
|
| G
|
Mbd3
|
methyl-CpG binding domain protein 3
|
|
IEP
|
mRNA:decreased expression:hippocampus
|
RGD |
PMID:12421618 |
RGD:9587846 |
NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,963,797...9,970,265
|
|
| G
|
Mbp
|
myelin basic protein
|
|
IEP
|
mRNA:increased expression:oligodendrocyte:
|
RGD |
PMID:11460777 |
RGD:7349336 |
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mcfd2
|
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:17610559 |
RGD:11062141 |
NCBI chr 6:13,028,036...13,039,388
Ensembl chr 6:13,016,104...13,039,379
|
|
| G
|
Mdm2
|
MDM2 proto-oncogene
|
treatment
|
IDA
|
|
RGD |
PMID:24334056 |
RGD:10412310 |
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
| G
|
Mecp2
|
methyl CpG binding protein 2
|
|
IEP
|
mRNA:increased expression:hippocampus
|
RGD |
PMID:12421618 |
RGD:9587846 |
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:156,941,234...156,943,560
|
|
| G
|
Mff
|
mitochondrial fission factor
|
treatment
|
IDA
|
|
RGD |
PMID:26116440 |
RGD:12879457 |
NCBI chr 9:91,455,931...91,484,171
Ensembl chr 9:91,455,871...91,484,171
|
|
| G
|
Mfn2
|
mitofusin 2
|
|
IEP
|
protein:decreased expression:brain (rat)
|
RGD |
PMID:25147362 |
RGD:13204807 |
NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495
|
|
| G
|
Mir126a
|
microRNA 126a
|
exacerbates
|
ISO
|
|
RGD |
PMID:28101763 |
RGD:401850574 |
NCBI chr 3:29,813,150...29,813,267
|
|
| G
|
Mir155
|
microRNA 155
|
treatment
|
IEP
|
|
RGD |
PMID:33081480 |
RGD:151347423 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178
|
|
| G
|
Mir195
|
microRNA 195
|
severity
|
IMP
|
|
RGD |
PMID:32272873 |
RGD:45073134 |
NCBI chr10:55,450,495...55,450,581
Ensembl chr10:55,450,495...55,450,581
|
|
| G
|
Mir223
|
microRNA 223
|
|
IMP
|
|
RGD |
PMID:31237865 |
RGD:25824937 |
NCBI chr X:65,151,383...65,151,492
Ensembl chr X:65,151,383...65,151,492
|
|
| G
|
Mmp2
|
matrix metallopeptidase 2
|
treatment
|
IDA IEP
|
protein:increased activity, increased expression:brain
|
RGD |
PMID:11592852 PMID:24828425 |
RGD:8547930, RGD:8657086 |
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
treatment
|
ISO IEP IDA
|
protein:increased activity, increased expression:brain
|
RGD |
PMID:16197500 PMID:24773551 PMID:23046750 PMID:11592852 |
RGD:8547921, RGD:13207320, RGD:13207323, RGD:8547930 |
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mrtfa
|
myocardin related transcription factor A
|
disease_progression
|
IEP
|
|
RGD |
PMID:28230854 |
RGD:596933303 |
NCBI chr 7:114,424,481...114,594,594
Ensembl chr 7:114,424,481...114,594,594
|
|
| G
|
Mt1a
|
metallothionein 1A
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:10884303 |
RGD:10412650 |
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
| G
|
Mt2
|
metallothionein 2
|
|
IEP
|
mRNA:increased expression:cerebral cortex
|
RGD |
PMID:10884303 |
RGD:10412650 |
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
|
|
| G
|
Mt3
|
metallothionein 3
|
|
IEP
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:10069533 |
RGD:9685804 |
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080
|
|
| G
|
Mtor
|
mechanistic target of rapamycin kinase
|
treatment
|
IEP
|
|
RGD |
PMID:30712471 |
RGD:155791663 |
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435
|
|
| G
|
Myb
|
MYB proto-oncogene, transcription factor
|
|
IEP
|
mRNA:increased expression:brain:
|
RGD |
PMID:24828495 |
RGD:11532683 |
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
|
|
| G
|
Nampt
|
nicotinamide phosphoribosyltransferase
|
treatment
|
IMP ISO
|
|
RGD |
PMID:28528966 PMID:25603815 |
RGD:13781879, RGD:13781895 |
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
|
|
| G
|
Ndrg2
|
NDRG family member 2
|
|
ISO
|
CTD Direct Evidence: marker/mechanism
|
CTD |
PMID:23451161 |
|
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:27,074,481...27,083,125
|
|
| G
|
Ndrg4
|
NDRG family member 4
|
|
ISO
|
|
RGD |
PMID:21636852 |
RGD:7247728 |
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:8726968 |
RGD:9743938 |
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nefl
|
neurofilament light chain
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:8726968 |
RGD:9743938 |
NCBI chr15:46,477,330...46,481,203
Ensembl chr15:46,458,204...46,482,515
|
|
| G
|
Nefm
|
neurofilament medium chain
|
|
IEP
|
protein:decreased expression:hippocampus
|
RGD |
PMID:8726968 |
RGD:9743938 |
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
|
|
| G
|
Nf1
|
neurofibromin 1
|
|
IEP
|
mRNA,protein:increased expression:astrocyte:
|
RGD |
PMID:8820972 |
RGD:12789703 |
NCBI chr10:64,803,986...65,037,086
Ensembl chr10:64,804,266...65,034,946
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
|
IEP
|
protein:increased expression:hippocampal pyramidal neuron, nucleus (rat)
|
RGD |
PMID:9158652 |
RGD:10045943 |
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Ngb
|
neuroglobin
|
treatment
|
IEP ISO IMP
|
associated with Hypertension;mRNA, protein:decreased expression:brain
|
RGD |
PMID:16647691 PMID:23342777 PMID:12621155 PMID:12621155 |
RGD:9743952, RGD:9743965, RGD:9743964, RGD:9743964 |
NCBI chr 6:112,475,332...112,480,786
Ensembl chr 6:112,475,332...112,480,786
|
|
| G
|
Ngfr
|
nerve growth factor receptor
|
|
IEP
|
|
RGD |
PMID:11124986 |
RGD:9743974 |
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
| G
|
Nod2
|
nucleotide-binding oligomerization domain containing 2
|
|
ISO
|
mRNA, protein:increased expression:brain
|
RGD |
PMID:20863826 |
RGD:5508733 |
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
|
|
| G
|
Nono
|
non-POU domain containing, octamer-binding
|
|
ISO
|
protein:altered localization:cerebral cortex (mouse)
|
RGD |
PMID:29426953 |
RGD:155883175 |
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:70,593,888...70,611,979
|
|
| G
|
Nos1
|
nitric oxide synthase 1
|
|
IDA IEP
|
protein:increased serine phosphorylation:dentate gyrus protein:altered expression:hippocampus :
|
RGD |
PMID:23806217 PMID:26607632 |
RGD:7257600, RGD:597538583 |
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
| G
|
Nos3
|
nitric oxide synthase 3
|
treatment
|
IEP IDA
|
protein:increased expression:serum (rat)
|
RGD |
PMID:28944915 PMID:29298658 PMID:29312485 |
RGD:13450951, RGD:13503353, RGD:13503330 |
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
| G
|
Notch1
|
notch receptor 1
|
treatment
|
IEP
|
|
RGD |
PMID:30258350 |
RGD:155663419 |
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
| G
|
Nox1
|
NADPH oxidase 1
|
ameliorates
|
IMP
|
|
RGD |
PMID:25617620 |
RGD:329955357 |
NCBI chr X:101,572,338...101,625,571
Ensembl chr X:101,572,340...101,595,520
|
|
| G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
treatment
|
IEP
|
protein:increased expression:cerebral cortex (rat) protein:increased expression:brain (rat)
|
RGD |
PMID:29017857 PMID:28169530 PMID:28552673 |
RGD:13439718, RGD:13442499, RGD:13439727 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
| G
|
Nrg1
|
neuregulin 1
|
treatment ameliorates
|
ISO
|
|
RGD |
PMID:31560696 PMID:30206770 |
RGD:405649728, RGD:405650589 |
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Nrp1
|
neuropilin 1
|
|
IEP
|
mRNA:increased expression:brain
|
RGD |
PMID:33675584 |
RGD:401901171 |
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
|
|
| G
|
Nrxn1
|
neurexin 1
|
|
IEP
|
associated with Hypertension;mRNA:decreased expression:cerebral cortex
|
RGD |
PMID:12437578 |
RGD:632385 |
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
|
|
| G
|
Ntrk2
|
neurotrophic receptor tyrosine kinase 2
|
treatment
|
IEP
|
associated with middle cerebral artery infarction
|
RGD |
PMID:33227709 |
RGD:597015753 |
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628
|
|
| G
|
Ocln
|
occludin
|
treatment
|
IEP
|
|
RGD |
PMID:28396190 |
RGD:597978119 |
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
| G
|
Ogg1
|
8-oxoguanine DNA glycosylase
|
|
IEP
|
protein:increased expression:cerebral cortex
|
RGD |
PMID:14600440 |
RGD:8657406 |
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604
|
|
| G
|
Opa1
|
OPA1, mitochondrial dynamin like GTPase
|
treatment
|
ISO IDA
|
protein:altered expression:brain
|
RGD |
PMID:22345048 PMID:24633199 |
RGD:7800722, RGD:13208946 |
NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955
|
|
| G
|
Optn
|
optineurin
|
|
IEP
|
protein:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:24235151 |
RGD:13434905 |
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
|
|
| G
|
Parl
|
presenilin associated, rhomboid-like
|
severity
|
ISO
|
|
RGD |
PMID:23921894 |
RGD:12902620 |
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:94,097,934...94,148,287
|
|
| G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
treatment
|
IDA IEP
|
|
RGD |
PMID:19840223 PMID:19840223 |
RGD:2325713, RGD:2325713 |
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
| G
|
Pawr
|
pro-apoptotic WT1 regulator
|
|
IEP ISO
|
mRNA:increased expression:brain: protein:increased expression:cortex,striatum:
|
RGD |
PMID:14705148 PMID:11323519 |
RGD:1302269, RGD:9835381 |
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492
|
|
| G
|
Pax6
|
paired box 6
|
|
IEP
|
protein:increased expression:cerebral cortex, striatum, astroglial cell (rat)
|
RGD |
PMID:24114637 |
RGD:8552354 |
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pcna
|
proliferating cell nuclear antigen
|
|
IEP
|
|
RGD |
PMID:9757027 |
RGD:10448974 |
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
| G
|
Pde4d
|
phosphodiesterase 4D
|
|
IEP
|
protein:increased expression:hippocampus CA1
|
RGD |
PMID:22860212 |
RGD:7327148 |
NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569
|
|
| G
|
Pdyn
|
prodynorphin
|
|
IEP
|
mRNA:decreased expression:dentate gyrus, granule cell
|
RGD |
PMID:8914861 |
RGD:401851049 |
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503
|
|
| G
|
Pecam1
|
platelet and endothelial cell adhesion molecule 1
|
|
ISO
|
protein:increased expression:brain (mouse)
|
RGD |
PMID:22382321 |
RGD:6766379 |
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839
|
|
| G
|
Plat
|
plasminogen activator, tissue type
|
|
IEP
|
Protein:increased expression, increased activity:hippocampus (rat)
|
RGD |
PMID:15882815 |
RGD:1580875 |
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
|
IEP IDA
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:21375013 PMID:19952306 |
RGD:7241584, RGD:7241795 |
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plxnd1
|
plexin D1
|
ameliorates
|
IMP
|
|
RGD |
PMID:30653356 |
RGD:155663383 |
NCBI chr 4:150,675,377...150,715,706
Ensembl chr 4:150,675,377...150,715,566
|
|
| G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
|
IMP IEP
|
|
RGD |
PMID:18378216 PMID:19221220 PMID:18973594 |
RGD:2301892, RGD:8553032, RGD:2301866 |
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
| G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
|
IEP
|
protein:increased expression:cerebral cortex (rat)
|
RGD |
PMID:15255948 |
RGD:9999154 |
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
| G
|
Ppp1r9a
|
protein phosphatase 1, regulatory subunit 9A
|
treatment
|
IDA
|
|
RGD |
PMID:21278085 |
RGD:10043805 |
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,988,827...34,258,927
|
|
| G
|
Ppp2r5e
|
protein phosphatase 2 regulatory subunit B', epsilon
|
treatment
|
IEP
|
|
RGD |
PMID:30712471 |
RGD:155791663 |
NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573
|
|
| G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
|
ISO
|
protein:decreased expression:cerebral cortex, striatum:
|
RGD |
PMID:12415119 |
RGD:10413862 |
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
|
|
| G
|
Ptafr
|
platelet-activating factor receptor
|
treatment
|
IEP IMP
|
mRNA:decreased expression:cerebral cortex (rat)
|
RGD |
PMID:17268849 PMID:8158141 |
RGD:9999221, RGD:10043297 |
NCBI chr 5:150,049,322...150,079,060
Ensembl chr 5:150,049,460...150,079,408
|
|
| G
|
Pten
|
phosphatase and tensin homolog
|
|
IEP
|
|
RGD |
PMID:12414116 |
RGD:1358425 |
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330
|
|
| G
|
Ptger4
|
prostaglandin E receptor 4
|
|
IEP
|
protein:increased expression:hippocampus (rat)
|
RGD |
PMID:16437207 |
RGD:10043375 |
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135
|
|
| G
|
Ptgis
|
prostaglandin I2 synthase
|
treatment
|
IMP
|
|
RGD |
PMID:27834752 |
RGD:401960086 |
NCBI chr 3:176,347,589...176,383,251
Ensembl chr 3:176,335,437...176,407,650
|
|
| G
|
Ptn
|
pleiotrophin
|
|
IEP
|
mRNA:increased expression:cerebral cortex, vasculature, macrophage (rat)
|
RGD |
PMID:9570800 |
RGD:9831440 |
NCBI chr 4:66,260,764...66,342,614
Ensembl chr 4:66,260,764...66,342,482
|
|
| G
|
Ptpn13
|
protein tyrosine phosphatase, non-receptor type 13
|
|
IEP
|
mRNA,protein:increased expression:cerebral cortex:
|
RGD |
PMID:18096138 |
RGD:4142863 |
NCBI chr14:6,412,841...6,587,238
Ensembl chr14:6,412,841...6,587,171
|
|
| G
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5
|
severity treatment
|
IEP ISO IDA
|
protein:decreased phosphorylation, decreased expression:striatum (rat)
|
RGD |
PMID:24198371 PMID:24198371 PMID:24198371 |
RGD:9835010, RGD:9835010, RGD:9835010 |
NCBI chr 1:106,756,896...106,817,369
Ensembl chr 1:106,756,896...106,816,828
|
|
| G
|
Rack1
|
receptor for activated C kinase 1
|
|
IDA
|
|
RGD |
PMID:24007266 |
RGD:9588303 |
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
|
|
| G
|
Robo1
|
roundabout guidance receptor 1
|
disease_progression
|
IEP ISO
|
protein:increased expression:hippocampus protein:increased expression:brain, astrocyte
|
RGD |
PMID:26764532 PMID:23473743 PMID:27686659 |
RGD:11573340, RGD:243048431, RGD:243048429 |
NCBI chr11:24,067,869...25,108,694
Ensembl chr11:24,067,878...25,108,694
|
|
| G
|
Robo2
|
roundabout guidance receptor 2
|
|
IEP
|
protein:increased expression:brain, astrocyte
|
RGD |
PMID:27686659 |
RGD:243048429 |
NCBI chr11:26,015,919...27,583,750
Ensembl chr11:26,015,919...26,876,185
|
|
| G
|
Robo4
|
roundabout guidance receptor 4
|
|
IEP
|
protein:increased expression:hippocampus
|
RGD |
PMID:26764532 |
RGD:11573340 |
NCBI chr 8:45,308,739...45,322,522
Ensembl chr 8:45,308,739...45,322,531
|
|
| G
|
Rps6
|
ribosomal protein S6
|
|
IDA
|
|
RGD |
PMID:26556340 |
RGD:11041643 |
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566
|
|
| G
|
Sema3e
|
semaphorin 3E
|
disease_progression
|
IEP
|
|
RGD |
PMID:30653356 |
RGD:155663383 |
NCBI chr 4:21,252,686...21,510,449
Ensembl chr 4:21,210,734...21,510,374
|
![JBrowse link JBrowse link]() | |